Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
| 5.500% Fixed-to-Floating Rate Subordinated Notes due 2048 |
AG48 |
New York Stock Exchange |
| 1 |
Identity of Directors, Senior Management and Advisers |
n/a | ||
| 2 |
Offer Statistics and Expected Timetable |
n/a | ||
| 3 |
Key Information |
|||
| 3A |
[Reserved] |
n/a | ||
| 3B |
Capitalization and indebtedness |
n/a | ||
| 3C |
Reasons for the offer and use of proceeds |
n/a | ||
| 3D |
Risk factors |
67-71, 150-170, 319-341, 361-364 | ||
| 4 |
Information on the Company |
|||
| 4A |
History and development of the Company |
2-3, 8-26, 260-261, 404 | ||
| 4B |
Business overview |
295-318 | ||
| 4C |
Organizational structure |
2-3 | ||
| 4D |
Property, plants and equipment |
343 | ||
| 4E |
Unresolved Staff Comments |
n/a | ||
| 5 |
Operating and Financial Review and Prospects |
|||
| 5A |
Operating results |
90-111 | ||
| 5B |
Liquidity and capital resources |
72-77, 191-192, 193-195, 225-226, 235-240, 345 | ||
| 5C |
Research and development, patent and licenses etc. |
n/a | ||
| 5D |
Trend information |
8-26, 88-89,90-111 | ||
| 5E |
Critical accounting estimates |
149-150, 253-257 | ||
| 6 |
Directors, Senior Management and Employees |
|||
| 6A |
Directors and senior management |
36-40 | ||
| 6B |
Compensation |
49-66, 184-186, 262-264 | ||
| 6C |
Board practices |
32-35 | ||
| 6D |
Employees |
16, 21-22, 82, 178, 344 | ||
| 6E |
Share ownership |
32-35, 281-283 | ||
| 7 |
Major Shareholders and Related Party Transactions |
|||
| 7A |
Major shareholders |
33-35, 281-283 | ||
| 7B |
Related party transactions |
262-264 | ||
| 7C |
Interest of experts and counsel |
n/a | ||
| 8 |
Financial Information |
|||
| 8A |
Consolidated Statements and Other Financial Information |
113-119, 284-290 | ||
| 8B |
Significant Changes |
n/a | ||
| 9 |
The Offer and Listing |
|||
| 9A |
Offer and listing details |
346 | ||
| 9B |
Plan of distribution |
n/a | ||
| 9C |
Markets |
346 | ||
| 9D |
Selling shareholders |
n/a | ||
| 9E |
Dilution |
n/a | ||
| 9F |
Expenses of the issue |
n/a | ||
| |
| 10 |
Additional Information |
|||
| 10A |
Share capital |
n/a | ||
| 10B |
Memorandum and articles of association |
347-348 | ||
| 10C |
Material contracts |
350 | ||
| 10D |
Exchange controls |
350 | ||
| 10E |
Taxation |
351-354 | ||
| 10F |
Dividends and paying agents |
n/a | ||
| 10G |
Statement by experts |
n/a | ||
| 10H |
Documents on display |
405 | ||
| 10I |
Subsidiary Information |
n/a | ||
| 11 |
Quantitative and Qualitative Disclosures About Market Risk |
67-71, 72-77, 150-170 | ||
| 12 |
Description of Securities Other than Equity Securities |
n/a | ||
| 13 |
Defaults, Dividend Arrearages and Delinquencies |
n/a | ||
| 14 |
Material Modifications to the Rights of Security Holders and Use of Proceeds |
n/a | ||
| 15 |
Controls and Procedures |
83-84 | ||
| 16A |
Audit committee financial expert |
44-45 | ||
| 16B |
Code of Ethics |
82 | ||
| 16C |
Principal Accountant Fees and Services |
355 | ||
| 16D |
Exemptions from the Listing Standards for Audit Committees |
n/a | ||
| 16E |
Purchases of Equity Securities by the Issuer and Affiliated Purchasers |
356 | ||
| 16F |
Change in Registrant’s Certifying Accountant |
n/a | ||
| 16G |
Corporate Governance |
32-35 | ||
| 16H |
Mine Safety Disclosure |
n/a | ||
| 16I |
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections |
n/a | ||
| 17 |
Financial Statements |
Refer to Item 18 | ||
| 18 |
Financial Statements |
113-279, 284-290 | ||
| 19 |
Exhibits |
406 | ||
2 |
||||
8 |
||||
10 |
||||
29 |
||||
30 |
||||
67 |
||||
78 |
||||
85 |
||||
90 |
||||
113 |
||||
295 |
||||
357 |
||||
358 |
||||
360 |
||||
365 |
||||
371 |
||||
Aegon Annual Report on Form 20-F 2021 1 |
About Aegon | ||||
Aegon Annual Report on Form 20-F 2021 2 |
About Aegon | ||||
| Aegon’s core markets | ||||
In the United States , | ||||
| In the Netherlands, | ||||
| In the United Kingdom, | ||||
Aegon’s growth markets | ||||
| |
In China, | |||
In Brazil, | ||||
| |
In Spain & Portugal, | |||
One global asset manager | ||||
| Aegon Asset Management is an active global investment business that manages and advises on assets of EUR 410 billion for a global client base consisting of pension plans, public funds, insurance companies (including Aegon’s subsidiaries), banks, wealth managers, family offices, and foundations. Aegon Asset Management is active in our core and growth markets, as well as in France, Germany, Hungary, and Japan. | ||||
Aegon Annual Report on Form 20-F 2021 3 |
About Aegon | ||||
¨ |
Transamerica ceases sales of variable annuities with significant interest-rate-sensitive riders, fixed index annuities, and standalone individual long-term care products. |
¨ |
Aegon UK launches the Financial Wellbeing Index in partnership with the Initiative for Financial Wellbeing and Edinburgh University. |
¨ |
To standardize its operating model and reduce costs, Aegon Asset Management (AAM) launches a program to reduce its IT complexity by approximately halving the number of systems it employs. AAM also creates a common front office platform and global portfolio risk environment, while shortening its client reporting from over five business days to between one and two business days. |
¨ |
Aegon the Netherlands successfully prices a EUR 657 million residential-mortgage-backed securitization to further diversify its mortgage funding. The transaction is oversubscribed three times by investors. |
¨ |
Aegon completes the divestment of Stonebridge, a UK-based provider of accident insurance products. |
¨ |
Together with its joint venture partner, Aegon ceases funding of GoBear, a digital financial supermarket in Southeast Asia. |
¨ |
Transamerica earns a score of 100% from the Human Rights Campaign Foundation on its annual Corporate Equality Index (CEI). |
¨ |
Aegon UK acquires Pension Geeks, a business specializing in connecting people with their finances through innovative engagement techniques, communication, and events. |
¨ |
The Hungarian Ministry of Interior denies the acquisition of the Aegon companies in Hungary by Vienna Insurance Group AG Wiener Versicherung Gruppe (VIG). Aegon and VIG jointly appeal this decision. For further details, see Q3 milestones on page 5. |
¨ |
To achieve cost and capital efficiencies, Aegon combines its programs for purchasing corporate insurance into a single existing US-based unit and centralizes all retained risks. |
¨ |
Transamerica completes the sale of its portfolio of fintech and insurtech companies to a fund managed and advised by private equity firm Montana Capital Partners. |
¨ |
Aegon the Netherlands expands mortgage options to help customers finance energy-efficient home improvements. |
¨ |
Together with the Aegon Transamerica Foundation in the United States, Aegon donates EUR 300,000 to support COVID-19 relief efforts in India. |
¨ |
Aegon places second in responsible investment NGO ShareAction’s 2021 ranking of how leading global life and health insurers approach responsible investment and underwriting. |
Aegon Annual Report on Form 20-F 2021 4 |
| About Aegon | ||||
¨ |
To reduce financial market exposure and release capital, Transamerica launches a program offering certain variable annuity customers a lump-sum payment in return for surrendering their policies. |
¨ |
Aegon the Netherlands ceases offering savings products to customers of its original savings bank, giving them the opportunity to transfer their funds to a Knab account or to another bank. |
¨ |
The European Commission grants the competition law clearance for the acquisition of Aegon’s businesses in Central & Eastern Europe by VIG. |
¨ |
The Budapest Metropolitan Court rejects a joint appeal by Aegon and VIG challenging the Ministry of the Interior’s decision to block the latter’s acquisition of Aegon’s Hungarian businesses. Subsequently, VIG and Aegon ask the Hungarian Supreme Court to review the ruling. VIG continued its dialogue with the Hungarian Ministry of Finance to clarify possibilities for a positive conclusion to the acquisition. In February 2022, VIG and the Hungarian government reached an agreement about a 45% participation of the Hungarian state in VIG’s and Aegon’s operations in Hungary. |
¨ |
Aegon calls USD 250 million in perpetual capital securities in line with the target to reduce gross financial leverage. |
¨ |
Aegon UK becomes a Living Wage Foundation accredited employer. |
¨ |
Aegon commits to transitioning its general account investment portfolio to net-zero greenhouse gas emissions by 2050 and, in doing so, joins the Net-Zero Asset Owner Alliance. |
¨ |
Aegon Asset Management becomes a signatory to the Net Zero Asset Managers initiative. |
¨ |
Aegon Asset Management and Aegon UK partner with the Global Ethical Finance Initiative (GEFI) to introduce the new Aegon Global Sustainable Sovereign Bond Fund at ‘COP26’. |
¨ |
Aegon becomes a signatory of the United Nations (UN) Global Compact, which calls upon companies to align on universal principles on human rights, labor, environment, and anti-corruption, and to advance societal goals. |
¨ |
Transamerica expands its dynamic hedging program to the legacy variable annuities portfolio to stabilize economic cash flows and reduce economic sensitivities to equity and interest rate risks. |
¨ |
Aegon reinsures an additional part of its longevity exposure in the Netherlands with Reinsurance Group of America, improving its risk profile. |
¨ |
Transamerica reinsures a portfolio of universal life secondary guarantee policies with Wilton Re, which reduces its exposure to mortality risk and policies with a large face amount. |
¨ |
Aegon maintains its position as leading third-party mortgage originator in the Netherlands, having originated EUR 10.9 billion worth of residential mortgages in 2021. |
¨ |
Aegon’s Global Sustainable Equity Fund wins the 2021 UNCTAD Global Sustainable Fund Award. |
Aegon Annual Report on Form 20-F 2021 5 |
About Aegon |
1 |
Addressable expenses are expenses reflected in the operating result, excluding deferrable acquisition expenses, expenses in joint ventures and associates, and expenses related to operations in CEE countries. |
About Aegon |
| The Hague, the Netherlands, March 21, 2022 Lard Friese CEO of Aegon |
Our purpose |
Our purpose |
1 |
For the world population (male plus female), measured in years. |
| Source World Bank database . |
2 |
Source World Bank database . |
Our strategy and value creation |
Our strategy and value creation |
¨ |
United States: Individual Solutions (certain life insurance products, investment products, and mutual funds), and Workplace Solutions (middle-market retirement plans and voluntary employee benefits); |
¨ |
The Netherlands: Workplace Solutions, mortgage origination, and banking; |
¨ |
United Kingdom: Workplace and Retail platform business and protection. |
¨ |
United States: Fixed and Variable Annuities with interest-rate-sensitive riders, and stand-alone long-term care; |
¨ |
The Netherlands: term life, individual deferred annuities, and defined benefit group pensions. |
Our strategy and value creation |
Our strategy and value creation |
Our strategy and value creation |
| 1. | Streamlining company-wide governance; |
| 2. | Identifying thematic priorities based on stakeholder engagement; and |
| 3. | Enhancing our sustainability reporting. |
Our strategy and value creation |
June 2020 |
Mid 2020 |
Nov 2020 |
Dec 2020 | |||
Public statement on Transamerica’s commitment to racial equity |
Aegon Asset Management and Aegon UK sign up to the Race at Work Charter |
I&D strengthened in Brand and Marketing Pledge |
I&D strengthened in Vendor Code of Conduct |
| 1 | For details on the methodology used, please see our TCFD disclosure (Methodology) on page 380. |
| 2 | For details on-the methodology used, please see footnote 1, Society: Operational footprint on page 396. |
Our strategy and value creation |
1 . |
Workplace |
2. |
Workforce |
3. |
Marketplace |
| Including diverse voices in our transformation At Aegon, we believe ideas are central to our transformation and we value different perspectives. Every initiative introduced at Aegon originally began as someone’s idea, and it is crucial we have a continuous stream of such ideas to fuel our ongoing improvement and growth. In July 2021, Transamerica’s Heads of Transformation hosted an ideation session for members of our Employee Resource Groups (ERGs). The session resulted in 34 new ideas generated by 23 ERG members, covering topics ranging from diversifying our intern population to improving efficiency through increased cross-training. Six ideas from the session are in the process of being taken forward and are now at varying stages of implementation. |
Our strategy and value creation |
| Asset manager: Our solutions Aegon Asset Management (AAM) has a Responsible Investment Framework that reflects the key elements of our Responsible Investment Policy, as well as similar policies put forward by AAM’s clients. The framework is structured as follows: ¨ ESG integration ¨ Active ownership ¨ Solutions 1. Exclusion-based strategies (Utilize negative screening to avoid certain sectors, companies or practices based on specific criteria); 2. Best-in-class strategies (Seek to outperform by emphasizing positive screening of issuers with better or improving ESG practices); 3. Sustainability-themed strategies (Focus on issuers aligned with sustainability themes in an effort to generate competitive returns over the long term); 4. Impact investments (Pursue financial returns alongside measurable positive social and/or environmental impact). Further information about Aegon Asset Management’s activities can be found in the dedicated Responsible Investment Report published by AAM. |
| Example: Active engagement with investee companies |
||||||
| Company |
Healthcare company |
|||||
| Objectives |
Calling on a globally important player to fight the COVID-19 pandemic to assure its products are available worldwide with equitable pricing. |
|||||
| |
How we engaged |
We challenged the company on the topic, sending an engagement letter, followed by phone calls and emails. |
||||
| Outcome |
The company announced an advanced vaccine purchase agreement with COVAX for low- and lower-middle-income countries. |
|||||
| Voting |
We supported the shareholder proposal requesting a ‘Report on Access to COVID-19 Products’. The report provides shareholders with additional information about access to the COVID-19 vaccine produced by the healthcare company. It provides information about the effect of the company’s decisions and how the related risks are managed. |
|||||
Our strategy and value creation |
Our strategy and value creation |
Our strategy and value creation |
Our strategy and value creation |
Our strategy and value creation |
Our strategy and value creation |
Our strategy and value creation |
Our strategy and value creation |
Our strategy and value creation |
| 1. | Aegon wants to be there for its customers. This means providing solutions that create long-term value and developing products and services that fully meet their needs and expectations at every stage of their lives. Customer satisfaction in each of our core markets, which is measured by benchmarked Net Promoter Score(SM), should be in line with or above the average of those of our industry peers. |
¨ |
Our US business, Transamerica, performed in line with the market average while Aegon UK was above average. Aegon the Netherlands performed slightly below the market average, though its score has been steadily improving over time. |
| 2. | For us to deliver on our promises to all our stakeholders, it is important that our employees are fully engaged and motivated to contribute to this task. |
¨ |
The employee engagement score in 2021 was 68, a decrease of 4 points. This decline reflects the challenge of maintaining engagement during a time when the company is undergoing significant change, including challenges due to the COVID-19 pandemic. |
| 3. | At Aegon, we value a diverse workforce, because we believe including different perspectives is critical for richer debates and innovation. |
¨ |
The proportion of female representation among our senior management increased by 2%-points to 34% in 2021. |
| 4. | Aegon seeks to ensure the reduction of the weighted average carbon intensity of the company’s investment portfolio is aligned to its net-zero ambitions, for the benefit of wider society. |
¨ |
In 2021, the weighted average carbon intensity of our own investment portfolio stayed flat compared with 2019. We remain on track to meet our target for a 25% reduction in the carbon intensity of our corporate fixed income and listed equity investments by 2025. |
Letter from our Supervisory Board Chairman |
Letter from our Supervisory Board Chairman |
| The Hague, the Netherlands, March 21, 2022 | | |
| William L. Connelly Supervisory Board Chairman Aegon |
Corporate governance |
¨ |
General Meeting of Shareholders |
¨ |
Supervisory Board |
¨ |
Executive Board |
Corporate governance |
¨ |
Audit Committee; |
¨ |
Risk Committee; |
¨ |
Remuneration Committee; and |
¨ |
Nomination and Governance Committee. |
Corporate governance |
¨ |
The acquisition by a third party of an interest in Aegon N.V. amounting to 15% or more; |
¨ |
A tender offer for Aegon N.V. shares; or |
¨ |
A proposed business combination by any person or group of persons, whether acting individually or as a group, other than in a transaction approved by the Company’s Executive and Supervisory Boards. |
Corporate governance |
Composition of the Boards |
Composition of the Boards |
Composition of the Boards |
Composition of the Boards |
Composition of the Boards |
Report of the Supervisory Boar d |
Report of the Supervisory Boar d |
Name |
Regular SB meeting |
Audit Committee |
Member | Risk Committee |
Member | Combined Audit & Risk Committee |
Remuneration Committee |
Member | Nomination & Governance Committee |
Member | Additional SB mtgs. / calls |
|||||||||||||
| Total no. Mtgs. |
7 | 5 | 4 | 1 | 6 | 6 | 2 | |||||||||||||||||
| SB members 1) |
||||||||||||||||||||||||
| Mr. William Connelly |
7/7 | 6/6 | v | 6/6 | Chair | 2/2 | ||||||||||||||||||
| Mr. Mark Ellman |
7/7 | 4/4 | v | 1/1 | 6/6 | v | 2/2 | |||||||||||||||||
| Mr. Jack McGarry 2) |
3/3 | 2/2 | v | 1/1 | 3/3 | v | 2/2 | |||||||||||||||||
| Mr. Ben Noteboom |
7/7 | 4/4 | v | 1/1 | 6/6 | Chair | 2/2 | |||||||||||||||||
| Ms. Caroline Ramsay |
7/7 | 5/5 | Chair | 4/4 | v | 1/1 | 2/2 | |||||||||||||||||
| Mr. Thomas Wellauer |
7/7 | 5/5 | v | 1/1 | 6/6 | v | 2/2 | |||||||||||||||||
| Ms. Corien Wortmann |
7/7 | 5/5 | v | 1/1 | 6/6 | v | 2/2 | |||||||||||||||||
| Ms. Dona Young 2) |
7/7 | 3/3 | 4/4 | Chair | 1/1 | 6/6 | v | 2/2 | ||||||||||||||||
1 |
The Supervisory Board is a separate independent corporate body, consisting of 8 members on December 31, 2021. |
2 |
Where a Supervisory Board member retired from the SB, stepped down from a Committee or was appointed throughout the year, only meetings during his / her tenure are taken into account. |
Report of the Supervisory Boar d |
¨ |
COVID-19 developments; |
¨ |
Strategy, including Aegon’s long-term value creation based on the three core markets, three growth markets and one global asset manager, its responsible business strategy and business reviews; |
¨ |
Approach to sustainability and the setting of Group wide commitments; |
¨ |
Acquisitions, divestments, and the strategic direction of Aegon’s businesses; |
¨ |
Executive Board and senior management succession planning; |
¨ |
Executive remuneration, including the remuneration framework; |
¨ |
Composition of the Supervisory Board, including the Board’s effectiveness; |
¨ |
Corporate Governance; |
¨ |
Human resources, including talent development, results of the global employee survey, organizational health developments, cultural change, and inclusion and diversity; |
¨ |
Annual and quarterly results, dividends, and the Company’s Medium Term Plan, including the 2022 budget, the capital plan and the funding plan; |
¨ |
Capital generation and solvency capital positions, including the impact of COVID-19, management actions, and developments in the financial markets; |
¨ |
Enterprise risk management, cybersecurity and information security risks, and the risks related to the execution of the strategy within the Company; |
¨ |
Investor relations, including Aegon’s shareholder base, market analysis and roadshow feedback; |
¨ |
Legal, regulatory and compliance topics, including Aegon’s engagement with regulators; |
¨ |
Highlighted topics by Supervisory Board Committees; |
¨ |
Regulatory changes at both a regional and global level; |
¨ |
Tax policy and tax developments; and |
¨ |
Technology, including the technology strategy, IT Security, technological developments, and innovations. |
Report of the Supervisory Boar d |
¨ |
Audit Committee; |
¨ |
Risk Committee; |
¨ |
Nomination and Governance Committee; and |
¨ |
Remuneration Committee. |
¨ |
The integrity of the consolidated quarterly, half-yearly and full-year financial statements and financial reporting processes; |
¨ |
Internal control systems and the effectiveness of the internal audit process; and |
¨ |
The performance of the external auditors and the effectiveness of the external audit process, including monitoring the independence and objectivity of the external auditor. |
Report of the Supervisory Boar d |
¨ |
Reviewed and discussed the management letter and follow up actions with the Executive and the Management Board, Internal Audit, and PwC; |
¨ |
Discussed PwC’s interim report leading to a review opinion on the interim financial statements; |
¨ |
Considered presentations on various topics by local business unit managers and chief financial officers; |
¨ |
Reviewed and discussed areas of significant judgments in the preparation of the financial statements, including, in particular: Solvency II, investment valuation and impairments, accounting changes, economic and actuarial assumption setting, and model validations; and |
¨ |
Reviewed and approved the internal and external audit plans for 2021 and monitored execution, including progress in respect of recommendations made. |
¨ |
Discussed quarterly updates on the activities of the internal audit function, together with details of progress on internal audits with the internal auditor. Areas of focus include the Internal Audit strategy, audit planning process, Internal Audit charter, Internal Audit functional governance, quality assurance reviews, issue tracking and resolution, control environment, and results of audits in the areas of information and cybersecurity, Solvency II, third party management and administration partnerships, General Data Protection Regulation, performance management and integrity; |
¨ |
Reviewed the internal control framework, among others with respect to the Sarbanes-Oxley Act; and |
¨ |
Discussed the internal control statement with the Executive Board. |
¨ |
The review and evaluation of the external auditor and the lead partner of the external audit team on at least an annual basis; |
¨ |
Non-audit services performed by the external auditor; and |
¨ |
Rotations of the external auditor and lead partner. |
¨ |
Risk strategy, risk tolerance, and risk governance; |
¨ |
Product development and pricing; |
¨ |
Risk assessment; |
¨ |
Risk responses and internal control effectiveness; |
¨ |
Risk monitoring; and |
¨ |
Risk reporting. |
Report of the Supervisory Boar d |
¨ |
Discussing the quarterly risk dashboard, including all material group level risks, with the Executive Board, Chief Risk Officer, and relevant senior managers. The material group level risks consisted of financial, underwriting, and operational risks, including cybersecurity and information security risk. Specific attention was paid to the regulatory roadmap of Aegon the Netherlands, and to hedging, especially in relation to the US Variable Annuity book; |
¨ |
Assessing a quarterly dashboard that outlined risks with regards to the execution of the strategic change programs in each region, and how those risks were monitored and mitigated; |
¨ |
Reviewing the Group risk appetite, which consists of the risk strategy, risk tolerances and indicators; and |
¨ |
Reviewing the risk governance structure and risk competencies, including the skills and resources necessary for the risk function. |
¨ |
Board member and senior management succession planning; |
¨ |
Drawing up selection criteria and procedures for the appointment of Board members, together with supervising the selection criteria and procedures for senior management; |
¨ |
Advising on and proposing nominations, appointments, and reappointments; |
¨ |
Assessing and advising on the approach to sustainability as part of the corporate strategy and overseeing the execution thereof; |
¨ |
Reviewing and updating the Supervisory Board profile and charters for the Supervisory Board and its committees; |
¨ |
Periodically assessing the functioning of individual members of the Supervisory Board and the Executive Board; |
¨ |
Overseeing the corporate governance structure of the Company, compliance with the Dutch Corporate Governance Code and any other applicable corporate governance legislation and regulations. |
Report of the Supervisory Boar d |
Report of the Supervisory Board |
¨ |
Reviewing the Aegon Group Global Remuneration Framework and making recommendations on the remuneration policies; |
¨ |
Overseeing the remuneration of the Executive Board and Heads of Group Control functions; |
¨ |
Preparing recommendations regarding variable compensation both at the beginning and at the end of the performance year; and |
¨ |
Preparing the information provided to shareholders on remuneration policies and practices, including the Remuneration Report. |
¨ |
Setting the outcome of the 2020 Group Performance Indicators and of the 2020 Individual Performance Indicators for Executive Board members, and allocating variable compensation related to 2020 where required; |
¨ |
Setting the 2021 Individual Performance Indicators for Executive Board members; |
¨ |
Setting the 2021 Group Performance Indicators and targets for remuneration purposes; |
¨ |
Preparing for the 2022 performance indicators; |
¨ |
Reviewing and/or approving the ex-ante risk assessments and ex-post assessments, any exemption requests (e.g. sign-on arrangements) under the remuneration policies, and changes to the list of Material Risk Takers (Identified Staff); and |
¨ |
Reviewing the related Remuneration Report. |
Remuneration Report |
Business performance highlights |
2021 |
2020 | ||
| Free cash flows (in EUR million) |
729 | 530 | ||
| Operating result (in EUR million) |
1,906 | 1,710 | ||
| Addressable expenses (in EUR million) |
2,903 | 2,986 | ||
| Market consistent value of new business (in EUR million) |
538 | 262 | ||
Remuneration Report |
¨ |
The total IFRS remuneration expenses for all employees, which are the total employee expenses (see Note 14) minus the CEO remuneration expenses: EUR 1.897 million – EUR 2.9 million = EUR 1.894 million. |
¨ |
Divided by the number of employees in scope, which are the total number of employees minus employees in joint ventures and associates (as their expenses are not included in Note 14 given the partial consolidation for these businesses) and minus the CEO: 22,271 – 4,228 – 1 = 18,043 employees. |
¨ |
Attract, retain, motivate, and reward a highly qualified and diverse workforce; |
¨ |
Align the interests of executives, managers and all other employees with the business strategy and risk tolerance, the values and the long-term interests of Aegon; |
¨ |
Provide a well-balanced and performance-related compensation package to all employees, taking into account shareholder and other stakeholder interests, relevant regulations, the corporate responsibilities and Aegon’s purpose, values and behaviors. |
Remuneration Report |
¨ |
employee-oriented by fostering a sense of value and appreciation in each individual employee; promoting the short- and long-term interests and well-being of Aegon’s employees through fair compensation and supporting the career development and mobility of employees; |
¨ |
performance-related by establishing a clear link between pay and performance by aligning objectives and target setting with performance evaluation and remuneration, reflecting individual as well as collective performance in line with Aegon’s long-term interests; |
¨ |
fairness-driven by promoting fairness and consistency in Aegon’s remuneration policies and practices, avoiding discrimination, and by providing total compensation packages in line with an appropriately established peer group at a country and/or functional level; and |
¨ |
risk-prudent (see Risk Management in relation to Remuneration below). |
¨ |
a minimum portion of variable compensation must be deferred and paid in non-cash instruments. |
¨ |
the employee’s individual goals are subject to an ex-ante risk assessment when they are set, which may lead to adjustments thereof. |
¨ |
before variable compensation is allocated and before deferred variable compensation is paid out (vests), it is subject to an ex-ante and ex-post risk assessment respectively, which may result in a downward adjustment (malus). |
¨ |
once variable compensation is paid out / has vested, it may be subject to a claw-back provision. |
Remuneration Report |
¨ |
The policy provides the Supervisory Board with the means to attract, motivate, and retain competent, diverse, and experienced Supervisory Board members for the long-term. This is essential for executing Aegon’s strategy and safeguarding and promoting its long-term interests and sustainability. |
¨ |
Supervisory Board members receive fixed remuneration for their responsibilities which does not depend on the Aegon results in order to protect their independence when supervising the manner in which the Executive Board members implement the long-term value creation strategy. These responsibilities are part of the membership of the Supervisory Board and its Committees and the position of (Vice) Chairman of the Supervisory Board and/or its Committees. The certainty of the fixed compensation also allows Supervisory Board members in their supervisory role to focus on the long-term interest and sustainability of Aegon. |
¨ |
The Supervisory Board members receive fixed remuneration for their activities, such as attending Committee meetings and additional Supervisory Board meetings, in order to regularly discuss the Aegon strategy, the implementation of the strategy and the principal risks associated with it, while taking into account the broader long-term interests and sustainability of Aegon. |
¨ |
Supervisory Board members are only allowed to privately own Aegon N.V. Shares if this is a long-term investment, aligning their interests with Aegon’s long-term interests. |
¨ |
Aegon is an international financial services group based in the Netherlands, that provides life insurance, pensions, and asset management. The main operations are in the US, the Netherlands, and the UK, while there is also significant presence in Southern and Eastern Europe, Asia, and Latin America. The policy provides the Supervisory Board with the means to attract, motivate, and retain Supervisory Board members from various countries, predominantly based in the Netherlands and the US. As Aegon is based in the Netherlands, the policy considers the European Insurance peers as well as Dutch General Industry peers to be the relevant external reference for the Supervisory Board member’s Remuneration. The policy is also influenced by the European and Dutch rules and regulations on (Executive) remuneration, which apply to Aegon as a result of its identity (i.e. being an Insurance firm in Europe and being a listed and financial company in the Netherlands). |
¨ |
In order to fulfill its company purpose, Aegon has a strategy to which this policy actively contributes (see above). |
¨ |
Aegon’s company values aim to create a company that is fit for the future: one that meets customers’ expectations, is right for a digitally-connected, data-driven world, and can adapt quickly to changing market conditions. These values are not explicitly reflected in the policy as a result of the fee-based remuneration structure. However, these values are strongly incorporated in the Supervisory Board Charter. |
¨ |
A base fee for membership of the Supervisory Board. No separate attendance fees are paid to members for attendance at the regular Supervisory Board meetings; |
¨ |
An attendance fee for each extra Board meeting attended, be it in person or by video and/or telephone conference; |
¨ |
A committee fee for members on each of the Supervisory Board’s Committees; |
¨ |
An attendance fee for each Committee meeting attended, be it in person or through video and/or telephone conference; and |
¨ |
An additional fee for attending meetings that require intercontinental, continental or US interstate travel between the Supervisory Board member’s home location and the meeting location. |
Remuneration Report |
Base fee for Supervisory Board membership |
EUR / year | |
| Chairman |
80,000 | |
| Vice-Chairman |
50,000 | |
| Member |
40,000 | |
Fee for Supervisory Board committee membership |
EUR / year | |
| Chairman of the Audit or Risk Committee |
13,000 | |
| Member of the Audit or Risk Committee |
8,000 | |
| Chairman of other committees |
10,000 | |
| Member of other committees |
5,000 | |
Attendance fees |
EUR | |
| Committee meeting |
3,000 | |
| Extra Supervisory Board meeting |
3,000 | |
Travel fees |
EUR | |
| Intercontinental |
4,000 | |
| Continental or US interstate |
2,000 | |
¨ |
Industry: Insurance, with a preference for Life Insurance; |
¨ |
Size: Average Market Capitalization, Employees, Revenue and Total Assets; |
¨ |
Geographic scope: Preferably companies that operate globally; and |
¨ |
Location: Headquarters based in Europe, excluding UK (because the non-executive directors typically have different responsibilities compared to their continental European counterparts). |
¨ |
Industry: General Industry and listed on the AEX; |
¨ |
Size: Average Market Capitalization, Employees, Revenue and Total Assets; |
¨ |
Location: Headquarters based in the Netherlands. |
Remuneration Report |
In EUR thousand |
Year | Base fees | |
Attendance fees |
1) |
Benefits | 2) |
|
Total compensation |
| ||||||||||
| William L. Connelly 3) |
2021 | 95 | 57 | 10 | 162 | |||||||||||||||
| 2020 | 95 | 45 | 4 | 144 | ||||||||||||||||
| 2019 | 95 | 54 | 20 | 169 | ||||||||||||||||
| Mark A. Ellman |
2021 | 53 | 45 | 4 | 102 | |||||||||||||||
| 2020 | 55 | 39 | 4 | 98 | ||||||||||||||||
| 2019 | 56 | 39 | 20 | 115 | ||||||||||||||||
| Ben J. Noteboom |
2021 | 58 | 45 | 4 | 107 | |||||||||||||||
| 2020 | 58 | 39 | - | 97 | ||||||||||||||||
| 2019 | 58 | 39 | 6 | 103 | ||||||||||||||||
| Corien M. Wortmann - Kool |
2021 | 63 | 45 | 4 | 112 | |||||||||||||||
| 2020 | 63 | 48 | - | 111 | ||||||||||||||||
| 2019 | 63 | 54 | 6 | 123 | ||||||||||||||||
| Dona D. Young 4) |
2021 | 62 | 51 | 6 | 119 | |||||||||||||||
| 2020 | 66 | 57 | 4 | 127 | ||||||||||||||||
| 2019 | 66 | 66 | 26 | 158 | ||||||||||||||||
| Caroline Ramsay (as of May 15, 2020) |
2021 | 61 | 39 | 21 | 121 | |||||||||||||||
| 2020 | 38 | 21 | 9 | 68 | ||||||||||||||||
| Thomas Wellauer (as of May 15, 2020) |
2021 | 53 | 45 | 13 | 111 | |||||||||||||||
| 2020 | 33 | 21 | 5 | 59 | ||||||||||||||||
| Jack McGarry (as of June 3, 2021) |
2021 | 31 | 24 | 6 | 61 | |||||||||||||||
| Ben van der Veer (up to May 15, 2020) |
2020 | 22 | 27 | - | 49 | |||||||||||||||
| 2019 | 58 | 54 | 6 | 118 | ||||||||||||||||
| Robert W. Dineen (up to Oct 11, 2019) |
2019 | 40 | 27 | 12 | 79 | |||||||||||||||
| Total compensation |
2021 | 476 | 351 | 69 | 896 | |||||||||||||||
| 2020 | 430 | 297 | 26 | 752 | ||||||||||||||||
| 2019 | 436 | 333 | 96 | 865 | ||||||||||||||||
| Recognized IFRS expenses 5) |
2021 | 482 | 357 | 72 | 911 | |||||||||||||||
| 2020 | 459 | 321 | 26 | 806 | ||||||||||||||||
| 2019 | 516 | 393 | 111 | 1,020 | ||||||||||||||||
1 |
The attendance fee for the additional Supervisory Board call on December 18, 2020, was paid in in the first quarter of 2021. Mr. Connelly, Mr. Ellman, and Mr. Noteboom received an attendance fee of EUR 3,000 for their attendance at the Supervisory Board audit committee call on March 16, 2021. Mr. Connelly received an attendance fee of EUR 3,000 for his attendance at the combined Supervisory Board audit and risk committee meeting on December 7, 2021. |
2 |
Benefits cover the travel fees for all Supervisory Board members and, retroactively as of May 15, 2020, the mandatory employer social security contributions in the home countries of Ms. Ramsay (UK) and Mr. Wellauer (Switzerland). |
3 |
In 2021, Mr. Connelly received EUR 6,000 in additional attendance fees and EUR 2,000 in additional travel fees for attending meetings outside the regular Supervisory Board meeting cycle. |
4 |
Ms. Young stepped down from the audit committee as of June 3, 2021. |
5 |
Based on a Decree of the Dutch State Secretary of Finance which came into force as from May 7, 2021, the Supervisory Board fees were not subject to Dutch VAT anymore, retroactively as from June 13, 2019. Therefore, Aegon has not paid Dutch VAT anymore on the fees of the Supervisory Board Members as from Q2 2021. Additionally, Aegon reclaimed VAT for the period Q3 2019 - Q1 2021, except for its Supervisory Board members based in the Netherlands for practical reasons. The 2019 and 2020 amounts were restated in this table for this VAT reclaim. This line also includes expenses or gains related to small exchange rate differences between the moment Ms. Ramsay’s fees were paid by our UK payroll and the moment these were recharged to Group. |
Remuneration Report |
In EUR thousand |
Annualized 1) |
2017 | 2018 | 2019 | 2020 | 2021 |
||||||||||||||||
| William L. Connelly (as of May 19, 2017) |
Compensation |
98 | 119 | 169 | 144 | 162 | ||||||||||||||||
| Change |
- | 22% | 42% | (15% | ) | 13% | ||||||||||||||||
| Mark A. Ellman (as of May 19, 2017) |
Compensation |
114 | 103 | 115 | 98 | 102 | ||||||||||||||||
Change |
- | (9% | ) | 12% | (15% | ) | 5% | |||||||||||||||
| Ben J. Noteboom |
Compensation |
102 | 86 | 103 | 97 | 107 | ||||||||||||||||
Change |
- | (15% | ) | 20% | (6% | ) | 10% | |||||||||||||||
| Corien M. Wortmann - Kool |
Compensation |
101 | 103 | 123 | 111 | 112 | ||||||||||||||||
Change |
- | 2% | 19% | (10% | ) | 1% | ||||||||||||||||
| Dona D. Young |
Compensation |
116 | 121 | 158 | 127 | 119 | ||||||||||||||||
Change |
- | 4% | 31% | (20% | ) | (6% | ) | |||||||||||||||
| Caroline Ramsay (as of May 15, 2020) |
Compensation |
- | - | - | 108 | 121 | ||||||||||||||||
Change |
- | - | - | - | 12% | |||||||||||||||||
| Thomas Wellauer (as of May 15, 2020) |
Compensation |
- | - | - | 94 | 111 | ||||||||||||||||
Change |
- | - | - | - | 18% | |||||||||||||||||
| Jack McGarry (as of June 3, 2021) |
Compensation |
- | - | - | - | 105 | ||||||||||||||||
Change |
- | - | - | - | - | |||||||||||||||||
| Ben van der Veer (up to May 15, 2020) |
Compensation |
106 | 101 | 118 | 131 | - | ||||||||||||||||
Change |
- | (5% | ) | 17% | 11% | - | ||||||||||||||||
| Robert W. Dineen (up to Oct 11, 2019) |
Compensation |
104 | 101 | 101 | - | - | ||||||||||||||||
Change |
- | (3% | ) | 1% | - | - | ||||||||||||||||
| Dirk P.M. Verbeek (up to May 18, 2018) |
Compensation |
100 | 76 | - | - | - | ||||||||||||||||
Change |
- | (24% | ) | - | - | - | ||||||||||||||||
| Robert J. Routs (up to May 18, 2018) |
Compensation |
134 | 125 | - | - | - | ||||||||||||||||
Change |
- | (7% | ) | - | - | - | ||||||||||||||||
| Aegon net result based on EU-IFRS |
In EUR million |
2,358 | 741 | 1,525 | 55 | 1,701 | ||||||||||||||||
| Aegon business performance 2) |
Target = 100% |
121% | 106% | 79% | 57% | 123% | ||||||||||||||||
| Inflation in the Netherlands |
Consumer Price Index |
1.4% | 1.7% | 2.6% | 1.3% | 2.7% | ||||||||||||||||
| Average employee compensation 3) |
Total compensation |
102 | 104 | 115 | 110 | 105 | ||||||||||||||||
| Annual change |
2% | 11% | (4% | ) | (5% | ) | ||||||||||||||||
1 |
Retroactive, per May 15, 2020, the compensation includes the mandatory employer social security contributions in the home countries of Ms. Ramsay (UK) and Mr. Wellauer (Switzerland). |
2 |
The weighted average Aegon financial and non-financial business performance, expressed as a percentage on a performance scale with 50% as threshold, 100% as target and 150% as maximum, as used for the allocation of variable compensation in the applicable year. |
3 |
Consistent with the CEO pay ratio calculation, the average employee compensation is based on the audited total EU-IFRS remuneration expenses for all employees divided by the number of employees in scope for these expenses. |
Remuneration Report |
¨ |
The policy provides the Supervisory Board with the means to attract, motivate and retain competent and experienced Executive Board members for the long-term. This is essential for executing Aegon’s strategy and safeguarding and promoting its long-term interests and sustainability. |
¨ |
The leading performance indicator categories for successful execution of Aegon’s strategy are Capital, Growth and Strategy. To support the execution of Aegon’s strategy, the policy makes these performance indicator categories mandatory for the Executive Board member. |
¨ |
Aegon strives to create long-term value for its stakeholders and the communities in which it operates. Due to the nature of Aegon’s business, value created is often financial, but it may also be social, economic, or environmental. The policy directly aligns Executive Board member’s personal long-term interests with those of Aegon and its shareholders by paying a significant part of the Executive Board members’ variable compensation (two-thirds) in shares, which must be held for 5 years after completion of the performance period. The pay-out in these restricted shares is combined with prohibiting Executive Board members using personal hedging strategies or insurance, which could undermine this long-term alignment of interests. Additionally, Executive Board members are aligned with the long-term interest of Aegon, its shareholders and other stakeholders through the use of mandatory performance indicator categories of Earnings, Shareholders and Other Stakeholders. |
¨ |
Aegon is committed to doing business responsibly and in a sustainable way. Variable compensation of Executive Board members can be adjusted downwards (i.e. malus) or clawed-back in cases where certain performance has not been achieved in a sustainable way. This includes but is not limited to: significant risk and compliance incidents, insufficient response to such incidents and/or insufficient evidence of embedding of good standards of practice, such as sound and responsible business practices and integrity of products and services delivered. Additionally, the policy makes the performance indicator category Environmental, Social and Governance (ESG), mandatory for Executive Board members to support this approach to doing business. |
¨ |
The total variable compensation amount that is allocated to an Executive Board member for a performance year cannot exceed 100% of the fixed compensation level. |
¨ |
Variable compensation should be based on a mix of Aegon and personal performance, with at least 50% weight on non-financial performance. |
¨ |
A substantial portion of any variable compensation award should be paid in a non-cash instrument (e.g. Aegon shares) and should be deferred for at least 3 years. Additionally, awarded shares should be restricted for 5 years. With a 3-year vesting period, this requires an additional holding period of 2-years. |
¨ |
Aegon can claw-back any variable compensation which has been paid (cash and shares) in specific circumstances such as a material financial restatement or individual gross misconduct. |
¨ |
The internal references are the compensation structure and levels of the members of the Management Board of Aegon N.V. and the annual compensation changes of the general employee population and senior managers within Europe and the Netherlands specifically. |
Remuneration Report |
¨ |
The external references are compensation trends in the market, economic developments (e.g. inflation) as well as quantitative assessments of the competitiveness against a peer group of insurance companies in Europe and a peer group of companies based in the Netherlands. |
¨ |
Additionally, the Remuneration Committee conducts a scenario analysis in case of a policy change to determine the long-term effect on the remuneration structure and level of each Executive Board member, and reports their findings to the Supervisory Board. |
¨ |
Industry: Insurance, with a preference for Life Insurance; |
¨ |
Size: Average market capitalization, employees, revenue and total assets; |
¨ |
Geographic scope: Preferably companies which operate globally; |
¨ |
Location: Headquarters based in Europe. |
¨ |
Industry: General Industry and listed on the AEX; |
¨ |
Size: Average Market Capitalization, Employees, Revenue and Total Assets; |
¨ |
Location: Headquarters based in the Netherlands. |
¨ |
It contains a mix of financial and non-financial performance indicators, with at least 50% weight allocated to the non-financial performance indicators in accordance with article 1:118.3 of the Dutch Financial Supervision Act; |
¨ |
The maximum weight for unadjusted financial indicators is determined by the Global Remuneration Framework and is currently set at 50%. |
¨ |
It contains a mix of Aegon and personal performance indicators, which can range in weight between 50-80% and 20-50% respectively, depending on the Aegon priorities of the performance year. |
¨ |
At least 20% of the indicators has a retrospective 3-year performance horizon, while the remainder has a 1-year performance horizon; |
¨ |
The indicators should cover the following mandatory performance indicator categories: Shareholders, Capital, Earnings, Growth, Stakeholders, ESG and Strategy. |
Remuneration Report |
¨ |
The performance indicators and weights are in line with the policy; |
¨ |
The financial performance indicators are consistent with the risk tolerance statements; |
¨ |
The non-financial performance indicators are consistent with risk tolerance levels, regulatory requirements, reasonable stakeholder expectations and are supporting sound and responsible business practices and integrity of the products and services delivered. |
¨ |
Significant risk or compliance incident(s); |
¨ |
Insufficient response to risk incident(s), compliance incident(s), regulatory fine(s) and/or insufficient execution of risk mitigating measures in response to these incidents; |
¨ |
Breaches of laws and regulations; |
¨ |
Insufficient evidence of embedding good standards of practice; |
¨ |
Significant deficiencies or material weaknesses relating to the Sarbanes-Oxley Act; and |
¨ |
Reputation damage due to risk events. |
¨ |
Participation in Aegon’s defined contribution pension plan for NL-based employees, for their eligible earnings up to EUR 110,111 (2021 threshold set by Dutch law). |
¨ |
Participation in Aegon’s defined contribution pension plan for NL-based employees, for their fixed income above EUR 110,111. |
¨ |
An additional gross allowance for pension to make the sum of these three pension contributions equal to 40% of their fixed compensation level. |
Remuneration Report |
Allocated compensation |
Fixed | Variable | Total | |||||||||||||||||
In EUR thousand |
compensation | compensation | Pension | Other Benefits | compensation | |||||||||||||||
| Lard Friese |
||||||||||||||||||||
| 2021 |
1,485 | 1,359 | 594 | 77 | 3,515 | |||||||||||||||
| 2020 1) |
931 | 634 | 373 | 49 | 1,987 | |||||||||||||||
| Matt Rider |
||||||||||||||||||||
| 2021 |
968 | 884 | 387 | 67 | 2,306 | |||||||||||||||
| 2020 |
941 | 640 | 376 | 67 | 2,024 | |||||||||||||||
| 2019 |
931 | 743 | 373 | 77 | 2,123 | |||||||||||||||
| Alex Wynaendts |
||||||||||||||||||||
| 2020 3) |
496 | 302 | 337 | 97 | 1,233 | |||||||||||||||
| 2019 |
1,314 | 1,048 | 1,302 | 252 | 3,916 | |||||||||||||||
| All Executive Board members |
||||||||||||||||||||
| 2021 |
2,453 | 2,243 | 981 | 144 | 5,821 | |||||||||||||||
| 2020 1) |
2,368 | 1,577 | 1,086 | 213 | 5,244 | |||||||||||||||
| 2019 |
2,245 | 1,791 | 1,675 | 329 | 6,039 | |||||||||||||||
1 |
The disclosed amounts for 2020 cover the period that Mr. Friese has been a member of the Executive Board (as of May 15, 2020), and excludes the sign-on arrangement of EUR 1,228 thousand that Mr. Friese received when joining Aegon in March 2020. |
2 |
Mr. Rider’s fixed compensation increased with 5% per June 2021. |
3 |
The disclosed amounts for 2020 cover the period that Mr. Wynaendts has been a member of the Executive Board (until May 15, 2020). Up to and including May 2019, Mr. Wynaendts participated in a defined benefit arrangement. This arrangement included a back service liability which reflected the increase of his fixed compensation in 2016 and 2018, as well as low interest rates and the final settlement made in May 2019. Additionally, Mr. Wynaendts was entitled to a gross payment of 28% of his fixed compensation level as part of a grandfathered pension arrangement. |
Remuneration Report |
2021 variable compensation |
Minimum | Target | Maximum | Result |
Pay-out | |||||||||||||
| Lard Friese |
||||||||||||||||||
| In % of fixed compensation |
50% | 80% | 100% | 92% | ||||||||||||||
| In total (EUR thousand) |
743 | 1,188 | 1,485 | 1,359 | Split in 33.33% cash and 66.67% shares | |||||||||||||
| In cash (EUR thousand) |
247 | 396 | 495 | 453 | Paid upfront in 2022 | |||||||||||||
| In shares 1) |
150,340 | 240,544 | 300,680 | 275,182 | Deferred for 3 years (2025) | |||||||||||||
| Matt Rider |
||||||||||||||||||
| In % of fixed compensation |
50% | 80% | 100% | 91% | ||||||||||||||
| In total (EUR thousand) |
484 | 775 | 968 | 884 | Split in 33.33% cash and 66.67% shares | |||||||||||||
| In cash (EUR thousand) |
161 | 258 | 323 | 295 | Paid upfront in 2022 | |||||||||||||
| In shares 1) |
98,039 | 156,863 | 196,078 | 178,961 | Deferred for 3 years (2025) | |||||||||||||
1 |
The 2021 grant price of the shares was EUR 3.2927, which is equal to the volume weighted average price on the Euronext Amsterdam stock exchange for the period December 15, 2020 to January 15, 2021. After vesting in 2025, these shares are subject to an additional 2-year holding period. |
| For Aegon bonus pools | Lard Friese |
Matt Rider |
||||||||||||||||||||||||||||||||
2021 performance indicators |
Weight | Target | Outcome | Result 1) |
Weight |
Result 2) |
Weight |
Result 2) |
||||||||||||||||||||||||||
| Group performance |
||||||||||||||||||||||||||||||||||
| Free cash flows 3) |
20% | 400 | 685 | 150% | ||||||||||||||||||||||||||||||
| Relative total shareholder return |
10% | Rank 5 | Rank 11 | 0% | ||||||||||||||||||||||||||||||
| Operating result |
10% | 1,394 | 1,906 | 150% | ||||||||||||||||||||||||||||||
| Addressable expenses |
10% | 2,933 | 2,903 | 110% | ||||||||||||||||||||||||||||||
| Market consistent value of new business |
10% | 319 | 538 | 150% | ||||||||||||||||||||||||||||||
| Transformation program: Earnings contribution |
10% | 100% | 115% | 138% | ||||||||||||||||||||||||||||||
| Transformation program: Timely initiative execution |
10% | 100% | 102% | 105% | ||||||||||||||||||||||||||||||
| Transformation program: Timely milestone completion |
10% | 100% | 116% | 139% | ||||||||||||||||||||||||||||||
| Transformation program: Timely health milestone completion |
10% | 100% | 117% | 142% | 70% | 89% | 70% | 89% | ||||||||||||||||||||||||||
| Personal performance |
||||||||||||||||||||||||||||||||||
| Strategic Roadmap development |
10% | 100% | 5% | 100% | ||||||||||||||||||||||||||||||
| Execution of capital initiatives in line with Strategic Roadmap |
10% | 100% | 5% | 95% | ||||||||||||||||||||||||||||||
| Women in senior management |
5% | 80% | 5% | 80% | ||||||||||||||||||||||||||||||
| ESG strategy development |
5% | 100% | ||||||||||||||||||||||||||||||||
| Finance strategy execution |
15% | 100% | ||||||||||||||||||||||||||||||||
| Total performance result |
123% |
92% |
91% |
|||||||||||||||||||||||||||||||
1 |
The Group performance results are measured on a 50-100-150% performance scale, which is used for the funding of the bonus pools for our employees. |
2 |
For the Executive Board members, the Group performance result (123%) is converted from a result on the 50-100-150% performance scale to a result on the 50-80-100% performance scale (89%). |
3 |
For remuneration purposes, the target and outcome exclude our businesses in CEE. The result in this table therefore differs from Aegon’s reported financial result (EUR 729 million). |
Remuneration Report |
2021 Aegon performance indicators |
Definition | |
| Free cash flows |
Free cash flows represent cash flows from remittances from the units less the Holding funding and operating expenses. The 2021 target was based on the 2021-2023 target which was disclosed at the Capital Market Day in December 2020. | |
| Relative total shareholder return |
Aegon’s position relative to 7 US and 7 non-US peers when looking at Total Shareholder Return for a retrospective 2-year performance period (2020-2021). These peers were selected for being the most similar to Aegon based on their index listing, industry classification, 5-year monthly Beta, Market Capitalization and Total Revenue 1) . | |
| Operating result |
Operating result reflects our profit from underlying business operations and excludes components that relate to accounting mismatches that are dependent on market volatility, updates to best estimate actuarial and economic assumptions and model updates or relate to events that are considered outside the normal course of business. The 2021 target was based on the 2021 budget. | |
| Addressable expenses |
Represents the adjusted operating expenses excluding deferable expenses. The 2021 target was based on the 2021-2023 target which was disclosed at the Capital Market Day in December 2020. | |
| Market consistent value of new business |
Represents how much value the sale of new insurance policies is generating for the company. This value represents the present value of our best estimate of incoming premiums and outgoing claims, benefits and expenses related to these new sales. The 2021 target was based on the 2021 budget. | |
| Transformation program: Earnings contributions | Measures the expected run-rate earnings contribution for performance improvement initiatives that moved to the execution phase in 2021, compared to the 2021 targets in the transformation program. | |
| Transformation program: Timely initiative execution | Measures whether performance improvement initiatives moved to the execution phase in time, compared to the 2021 targets in the transformation program. | |
| Transformation program: Timely milestone completion | Measures the timely milestone completion of the performance improvement initiatives, compared to the 2021 targets in the transformation program. | |
| Transformation program: Timely health milestone completion | Measures the timely organizational health milestone completion of the performance improvement initiatives, compared to the 2021 targets in the transformation program. | |
1 |
These peers are in order of the 2020-2021 ranking result: 1) NN Group NV, 2) Principal Financial Group Inc, 3) Axa Equitable Holdings Inc, 4) Swiss Life Holding AG, 5) ASR Nederland NV, 6) Brighthouse Financial Inc, 7) MetLife Inc, 8) Prudential Financial Inc, 9) Lincoln National Corp, 10) Assicurazioni Generali SpA, 11) Aegon NV, 12) Prudential PLC, 13) Baloise Holding AG, 14) Unum Group and 15) Athene Holding Ltd / Helvetia Holding. The Athene Holding Ltd / Helvetia Holding result is a blend of the initial peer Athene and the back-up peer Helvetia, which replaced Athene per March 9, 2021, in accordance with our plan rules, following the merger with Apollo announced by Athene. |
Lard Friese |
Target |
Result | ||
| 10% Strategic Roadmap Development | Develop Strategic Roadmap for strategic assets and assets outside of the core perimeter. | 100%. Building on the Aegon strategy, extensive roadmaps were delivered for various strategic assets (invest in profitable growth by expanding customer base and increasing margins) and assets outside of the core perimeter (tight capital management, bias to exit and restructuring). | ||
| 10% Execution of capital initiatives in line with Strategic Roadmap | Complete management actions in relation to financial assets and assets outside of the core perimeter. | 100%. The organization and governance to manage US and NL financial assets were significantly strengthened. Reduced Aegon’s risk profile by actions in the US related to long-term care rate increases, lump-sum buy-out program and the dynamic hedging of the legacy Variable Annuities portfolio, resulting in a lower cost of capital. Reduced risk profile and strengthened capital position of NL Life. On assets outside the core perimeter, prepared and supported the closing of the announced sale of CEE and Turkey to VIG, sold Stonebridge, ended funding of GoBear and sold US portfolio of fintech and insurtech companies. | ||
| 5% Women in Senior Management | Increase the number of women in Aegon’s senior management layer worldwide to at least 34%. | 80%. At the end of 2021, 34% of the people in Aegon’s senior management layer were women. | ||
| 5% ESG Strategy Development | Further integrate ESG into Group Strategy. | 100%. Announced Group-wide commitment to transition general account investment portfolio to net-zero greenhouse gas emissions by 2050, joined the Net-Zero Asset Owner Alliance, set a clear 2025 reduction target, and committed to regularly engage with most carbon intensive companies in our portfolio. Established new sustainability governance, prepared migration of sustainability reporting, selected two priority sustainability themes (climate change and inclusion & diversity) and embedded these priorities in the redefined purpose and behaviors. | ||
Remuneration Report |
Matt Rider |
Target |
Result | ||
| 5% Strategic Roadmap Development | Support development of Strategic Roadmap for strategic assets and assets outside of the core perimeter. | 100%. Building our the Aegon strategy, supported the delivery of extensive roadmaps for various strategic assets (invest in profitable growth by expanding customer base and increasing margins) and assets outside of the core perimeter (tight capital management, bias to exit and restructuring). | ||
| 5% Execution of capital initiatives in line with Strategic Roadmap | Support completion of management actions in relation to financial assets and assets outside of the core perimeter. | 95%. Supported actions that significantly strengthened the organization and governance to manage US and NL financial assets. Reduced Aegon’s risk profile by actions in the US related to long-term care rate increases, lump-sum buy-out program and the dynamic hedging of the legacy Variable Annuities portfolio, resulting in a lower cost of capital. Reduced risk profile and strengthened capital position of NL Life. On assets outside the core perimeter, prepared and supported the closing of the announced sale of CEE and Turkey to VIG, sold Stonebridge, ended funding of GoBear and sold US portfolio of fintech and insurtech companies | ||
| 5% Women in Senior Management | Increase the number of women in Aegon’s senior management layer worldwide to at least 34%. | 80%. At the end of 2021, 34% of the people in Aegon’s senior management layer were women. | ||
| 15% ESG Strategy Development | Complete the 2021 milestones from the Finance Strategy. | 100%. Completed the maximum number of milestones. Implemented organizational efficiencies, completed scheduled IFRS 17 implementation actions, transitioned back to quarterly reporting, improved management reporting and ran effectively operating control environment. | ||
| Years of vesting | ||||||||||||||||||||||||||||||||||||
Shares by plan year |
VWAP 1) |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Total | |||||||||||||||||||||||||||
| Lard Friese |
||||||||||||||||||||||||||||||||||||
| 2020 |
EUR 4.083 | - | - | - | - | - | 103,580 | - | 103,580 | |||||||||||||||||||||||||||
| 2021 |
EUR 3.293 | - | - | - | - | - | 275,182 | 275,182 | ||||||||||||||||||||||||||||
| Total number of shares |
- |
- |
- |
- |
- |
103,580 |
275,182 |
|||||||||||||||||||||||||||||
| Matt Rider |
||||||||||||||||||||||||||||||||||||
| 2017 |
EUR 5.246 | 9,508 | 9,508 | 9,508 | - | - | - | - | 28,524 | |||||||||||||||||||||||||||
| 2018 |
EUR 5.405 | 28,110 | 14,054 | 14,054 | 14,054 | - | - | - | 70,272 | |||||||||||||||||||||||||||
| 2019 |
EUR 4.162 | - | 35,693 | 17,847 | 17,847 | 17,847 | - | - | 89,234 | |||||||||||||||||||||||||||
| 2020 |
EUR 4.083 | - | - | - | - | - | 104,547 | - | 104,547 | |||||||||||||||||||||||||||
| 2021 |
EUR 3.293 | - | - | - | - | - | - | 178,961 | 178,961 | |||||||||||||||||||||||||||
| Total number of shares |
37,618 |
59,255 |
41,409 |
31,901 |
17,847 |
104,547 |
178,961 |
|||||||||||||||||||||||||||||
| Alex Wynaendts |
||||||||||||||||||||||||||||||||||||
| 2015 |
EUR 6.106 | 15,110 | - | - | - | - | - | - | 15,110 | |||||||||||||||||||||||||||
| 2016 |
EUR 5.128 | 20,361 | 20,361 | - | - | - | - | - | 40,722 | |||||||||||||||||||||||||||
| 2017 |
EUR 5.246 | 21,866 | 21,866 | 21,866 | - | - | - | - | 65,598 | |||||||||||||||||||||||||||
| 2018 |
EUR 5.405 | 39,314 | 19,656 | 19,656 | 19,656 | - | - | - | 98,282 | |||||||||||||||||||||||||||
| 2019 |
EUR 4.162 | - | 50,345 | 25,174 | 25,174 | 25,174 | - | - | 125,867 | |||||||||||||||||||||||||||
| 2020 |
EUR 4.083 | - | - | - | - | - | 49,346 | - | 49,346 | |||||||||||||||||||||||||||
| Total number of shares |
96,651 |
112,228 |
66,696 |
44,830 |
25,174 |
49,346 |
- |
|||||||||||||||||||||||||||||
| Darryl Button |
||||||||||||||||||||||||||||||||||||
| 2015 |
EUR 6.106 | 11,811 | - | - | - | - | - | - | 11,811 | |||||||||||||||||||||||||||
| 2016 |
EUR 5.128 | 14,808 | 14,808 | - | - | - | - | - | 29,616 | |||||||||||||||||||||||||||
| Total number of shares |
26,619 |
14,808 |
- |
- |
- |
- |
- |
|||||||||||||||||||||||||||||
1 |
This is the volume weighted average price (VWAP) of Aegon on the Euronext Amsterdam stock exchange for the period December 15 to January 15. For instance for the 2021 plan year, this is the VWAP for the period December 15, 2020 to January 15, 2021. |
Remuneration Report |
| Years of vesting | ||||||||||||||||||||||||
Cash by plan year (in EUR) |
2019 | 2020 | 2021 | 2022 | 2023 | Total | ||||||||||||||||||
| Lard Friese |
||||||||||||||||||||||||
| 2020 |
- | - | 211,431 | - | - | 211,431 | ||||||||||||||||||
| 2021 |
- | - | - | 452,981 | - | 452,981 | ||||||||||||||||||
| Total cash |
- |
- |
211,431 |
452,981 |
- |
|||||||||||||||||||
| Matt Rider |
||||||||||||||||||||||||
| 2017 |
49,878 | 49,878 | 49,878 | - | - | 149,634 | ||||||||||||||||||
| 2018 |
151,931 | 75,964 | 75,964 | 75,964 | - | 379,823 | ||||||||||||||||||
| 2019 |
- | 148,560 | 74,278 | 74,278 | 74,278 | 371,394 | ||||||||||||||||||
| 2020 |
- | - | 213,404 | - | - | 213,404 | ||||||||||||||||||
| 2021 |
- | - | - | 294,589 | - | 294,589 | ||||||||||||||||||
| Total cash |
201,809 |
274,402 |
413,524 |
444,831 |
74,278 |
|||||||||||||||||||
| Alex Wynaendts |
||||||||||||||||||||||||
| 2015 |
92,261 | - | - | - | - | 92,261 | ||||||||||||||||||
| 2016 |
104,412 | 104,412 | - | - | - | 208,824 | ||||||||||||||||||
| 2017 |
114,710 | 114,710 | 114,710 | - | - | 344,130 | ||||||||||||||||||
| 2018 |
212,490 | 106,243 | 106,243 | 106,243 | - | 531,219 | ||||||||||||||||||
| 2019 |
- | 209,548 | 104,772 | 104,772 | 104,772 | 523,864 | ||||||||||||||||||
| 2020 |
- | - | 100,725 | - | - | 100,725 | ||||||||||||||||||
| Total cash |
523,873 |
534,913 |
426,450 |
211,015 |
104,772 |
|||||||||||||||||||
| Darryl Button |
||||||||||||||||||||||||
| 2015 |
78,431 | - | - | - | - | 78,431 | ||||||||||||||||||
| 2016 |
74,674 | 74,674 | - | - | - | 149,348 | ||||||||||||||||||
| Total cash |
153,105 |
74,674 |
- |
- |
- |
|||||||||||||||||||
Remuneration Report |
IFRS expenses for compensation |
Fixed | Variable | ||||||||||||||||||
In EUR thousand |
compensation | compensation | Pension | Other Benefits | Total | |||||||||||||||
| Lard Friese |
||||||||||||||||||||
| 2021 1) |
1,576 | 692 | 594 | 77 | 2,939 | |||||||||||||||
| 2020 1) |
1,869 | 282 | 373 | 49 | 2,572 | |||||||||||||||
| Matt Rider |
||||||||||||||||||||
| 2021 |
968 | 583 | 387 | 67 | 2,005 | |||||||||||||||
| 2020 |
941 | 528 | 376 | 67 | 1,912 | |||||||||||||||
| 2019 |
931 | 627 | 387 | 77 | 2,022 | |||||||||||||||
| Alex Wynaendts |
||||||||||||||||||||
| 2020 2) |
496 | 497 | 337 | 97 | 1,427 | |||||||||||||||
| 2019 |
1,314 | 976 | 1,243 | 252 | 3,786 | |||||||||||||||
| All Executive Board members |
||||||||||||||||||||
| 2021 |
2,545 | 1,275 | 981 | 144 | 4,944 | |||||||||||||||
| 2020 |
3,306 | 1,307 | 1,086 | 213 | 5,911 | |||||||||||||||
| 2019 |
2,245 | 1,604 | 1,630 | 329 | 5,808 | |||||||||||||||
1 |
Includes the fixed compensation expenses for the sign-on arrangement of EUR 1,228 thousand that Mr. Friese received when joining Aegon in March 2020. These were EUR 91 thousand in 2021 and EUR 938 thousand in 2020. |
2 |
The disclosed amounts for 2020 cover the period that Mr. Wynaendts has been a member of the Executive Board (until May 15, 2020). |
| Fixed | Variable | One-off |
Pension | Total | Ratio Fixed/Variable 3) | |||||||||||||||||||||||||||||||
In EUR thousand |
Salary | Benefits | Upfront 1) |
Deferred 2) |
||||||||||||||||||||||||||||||||
| Lard Friese |
2021 | 4) |
1,485 | 77 | 211 | - | 255 | 594 | 2,622 | 82% /18% | ||||||||||||||||||||||||||
| 2020 | 5) |
931 | 49 | - | - | 565 | 373 | 1,918 | 71% / 29% | |||||||||||||||||||||||||||
| Matt Rider |
2021 | 968 | 67 | 213 | 363 | - | 387 | 1,999 | 71% / 29% | |||||||||||||||||||||||||||
| 2020 | 941 | 67 | 223 | 175 | - | 376 | 1,782 | 78% / 22% | ||||||||||||||||||||||||||||
1 |
The upfront cash and share payments of variable compensation that was allocated for the previous performance year. The shares are valued at their price at vesting. For example, the upfront cash and shares of the 2020 variable compensation award that were paid in 2021. |
2 |
The deferred cash and share payments of the variable compensation that was allocated for performance years before the previous performance year. The shares are valued at their price at vesting. For example, the deferred cash and shares of the 2017-2019 variable compensation awards that were paid in 2021. |
3 |
Fixed (the numerator) is the sum of Salary, Benefits and Pension divided by the Total. Variable (the denominator) is the sum of Upfront, Deferred and One-off divided by the Total. |
4 |
The upfront variable amount covers the pro-rated cash bonus payment that was awarded for the period as Executive Board member during 2020 (from May 15 to December 31). The one-off item concerns the payments of the 2020 sign-on arrangement that were deferrred for one year (EUR 105 thousand in cash and 37,980 shares at a vesting price of EUR 3.934). |
5 |
The salary, benefits and pension amounts cover the pro-rated period as Executive Board member during 2020 (from May 15 to December 31). The one-off item concerns the upfront payments of the 2020 sign-on arrangement (EUR 427 thousand in cash and 66,526 shares at a vesting price of EUR 2.079). |
Remuneration Report |
In EUR thousand |
Annualized |
2017 | 2018 | 2019 | 2020 | 2021 | ||||||||||||||||||||
| Lard Friese |
Awarded and due |
- | - | - | 2,719 | 2,748 | ||||||||||||||||||||
Change |
- | - | - | - | 1% | |||||||||||||||||||||
| Matt Rider (as of May 19, 2017) |
Awarded and due |
1,357 | 1,670 | 1,799 | 1,824 | 2,052 | ||||||||||||||||||||
Change |
- | 23% | 8% | 1% | 12% | |||||||||||||||||||||
| Alex Wynaendts |
Awarded and due |
4,431 | 4,969 | 3,806 | 3,268 | - | ||||||||||||||||||||
Change |
- | 12% | (23%) | (14%) | - | |||||||||||||||||||||
| Aegon net result (EU-IFRS) |
In EUR million |
2,358 | 741 | 1,525 | 55 | 1,701 | ||||||||||||||||||||
| Aegon business performance 1) |
Target = 100% |
121% | 106% | 79% | 57% | 123% | ||||||||||||||||||||
| Vesting price Aegon shares |
In EUR |
4.423 | 5.848 | 4.287 | 2.079 | 3.934 | ||||||||||||||||||||
| Inflation in the Netherlands |
Consumer Price Index |
1.4% | 1.7% | 2.6% | 1.3% | 2.7% | ||||||||||||||||||||
| Average employee compensation 2) |
Total compensation |
102 | 104 | 115 | 110 | 105 | ||||||||||||||||||||
Annual change |
2% | 11% | (4%) | (5%) | ||||||||||||||||||||||
1 |
The weighted average Aegon financial and non-financial business performance, expressed as a percentage on a performance scale with 50% as threshold, 100% as target and 150% as maximum, as used for the allocation of variable compensation in the applicable year. |
2 |
Consistent with the CEO pay ratio calculation, the average employee compensation is based on the audited total EU-IFRS remuneration expenses for all employees divided by the number of employees in scope for these expenses. |
2022 performance indicator weights |
For Aegon bonus pools | Lard Friese |
Matt Rider | |||||||||
| Group performance |
||||||||||||
| Free cash flows |
20% | |||||||||||
| Relative total shareholder return |
10% | |||||||||||
| Operating result |
10% | |||||||||||
| Addressable expenses savings |
10% | |||||||||||
| Market consistent value of new business |
10% | |||||||||||
| Transformation program: Earnings contribution |
10% | |||||||||||
| Transformation program: Timely initiative execution |
10% | |||||||||||
| Transformation program: Timely milestone completion |
10% | |||||||||||
| Employee engagement |
10% | 70% | 70% | |||||||||
| Personal performance |
||||||||||||
| Strategic Roadmap development |
10% | 5% | ||||||||||
| Execution of capital initiatives in line with Strategic Roadmap |
10% | 5% | ||||||||||
| Sustainabiity integration and execution |
5% | 5% | ||||||||||
| Women in senior management |
5% | |||||||||||
| Finance strategy execution |
10% | |||||||||||
Total weight |
100% |
100% |
100% |
|||||||||
Remuneration Report |
2022 performance indicators |
Definition | |
| Free cash flows | Free cash flows represent cash flows from remittances from the units less the Holding funding and operating expenses. For 2022 it will be measured on a retrospective 2-year performance period (2021-2022). The 2021-2022 target is based on the 2021-2023 cumulative free cash flows target that was disclosed at the Capital Market Day in December 2020 and the updated guidance in February 2022. | |
| Relative total shareholder return | Aegon’s position relative to 7 US and 7 non-US peers when looking at Total Shareholder Return for a retrospective 3-year performance period (2020-2022). These peers were selected for being the most similar to Aegon based on their index listing, industry classification, 5 year monthly Beta, Market Capitalization and Total Revenue 1) | |
| Operating result | Operating result reflects our profit before tax from underlying business operations and excludes components that relate to accounting mismatches that are dependent on market volatility, updates to best estimate actuarial and economic assumptions and model updates or events that are considered outside the normal course of business. The 2022 target is based on the 2022 budget. | |
| Addressable expenses savings | Addressable expenses are expenses reflected in the operating result, excluding deferrable acquisition expenses, expenses in joint ventures and associates and expenses related to operations in CEE countries. For 2022 it will be measured on a retrospective 2-year performance period (2021-2022). The 2021-2022 target is based on the 2021-2023 savings target that was disclosed at the Capital Market Day in December 2020. | |
| Market consistent value of new business | Represents how much value the sale of new insurance policies is generating for the company. This value represents the present value of our best estimate of incoming premiums and outgoing claims, benefits and expenses related to these new sales. The 2022 target is based on the 2022 budget. | |
| Transformation program: Earnings contributions | Measures the expected cumulative run-rate earnings contribution for performance improvement initiatives that moved to the execution phase during the retrospective 3-year performance period 2020-2022, compared to the cumulative 2020-2022 target in the transformation program. | |
| Transformation program: Timely initiative execution | Measures whether performance improvement initiatives moved to the execution phase in time, compared to the 2022 targets in the transformation program. | |
| Transformation program: Timely milestone completion | Measures the timely milestone completion of the performance improvement initiatives, compared to the 2022 targets in the transformation program. | |
| Employee Engagement | Increase Aegon’s employee engagement to at least 70% in 2022 (+2% compared to 2021). | |
| Strategic Roadmap Development | Further evolve the Strategic Roadmap for strategic assets and non-core assets in 2022. | |
| Execution of capital initiatives in line with Strategic Roadmap | Complete management actions in relation to financial assets and non-core assets in 2022. | |
| Sustainability integration and execution | Complete milestones in 2022 related to further integrating our ESG priorities in Aegon’s strategy, sustainability reporting and reaching our 2025 carbon emission reduction target. | |
| Women in Senior Management | Increase the number of women in Aegon’s senior management layer worldwide to at least 36% in 2022 (2% increase compared to 2021). | |
| Finance Strategy Execution | Complete the 2022 milestones from the Finance Strategy. |
1 |
These peers are in order of the 2020-2021 ranking result: 1) NN Group NV, 2) Principal Financial Group Inc, 3) Axa Equitable Holdings Inc, 4) Swiss Life Holding AG, 5) ASR Nederland NV, 6) Brighthouse Financial Inc, 7) MetLife Inc, 8) Prudential Financial Inc, 9) Lincoln National Corp, 10) Assicurazioni Generali SpA, 11) Aegon NV, 12) Prudential PLC, 13) Baloise Holding AG, 14) Unum Group and 15) Athene Holding Ltd / Helvetia Holding. The Athene Holding Ltd / Helvetia Holding result is a blend of the initial peer Athene and the back-up peer Helvetia, which replaced Athene per March 9, 2021, in accordance with our plan rules, following the merger with Apollo announced by Athene. |
Risk management |
¨ |
Understanding risks that the Company faces; |
¨ |
Maintaining a group-wide framework through which the risk-return trade-off associated with these risks can be assessed; |
¨ |
Maintaining risk tolerances and supporting policies to limit exposure to a particular risk or combination of risks; and |
¨ |
Monitoring risk exposures and actively maintaining oversight of the Company’s overall risk and solvency positions. |
¨ |
Solvency, including Cash Capital at Holding and capital generation, to ensure that Aegon remains solvent even under adverse scenarios. |
¨ |
Liquidity, to ensure that Aegon remains liquid even under extreme scenarios. |
¨ |
Risk balance, to ensure a healthy balance of risk exposures that supports delivering on our capital generation and return on capital targets. |
¨ |
Responsible business with effective controls, which acknowledges an acceptable level of operational risk and stresses a low tolerance for (lack of) actions which could lead to material adverse risk events that result in breaking promises or not meeting reasonable expectations of customers, legal breaches or reputational damage. |
Risk category |
Description |
Appetite | ||
| Underwriting |
The risk of incurring losses when actual experience deviates from Aegon’s best estimate assumptions on mortality, longevity, morbidity, policyholder behavior, P&C claims and expenses used to price products and establish technical provisions. | Medium to high - Underwriting risk is Aegon’s core business and meets customer needs. | ||
| Financial |
The risk of incurring financial losses due to movements in financial markets and the market value of balance sheet items. Elements of financial risk are credit risk, investment risk, interest rate risk and currency risk. | Low to medium - Accepted where it meets customer needs and the risk return profile is acceptable. | ||
| Operational |
The risk of losses resulting from inadequate or failed internal processes and controls, people and systems or from external events, such as processing errors, legal and compliance issues, natural or man-made disasters, and cybercrime. | Low - Accepted as a necessary condition of conducting business, but mitigated as much as possible in an economically efficient manner. |
Risk management |
¨ |
Risk acceptance when the exposure is within the set risk tolerance; and |
¨ |
Risk control, transfer or avoidance when the exposure exceeds the established risk tolerance or if cost-benefit analysis supports further actions. |
¨ |
Financial markets risks (particularly related to credit, equity, and interest rates); |
¨ |
Underwriting risk (particularly related to longevity and policyholder behavior); and |
¨ |
Operational risks (particularly related to reputation and continuity of operations). |
Risk management |
¨ |
Define roles and responsibilities, and risk reporting procedures for decision makers; |
¨ |
Institute a proper system of checks and balances; |
¨ |
Provide a consistent framework for managing risk in line with the targeted risk profile; and |
¨ |
Facilitate risk diversification. |
¨ |
The Supervisory Board and the Supervisory Board Risk Committee (SBRC); |
¨ |
The Executive Board and the Management Board; |
¨ |
The Group Risk & Capital Committee (GRCC) and its sub-committees; and |
¨ |
The Regional Risk & Capital Committees. |
Risk management |
¨ |
Advising on risk-related matters including risk tolerance, risk governance, risk methodology and risk policies; |
¨ |
Supporting and facilitating the development, incorporation, maintenance and embedding of the ERM framework and sound practices; and |
¨ |
Monitoring and challenging the implementation and effectiveness of ERM practices. |
Risk management |
¨ |
The overarching ERM Framework supports Aegon’s corporate strategy and enables management to effectively deal with uncertainty and the associate risk-return trade-offs. |
¨ |
The GRA is linked to and supports Aegon’s strategy and purpose and translates into risk tolerances and risk limits. |
¨ |
All material risks are captured and classified in Aegon’s risk universe. An emerging risk process is in place to ensure that risk universe remains up-to-date and complete. |
¨ |
A risk governance framework is in place across all levels of the company, including formal committees, committee charters, memberships across relevant functions, and escalation procedures. |
¨ |
Risk policies and standards set out requirements, roles and responsibilities and processes to manage risks across the risk universe. |
¨ |
The ERM Framework is embedded in Aegon’s key business areas. The Own Risk Self-Assessment (ORSA) unites the risk and capital management and the business planning processes across Aegon and aligns to its strategy. The risk strategy is aligned with the business strategy, the strategy execution is closely monitored, and risks are timely identified to help steer towards strong delivery in a safe and timely manner. |
¨ |
Major business (and risk) decisions are risk-based; properly risk informed and, where relevant, challenged by the Risk Management function to protect the balance sheet and proper customer conduct. |
¨ |
Risks across the risk universe are monitored and reported. |
¨ |
Risk culture is embedded across the company. |
¨ |
Awareness of employees, management, and leadership of relevant risks and how risks are managed. |
Capital and liquidity management |
¨ |
Promoting strong capital adequacy in Aegon’s businesses and operating units; |
¨ |
Managing and allocating capital efficiently in support of the strategy and in line with its risk tolerance; |
¨ |
Maintaining an efficient capital structure, with an emphasis on optimizing Aegon’s cost of capital; |
¨ |
Maintaining adequate liquidity in both the operating units and the Holding to ensure that the Company is able to meet its obligations by enforcing stringent liquidity risk policies; and |
¨ |
Maintaining continued access to international capital markets on competitive terms. |
Capital requirements |
Regulatory capital requirement |
Minimum dividend payment level |
Operating level | Actual capitalization | ||||||||||||
| US RBC ratio |
100% | 350% | 400% | 426% | ||||||||||||
| NL Life Solvency II ratio |
100% | 135% | 150% | 186% | ||||||||||||
| Scottish Equitable Plc (UK) Solvency II ratio |
100% | 135% | 150% | 167% | ||||||||||||
Capital and liquidity management |
Capital and liquidity management |
¨ |
Gross financial leverage ratio; |
¨ |
Fixed charge coverage; |
¨ |
Various rating agency leverage metrics; and |
¨ |
Other metrics, including gross financial leverage divided by operating capital generation. |
¨ |
Shareholders’ equity, excluding revaluation reserves and cash flow hedge reserves, based on IFRS as adopted by the EU; |
¨ |
Non-controlling interests and shares related to Long Term Incentive Plans that have not yet vested; and |
¨ |
Gross (or total) financial leverage. |
December 31, 2021 |
Aegon N.V. |
Aegon USA |
Aegon the Netherlands |
Aegon UK | ||||||||||||
| S&P Global 1) |
||||||||||||||||
| Financial strength |
- | A+ | A+ | A+ | ||||||||||||
| Long-term issuer |
A- | - | - | - | ||||||||||||
| Senior debt |
A- | - | - | - | ||||||||||||
| Subordinated debt |
BBB | - | - | - | ||||||||||||
| Moody’s Investors Service 1) |
||||||||||||||||
| Financial strength |
- | A1 | - | - | ||||||||||||
| Long-term issuer |
A3 | - | - | - | ||||||||||||
| Senior debt |
A3 | - | - | - | ||||||||||||
| Subordinated debt |
Baa1 | - | - | - | ||||||||||||
| Commerical paper 2) |
P-2 | - | - | - | ||||||||||||
| A.M. Best 1) |
||||||||||||||||
| Financial strength |
- | A | - | - | ||||||||||||
1 |
S&P Global and A.M. Best have a stable outlook on the ratings. Moody’s Investors Service has a negative outlook on the ratings. |
2 |
Following Aegon’s requests, S&P Global withdrew its commercial paper rating of Aegon N.V. on November 23, 2021 and Moody’s Investors Service withdrew the commercial paper rating on Aegon N.V. on January 28, 2022. |
Capital and liquidity management |
December 31, 2021 1) |
December 31, 2020 | |||
| Group Own Funds |
19,431 | 18,582 | ||
| Group SCR |
9,226 | 9,473 | ||
| Group Solvency II ratio |
211% | 196% | ||
1 |
The Solvency II ratios are estimates and are not final until filed with the respective supervisory authority. |
| Group |
Americas 1) |
NL Life |
SE Plc |
|||||||||||||||||||||||||||||||||
| Scenario | 2021 |
2020 | 2021 |
2020 | 2021 |
2020 | 2021 |
2020 | ||||||||||||||||||||||||||||
| Equity markets |
(25% | ) | (8% | ) | (11% | ) | (24% | ) | (29% | ) | (2% | ) | (5% | ) | 2% | (5% | ) | |||||||||||||||||||
| Equity markets |
+25% | 2% | 7% | 14% | 20% | (1% | ) | 1% | (3% | ) | (1% | ) | ||||||||||||||||||||||||
| Interest rates |
-50bps | (0% | ) | 0% | 1% | (3% | ) | 7% | 9% | (2% | ) | (1% | ) | |||||||||||||||||||||||
| Interest rates |
+50bps | (1% | ) | 1% | 0% | 4% | (8% | ) | (8% | ) | 1% | 1% | ||||||||||||||||||||||||
| Curve steepening |
+10bps | (2% | ) | n.a. | n.a. | n.a. | (7% | ) | n.a. | n.a. | n.a. | |||||||||||||||||||||||||
| Govt spreads excl EIOPA VA |
-50bps | 0% | 3% | n.a. | n.a. | (3% | ) | 3% | 4% | 5% | ||||||||||||||||||||||||||
| Govt spreads excl EIOPA VA |
+50bps | 0% | (2% | ) | n.a. | n.a. | 6% | (2% | ) | (4% | ) | (5% | ) | |||||||||||||||||||||||
| Non-govt spreads excl EIOPA VA 2) |
-50bps | (1% | ) | 0% | (3% | ) | (1% | ) | 11% | 9% | (9% | ) | (10% | ) | ||||||||||||||||||||||
| Non-govt spreads excl EIOPA VA 2) |
+50bps | (1% | ) | 0% | 4% | 1% | (11% | ) | (10% | ) | 1% | 6% | ||||||||||||||||||||||||
| US Credit Defaults 3) |
~+200 bps | (17% | ) | (18% | ) | (38% | ) | (38% | ) | n.a. | n.a. | n.a. | n.a. | |||||||||||||||||||||||
| UFR |
-15bps | (2% | ) | (2% | ) | n.a. | n.a. | (6% | ) | (6% | ) | n.a. | n.a. | |||||||||||||||||||||||
| Longevity 4) |
+5% | (5% | ) | (7% | ) | (8% | ) | (12% | ) | (8% | ) | (10% | ) | (2% | ) | (3% | ) | |||||||||||||||||||
| Mortgage spreads |
-50bps | 2% | 2% | n.a. | n.a. | 6% | 6% | n.a. | n.a. | |||||||||||||||||||||||||||
| Mortgage spreads |
+50bps | (2% | ) | (2% | ) | n.a. | n.a. | (6% | ) | (6% | ) | n.a. | n.a. | |||||||||||||||||||||||
| EIOPA VA |
-5bps | 0% | 0% | n.a. | n.a. | 1% | (1% | ) | n.a. | n.a. | ||||||||||||||||||||||||||
| EIOPA VA |
+5bps | (0% | ) | 0% | n.a. | n.a. | (1% | ) | 1% | n.a. | n.a. | |||||||||||||||||||||||||
1 |
The sensitivities presented for Americas includes US regulated (life) companies, non-regulated holding companies and the employee pension plan. The sensitivities are presented on a Solvency II basis, after application of the conversion methodology to US regulated (life) companies. |
2 |
Non-government credit spreads include mortgage spreads. |
3 |
Additional 130 bps defaults for 1 year plus assumed rating migration. |
4 |
Reduction of annual mortality rates by 5%. |
Capital and liquidity management |
Capital and liquidity management |
| December 31, 2021 |
December 31, 2020 | |||||||||||||||
Available Own Funds |
Eligible Own Funds |
Available Own Funds | Eligible Own Funds | |||||||||||||
| Unrestricted Tier 1 |
14,044 | 14,044 | 12,972 | 12,972 | ||||||||||||
| Restricted Tier 1 |
2,364 | 2,364 | 2,571 | 2,571 | ||||||||||||
| Tier 2 |
2,348 | 2,348 | 2,340 | 2,340 | ||||||||||||
| Tier 3 |
675 | 675 | 700 | 700 | ||||||||||||
| Total Tiers |
19,431 |
19,431 |
18,582 |
18,582 |
||||||||||||
Regulation and supervision |
Regulation and supervision |
Regulation and supervision |
Regulation and supervision |
Code of Conduct |
Controls and procedures |
¨ |
Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; |
¨ |
Provide reasonable assurance that transactions are recorded as necessary to permit the preparation of financial statements in accordance with generally accepted accounting principles; |
¨ |
Provide reasonable assurance that receipts and expenditures are made only in accordance with the authorizations of management and directors of the Company; and |
¨ |
Provide reasonable assurance that unauthorized acquisition, use or disposition of company assets that could have a material effect on Aegon’s financial statements would be prevented or detected in a timely manner. |
Controls and procedures |
Financial information | ||||
88 |
||||
90 |
||||
| 91 | ||||
| 95 | ||||
| 99 | ||||
| 103 | ||||
| 106 | ||||
| 110 | ¨ Results 2021 Asset Management | |||
Consolidated financial statements of Aegon N.V. | ||||
112 |
||||
113 |
||||
114 |
||||
115 |
||||
116 |
||||
119 |
||||
Notes to the consolidated financial statements | ||||
120 |
1 |
|||
120 |
2 |
|||
146 |
3 |
|||
150 |
4 |
|||
170 |
5 |
|||
180 |
6 |
|||
181 |
7 |
|||
181 |
8 |
|||
181 |
181 |
|||
182 |
182 |
|||
183 |
183 |
|||
184 |
184 |
|||
184 |
184 |
|||
186 |
186 |
|||
187 |
187 |
|||
187 |
187 |
|||
188 |
188 |
|||
189 |
189 |
|||
190 |
190 |
|||
191 |
191 |
|||
193 |
193 |
|||
195 |
195 |
|||
196 |
196 |
|||
199 |
199 |
|||
202 |
202 |
|||
203 |
27 |
|||
204 |
204 |
|||
207 |
29 |
|||
208 |
30 |
|||
214 |
31 |
|||
215 |
32 |
|||
216 |
33 |
|||
216 |
34 |
|||
220 |
35 |
|||
221 |
36 |
|||
225 |
37 |
|||
226 |
38 |
|||
227 |
39 |
|||
233 |
40 |
|||
235 |
41 |
|||
235 |
42 |
|||
235 |
43 |
|||
241 |
44 |
|||
253 |
45 |
|||
257 |
46 |
|||
259 |
47 |
|||
260 |
48 |
|||
261 |
49 |
|||
262 |
50 |
|||
265 |
51 |
|||
Financial statements of Aegon N.V. | ||||
267 |
||||
268 |
||||
Notes to the financial statements of Aegon N.V. | ||||
269 |
1 |
|||
269 |
2 |
|||
269 |
3 |
|||
269 |
4 |
|||
270 |
5 |
|||
270 |
6 |
|||
270 |
7 |
|||
270 |
8 |
|||
271 |
9 |
|||
271 |
10 |
|||
271 |
11 |
|||
271 |
12 |
|||
271 |
13 |
|||
273 |
14 |
|||
276 |
15 |
|||
277 |
16 |
|||
277 |
17 |
|||
277 |
18 |
|||
278 |
19 |
|||
278 |
20 |
|||
278 |
21 |
|||
278 |
22 |
|||
279 |
23 |
|||
Other information | ||
280 |
||
281 |
||
Other financial information | ||
284 |
||
285 |
||
287 |
||
289 |
||
290 |
||
291 |
Auditor’s report on the Annual Report on Form 20-F | |
Additional information | ||
295 |
||
301 |
||
307 |
||
311 |
||
317 |
||
319 |
||
342 |
||
343 |
||
344 |
||
345 |
||
346 |
||
347 |
||
349 |
||
350 |
||
350 |
||
351 |
||
355 |
||
356 |
||
Non-financial information | ||
358 |
||
360 |
||
365 |
||
371 |
||
390 |
||
401 |
||
402 |
||
404 |
||
Selected financial data |
In EUR millions (except per share amount) |
2021 |
2020 | 2019 | 2018 | 2017 | |||||||||||||||
| Amounts based upon IFRS |
||||||||||||||||||||
| Premium income |
15,444 | 16,099 | 18,138 | 19,316 | 22,826 | |||||||||||||||
| Investment income |
6,967 | 7,149 | 7,531 | 7,035 | 7,338 | |||||||||||||||
| Total revenues 1) |
25,209 | 25,657 | 28,197 | 28,914 | 32,973 | |||||||||||||||
| Result before tax |
2,400 | (364 | ) | 1,453 | 746 | 2,534 | ||||||||||||||
| Net result |
2,029 | (135 | ) | 1,236 | 707 | 2,469 | ||||||||||||||
| Earnings per common share |
||||||||||||||||||||
| Basic |
0.94 | (0.09 | ) | 0.56 | 0.29 | 1.14 | ||||||||||||||
| Diluted |
0.94 | (0.09 | ) | 0.56 | 0.29 | 1.14 | ||||||||||||||
| Earnings per common share B |
||||||||||||||||||||
| Basic |
0.02 | (0.00 | ) | 0.01 | 0.01 | 0.03 | ||||||||||||||
| Diluted |
0.02 | (0.00 | ) | 0.01 | 0.01 | 0.03 | ||||||||||||||
| 1 Excluded from the income statements prepared in accordance with IFRS are receipts related to investment-type annuity products and investment contracts. |
| |||||||||||||||||||
| Selected consolidated balance sheet information |
||||||||||||||||||||
In EUR millions |
2021 |
2020 | 2019 | 2018 | 2017 | |||||||||||||||
| Amounts based upon IFRS |
||||||||||||||||||||
| Total assets |
468,252 | 443,814 | 439,769 | 392,008 | 395,923 | |||||||||||||||
| Insurance and investment contracts |
400,104 | 370,286 | 371,014 | 329,974 | 324,392 | |||||||||||||||
| Borrowings including subordinated and trust pass-through securities |
11,980 | 10,735 | 11,650 | 13,583 | 14,532 | |||||||||||||||
| Shareholders’ equity |
23,813 | 22,018 | 21,842 | 19,189 | 20,266 | |||||||||||||||
| Number of common shares |
||||||||||||||||||||
In thousands |
2021 |
2020 | 2019 | 2018 | 2017 | |||||||||||||||
| Balance at January 1 |
2,098,114 | 2,105,139 | 2,095,648 | 2,095,648 | 2,074,549 | |||||||||||||||
| Share issuance |
- | - | - | - | - | |||||||||||||||
| Stock dividends |
10,665 | 2,466 | 9,491 | - | 21,099 | |||||||||||||||
| Shares withdrawn |
(2,466 | ) | (9,491 | ) | - | - | - | |||||||||||||
| Balance at end of period |
2,106,313 |
2,098,114 |
2,105,139 |
2,095,648 |
2,095,648 |
|||||||||||||||
Selected financial data |
In thousands |
2021 |
2020 | 2019 | 2018 | 2017 | |||||||||||||||
| Balance at January 1 |
571,795 | 585,022 | 585,022 | 585,022 | 585,022 | |||||||||||||||
| Shares withdrawn |
(2,956 | ) | (13,227 | ) | - | - | - | |||||||||||||
| Balance at end of period |
568,839 |
571,795 |
585,022 |
585,022 |
585,022 |
|||||||||||||||
EUR per common share 1) |
USD per common share 1) |
|||||||||||||||||||||||
Year |
Interim |
Final | Total | Interim | Final | Total | ||||||||||||||||||
| 2017 |
0.13 | 0.14 | 0.27 | 0.15 | 0.16 | 0.32 | ||||||||||||||||||
| 2018 |
0.14 | 0.15 | 0.29 | 0.16 | 0.17 | 0.33 | ||||||||||||||||||
| 2019 |
0.15 | 0.00 2) |
0.15 | 0.17 | - | 0.17 | ||||||||||||||||||
| 2020 |
0.06 | 0.06 | 0.12 | 0.07 | 0.07 | 0.14 | ||||||||||||||||||
| 2021 |
0.08 | 0.09 3) |
0.17 | 0.09 | ||||||||||||||||||||
1 |
Paid at each shareholders’ option in cash or in stock. |
2 |
Aegon forewent the 2019 final dividend of EUR 0.16 to strengthen its balance sheet and improve its risk profile. |
3 |
Proposed. |
Results of operations |
Results of operations – Worldwide |
Amounts in EUR millions |
2021 |
2020 | % | |||||||||
| Operating result after tax |
1,582 |
1,425 |
11 |
|||||||||
| Tax on operating result |
324 | 285 | 14 |
|||||||||
| Operating result |
||||||||||||
| Americas |
788 | 792 | - |
|||||||||
| The Netherlands |
755 | 665 | 13 |
|||||||||
| United Kingdom |
184 | 144 | 28 |
|||||||||
| International |
145 | 164 | (12) |
|||||||||
| Asset Management |
253 | 182 | 39 |
|||||||||
| Holding and other activities |
(219) | (237) | 8 |
|||||||||
| Operating result |
1,906 |
1,710 |
11 |
|||||||||
| Fair value items |
854 | (701) | n.m. |
|||||||||
| Realized gains / (losses) on investments |
446 | 150 | 196 |
|||||||||
| Net impairments |
53 | (237) | n.m. |
|||||||||
| Non-operating items |
1,352 |
(788) |
n.m. |
|||||||||
| Other income / (charges) |
(780) | (1,239) | 37 |
|||||||||
Result before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) |
2,478 |
(317) |
n.m. |
|||||||||
| Income tax from certain proportionately consolidated joint ventures and associates included in result before tax |
78 | 47 | 64 |
|||||||||
| Income tax |
(449) | 181 | n.m. |
|||||||||
| Of which Income tax from certain proportionately consolidated joint ventures and associates included in result before tax |
(78) | (47) | (64) |
|||||||||
| Net result |
2,029 |
(135) |
n.m. |
|||||||||
| Operating expenses |
3,775 | 3,852 | (2) |
|||||||||
| of which addressable expenses |
2,903 | 2,986 | (3) |
|||||||||
| New life sales |
||||||||||||
Amounts in EUR millions |
2021 |
2020 | % | |||||||||
| Americas |
430 | 380 | 13 |
|||||||||
| The Netherlands |
74 | 92 | (19) |
|||||||||
| United Kingdom |
31 | 33 | (7) |
|||||||||
| International |
151 | 233 | (35) |
|||||||||
| Total recurring plus 1/10 single |
686 |
737 |
(7) |
|||||||||
Amounts in EUR millions |
2021 |
2020 | % | |||||||||
| New premium production accident and health insurance |
170 | 180 | (6) |
|||||||||
| New premium production property & casualty insurance |
96 | 126 | (23) |
|||||||||
| Gross deposits (on and off balance) |
||||||||||||
Amounts in EUR millions |
2021 |
2020 | % | |||||||||
| Americas 2) |
32,861 | 36,359 | (10) |
|||||||||
| The Netherlands |
19,902 | 16,399 | 21 |
|||||||||
| United Kingdom |
24,764 | 8,599 | 188 |
|||||||||
| International |
26 | 320 | (92) |
|||||||||
| Asset Management 1) |
157,290 | 135,375 | 16 |
|||||||||
| Total gross deposits 2) |
234,843 |
197,053 |
19 |
|||||||||
1 |
Includes deposits from Third-Party and Strategic Partnerships only. |
2 |
Retirement Plans deposits for previous reporting periods have been updated to correct for a double count of intra-plan transfers. Account balances have not been impacted, as there was an offset in the market attribution. The cumulative adjustment for 2020 amounted to EUR (1,461) for gross and net deposits and the equal and opposite amount for market impacts. |
Results of operations – Worldwide |
Amounts in EUR millions |
2021 |
2020 | % | |||||||||
| Americas 2) |
(17,469 | ) | (19,461 | ) | 10 |
|||||||
| The Netherlands |
(273 | ) | 1,758 | n.m. |
||||||||
| United Kingdom |
10,228 | (3,587 | ) | n.m. |
||||||||
| International |
3 | 155 | (98) |
|||||||||
| Asset Management 1) |
12,885 | 5,912 | 118 |
|||||||||
| Total net deposits / (outflows) 2) |
5,374 |
(15,223 |
) |
n.m. |
||||||||
1 |
Includes deposits from Third-Party and Strategic Partnerships only. |
2 |
Retirement Plans deposits for previous reporting periods have been updated to correct for a double count of intra-plan transfers. Account balances have not been impacted, as there was an offset in the market attribution. The cumulative adjustment for 2020 amounted to EUR (1,461) for gross and net deposits and the equal and opposite amount for market impacts. |
Amounts in EUR millions |
Ameri- cas |
The Nether- lands |
United King- dom |
Interna- tional |
Asset Man- age- ment |
Holding and other activi- ties |
Segment total |
Associ- ates and Joint Ven- tures elimina- tions |
Consoli- dated | |||||||||||||||||||||||||||
| Total life insurance gross premiums |
7,108 | 1,323 | 4,613 | 1,181 | - | - | 14,225 | (825 | ) | 13,400 | ||||||||||||||||||||||||||
| Accident and health insurance premiums |
1,273 | 254 | 3 | 179 | - | - | 1,709 | (67 | ) | 1,643 | ||||||||||||||||||||||||||
| Property & casualty insurance premiums |
- | 136 | - | 432 | - | - | 569 | (168 | ) | 401 | ||||||||||||||||||||||||||
| Total gross premiums |
8,381 |
1,713 |
4,616 |
1,793 |
- |
- |
16,504 |
(1,060 |
) |
15,444 |
||||||||||||||||||||||||||
| Investment income |
2,910 | 2,088 | 1,691 | 360 | 12 | (19 | ) | 7,042 | (75 | ) | 6,967 | |||||||||||||||||||||||||
| Fee and commission income |
1,920 | 300 | 223 | 59 | 800 | (183 | ) | 3,120 | (335 | ) | 2,785 | |||||||||||||||||||||||||
| Other revenue |
11 | - | - | 2 | 2 | 12 | 27 | (15 | ) | 13 | ||||||||||||||||||||||||||
| Total revenues |
13,222 |
4,101 |
6,531 |
2,215 |
814 |
(190 |
) |
26,693 |
(1,484 |
) |
25,209 |
|||||||||||||||||||||||||
| Number of employees, including agent employees |
7,675 | 3,534 | 2,476 | 6,590 | 1,675 | 321 | 22,271 | |||||||||||||||||||||||||||||
Amounts in EUR millions |
Americas | The Nether- lands |
United Kingdom |
Interna- tional |
Asset Man- age- ment |
Holding and other activi- ties |
Segment total |
Associ- ates and Joint Ventures elimina- tions |
Consoli- dated | |||||||||||||||||||||||||||
| Total life insurance gross premiums |
7,105 | 1,619 | 4,833 | 1,095 | - | 1 | 14,654 | (726 | ) | 13,929 | ||||||||||||||||||||||||||
| Accident and health insurance premiums |
1,380 | 245 | 25 | 193 | - | - | 1,844 | (59 | ) | 1,784 | ||||||||||||||||||||||||||
| General insurance premiums |
- | 130 | - | 388 | - | - | 519 | (132 | ) | 386 | ||||||||||||||||||||||||||
| Total gross premiums |
8,485 |
1,994 |
4,858 |
1,677 |
- |
1 |
17,016 |
(917 |
) |
16,099 |
||||||||||||||||||||||||||
| Investment income |
2,986 | 2,083 | 1,795 | 362 | 7 | (20 | ) | 7,212 | (63 | ) | 7,149 | |||||||||||||||||||||||||
| Fee and commission income |
1,653 | 255 | 194 | 50 | 750 | (189 | ) | 2,713 | (308 | ) | 2,405 | |||||||||||||||||||||||||
| Other revenue |
7 | - | - | 1 | 2 | 3 | 14 | (10 | ) | 4 | ||||||||||||||||||||||||||
| Total revenues |
13,131 |
4,332 |
6,847 |
2,091 |
759 |
(204 |
) |
26,955 |
(1,298 |
) |
25,657 |
|||||||||||||||||||||||||
| Number of employees, including agent employees |
7,960 | 3,521 | 2,307 | 6,598 | 1,527 | 409 | 22,322 | |||||||||||||||||||||||||||||
Results of operations – Worldwide |
¨ |
The Americas’ operating result in 2021 decreased by 1% compared with 2020 to EUR 788 million as favorable morbidity experience in Long-Term Care and the impact of favorable market performance in Mutual Funds, Variable Annuities and Retirement Plans and lower expenses largely offset the impact of adverse mortality in the Life business and unfavorable currency movements. |
¨ |
Operating result from the Netherlands increased by 13% compared with 2020 to EUR 755 million in 2021. The increase in the operating result reflects the benefits from expense savings, business growth and an improved investment margin in the Life segment. |
¨ |
In the United Kingdom, the operating result rose by 28% compared with 2020 to EUR 184 million in 2021. The increase in operating result was mainly driven by higher fee revenues from the growth of the platform business and favorable equity markets, and provision releases along with lower expenses, which more than offset the impacts from the loss of earnings due to the sale of Stonebridge and the gradual run-off of the traditional product portfolio. |
¨ |
The operating result from International decreased by 12% compared with 2020 to EUR 145 million in 2021. The decrease reflects the reclassification of the result of Aegon’s businesses in Central & Eastern Europe from operating result to Other income, following the announced divestment of the business. Adjusted for this, International’s operating results increased when compared with 2020, driven by higher results in Spain & Portugal, China and TLB. This reflects portfolio growth in Spain & Portugal and China, and favorable claims experience. |
¨ |
The operating result from Asset Management increased by 39% compared with 2020 to EUR 253 million in 2021. This increase was mainly driven by higher management fees as a result of net deposits and favorable markets. |
¨ |
The operating result for Holdings and other activities amounted to a loss of EUR 219 million in 2021 compared with a loss of EUR 237 million in 2020. |
Results of operations – Worldwide |
Results of operations – Americas |
| Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
2021 |
2020 | % |
2021 |
2020 | % | |||||||||||||||||||
| Operating result after tax |
845 |
824 |
3 |
714 |
721 |
(1) |
||||||||||||||||||
| Tax on operating result |
88 | 80 | 9 |
74 | 70 | 5 |
||||||||||||||||||
| Operating result |
||||||||||||||||||||||||
| Individual Solutions |
668 | 639 | 5 |
565 | 560 | 1 |
||||||||||||||||||
| Workplace Solutions |
268 | 254 | 6 |
226 | 222 | 2 |
||||||||||||||||||
| Brazil |
(3 | ) | 11 | n.m. |
(3 | ) | 10 | n.m. |
||||||||||||||||
| Operating result |
932 |
904 |
3 |
788 |
792 |
- |
||||||||||||||||||
| Fair value items |
826 | (511 | ) | n.m. |
698 | (448 | ) | n.m. |
||||||||||||||||
| Realized gains / (losses) on investments |
370 | 106 | n.m. |
313 | 93 | n.m. |
||||||||||||||||||
| Net impairments |
17 | (166 | ) | n.m. |
15 | (146 | ) | n.m. |
||||||||||||||||
| Non-operating items |
1,213 |
(571 |
) |
n.m. |
1,025 |
(500 |
) |
n.m. |
||||||||||||||||
| Other income / (charges) |
(789 | ) | (1,267 | ) | 38 |
(667 | ) | (1,110 | ) | 40 |
||||||||||||||
Result before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) |
1,357 |
(935 |
) |
n.m. |
1,147 |
(819 |
) |
n.m. |
||||||||||||||||
| Income tax from certain proportionately consolidated joint ventures and associates included in result before tax |
- | 5 | (98) |
- | 5 | (98) |
||||||||||||||||||
| Income tax |
(162 | ) | 324 | n.m. |
(137 | ) | 284 | n.m. |
||||||||||||||||
| Of which Income tax from certain proportionately consolidated joint ventures and associates included in result before tax |
- | (5 | ) | 98 |
- | (5 | ) | 98 |
||||||||||||||||
| Net result |
1,195 |
(611 |
) |
n.m. |
1,010 |
(535 |
) |
n.m. |
||||||||||||||||
| Life insurance gross premiums |
8,409 | 8,111 | 4 |
7,108 | 7,105 | - |
||||||||||||||||||
| Accident and health insurance premiums |
1,506 | 1,575 | (4) |
1,273 | 1,380 | (8) |
||||||||||||||||||
| Total gross premiums |
9,915 |
9,686 |
2 |
8,381 |
8,485 |
(1) |
||||||||||||||||||
| Investment income |
3,442 | 3,408 | 1 |
2,910 | 2,986 | (3) |
||||||||||||||||||
| Fee and commission income |
2,272 | 1,887 | 20 |
1,920 | 1,653 | 16 |
||||||||||||||||||
| Other revenues |
13 | 8 | 60 |
11 | 7 | 54 |
||||||||||||||||||
| Total revenues |
15,643 |
14,990 |
4 |
13,222 |
13,131 |
1 |
||||||||||||||||||
| Operating expenses |
1,750 | 1,784 | (2) |
1,479 | 1,562 | (5) |
||||||||||||||||||
| of which addressable expenses |
1,541 | 1,557 | (1) |
1,303 | 1,364 | (4) |
||||||||||||||||||
| Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
2021 |
2020 | % |
2021 |
2020 | % |
|||||||||||||||||||
| Individual Solutions |
360 | 302 | 19 |
304 | 264 | 15 |
||||||||||||||||||
| Workplace Solutions |
57 | 56 | 1 |
48 | 49 | (2) |
||||||||||||||||||
| Brazil |
92 | 75 | 22 |
77 | 66 | 18 |
||||||||||||||||||
| Total recurring plus 1/10 single |
508 |
433 |
17 |
430 |
380 |
13 |
||||||||||||||||||
| Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
2021 |
2020 | % |
2021 |
2020 | % |
|||||||||||||||||||
| New premium production accident and health insurance |
152 | 154 | (1) |
129 | 135 | (5) |
||||||||||||||||||
Results of operations – Americas |
| Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
2021 |
2020 | % |
2021 |
2020 | % | |||||||||||||||||||
| Individual Solutions |
10,298 | 12,374 | (17) |
8,704 | 10,839 | (20) |
||||||||||||||||||
| Workplace Solutions 1) |
28,154 | 28,954 | (3) |
23,797 | 25,363 | (6) |
||||||||||||||||||
| Brazil |
427 | 180 | 138 |
361 | 157 | 129 |
||||||||||||||||||
| Total gross deposits 1) |
38,878 |
41,508 |
(6) |
32,861 |
36,359 |
(10) |
||||||||||||||||||
1 |
Retirement Plans deposits for previous reporting periods have been updated to correct for a double count of intra-plan transfers. Account balances have not been impacted, as there was an offset in the market attribution. The cumulative adjustment for 2020 amounted to USD (1,668) / EUR (1,461) for gross and net deposits and the equal and opposite amount for market impacts. |
| Amounts in USD millions | Amounts in EUR millions | |||||||||||||||||||||||
2021 |
2020 | % |
2021 |
2020 | % | |||||||||||||||||||
| Individual Solutions |
(7,709) | (3,184) | (142) |
(6,516) | (2,789) | (134) |
||||||||||||||||||
| Workplace Solutions 1) |
(13,179) | (19,054) | 31 |
(11,140) | (16,691) | 33 |
||||||||||||||||||
| Brazil |
222 | 21 | n.m. |
187 | 18 | n.m. |
||||||||||||||||||
| Total net deposits / (outflows) 1) |
(20,667) |
(22,217) |
7 |
(17,469) |
(19,461) |
10 |
||||||||||||||||||
1 |
Retirement Plans deposits for previous reporting periods have been updated to correct for a double count of intra-plan transfers. Account balances have not been impacted, as there was an offset in the market attribution. The cumulative adjustment for 2020 amounted to USD (1,668) / EUR (1,461) for gross and net deposits and the equal and opposite amount for market impacts. |
| Weighted average rate | Closing rate as of | |||||||||||||||
Per 1 EUR |
2021 |
2020 | December 31, 2021 |
December 31, 2020 | ||||||||||||
| USD |
1.1831 | 1.1416 | 1.1372 | 1.2236 | ||||||||||||
Results of operations – Americas |
¨ |
Gains on fair value investments of USD 752 million, mainly driven by the outperformance of private equity and real estate. |
¨ |
The result on fair value hedges with an accounting match – which includes the hedges of the variable annuities GMWB portfolio – amounted to a gain of USD 146 million caused by gains on unhedged risks. |
¨ |
Hedges without an accounting match under IFRS resulted in a loss of USD 72 million. This was mainly driven by the macro hedge program net of reserve movements as a result of equity markets movements through the end of the third quarter of 2021, and losses on unhedged risks and unhedged volatility in indexed universal life. Starting in the fourth quarter of 2021, the dynamic hedge program was expanded to cover guaranteed minimum income benefit (GMIB) and guaranteed minimum death benefit (GMDB) riders, and the former macro hedge programs ended at the end of the third quarter 2021. Due to the accounting treatment for the GMIB and GMDB riders, the results related to the dynamic hedge on this block are reported as fair value hedges without accounting match. |
¨ |
The operating result from Life resulted in a loss of USD 111 million in 2021 compared to an operating result of USD 3 million in 2020. The Life operating result was impacted by adverse mortality of USD 384 million, which was driven by larger claims at older ages in universal life products and elevated claims in universal life, traditional and term life products. USD 207 million of these claims can specifically be attributed to COVID-19 as direct cause of death, and Aegon believes much of the remaining adverse mortality experience is indirectly related to COVID-19. |
Results of operations – Americas |
¨ |
Accident & Health operating result of USD 356 million in 2021 compared with USD 305 million in 2020, mainly due to favorable morbidity experience of USD 209 million. Most of the favorable morbidity experience was related to the closed block of Long-Term Care insurance, where the actual to expected claim ratio amounted to 64% in 2021 compared to 79% in 2020. This was partly driven by the partial release of the incurred but not reported (IBNR) reserve in 2021 that had been set up in 2020, as new claims trended back to pre-pandemic levels over the course of 2021. |
¨ |
The Mutual Funds operating result of USD 58 million in 2021 compared with USD 30 million in 2020 due to an increase in fees from favorable market performance and net deposits. |
¨ |
The Variable Annuities operating result of USD 345 million in 2021 compared with USD 263 million in 2020, driven by higher fees as a result of favorable equity market performance, partly offset by net outflows. |
¨ |
The Fixed Annuities operating result of USD 20 million in 2021 compared with USD 39 million in 2020, mainly due to the impact of lower interest rates on reinvestments and lower account balances. |
¨ |
Life operating result of USD 13 million in 2021 compared with USD 23 million in 2020, reflecting adverse mortality experience of USD 24 million. |
¨ |
Accident & Health operating result of USD 21 million in 2021 compared with USD 56 million in 2020, reflecting more normalized claims utilization driving morbidity claims to pre-pandemic levels. |
¨ |
Retirement Plans operating result of USD 156 million in 2021 compared with USD 95 million in 2020, driven by higher investment income from transferring customer assets to higher yielding general account products, as well as higher fees driven by favorable market performance despite net outflows and continued margin pressure. |
¨ |
Stable Value Solutions operating result of USD 77 million in 2021 compared with USD 80 million in 2020, due to the decrease in fee revenue from lower fee rates and notional balances. |
Results of operations – The Netherlands |
Amounts in EUR millions |
2021 |
2020 | % | |||||||||
| Operating result after tax |
573 |
495 |
16 |
|||||||||
| Tax on operating result |
181 | 170 | 7 |
|||||||||
| Operating result |
||||||||||||
| Life |
519 | 466 | 11 |
|||||||||
| Mortgages |
71 | 51 | 39 |
|||||||||
| Bank |
115 | 113 | 2 |
|||||||||
| Workplace solutions |
50 | 35 | 41 |
|||||||||
| Operating result |
755 |
665 |
13 |
|||||||||
| Fair value items |
221 | (230 | ) | n.m. |
||||||||
| Realized gains / (losses) on investments |
118 | 14 | n.m. |
|||||||||
| Net impairments |
40 | (49 | ) | n.m. |
||||||||
| Non-operating items |
378 |
(265 |
) |
n.m. |
||||||||
| Other income / (charges) |
(23 | ) | 78 | n.m. |
||||||||
Result before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) |
1,110 |
478 |
132 |
|||||||||
| Income tax from certain proportionately consolidated joint ventures and associates included in result before tax |
- | - | n.m. |
|||||||||
| Income tax |
(276 | ) | (107 | ) | (158) |
|||||||
| Of which Income tax from certain proportionately consolidated joint ventures and associates included in result before tax |
- | - | n.m. |
|||||||||
| Net result |
833 |
371 |
(10) |
|||||||||
| Life insurance gross premiums |
1,323 | 1,619 | (18) |
|||||||||
| Accident and health insurance premiums |
254 | 245 | 4 |
|||||||||
| Property & casualty insurance |
136 | 130 | 5 |
|||||||||
| Total gross premiums |
1,713 |
1,994 |
(14) |
|||||||||
| Investment income |
2,088 | 2,083 | - |
|||||||||
| Fee and commission income |
300 | 255 | 18 |
|||||||||
| Other revenues |
- | - | n.m. |
|||||||||
| Total revenues |
4,101 |
4,332 |
(5) |
|||||||||
| Operating expenses |
729 | 763 | (4) |
|||||||||
| of which addressable expenses |
607 | 633 | (4) |
|||||||||
New Life Sales |
||||||||||||
Amounts in EUR millions |
2021 |
2020 | % | |||||||||
| Life |
74 | 92 | (19) |
|||||||||
| Total recurring plus 1/10 single |
74 |
92 |
(19) |
|||||||||
Amounts in EUR millions |
2021 |
2020 | % | |||||||||
| Mortgage origination |
10,856 | 11,069 | (2) |
|||||||||
| New premium production accident and health insurance |
10 | 16 | (37) |
|||||||||
| New premium production property & casualty insurance |
20 | 15 | 40 |
|||||||||
Gross deposits (on and off balance) |
||||||||||||
Amounts in EUR millions |
2021 |
2020 | % | |||||||||
| Bank |
19,006 | 15,453 | 23 |
|||||||||
| Workplace solutions |
896 | 946 | (5) |
|||||||||
| Total gross deposits |
19,902 |
16,399 |
21 |
|||||||||
Results of operations – The Netherlands |
Net deposits (on and off balance) |
||||||||||||
Amounts in EUR millions |
2021 |
2020 | % |
|||||||||
| Bank |
(1,012 | ) | 960 | n.m. |
||||||||
| Workplace solutions |
739 | 798 | (7) |
|||||||||
| Total net deposits |
(273 |
) |
1,758 |
n.m. |
||||||||
Results of operations – The Netherlands |
¨ |
The operating result from Life increased by 11% compared with 2020 to EUR 519 million in 2021. The increase was driven by a higher investment margin – in turn mainly driven by lower interest rate credited – and by the favorable impact from expense savings initiatives. There was a partial offset from less favorable claims experience. |
¨ |
The operating result from Mortgages increased by 39% compared with 2020 to EUR 71 million in 2021, mainly due to higher fees resulting from business growth. Mortgages under administration increased by EUR 5 billion in 2021 to EUR 60 billion at December 31, 2021. Expense saving initiatives and higher revenues from customer pre-payment compensation also contributed favorably. |
¨ |
The operating result from Banking rose by 2% compared with 2020 to EUR 115 million in 2021. Higher fee income from growth in the number of fee-paying customers at Knab and the favorable impact from expense savings initiatives were partly offset by a lower interest income. The latter was primarily due to a reduction of the unsecured loan portfolio. |
¨ |
The operating result from Workplace Solutions increased by 42% to EUR 50 million in 2021. Improved results from the non-life business were the main driver, due to favorable claims experience in 2021 and reserve additions in 2020. This more than offset a decrease in revenue at TKP due to a large pension fund having left at the beginning of 2021. |
Results of operations – The Netherlands |
Results of operations – United Kingdom |
| Amounts in GBP millions | Amounts in EUR millions | |||||||||||||||||||||||
2021 |
2020 | % |
2021 | 2020 | % | |||||||||||||||||||
| Operating result after tax |
143 |
126 |
14 |
166 |
142 |
17 |
||||||||||||||||||
| Tax on operating result |
15 | 2 | n.m. |
17 | 2 | n.m. |
||||||||||||||||||
| Operating result |
158 |
128 |
24 |
184 |
144 |
28 |
||||||||||||||||||
| Fair value items |
(53 | ) | (2 | ) | n.m. |
(62 | ) | (2 | ) | n.m. |
||||||||||||||
| Realized gains / (losses) on investments |
9 | - | n.m. |
10 | - | n.m. |
||||||||||||||||||
| Non-operating items |
(44 |
) |
(1 |
) |
n.m. |
(51 |
) |
(1 |
) |
n.m. |
||||||||||||||
| Other income / (charges) |
1 | (61 | ) | n.m. |
1 | (68 | ) | n.m. |
||||||||||||||||
Result before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) |
115 |
66 |
74 |
134 |
74 |
80 |
||||||||||||||||||
| Income tax from certain proportionately consolidated joint ventures and associates included in result before tax |
- | - | n.m. |
- | - | n.m. |
||||||||||||||||||
| Income tax |
(10 | ) | (6 | ) | (62) |
(12 | ) | (7 | ) | (68) |
||||||||||||||
| Of which Income tax from certain proportionately consolidated joint ventures and associates included in result before tax |
- | - | n.m. |
- | - | n.m. |
||||||||||||||||||
| Net result |
104 |
60 |
75 |
122 |
67 |
81 |
||||||||||||||||||
| Life insurance gross premiums |
3,966 | 4,298 | (8) |
4,613 | 4,833 | (5) |
||||||||||||||||||
| Accident and health insurance premiums |
3 | 23 | (88) |
3 | 25 | (87) |
||||||||||||||||||
| Total gross premiums |
3,969 |
4,320 |
(8) |
4,616 |
4,858 |
(5) |
||||||||||||||||||
| Investment income |
1,454 | 1,596 | (9) |
1,691 | 1,795 | (6) |
||||||||||||||||||
| Fee and commission income |
192 | 172 | 11 |
223 | 194 | 15 |
||||||||||||||||||
| Total revenues |
5,615 |
6,089 |
(8) |
6,531 |
6,847 |
(5) |
||||||||||||||||||
| Operating expenses |
386 | 406 | (5) |
448 | 631 | (29) |
||||||||||||||||||
| of which addressable expenses |
335 | 341 | (2) |
390 | 456 | (15) |
||||||||||||||||||
New life sales |
||||||||||||||||||||||||
| Amounts in GBP millions | Amounts in EUR millions | |||||||||||||||||||||||
2021 |
2020 | % |
2021 |
2020 | % | |||||||||||||||||||
| Total recurring plus 1/10 single |
27 |
30 |
(10) |
31 |
33 |
(7) |
||||||||||||||||||
Gross deposits (on and off balance) |
||||||||||||||||||||||||
| Amounts in GBP millions | Amounts in EUR millions | |||||||||||||||||||||||
2021 |
2020 | % |
2021 |
2020 | % | |||||||||||||||||||
| Total gross deposits |
21,292 |
7,646 |
178 |
24,764 |
8,599 |
188 |
||||||||||||||||||
Net deposits (on and off balance) |
||||||||||||||||||||||||
| Amounts in GBP millions | Amounts in EUR millions | |||||||||||||||||||||||
2021 |
2020 | % |
2021 |
2020 | % | |||||||||||||||||||
| Retail |
(210 | ) | (1,095 | ) | 81 |
(244 | ) | (1,232 | ) | 80 |
||||||||||||||
| Workplace solutions |
1,493 | 1,104 | 35 |
1,736 | 1,242 | 40 |
||||||||||||||||||
| Institutional |
8,754 | (2,548 | ) | n.m. |
10,181 | (2,865 | ) | n.m. |
||||||||||||||||
| Traditional products |
(1,246 | ) | (651 | ) | (91) |
(1,449 | ) | (732 | ) | (98) |
||||||||||||||
| Total net deposits |
8,792 |
(3,190 |
) |
n.m. |
10,228 |
(3,587 |
) |
n.m. |
||||||||||||||||
Results of operations – United Kingdom |
Exchange rates |
||||||||||||||||
| Weighted average rate | Closing rate as of | |||||||||||||||
Per 1 EUR |
2021 |
2020 | December 31, 2021 |
December 31, 2020 | ||||||||||||
| Pound Sterling |
0.8598 | 0.8892 | 0.8396 | 0.8951 | ||||||||||||
Results of operations – United Kingdom |
Results of operations – International |
| Results 2021 International |
||||||||||||
Amounts in EUR millions |
2021 |
2020 | % | |||||||||
| Operating result after tax |
112 |
132 |
(15) |
|||||||||
| Tax on operating result |
33 | 33 | 1 |
|||||||||
| Operating result |
||||||||||||
| Spain & Portugal |
75 | 53 | 41 |
|||||||||
| China |
24 | 18 | 38 |
|||||||||
| TLB |
77 | 57 | 34 |
|||||||||
| Other |
(31 | ) | 36 | n.m. |
||||||||
| Operating result |
145 |
164 |
(12) |
|||||||||
| Fair value items |
(18 | ) | (7 | ) | (142) |
|||||||
| Realized gains / (losses) on investments |
2 | 46 | (96) |
|||||||||
| Net impairments |
1 | (16 | ) | n.m. |
||||||||
| Non-operating items |
(15 |
) |
22 |
n.m. |
||||||||
| Other income / (charges) |
65 | (1 | ) | n.m. |
||||||||
Result before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) |
195 |
186 |
5 |
|||||||||
| Income tax from certain proportionately consolidated joint ventures and associates included in result before tax |
20 | 3 | n.m. |
|||||||||
| Income tax |
(36 | ) | (22 | ) | (68) |
|||||||
| Of which Income tax from certain proportionately consolidated joint ventures and associates included in result before tax |
(20 | ) | (3 | ) | n.m. |
|||||||
| Net result |
159 |
164 |
(3) |
|||||||||
| Life insurance gross premiums |
1,181 | 1,095 | 8 |
|||||||||
| Accident and health insurance premiums |
179 | 193 | (7) |
|||||||||
| Property & casualty insurance premiums |
432 | 388 | 11 |
|||||||||
| Total gross premiums |
1,793 |
1,677 |
7 |
|||||||||
| Investment income |
360 | 362 | - |
|||||||||
| Fee and commission income |
59 | 50 | 18 |
|||||||||
| Other revenues |
2 | 1 | 68 |
|||||||||
| Total revenues |
2,215 |
2,091 |
6 |
|||||||||
| Operating expenses |
386 | 400 | (3) |
|||||||||
| of which addressable expenses |
113 | 115 | (2) |
|||||||||
| New life sales |
||||||||||||
Amounts in EUR millions |
2021 |
2020 | % |
|||||||||
| Spain & Portugal |
48 | 43 | 11 |
|||||||||
| China |
90 | 97 | (7) |
|||||||||
| TLB |
11 | 8 | 34 |
|||||||||
| Other |
2 | 84 | (97) |
|||||||||
| Total recurring plus 1/10 single |
151 |
233 |
(35) |
|||||||||
Amounts in EUR millions |
2021 |
2020 | % |
|||||||||
| New premium production accident and health insurance |
31 | 29 | 6 |
|||||||||
| New premium production property & casualty insurance |
76 | 111 | (32) |
|||||||||
Results of operations – International |
| Gross deposits (on and off balance) |
||||||||||||||||
Amounts in EUR millions |
2021 |
2020 | % | |||||||||||||
| Spain & Portugal |
15 | 15 | 4 |
|||||||||||||
| China |
10 | 9 | 14 |
|||||||||||||
| Other |
- | 296 | n.m. |
|||||||||||||
| Total gross deposits |
26 |
320 |
(92) |
|||||||||||||
| Net deposits (on and off balance) |
||||||||||||||||
Amounts in EUR millions |
2021 |
2020 |
% | |||||||||||||
| Spain & Portugal |
- | 3 | (89) |
|||||||||||||
| China |
3 | 3 | (17) |
|||||||||||||
| Other |
- | 148 | n.m. |
|||||||||||||
| Total net deposits |
3 |
155 |
(98) |
|||||||||||||
| Exchange rates |
||||||||||||||||
| Weighted average rate | Closing rate as of | |||||||||||||||
Per 1 EUR |
2021 |
2020 | December 31, 2021 |
December 31, 2020 | ||||||||||||
| USD |
1.1831 | 1.1416 | 1.1372 | 1.2236 | ||||||||||||
| Chinese Yuan Renminbi |
7.6313 | 7.8726 | 7.2478 | 8.0018 | ||||||||||||
| Czech Koruna |
25.6418 | 26.4557 | 24.8500 | 26.2620 | ||||||||||||
| Hungarian Florint |
358.4993 | 351.1554 | 368.5650 | 362.6850 | ||||||||||||
| Polish Zloty |
4.5641 | 4.4433 | 4.5834 | 4.5589 | ||||||||||||
| Romanian Leu |
4.9211 | 4.8370 | 4.9488 | 4.8675 | ||||||||||||
| Turkish Lira |
10.4938 | 8.0394 | 15.1017 | 9.0940 | ||||||||||||
| Ukrainian Hryvnia |
32.2848 | 30.8293 | 31.0257 | 34.6693 | ||||||||||||
Results of operations – International |
¨ |
Operating result from Spain & Portugal was EUR 75 million, 41% higher compared with 2020. This was mainly driven by portfolio growth and favorable claims experience. |
¨ |
Operating result from China increased by 38% compared with 2020 to EUR 24 million in 2021 largely reflecting a growing portfolio. |
¨ |
TLB, the high-net-worth business, recorded operating result of EUR 77 million, an increase of EUR 20 million compared with 2020. This was mainly driven by an improved investment margin, reflecting a lowering of the crediting rate with the aim to offset lower reinvestment yields and favorable claims experience. In addition, expense savings initiatives led to a decrease in expenses. |
¨ |
For the Others segment, the result decreased to a loss of EUR 31 million, an EUR 67 million decrease compared with 2020. This was largely due to the reclassification of the result of Central & Eastern Europe from operating result to Other income. This was partly offset by reduced regional expenses. |
¨ |
New life sales from the China joint venture decreased by EUR 7 million to EUR 90 million in 2021 reflecting industry-wide lower demand for critical illness products. |
¨ |
For TLB, new life sales increased by EUR 3 million to EUR 11 million in 2021 driven by higher Index Universal Life sales following the launch of new, capital-light products. |
¨ |
Spain & Portugal increased by EUR 5 million to EUR 48 million in 2021 mainly due to sales growth in the bancassurance channel. |
¨ |
In the Other segment, new life sales decreased by EUR 82 million to EUR 2 million, largely reflecting the exclusion of sales from Central & Eastern Europe as of 2021, following the announced divestment of the business. |
Results of operations – International |
Results of operations – Aegon Asset Management |
| Results 2021 Asset Management |
| |||||||||||||||
Amounts in EUR millions |
2021 |
2020 | % | |||||||||||||
| Operating result |
181 |
130 |
39 |
|||||||||||||
| Tax on operating result |
72 | 51 | 40 |
|||||||||||||
| Operating result |
||||||||||||||||
| Global Platforms |
54 | 46 | 17 |
|||||||||||||
| Strategic Partnerships |
199 | 136 | 47 |
|||||||||||||
| Operating result |
253 |
182 |
39 |
|||||||||||||
| Fair value items |
(1 | ) | 22 | n.m. |
||||||||||||
| Realized gains / (losses) on investments |
2 | 1 | 148 |
|||||||||||||
| Net impairments |
(1 | ) | (1 | ) | 53 |
|||||||||||
| Non-operating items |
- |
22 |
(99) |
|||||||||||||
| Other income / (charges) |
(18 | ) | (8 | ) | (123) |
|||||||||||
Result before tax (excluding income tax from certain proportionately consolidated joint ventures and associates) |
235 |
195 |
21 |
|||||||||||||
| Income tax from certain proportionately consolidated joint ventures and associates included in result before tax |
(57 | ) | 40 | n.m. |
||||||||||||
| Income tax |
(65 | ) | (44 | ) | (47) |
|||||||||||
| Of which Income tax from certain proportionately consolidated joint ventures and associates included in result before tax |
57 | (40 | ) | n.m. |
||||||||||||
| Net result |
170 |
151 |
13 |
|||||||||||||
| Management fees |
602 | 506 | 19 |
|||||||||||||
| Performance fees |
112 | 105 | 7 |
|||||||||||||
| Other |
75 | 65 | 16 |
|||||||||||||
| Total revenues |
788 |
676 |
17 |
|||||||||||||
| Operating expenses |
552 | 485 | 14 |
|||||||||||||
| of which addressable expenses |
371 | 359 | 3 |
|||||||||||||
| Operating Margin - Global Platforms only |
12.6% | 10.9% | ||||||||||||||
| Gross deposits (on and off balance) |
||||||||||||||||
Amounts in EUR millions |
2021 |
2020 | % |
|||||||||||||
| Global Platforms |
52,845 | 51,950 | 2 |
|||||||||||||
| Strategic Partnerships |
131,204 | 115,544 | 14 |
|||||||||||||
| Total gross deposits |
184,049 |
167,494 |
10 |
|||||||||||||
Exchange rates |
||||||||||||||||
| Weighted average rate | Closing rate as of | |||||||||||||||
Per 1 EUR |
2021 |
2020 | December 31, 2021 |
December 31, 2020 |
||||||||||||
| USD |
1.1831 | 1.1416 | 1.1372 | 1.2236 | ||||||||||||
| Pound Sterling |
0.8598 | 0.8892 | 0.8396 | 0.8951 | ||||||||||||
| Hungarian Florint |
358.4993 | 351.1554 | 368.5650 | 362.6850 | ||||||||||||
| Chinese Yuan Renminbi |
7.6313 | 7.8726 | 7.2478 | 8.0018 | ||||||||||||
Results of operations – International |
¨ |
The operating result from Strategic Partnerships increased to EUR 199 million in 2021 compared with EUR 136 million in 2020. This was mainly driven by higher management fees as a result of net deposits and favorable markets in AIFMC in 2021. Performance fees net of performance-based compensation were EUR 73 million. |
¨ |
The operating result from Global Platforms increased from EUR 46 million in 2020 to EUR 54 million in 2021. This was driven by higher management fees, mainly in the fixed income platform, as a result of third-party net deposits and favorable markets. This more than offset higher expenses driven by accruals of performance-related compensation. |
Exchange rates |
2021 |
2020 | 2019 | ||||||||||||||||||||||||||||||||||||
EUR |
USD |
GBP |
EUR | USD | GBP | EUR | USD | GBP | ||||||||||||||||||||||||||||||
| 1 |
EUR |
- |
1.1372 |
0.8396 |
- |
1.2236 |
0.8951 |
- |
1.1225 |
0.8473 |
||||||||||||||||||||||||||||
| 1 |
USD |
0.8794 |
- |
0.7383 |
0.8173 |
- |
0.7315 |
0.8909 |
- |
0.7548 |
||||||||||||||||||||||||||||
| 1 |
GBP |
1.1910 |
1.3545 |
- |
1.1172 |
1.3670 |
- |
1.1802 |
1.3248 |
- |
||||||||||||||||||||||||||||
2021 |
2020 | 2019 | ||||||||||||||||||||||||||||||||||||
EUR |
USD |
GBP |
EUR | USD | GBP | EUR | USD | GBP | ||||||||||||||||||||||||||||||
| 1 |
EUR |
- |
1.1831 |
0.8598 |
- |
1.1416 |
0.8892 |
- |
1.1197 |
0.8770 |
||||||||||||||||||||||||||||
| 1 |
USD |
0.8452 |
- |
0.7267 |
0.8760 |
- |
0.7789 |
0.8931 |
- |
0.7832 |
||||||||||||||||||||||||||||
| 1 |
GBP |
1.1631 |
1.3760 |
- |
1.1246 |
1.2839 |
- |
1.1403 |
1.2767 |
- |
||||||||||||||||||||||||||||
Consolidated financial statements of Aegon N.V. |
Amounts in EUR millions (except per share data) |
Note |
2021 |
2020 | 2019 | ||||||||||||
| Premium income |
6 |
|||||||||||||||
| Investment income |
7 |
|||||||||||||||
| Fee and commission income |
8 |
|||||||||||||||
| Other revenues |
||||||||||||||||
| Total revenues |
||||||||||||||||
| Income from reinsurance ceded |
9 |
|||||||||||||||
| Results from financial transactions |
10 |
|||||||||||||||
| Other income |
11 |
|||||||||||||||
| Total income |
||||||||||||||||
| Premiums paid to reinsurers |
6 |
|||||||||||||||
| Policyholder claims and benefits |
12 |
|||||||||||||||
| Profit sharing and rebates |
13 |
|||||||||||||||
| Commissions and expenses |
14 |
|||||||||||||||
| Impairment charges / (reversals) |
15 |
|||||||||||||||
| Interest charges and related fees |
16 |
|||||||||||||||
| Other charges |
17 |
|||||||||||||||
| Total charges |
||||||||||||||||
Result before share in profit / (loss) of joint ventures, associates and tax |
( |
) |
||||||||||||||
| Share in profit / (loss) of joint ventures |
25 |
|||||||||||||||
| Share in profit / (loss) of associates |
25 |
|||||||||||||||
| Result before tax |
( |
) |
||||||||||||||
| Income tax (expense) / benefit |
18 |
( |
) | ( |
) | |||||||||||
| Net result |
( |
) |
||||||||||||||
| Net result attributable to: |
||||||||||||||||
| Owners of Aegon N.V. |
( |
) | ||||||||||||||
| Non-controlling interests |
||||||||||||||||
| Earnings per share (EUR per share) |
19 |
|||||||||||||||
| Basic earnings per common share |
( |
) | ||||||||||||||
| Basic earnings per common share B |
||||||||||||||||
| Diluted earnings per common share |
( |
) | ||||||||||||||
| Diluted earnings per common share B |
||||||||||||||||
Consolidated financial statements of Aegon N.V. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
Amounts in EUR millions |
2021 |
1) |
2019 | |||||||||
| Net result |
( |
) |
||||||||||
| Items that will not be reclassified to profit or loss: |
||||||||||||
| Changes in revaluation reserve real estate held for own use |
( |
) | ( |
) | ||||||||
| Remeasurements of defined benefit plans |
( |
) | ( |
) | ||||||||
| Income tax relating to items that will not be reclassified |
( |
) | ||||||||||
| Items that may be reclassified subsequently to profit or loss: |
||||||||||||
| Gains / (losses) on revaluation of available-for-sale |
( |
) | ||||||||||
| (Gains) / losses transferred to income statement on disposal and impairment of available-for-sale |
( |
) | ( |
) | ||||||||
| Changes in cash flow hedging reserve |
( |
) | ( |
) | ( |
) | ||||||
| Movement in foreign currency translation and net foreign investment hedging reserves |
( |
) | ||||||||||
| Equity movements of joint ventures |
||||||||||||
| Equity movements of associates |
( |
) | ||||||||||
| Disposal of group assets |
( |
) | ( |
) | ||||||||
| Income tax relating to items that may be reclassified |
( |
) | ( |
) | ||||||||
| Other |
||||||||||||
| Total other comprehensive income / (loss) |
||||||||||||
| Total comprehensive income / (loss) |
||||||||||||
| Total comprehensive income / (loss) attributable to: |
||||||||||||
| Owners of Aegon N.V. |
||||||||||||
| Non-controlling interests |
( |
) | ||||||||||
1 |
Comparative amounts have been updated to reflect revised disclosure on the change in ownership non-controlling interest. |
Consolidated financial statements of Aegon N.V. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts in EUR millions |
Note |
2021 |
2020 | 2019 | ||||||||||||
| Assets |
||||||||||||||||
| Cash and cash equivalents |
21 |
|||||||||||||||
| Investments |
22 |
|||||||||||||||
| Investments for account of policyholders |
23 |
|||||||||||||||
| Derivatives |
24 |
|||||||||||||||
| Investments in joint ventures |
25 |
|||||||||||||||
| Investments in associates |
25 |
|||||||||||||||
| Reinsurance assets |
26 |
|||||||||||||||
| Defined benefit assets |
39 |
|||||||||||||||
| Deferred tax assets |
40 |
|||||||||||||||
| Deferred expenses |
27 |
|||||||||||||||
| Other assets and receivables |
28 |
|||||||||||||||
| Intangible assets |
29 |
|||||||||||||||
| Total assets |
||||||||||||||||
| Equity and liabilities |
||||||||||||||||
| Shareholders’ equity |
30 |
|||||||||||||||
| Other equity instruments |
31 |
|||||||||||||||
| Issued capital and reserves attributable to owners of Aegon N.V. |
||||||||||||||||
| Non-controlling interests |
||||||||||||||||
| Group equity |
||||||||||||||||
| Subordinated borrowings |
32 |
|||||||||||||||
| Trust pass-through securities |
33 |
|||||||||||||||
| Insurance contracts |
34 |
|||||||||||||||
| Insurance contracts for account of policyholders |
34 |
|||||||||||||||
| Investment contracts |
35 |
|||||||||||||||
| Investment contracts for account of policyholders |
35 |
|||||||||||||||
| Derivatives |
24 |
|||||||||||||||
| Borrowings |
37 |
|||||||||||||||
| Provisions |
38 |
|||||||||||||||
| Defined benefit liabilities |
39 |
|||||||||||||||
| Deferred gains |
||||||||||||||||
| Deferred tax liabilities |
40 |
|||||||||||||||
| Other liabilities |
41 |
|||||||||||||||
| Accruals |
42 |
|||||||||||||||
| Total liabilities |
||||||||||||||||
| Total equity and liabilities |
||||||||||||||||
Consolidated financial statements of Aegon N.V. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts in EUR millions |
Note |
Share capital |
Retained earnings |
Revaluation reserves |
Remea- surement of defined benefit plans |
Other reserves |
Other equity instru- ments |
Issued capital and reserves 1) |
Non- control- ling interests |
Total |
||||||||||||||||||||||||||||||
| At January 1, 2021 |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||
| Net result recognized in the income statement |
- | - | - | - | - | |||||||||||||||||||||||||||||||||||
| Other comprehensive income: |
||||||||||||||||||||||||||||||||||||||||
Items that will not be reclassified to profit or loss: |
||||||||||||||||||||||||||||||||||||||||
| Changes in revaluation reserve real estate held for own use |
- | - | ( |
) | - | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Remeasurements of defined benefit plans |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Income tax relating to items that will not be reclassified |
- | - | ( |
) | - | - | ( |
) | - | ( |
) | |||||||||||||||||||||||||||||
Items that may be reclassified subsequently to profit or loss: |
||||||||||||||||||||||||||||||||||||||||
| Gains / (losses) on revaluation of available-for-sale |
- | - | ( |
) | - | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| (Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments |
- | - | ( |
) | - | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Changes in cash flow hedging reserve |
- | - | ( |
) | - | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Movements in foreign currency translation and net foreign investment hedging reserves |
- | - | ( |
) | - | |||||||||||||||||||||||||||||||||||
| Equity movements of joint ventures |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Equity movements of associates |
- | - | - | - | ( |
) | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Disposal of group assets |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Income tax relating to items that may be reclassified |
- | - | - | - | - | |||||||||||||||||||||||||||||||||||
| Other |
- | - | - | - | - | |||||||||||||||||||||||||||||||||||
Total other comprehensive income / (loss) |
- |
( |
) |
- |
||||||||||||||||||||||||||||||||||||
Total comprehensive income / (loss) for 2021 |
( |
) |
||||||||||||||||||||||||||||||||||||||
| Shares issued |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Issuance and purchase of treasury shares |
- | ( |
) | - | - | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Issuance and redemption of other equity instruments |
- | - | - | - | - | ( |
) | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Dividends paid on common shares |
( |
) | ( |
) | - | - | - | - | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
| Coupons on perpetual securities |
- | ( |
) | - | - | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Incentive plans |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Change in ownership non-controlling interest |
- | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
| At December 31, 2021 |
30,31 |
( |
) |
|||||||||||||||||||||||||||||||||||||
1 |
Issued capital and reserves attributable to owners of Aegon N.V. |
Consolidated financial statements of Aegon N.V. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts in EUR millions |
Note |
Share capital |
Retained earnings |
Revaluation reserves |
Remea- surement of defined benefit plans |
Other reserves |
Other equity instru- ments |
Issued capital and reserves 1) |
Non- controlling interests 2) |
Total |
||||||||||||||||||||||||||||||
| At January 1, 2020 |
( |
) | ||||||||||||||||||||||||||||||||||||||
| Net result recognized in the income statement |
- | ( |
) | - | - | - | - | ( |
) | ( |
) | |||||||||||||||||||||||||||||
| Other comprehensive income: |
||||||||||||||||||||||||||||||||||||||||
Items that will not be reclassified to profit or loss: |
||||||||||||||||||||||||||||||||||||||||
| Changes in revaluation reserve real estate held for own use |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Remeasurements of defined benefit plans |
- | - | - | ( |
) | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Income tax relating to items that will not be reclassified |
- | - | ( |
) | - | - | - | |||||||||||||||||||||||||||||||||
Items that may be reclassified subsequently to profit or loss: |
||||||||||||||||||||||||||||||||||||||||
| Gains / (losses) on revaluation of available-for-sale |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| (Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Changes in cash flow hedging reserve |
- | - | ( |
) | - | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Movements in foreign currency translation and net foreign investment hedging reserves |
- | - | ( |
) | ( |
) | - | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||||||
| Equity movements of joint ventures |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Equity movements of associates |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Disposal of group assets |
- | - | - | ( |
) | - | ( |
) | - | ( |
) | |||||||||||||||||||||||||||||
| Income tax relating to items that may be reclassified |
- | - | ( |
) | - | ( |
) | - | ( |
) | - | ( |
) | |||||||||||||||||||||||||||
| Other |
- | - | - | - | ||||||||||||||||||||||||||||||||||||
Total other comprehensive income / (loss) |
- |
( |
) |
( |
) |
- |
( |
) |
||||||||||||||||||||||||||||||||
Total comprehensive income / (loss) for 2020 |
- |
( |
) |
( |
) |
( |
) |
- |
||||||||||||||||||||||||||||||||
| Shares issued |
( |
) | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||
| Issuance and purchase of treasury shares |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Issuance and redemption of other equity instruments |
- | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||
| Dividends paid on common shares |
( |
) | ( |
) | - | - | - | - | ( |
) | - | ( |
) | |||||||||||||||||||||||||||
| Dividend withholding tax reduction |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Coupons on perpetual securities |
- | ( |
) | - | - | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Incentive plans |
- | - | - | - | ( |
) | - | |||||||||||||||||||||||||||||||||
| Change in ownership non-controlling interest |
- | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||
| At December 31, 2020 |
30,31 |
( |
) |
( |
) |
|||||||||||||||||||||||||||||||||||
1 |
Issued capital and reserves attributable to owners of Aegon N.V. |
2 |
Comparative amounts have been updated to reflect revised disclosure on the change in ownership non-controlling interest. |
Consolidated financial statements of Aegon N.V. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts in EUR millions |
Note |
Share capital |
Retained earnings |
Revalua- tion reserves |
Remea- surement of defined benefit plans |
Other reserves |
Other equity instru- ments |
Issued capital and reserves 1) |
Non-controlling interests |
Total |
||||||||||||||||||||||||||||||
At January 1, 2019 (as previously stated) |
( |
) | ||||||||||||||||||||||||||||||||||||||
| Voluntary change in accounting policy |
2.1.2 |
- | ( |
) | - | - | - | - | ( |
) | - | ( |
) | |||||||||||||||||||||||||||
| At January 1, 2019 |
( |
) | ||||||||||||||||||||||||||||||||||||||
| Net result recognized in the income statement |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Other comprehensive income: |
||||||||||||||||||||||||||||||||||||||||
Items that will not be reclassified to profit or loss: |
||||||||||||||||||||||||||||||||||||||||
| Changes in revaluation reserve real estate held for own use |
- | ( |
) | - | - | - | ( |
) | - | ( |
) | |||||||||||||||||||||||||||||
| Remeasurements of defined benefit plans |
- | - | - | ( |
) | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Income tax relating to items that will not be reclassified |
- | ( |
) | - | - | - | ||||||||||||||||||||||||||||||||||
Items that may be reclassified subsequently to profit or loss: |
||||||||||||||||||||||||||||||||||||||||
| Gains / (losses) on revaluation of available-for-sale |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| (Gains) / losses transferred to income statement on disposal and impairment of available-for-sale investments |
- | - | ( |
) | - | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Changes in cash flow hedging reserve |
- | - | ( |
) | - | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Movements in foreign currency translation and net foreign investment hedging reserves |
- | - | ( |
) | - | - | ||||||||||||||||||||||||||||||||||
| Equity movements of joint ventures |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Equity movements of associates |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Disposal of group assets |
- | - | - | - | ( |
) | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Income tax relating to items that may be reclassified |
- | - | ( |
) | - | ( |
) | - | ( |
) | - | ( |
) | |||||||||||||||||||||||||||
| Other |
- | - | - | - | - | ( |
) | |||||||||||||||||||||||||||||||||
Total other comprehensive income / (loss) |
- |
( |
) |
- |
( |
) |
||||||||||||||||||||||||||||||||||
Total comprehensive income / (loss) for 2019 |
- |
( |
) |
- |
( |
) |
||||||||||||||||||||||||||||||||||
| Shares issued |
- | - | - | - | - | - | ||||||||||||||||||||||||||||||||||
| Issuance and purchase of treasury shares |
- | ( |
) | - | - | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Issuance and redemption of other equity instruments |
- | ( |
) | - | - | - | ( |
) | ( |
) | - | ( |
) | |||||||||||||||||||||||||||
| Dividends paid on common shares |
( |
) | ( |
) | - | - | - | - | ( |
) | - | ( |
) | |||||||||||||||||||||||||||
| Dividend withholding tax reduction |
- | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||
| Coupons on perpetual securities |
- | ( |
) | - | - | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||
| Incentive plans |
- | - | - | - | ( |
) | ( |
) | - | ( |
) | |||||||||||||||||||||||||||||
| At December 31, 2019 |
30,31 |
( |
) |
|||||||||||||||||||||||||||||||||||||
1 |
Issued capital and reserves attributable to owners of Aegon N.V. |
Consolidated financial statements of Aegon N.V. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amounts in EUR millions |
Note |
2021 |
2020 | 2019 | ||||||||||||
| Result before tax |
( |
) |
||||||||||||||
| Results from financial transactions |
( |
) | ( |
) | ( |
) | ||||||||||
| Amortization and depreciation |
||||||||||||||||
| Impairment losses |
||||||||||||||||
| Income from joint ventures |
( |
) | ( |
) | ( |
) | ||||||||||
| Income from associates |
( |
) | ( |
) | ( |
) | ||||||||||
| Release of cash flow hedging reserve |
( |
) | ( |
) | ( |
) | ||||||||||
| Other |
||||||||||||||||
| Adjustments of non-cash items |
( |
) |
( |
) |
( |
) | ||||||||||
| Insurance and investment liabilities |
( |
) | ||||||||||||||
| Insurance and investment liabilities for account of policyholders |
||||||||||||||||
| Accrued expenses and other liabilities |
( |
) | ||||||||||||||
| Accrued income and prepayments |
( |
) | ( |
) | ( |
) | ||||||||||
| Changes in accruals |
||||||||||||||||
| Purchase of investments (other than money market investments) |
( |
) | ( |
) | ( |
) | ||||||||||
| Purchase of derivatives |
( |
) | ( |
) | ||||||||||||
| Disposal of investments (other than money market investments) |
||||||||||||||||
| Disposal of derivatives |
||||||||||||||||
| Net purchase of investments for account of policyholders |
||||||||||||||||
| Net change in cash collateral |
( |
) | ( |
) | ||||||||||||
| Net purchase of money market investments |
( |
) | ||||||||||||||
| Cash flow movements on operating items not reflected in income |
||||||||||||||||
| Tax (paid)/ received |
( |
) | ( |
) | ||||||||||||
| Other |
( |
) | ( |
) | ||||||||||||
| Net cash flows from operating activities |
21 |
( |
) |
( |
) |
|||||||||||
| Purchase of individual intangible assets (other than VOBA and future servicing rights) |
( |
) | ( |
) | ( |
) | ||||||||||
| Purchase of equipment and real estate for own use |
( |
) | ( |
) | ( |
) | ||||||||||
| Acquisition of subsidiaries, net of cash |
( |
) | ( |
) | ||||||||||||
| Acquisition/capital contributions joint ventures and associates |
( |
) | ( |
) | ( |
) | ||||||||||
| Disposal of intangible asset |
||||||||||||||||
| Disposal of equipment |
||||||||||||||||
| Disposal of subsidiaries and businesses, net of cash |
- | |||||||||||||||
| Disposal joint ventures and associates |
||||||||||||||||
| Dividend received from joint ventures and associates |
||||||||||||||||
| Net cash flows from investing activities |
21 |
( |
) |
( |
) |
( |
) | |||||||||
| Issuance of treasury shares |
- | |||||||||||||||
| Issuance of perpetuals |
- | |||||||||||||||
| Purchase of treasury shares |
( |
) | ( |
) | ( |
) | ||||||||||
| Proceeds from TRUPS 1) , Subordinated borrowings and borrowings |
||||||||||||||||
| Repayment of perpetuals |
( |
) | - | ( |
) | |||||||||||
| Repayment of TRUPS 1) , Subordinated borrowings and borrowings |
( |
) | ( |
) | ( |
) | ||||||||||
| Dividends paid |
( |
) | ( |
) | ( |
) | ||||||||||
| Coupons on perpetual securities |
( |
) | ( |
) | ( |
) | ||||||||||
| Payment of Right-of-use |
( |
) | ( |
) | ( |
) | ||||||||||
| Change in ownership non-controlling interests |
- | - | ||||||||||||||
| Net cash flows from financing activities |
21 |
( |
) |
( |
) | |||||||||||
| Net increase / (decrease) in cash and cash equivalents 2) |
( |
) |
( |
) |
||||||||||||
| Net cash and cash equivalents at the beginning of the year |
||||||||||||||||
| Effects of changes in exchange rate |
( |
) | ||||||||||||||
| Net cash and cash equivalents at the end of the year |
21 |
|||||||||||||||
1 |
Trust pass-through securities. |
2 |
Included in net increase / (decrease) in cash and cash equivalents are interest received EUR |
Notes to the consolidated financial statements Note 1 |
Notes to the consolidated financial statements Note 2 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shareholders’ equity | Net result | |||||||||||||||||||||||
2021 |
2020 | 2019 | 2021 |
2020 | 2019 | |||||||||||||||||||
| In accordance with IFRS |
( |
) |
||||||||||||||||||||||
| Adjustment of EU ‘IAS 39’ carve-out |
( |
) | ||||||||||||||||||||||
| Tax effect of the adjustment |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
| Effect of the adjustment after tax |
( |
) |
||||||||||||||||||||||
| In accordance with EU-IFRS |
||||||||||||||||||||||||
| |
|
|
|
|
| Accounting standard/ amendment/ interpretation |
IASB effective date |
Impact for Aegon | ||
| Interest Rate Benchmark Reform – Phase 2 (Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16) |
January 1, 2021 | See below for comments | ||
| Extension of the Temporary Exemption from Applying IFRS 9 (Amendments to IFRS 4 Insurance Contracts) |
January 1, 2021 | See 2.1.2 for comments | ||
| Early adopted: |
||||
| COVID-19-Related |
April 1, 2021 | Low | ||
Notes to the consolidated financial statements Note 2 |
Accounting standard/ amendment/ interpretation |
IASB effective date |
Early adopted by Aegon |
Impact for Aegon | |||
IFRS 17 Insurance contracts |
January 1, 2023 | No | See below for comments | |||
Initial Application of IFRS 17 and IFRS 9 - Comparative Information (Amendments to IFRS 17) |
January 1, 2023 | No | See below for comments | |||
IFRS 9 Financial instruments |
January 1, 2018 1) |
No | See below for comments | |||
Prepayment Features with Negative Compensation (Amendments to IFRS 9) |
January 1, 2019 1) |
No | See below for comments | |||
Reference to the Conceptual Framework (Amendments to IFRS 3) |
January 1, 2022 | No | Low | |||
Property, Plant and Equipment: Proceeds before Intended Use (Amendments to IAS 16) |
January 1, 2022 | No | Low | |||
Onerous Contracts – Cost of Fulfilling a Contract (Amendments to IAS 37) |
January 1, 2022 | No | Low | |||
Annual Improvements to IFRS Standards 2018–2020 |
January 1, 2022 | No | Low | |||
Classification of Liabilities as Current or Non-current (Amendments toIAS 1) |
January 1, 2023 | No | Low | |||
Disclosure of Accounting Policies (Amendments to IAS 1 and IFRS Practice Statement 2) |
January 1, 2023 | No | Low | |||
Definition of Accounting Estimates (Amendments to IAS 8) |
January 1, 2023 | No | Low | |||
Deferred Tax related to Assets and Liabilities arising from a Single Transaction (Amendments to IAS 12) |
January 1, 2023 | No | Low | |||
1 |
The amendments to IFRS 4, Applying IFRS 9 Financial Instruments with IFRS 4 Insurance Contracts, issued in September 2016, allow entities that issue insurance contracts within the scope of IFRS 4 to defer the implementation of IFRS 9 (and linked amendments ‘Amendments to IFRS 9 Financial instruments on prepayment features with negative compensation’). The amendments to IFRS 4 are further explained below. |
¨ |
Greater than 90% of the total carrying value of all liabilities; or |
¨ |
Between 80% and 90% of the total carrying value of all its liabilities, and the insurer does not have significant activities unrelated to insurance. |
Notes to the consolidated financial statements Note 2 |
¨ |
SPPI: assets of which cash flows represent solely payments of principal and interest (SPPI) on an outstanding principal amount, excluding any financial assets that meet the definition of held for trading in IFRS 9, or that are managed and whose performance is evaluated on a fair value basis; and |
¨ |
Other: all financial assets other than those specified in SPPI: |
¨ |
with contractual terms that do not give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding; |
¨ |
that meet the definition of held for trading in IFRS 9; or |
¨ |
that are managed and whose performance are evaluated on a fair value basis. |
2021 |
2020 | |||||||||||||||||||||||
Financial assets at fair value |
Fair value at the end of the reporting period |
Change in fair value during the reporting period |
Fair value at the end of the reporting period |
Change in fair value during the reporting period |
||||||||||||||||||||
Shares 1) |
SPPI | |||||||||||||||||||||||
| Other | ||||||||||||||||||||||||
Debt securities |
SPPI | ( |
) | |||||||||||||||||||||
| Other | ( |
) | ||||||||||||||||||||||
Money Markets and other short-term investments |
SPPI | ( |
) | |||||||||||||||||||||
| Other | ||||||||||||||||||||||||
Mortgage loans |
SPPI | ( |
) | |||||||||||||||||||||
| Other | - | - | ||||||||||||||||||||||
Private loans |
SPPI | ( |
) | |||||||||||||||||||||
| Other | ( |
) | ||||||||||||||||||||||
Deposits with financial institutions |
SPPI | |||||||||||||||||||||||
| Other | - | - | ||||||||||||||||||||||
Policy loans |
SPPI | |||||||||||||||||||||||
| Other | ( |
) | ||||||||||||||||||||||
Other financial assets |
SPPI | - | - | |||||||||||||||||||||
| Other | ( |
) | ||||||||||||||||||||||
At December 31 |
( |
) |
||||||||||||||||||||||
1 |
The SPPI-compliant shares include preferred equity instruments. |
Notes to the consolidated financial statements Note 2 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
SPPI compliant financial assets at carrying value |
AAA | AA | A | BBB | BB | B | CCC or lower |
Not Rated |
Total | |||||||||||||||||||||||||||
| 2021 |
||||||||||||||||||||||||||||||||||||
| Shares – Carried at fair value |
- | - | - | - | - | |||||||||||||||||||||||||||||||
| Debt securities – Carried at fair value |
||||||||||||||||||||||||||||||||||||
| Money market and other short-term investments- carried at fair value |
- | - | - | - | ||||||||||||||||||||||||||||||||
| Mortgage loans– Carried at amortized cost |
- | - | ||||||||||||||||||||||||||||||||||
| Private loans – Carried at amortized cost |
- | - | ||||||||||||||||||||||||||||||||||
| Other financial assets – Carried at fair value |
- | - | - | - | ||||||||||||||||||||||||||||||||
| At December 31 |
||||||||||||||||||||||||||||||||||||
| 2020 |
||||||||||||||||||||||||||||||||||||
| Shares – Carried at fair value |
- | - | - | |||||||||||||||||||||||||||||||||
| Debt securities – Carried at fair value |
||||||||||||||||||||||||||||||||||||
| Money market and other short-term investments- carried at fair value |
- | - | - | - | ||||||||||||||||||||||||||||||||
| Mortgage loans– Carried at amortized cost |
- | - | ||||||||||||||||||||||||||||||||||
| Private loans – Carried at amortized cost |
- | - | ||||||||||||||||||||||||||||||||||
| Other financial assets – Carried at fair value |
- | - | ||||||||||||||||||||||||||||||||||
| At December 31 |
||||||||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
2020 | |||||||||||||||||||||||
SPPI compliant financial assets rated BB or below |
Carrying amount |
Fair value |
Carrying amount | Fair value | ||||||||||||||||||||
| Shares – Carried at fair value |
||||||||||||||||||||||||
| Debt securities – Carried at fair value |
||||||||||||||||||||||||
| Mortgage loans – Carried at amortized cost |
||||||||||||||||||||||||
| Private loans – Carried at amortized cost |
||||||||||||||||||||||||
| Deposits with financial institutions – Carried at amortized cost |
||||||||||||||||||||||||
| Other financial assets – Carried at fair value |
||||||||||||||||||||||||
| At December 31 |
||||||||||||||||||||||||
1 |
Mortgage loans with no low credit risk are defined as being more than 90 days past due, in line with regulatory guidelines. |
Notes to the consolidated financial statements Note 2 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
2020 | |||||||||||||||||||||||
Financial assets at fair value |
Fair value at the end of the reporting period |
Change in fair value during the reporting period |
Fair value at the end of the reporting period |
Change in fair value during the reporting period |
||||||||||||||||||||
| Debt securities |
SPPI | |||||||||||||||||||||||
| Other | ||||||||||||||||||||||||
| Money Markets and other short-term investments |
SPPI | |||||||||||||||||||||||
| Other | ||||||||||||||||||||||||
| At December 31 |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SPPI compliant financial assets at carrying value |
AAA | AA | A | BBB | BB | B | CCC or lower |
Not Rated |
Total | |||||||||||||||||||||||||||
| 2021 |
||||||||||||||||||||||||||||||||||||
| Debt securities – Carried at fair value |
- | - | - | - | ||||||||||||||||||||||||||||||||
| At December 31 |
- |
- |
- |
- |
||||||||||||||||||||||||||||||||
| 2020 |
||||||||||||||||||||||||||||||||||||
| Debt securities – Carried at fair value |
- | - | - | - | ||||||||||||||||||||||||||||||||
| At December 31 |
- |
- |
- |
- |
||||||||||||||||||||||||||||||||
¨ |
Aegon Bank N.V. |
¨ |
Aegon Hypotheken B.V. |
¨ |
Aegon Asset Management Holding B.V. |
¨ |
Amvest Vastgoed B.V. |
¨ |
Amvest Development Fund B.V. |
¨ |
Amvest Living & Care Fund |
¨ |
Amvest Residential Core Fund |
Notes to the consolidated financial statements Note 2 |
¨ |
Control structure of the asset manager (i.e. whether an Aegon subsidiary); |
¨ |
The investment constraints posed by investment mandate; |
¨ |
Legal rights held by the policyholder to the separate assets in the investment vehicle (e.g. policyholders could have the voting rights related to these investments); |
¨ |
The governance structure, such as an independent board of directors, representing the policyholders, which has substantive rights (e.g. to elect or remove the asset manager); and |
¨ |
Rights held by other parties (e.g. voting rights of policyholders that are substantive or not). |
¨ |
General account investment of Aegon; |
¨ |
Aegon’s investments held for policyholder; |
¨ |
Guarantees provided by Aegon on return of policyholders in specific investment vehicles; |
Notes to the consolidated financial statements Note 2 |
¨ |
• Fees dependent on fund value (including, but not limited to, asset management fees); and |
¨ |
• Fees dependent on performance of the fund (including, but not limited to, performance fees). |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
¨ |
When considering the ‘highly probable’ requirement, it is assumed that the current benchmark interest rate on which the hedged positions is based will not change as a result of IBOR reform. |
¨ |
In assessing whether the hedge is expected to be ‘highly effective’ on a forward-looking basis, it is assumed that the current benchmark interest rate on which the cash flows of the hedged item and the derivative that hedges it are based is not altered as a result of the IBOR reform. |
¨ |
Hedge accounting is not discontinued during the period of IBOR-related uncertainty solely because the retrospective effectiveness falls outside the required 80-125% range. |
¨ |
The cash flows hedge reserve relating to the period after the IBOR reform is expected to take effect, is not recycled solely because cash flows are expected to change. |
¨ |
designating an alternative benchmark rate as the hedged risk; |
¨ |
amending the description of the hedged item, including the description of the designated portion of the cash flows or fair value being hedged; |
¨ |
amending the description of the hedging instrument; or |
¨ |
amending the description of the method for assessing hedge effectiveness. |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
¨ |
• Current year service cost which is recognized in profit or loss; and |
¨ |
• Net interest on the net defined benefit liability (asset) which is recognized in profit or loss. |
¨ |
• Actuarial gains and losses; |
¨ |
• The return on plan assets, excluding amounts included in net interest on the net defined benefit liability (asset); and |
¨ |
Any change in the effect of the asset ceiling, excluding amounts included in net interest on the net defined benefit liability (asset). |
¨ |
• The present value of the defined benefit obligation being settled, as determined on the date of settlement; and |
¨ |
• The settlement price, including any plan assets transferred and any payments made directly by Aegon in connection with the settlement. |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 2 |
Notes to the consolidated financial statements Note 3 |
Notes to the consolidated financial statements Note 3 |
Notes to the consolidated financial statements Note 3 |
2021 |
2020 | |||
Estimated approximate effect |
DPAC /VOBA |
DPAC /VOBA | ||
( |
( |
2021 |
2020 | |||||||
Estimated approximate effect |
Net Result |
Net Result | ||||||
| |
( |
) |
( |
) | ||||
| |
||||||||
Notes to the consolidated financial statements Note 3 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
2020 | |||||||||||
Estimated approximate effect |
GPV |
GPV | ||||||||||
| |
||||||||||||
| |
( |
) | ( |
) | ||||||||
| |
||||||||||||
| |
( |
) | ( |
) | ||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
2020 | |||||||||||||
Estimated approximate effect in EUR billion |
LAT deficit |
LAT deficit | ||||||||||||
| 100 bps increase in interest rate |
( |
) | ( |
) | ||||||||||
| 100 bps decrease in interest rate |
||||||||||||||
| 50 bps increase in bond credit spread |
||||||||||||||
| 50 bps decrease in bond credit spread |
( |
) | ( |
) | ||||||||||
| 50 bps increase in mortgage spread |
||||||||||||||
| 50 bps decrease in mortgage spread |
( |
) | ( |
) | ||||||||||
| 5 bps increase in liquidity premium |
( |
) | ( |
) | ||||||||||
| 5 bps decrease in liquidity premium |
||||||||||||||
¨ |
• In the principal market for the asset or liability; or |
¨ |
• In the absence of a principal market, in the most advantageous market for the asset or liability. |
Notes to the consolidated financial statements Note 4 |
¨ |
Level I: quoted prices (unadjusted) in active markets for identical assets or liabilities that Aegon can access at the measurement date; |
¨ |
Level II: inputs other than quoted prices included within Level I that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices of identical or similar assets and liabilities) using valuation techniques for which all significant inputs are based on observable market data; and |
¨ |
Level III: inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs) using valuation techniques for which any significant input is not based on observable market data. |
Notes to the consolidated financial statements Note 4 |
Notes to the consolidated financial statements Note 4 |
¨ |
Concentration per risk type: Risk exposures are measured per risk type as part of Aegon’s internal economic framework. A risk tolerance framework is in place which sets risk limits per risk type to target desired risk balance and promote diversification across risk types; |
¨ |
Concentration per counterparty: Risk exposure is measured and risk limits are in place per counterparty as part of the Counterparty Name Limit Policy; and |
¨ |
Concentration per sector, geography and asset class: Aegon’s investment strategy is translated in investment mandates for its internal and external asset managers. Through these investment mandates limits on sector, geography and asset class are set. Compliance monitoring of the investment mandates is done by the insurance operating companies. |
¨ |
• Credit risk |
¨ |
• Equity market risk and other investment risks |
¨ |
• Interest rate risk |
¨ |
• Currency exchange risk |
¨ |
• Liquidity risk |
Notes to the consolidated financial statements Note 4 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
Maximum exposure to credit risk |
Cash |
Securities |
Letters of credit / guaran- tees |
Real estate property |
Master netting agree- ments |
Other |
Total collateral |
Surplus collateral (or overcollater- alization) |
Net exposure |
||||||||||||||||||
| Debt securities - carried at fair value |
- | - | - | - | - | - | ||||||||||||||||||||||
| Money market and other short-term investments - carried at fair value |
- | - | - | - | - | |||||||||||||||||||||||
| Mortgage loans - carried at amortized cost |
- | - | - | |||||||||||||||||||||||||
| Private loans - carried at amortized cost |
- | - | - | - | - | - | ||||||||||||||||||||||
| Other loans - carried at amortized cost |
- | - | - | - | - | |||||||||||||||||||||||
| Other financial assets - carried at fair value |
- | - | - | - | - | - | - | - | ||||||||||||||||||||
| Derivatives |
- | - | - | |||||||||||||||||||||||||
| Reinsurance assets |
- | - | - | - | - | |||||||||||||||||||||||
| At December 31 |
||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2020 |
Maximum exposure to credit risk |
Cash | Securities | Letters of credit / guaran- tees |
Real estate property |
Master netting agree- ments |
Other | Total collateral |
Surplus collateral (or overcollateral- ization) |
Net exposure |
||||||||||||||||||
| Debt securities - carried at fair value |
- | - | - | - | - | - | ||||||||||||||||||||||
| Money market and other short-term investments - carried at fair value |
- | - | - | - | - | |||||||||||||||||||||||
| Mortgage loans - carried at amortized cost |
- | - | - | |||||||||||||||||||||||||
| Private loans - carried at amortized cost |
- | - | - | - | - | - | ||||||||||||||||||||||
| Other loans - carried at amortized cost |
- | - | - | - | - | |||||||||||||||||||||||
| Other financial assets - carried at fair value |
- | - | - | - | - | - | - | - | ||||||||||||||||||||
| Derivatives |
- | - | ||||||||||||||||||||||||||
| Reinsurance assets |
- | - | - | - | - | |||||||||||||||||||||||
| At December 31 |
||||||||||||||||||||||||||||
Notes to the consolidated financial statements Note 4 |
Notes to the consolidated financial statements Note 4 |
| |
|
|
|
|
|
|
|
|
Amounts in EUR million |
2021 |
2020 | ||||||
| AAA |
|
|
||||||
| AA |
|
|
||||||
| A |
|
|
||||||
| BBB |
|
|
||||||
| BB |
|
|
||||||
| B |
|
|
||||||
| CCC or lower |
|
|
||||||
Notes to the consolidated financial statements Note 4 |
Credit rating general account investments, excluding reinsurance assets 2021 |
Americas |
The Netherlands |
United Kingdom |
International |
||||||||||||||||||||||||||||
Amortized cost |
Fair value |
Amortized cost |
Fair value |
Amortized cost |
Fair value |
Amortized cost |
Fair value |
|||||||||||||||||||||||||
AAA |
- | - | ||||||||||||||||||||||||||||||
AA |
- | - | ||||||||||||||||||||||||||||||
A |
- | |||||||||||||||||||||||||||||||
BBB |
- | ( |
) | |||||||||||||||||||||||||||||
BB |
- | - | ||||||||||||||||||||||||||||||
B |
- | - | - | - | ||||||||||||||||||||||||||||
CCC or lower |
- | - | - | - | - | |||||||||||||||||||||||||||
Assets not rated |
- | |||||||||||||||||||||||||||||||
Total |
- |
|||||||||||||||||||||||||||||||
Past due and/or impaired assets |
- | - | - | |||||||||||||||||||||||||||||
At December 31 |
- |
|||||||||||||||||||||||||||||||
Asset Management |
Total 2021 1) |
|||||||||||||||||||
Credit rating general account investments, excluding reinsurance assets 2021 |
Amortized cost |
Fair value |
Amortized cost |
Fair value |
Total carrying value |
|||||||||||||||
AAA |
- | |||||||||||||||||||
AA |
- | - | ||||||||||||||||||
A |
- | - | ||||||||||||||||||
BBB |
- | - | ||||||||||||||||||
BB |
- | - | ||||||||||||||||||
B |
- | - | ||||||||||||||||||
CCC or lower |
- | - | - | |||||||||||||||||
Assets not rated |
- | |||||||||||||||||||
Total |
- |
|||||||||||||||||||
Past due and/or impaired assets |
- | - | ||||||||||||||||||
At December 31 |
- |
|||||||||||||||||||
1 |
Includes investments of Holding and other activities. |
Credit rating general account investments, excluding reinsurance assets 2020 |
Americas | The Netherlands | United Kingdom | International | ||||||||||||||||||||||||||||
| Amortized cost |
Fair value |
Amortized cost |
Fair value |
Amortized cost |
Fair value |
Amortized cost |
Fair value |
|||||||||||||||||||||||||
AAA |
- | - | ||||||||||||||||||||||||||||||
AA |
- | - | ||||||||||||||||||||||||||||||
A |
- | |||||||||||||||||||||||||||||||
BBB |
- | ( |
) | |||||||||||||||||||||||||||||
BB |
- | - | ||||||||||||||||||||||||||||||
B |
- | - | - | - | ||||||||||||||||||||||||||||
CCC or lower |
- | - | - | - | ||||||||||||||||||||||||||||
Assets not rated |
- | |||||||||||||||||||||||||||||||
Total |
- |
|||||||||||||||||||||||||||||||
Past due and/or impaired assets |
- | - | - | |||||||||||||||||||||||||||||
At December 31 |
- |
|||||||||||||||||||||||||||||||
Notes to the consolidated financial statements Note 4 |
| Asset Management | Total 2020 1) |
|||||||||||||||||||
Credit rating general account investments, excluding reinsurance assets 2020 |
Amortized cost |
Fair value |
Amortized cost |
Fair value |
Total carrying value |
|||||||||||||||
AAA |
- | |||||||||||||||||||
AA |
- | |||||||||||||||||||
A |
- | |||||||||||||||||||
BBB |
- | |||||||||||||||||||
BB |
- | |||||||||||||||||||
B |
- | |||||||||||||||||||
CCC or lower |
- | |||||||||||||||||||
Assets not rated |
- | |||||||||||||||||||
Total |
- |
|||||||||||||||||||
Past due and/or impaired assets |
- | - | ||||||||||||||||||
At December 31 |
- |
|||||||||||||||||||
1 |
Includes investments of Holding and other activities. |
Carrying value 2021 |
Carrying value 2020 |
|||||||
AAA |
- | - | ||||||
AA |
||||||||
A |
||||||||
Below A |
||||||||
Not rated |
||||||||
At December 31 |
||||||||
Credit risk concentrations – debt securities and money market investments 2021 |
Americas |
The Netherlands |
United Kingdom |
Interna- tional |
Asset Management |
Total 2021 1) |
Of which past due and/or impaired assets |
|||||||||||||||||||||
Residential mortgage-backed securities (RMBSs) |
- | |||||||||||||||||||||||||||
Commercial mortgage-backed securities (CMBSs) |
- | |||||||||||||||||||||||||||
Asset-backed securities (ABSs) - CDOs backed by ABS, Corp. bonds, Bank loans |
- | - | ||||||||||||||||||||||||||
ABSs – Other |
||||||||||||||||||||||||||||
Financial - Banking |
- | |||||||||||||||||||||||||||
Financial - Other |
||||||||||||||||||||||||||||
Capital goods and other industry |
- | |||||||||||||||||||||||||||
Communications & Technology |
- | |||||||||||||||||||||||||||
Consumer cyclical |
- | |||||||||||||||||||||||||||
Consumer non-cyclical |
- | |||||||||||||||||||||||||||
Energy |
- | |||||||||||||||||||||||||||
Transportation |
- | - | ||||||||||||||||||||||||||
Utility |
- | |||||||||||||||||||||||||||
Government bonds |
||||||||||||||||||||||||||||
At December 31 |
||||||||||||||||||||||||||||
1 |
Includes investments of Holding and other activities. |
Notes to the consolidated financial statements Note 4 |
| Credit risk concentrations – Government bonds per country of risk 2021 |
Americas |
The Netherlands |
United Kingdom |
International |
Asset Management |
Total 2021 1) |
||||||||||||||||||
| United States |
- | - | - | |
||||||||||||||||||||
| Netherlands |
- | - | - | - | ||||||||||||||||||||
| United Kingdom |
- | - | ||||||||||||||||||||||
| Austria |
- | - | - | |||||||||||||||||||||
| Belgium |
- | - | - | |||||||||||||||||||||
| Finland |
- | - | - | - | ||||||||||||||||||||
| France |
- | - | ||||||||||||||||||||||
| Germany |
- | - | - | - | ||||||||||||||||||||
| Hungary |
- | - | - | - | ||||||||||||||||||||
| Indonesia |
- | - | ||||||||||||||||||||||
| Luxembourg |
- | - | - | |||||||||||||||||||||
| Spain |
- | - | - | |||||||||||||||||||||
| Rest of Europe |
- | - | ||||||||||||||||||||||
| Rest of world |
- | |||||||||||||||||||||||
| Supranational |
- | - | - | |||||||||||||||||||||
| At December 31 |
||||||||||||||||||||||||
1 |
Includes investments of Holding and other activities. |
Credit risk concentrations – Credit rating 2021 2) |
Government bonds |
Corporate bonds |
RMBSs CMBSs ABSs |
Other |
Total 2021 1) |
|||||||||||||||
| AAA |
||||||||||||||||||||
| AA |
- | |||||||||||||||||||
| A |
- | |||||||||||||||||||
| BBB |
- | |||||||||||||||||||
| BB |
- | |||||||||||||||||||
| B |
- | |||||||||||||||||||
| CCC or lower |
- | |||||||||||||||||||
| Assets not rated |
- | |||||||||||||||||||
| At December 31 |
||||||||||||||||||||
1 |
Includes investments of Holding and other activities. |
2 |
CNLP Ratings are used and are the lower of the Barclay’s Rating and the Internal Rating with the Barclay’s rating being a blended rating of S&P, Fitch, and Moody’s. |
| Credit risk concentrations – debt securities and money market investments 2020 |
Americas | The Netherlands |
United Kingdom |
International | Asset Management |
Total 2020 1) |
Of which past due and/or impaired assets |
|||||||||||||||||||||
| Residential mortgage-backed securities (RMBSs) |
- | |||||||||||||||||||||||||||
| Commercial mortgage-backed securities (CMBSs) |
- | |||||||||||||||||||||||||||
| Asset-backed securities (ABSs) - CDOs backed by ABS, Corp. bonds, Bank loans |
- | - | ||||||||||||||||||||||||||
| ABSs – Other |
||||||||||||||||||||||||||||
| Financial - Banking |
||||||||||||||||||||||||||||
| Financial - Other |
||||||||||||||||||||||||||||
| Capital goods and other industry |
||||||||||||||||||||||||||||
| Communications & Technology |
||||||||||||||||||||||||||||
| Consumer cyclical |
- | |||||||||||||||||||||||||||
| Consumer non-cyclical |
||||||||||||||||||||||||||||
| Energy |
||||||||||||||||||||||||||||
| Transportation |
- | |||||||||||||||||||||||||||
| Utility |
- | |||||||||||||||||||||||||||
| Government bonds |
||||||||||||||||||||||||||||
| At December 31 |
||||||||||||||||||||||||||||
1 |
Includes investments of Holding and other activities. |
Notes to the consolidated financial statements Note 4 |
Credit risk concentrations – Government bonds per country of risk 2020 |
Americas | The Netherlands |
United Kingdom |
International | Asset Management |
Total 2020 1) |
||||||||||||||||||
| United States |
- | |||||||||||||||||||||||
| Netherlands |
- | - | - | - | ||||||||||||||||||||
| United Kingdom |
- | - | ||||||||||||||||||||||
| Austria |
- | - | - | |||||||||||||||||||||
| Belgium |
- | - | - | |||||||||||||||||||||
| Finland |
- | - | - | - | ||||||||||||||||||||
| France |
- | - | ||||||||||||||||||||||
| Germany |
- | - | - | - | ||||||||||||||||||||
| Hungary |
- | - | ||||||||||||||||||||||
| Luxembourg |
- | - | - | |||||||||||||||||||||
| Spain |
- | - | - | |||||||||||||||||||||
| Rest of Europe |
- | |||||||||||||||||||||||
| Rest of world |
||||||||||||||||||||||||
| Supranational |
- | - | - | |||||||||||||||||||||
| At December 31 |
||||||||||||||||||||||||
1 |
Includes investments of Holding and other activities. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit risk concentrations – Credit rating 2020 2) |
Government bonds |
Corporate bonds |
RMBSs CMBSs ABSs |
Other | Total 2020 1) |
|||||||||||||||
| AAA |
||||||||||||||||||||
| AA |
||||||||||||||||||||
| A |
- | |||||||||||||||||||
| BBB |
- | |||||||||||||||||||
| BB |
- | |||||||||||||||||||
| B |
- | |||||||||||||||||||
| CCC or lower |
- | |||||||||||||||||||
| Assets not rated |
- | |||||||||||||||||||
| At December 31 |
||||||||||||||||||||
1 |
Includes investments of Holding and other activities. |
2 |
CNLP Ratings are used and are the lower of the Barclay’s Rating and the Internal Rating with the Barclay’s rating being a blended rating of S&P, Fitch, and Moody’s. |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Credit risk concentrations – mortgage loans 2021 |
Americas |
The Netherlands |
United Kingdom |
International |
Asset Management |
Total 2021 |
Of which past due and/or impaired assets |
|||||||||||||||||||||
| Agricultural |
- | - | - | - | - | |||||||||||||||||||||||
| Apartment |
- | - | - | - | ||||||||||||||||||||||||
| Industrial |
- | - | - | - | - | |||||||||||||||||||||||
| Office |
- | - | - | - | - | |||||||||||||||||||||||
| Retail |
- | - | - | - | ||||||||||||||||||||||||
| Other commercial |
- | - | - | - | ||||||||||||||||||||||||
| Residential |
- | - | ||||||||||||||||||||||||||
| At December 31 |
- |
- |
||||||||||||||||||||||||||
Notes to the consolidated financial statements Note 4 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Credit risk concentrations – mortgage loans 2020 |
Americas | The Netherlands | United Kingdom |
International | Asset Management |
Total 2020 |
Of which past due and/or impaired assets |
|||||||||||||||||||||
| Agricultural |
- | - | - | - | - | |||||||||||||||||||||||
| Apartment |
- | - | - | - | ||||||||||||||||||||||||
| Industrial |
- | - | - | - | - | |||||||||||||||||||||||
| Office |
- | - | - | - | - | |||||||||||||||||||||||
| Retail |
- | - | - | |||||||||||||||||||||||||
| Other commercial |
- | - | - | |||||||||||||||||||||||||
| Residential |
- | - | ||||||||||||||||||||||||||
| At December 31 |
- |
- |
||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total result 2021 |
December 31, 2021 |
|||||||||||||||
2021 |
Interest income |
Total gains and losses on sale of assets |
Total |
Investments |
||||||||||||
| Residential mortgage-backed securities |
( |
) | ||||||||||||||
| Commercial mortgage-backed securities |
( |
) | ||||||||||||||
| Asset-backed securities |
||||||||||||||||
| ABSs - Other |
( |
) | ||||||||||||||
| Total |
( |
) |
||||||||||||||
Notes to the consolidated financial statements Note 4 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total result 2020 | December 31, 2020 | |||||||||||||||
2020 |
Interest income | Total gains and losses on sale of assets |
Total |
Investments | ||||||||||||
| Residential mortgage-backed securities |
||||||||||||||||
| Commercial mortgage-backed securities |
||||||||||||||||
| Asset-backed securities |
( |
) | ||||||||||||||
| ABSs - Other |
||||||||||||||||
| Total |
||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
Amortized cost |
Unrealized gains |
Unrealized losses |
Total fair value |
Fair value of instruments with unrealized gains |
Fair value of instruments with unrealized losses |
||||||||||||||||||
Debt securities, money market instruments and other |
||||||||||||||||||||||||
| United States government |
( |
) | ||||||||||||||||||||||
| Dutch government |
( |
) | ||||||||||||||||||||||
| Other government |
( |
) | ||||||||||||||||||||||
| Mortgage-backed securities |
( |
) | ||||||||||||||||||||||
| Asset-backed securities |
( |
) | ||||||||||||||||||||||
| Corporate |
( |
) | ||||||||||||||||||||||
| Money market investments |
( |
) | ||||||||||||||||||||||
| Other |
( |
) | ||||||||||||||||||||||
| Total |
( |
) |
||||||||||||||||||||||
| Of which held by Aegon Americas and NL |
( |
) | ||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2020 |
Amortized cost |
Unrealized gains |
Unrealized losses |
Total fair value |
Fair value of instruments with unrealized gains |
Fair value of instruments with unrealized losses |
||||||||||||||||||
Debt securities, money market instruments and other |
||||||||||||||||||||||||
| United States government |
( |
) | ||||||||||||||||||||||
| Dutch government |
- | |||||||||||||||||||||||
| Other government |
( |
) | ||||||||||||||||||||||
| Mortgage-backed securities |
( |
) | ||||||||||||||||||||||
| Asset-backed securities |
( |
) | ||||||||||||||||||||||
| Corporate |
( |
) | ||||||||||||||||||||||
| Money market investments |
- | ( |
) | |||||||||||||||||||||
| Other |
( |
) | ||||||||||||||||||||||
| Total |
( |
) |
||||||||||||||||||||||
| Of which held by Aegon Americas and NL |
( |
) | ||||||||||||||||||||||
Notes to the consolidated financial statements Note 4 |
December 31, 2021 |
December 31, 2020 | |||||||||||||||
Unrealized losses - debt securities, money market investments and other |
Carrying value of instruments with unrealized losses |
Unrealized losses |
Carrying value of instruments with unrealized losses |
Unrealized losses | ||||||||||||
Residential mortgage-backed securities (RMBSs) |
( |
) | ( |
) | ||||||||||||
Commercial mortgage-backed securities (CMBSs) |
( |
) | ( |
) | ||||||||||||
Asset-backed securities (ABSs) - CDOs backed by ABS, Corp. bonds, Bank loans |
( |
) | ( |
) | ||||||||||||
ABSs - Other |
( |
) | ( |
) | ||||||||||||
Financial Industry - Banking |
( |
) | ( |
) | ||||||||||||
Financial Industry - Insurance |
( |
) | ( |
) | ||||||||||||
Financial Industry - Other |
( |
) | ( |
) | ||||||||||||
Industrial |
( |
) | ( |
) | ||||||||||||
Utility |
( |
) | ( |
) | ||||||||||||
Government |
( |
) | ( |
) | ||||||||||||
Other |
( |
) | ( |
) | ||||||||||||
Total held by Aegon Americas and NL |
( |
) |
( |
) | ||||||||||||
Held by other segments |
( |
) | ( |
) | ||||||||||||
Total |
( |
) |
( |
) | ||||||||||||
2021 |
2020 | |||||||||||||||||||||||||||||||
Past due but not impaired assets |
0-6 months |
6-12 months |
> 1 year |
Total |
0-6 months |
6-12 months |
> 1 year | Total | ||||||||||||||||||||||||
Debt securities - carried at fair value |
||||||||||||||||||||||||||||||||
Mortgage loans |
||||||||||||||||||||||||||||||||
Other loans |
||||||||||||||||||||||||||||||||
Accrued interest |
||||||||||||||||||||||||||||||||
Other financial assets - carried at fair value |
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||
At December 31 |
||||||||||||||||||||||||||||||||
Notes to the consolidated financial statements Note 4 |
Impaired financial assets |
Carrying amount 2021 |
Carrying amount 2020 |
||||||
Shares |
||||||||
Debt securities - carried at fair value |
||||||||
Mortgage loans |
||||||||
Other loans |
||||||||
Other financial assets - carried at fair value |
||||||||
At December 31 |
||||||||
Equity, real estate and non-fixed income exposure |
Americas |
The Netherlands |
United Kingdom |
International |
Asset Management |
Holding and other activities |
Total 2021 |
|||||||||||||||||||||
Equity funds |
- | - | ||||||||||||||||||||||||||
Common shares 1) |
- | - | ||||||||||||||||||||||||||
Preferred shares |
- | - | - | - | - | |||||||||||||||||||||||
Investments in real estate |
- | - | - | |||||||||||||||||||||||||
Hedge funds |
- | - | - | - | - | |||||||||||||||||||||||
Other alternative investments |
- | - | - | - | ||||||||||||||||||||||||
Other financial assets |
- | |||||||||||||||||||||||||||
At December 31 |
||||||||||||||||||||||||||||
1 |
Common shares in Holding and other activities includes the elimination of treasury shares in the general account for an amount of EUR nil million. |
Equity, real estate and non-fixed income exposure |
Americas | The Netherlands | United Kingdom |
International | Asset Management |
Holding and other activities |
Total 2020 |
|||||||||||||||||||||
Equity funds |
- | - | ||||||||||||||||||||||||||
Common shares 1) |
- | - | ||||||||||||||||||||||||||
Preferred shares |
- | - | - | - | ||||||||||||||||||||||||
Investments in real estate |
- | - | - | |||||||||||||||||||||||||
Hedge funds |
- | - | - | - | - | |||||||||||||||||||||||
Other alternative investments |
- | - | - | |||||||||||||||||||||||||
Other financial assets |
- | |||||||||||||||||||||||||||
At December 31 |
||||||||||||||||||||||||||||
1 |
Common shares in Holding and other activities includes the elimination of treasury shares in the general account for an amount of EUR nil million. |
Notes to the consolidated financial statements Note 4 |
Market risk concentrations – shares |
Americas |
The Netherlands |
United Kingdom |
International |
Asset Management |
Total 2021 1) |
Of which impaired assets |
|||||||||||||||||||||
Communication |
- | - | - | - | - | |||||||||||||||||||||||
Consumer |
- | - | - | - | ||||||||||||||||||||||||
Financials |
- | - | ||||||||||||||||||||||||||
Funds |
- | - | ||||||||||||||||||||||||||
Industries |
- | - | - | - | ||||||||||||||||||||||||
Other |
- | - | - | |||||||||||||||||||||||||
At December 31 |
||||||||||||||||||||||||||||
Market risk concentrations – shares |
Americas | The Netherlands | United Kingdom |
International | Asset Management |
Total 2020 1) |
Of which impaired assets |
|||||||||||||||||||||
Communication |
- | - | - | - | - | |||||||||||||||||||||||
Consumer |
- | - | - | - | ||||||||||||||||||||||||
Financials |
- | |||||||||||||||||||||||||||
Funds |
- | - | ||||||||||||||||||||||||||
Industries |
- | - | ||||||||||||||||||||||||||
Other |
- | - | ||||||||||||||||||||||||||
At December 31 |
||||||||||||||||||||||||||||
1 |
Includes investments of Holding and other activities. |
2021 |
2020 | 2019 | 2018 | 2017 | ||||||||||||||||
S&P 500 |
||||||||||||||||||||
Nasdaq |
||||||||||||||||||||
FTSE 100 |
||||||||||||||||||||
AEX |
||||||||||||||||||||
Immediate change of |
Estimated approximate effects on net result |
Estimated approximate effects on shareholders’ equity |
||||||
2021 |
||||||||
Equity increase 10% |
||||||||
Equity decrease 10% |
( |
) | ( |
) | ||||
Equity increase 25% |
||||||||
Equity decrease 25% |
( |
) | ( |
) | ||||
2020 |
||||||||
Equity increase 10% |
||||||||
Equity decrease 10% |
( |
) | ( |
) | ||||
Equity increase 25% |
||||||||
Equity decrease 25% |
( |
) | ( |
) | ||||
Notes to the consolidated financial statements Note 4 |
2021 |
2020 | 2019 | 2018 | 2017 | ||||||||||||||||
3-month US LIBOR |
||||||||||||||||||||
3-month EURIBOR |
( |
( |
( |
) | ( |
( |
||||||||||||||
10-year US Treasury |
||||||||||||||||||||
10-year Dutch government |
( |
( |
( |
) | ||||||||||||||||
Notes to the consolidated financial statements Note 4 |
Parallel movement of yield curve |
Estimated approximate effects on net result |
Estimated approximate effects on shareholders’ equity |
||||||
2021 |
||||||||
Shift up 100 basis points |
( |
) | ||||||
Shift down 100 basis points |
( |
) | ||||||
2020 |
||||||||
Shift up 100 basis points |
( |
) | ||||||
Shift down 100 basis points |
( |
) | ||||||
¨ |
¨ |
¨ |
¨ |
¨ |
Notes to the consolidated financial statements Note 4 |
2021 |
||||||||
Non derivative financial instruments to transition to alternative benchmark |
Financial assets non-derivatives |
Financial liabilities non-derivatives |
||||||
By benchmark rate |
||||||||
GBP LIBOR |
||||||||
USD LIBOR |
||||||||
Euribor |
||||||||
Fed Funds |
||||||||
Total |
||||||||
2021 |
||||
Derivative financial instruments to transition to alternative benchmark |
Nominal Value |
|||
By benchmark rate |
||||
GBP LIBOR |
||||
USD LIBOR |
||||
Euribor |
||||
Fed Funds |
||||
Total |
||||
2021 |
2020 | 2019 | ||||||||||
Net result |
||||||||||||
Americas (in USD) |
( |
) | ||||||||||
United Kingdom (in GBP) |
( |
|||||||||||
Equity in functional currency |
||||||||||||
Americas (in USD) |
||||||||||||
United Kingdom (in GBP) |
||||||||||||
Notes to the consolidated financial statements Note 4 |
Closing rates |
2021 |
2020 | 2019 | 2018 | 2017 | |||||||||||||||
USD |
||||||||||||||||||||
GBP |
||||||||||||||||||||
Movement of currency exchange rates 1) |
Estimated approximate effects on net result |
Estimated approximate effects on shareholders’ equity |
||||||
2021 |
||||||||
Increase by 15% of USD currencies relative to the euro |
||||||||
Increase by 15% of GBP currencies relative to the euro |
||||||||
Increase by 15% of non-euro currencies relative to the euro |
||||||||
Decrease by 15% of USD currencies relative to the euro |
( |
) | ( |
) | ||||
Decrease by 15% of GBP currencies relative to the euro |
||||||||
Decrease by 15% of non-euro currencies relative to the euro |
( |
) | ( |
) | ||||
2020 |
||||||||
Increase by 15% of USD currencies relative to the euro |
( |
) | ||||||
Increase by 15% of GBP currencies relative to the euro |
( |
) | ||||||
Increase by 15% of non-euro currencies relative to the euro |
( |
) | ||||||
Decrease by 15% of USD currencies relative to the euro |
( |
) | ||||||
Decrease by 15% of GBP currencies relative to the euro |
( |
) | ||||||
Decrease by 15% of non-euro currencies relative to the euro |
( |
) | ||||||
1 |
The effect of currency exchange movements is reflected as a one-time shift up or down in the value of the non-euro currencies relative to the euro on December 31. |
Notes to the consolidated financial statements Note 4 |
Maturity analysis – gross undiscounted contractual cash flows (for non-derivatives) |
On demand | < 1 yr amount |
1 < 5 yrs amount |
5 < 10 yrs amount |
> 10 yrs amount |
Total amount |
||||||||||||||||||
2021 |
||||||||||||||||||||||||
Trust pass-through securities |
- | |||||||||||||||||||||||
Subordinated loans |
- | |||||||||||||||||||||||
Borrowings |
- | |||||||||||||||||||||||
Lease liabilities |
- | |||||||||||||||||||||||
Other financial liabilities |
||||||||||||||||||||||||
Total financial liabilities (excluding investment/insurance contracts) |
||||||||||||||||||||||||
Investment contracts 1) |
||||||||||||||||||||||||
Investment contracts for account of policyholders 1) |
||||||||||||||||||||||||
Total investment contracts |
||||||||||||||||||||||||
2020 |
||||||||||||||||||||||||
Trust pass-through securities |
- | |||||||||||||||||||||||
Subordinated loans |
- | |||||||||||||||||||||||
Borrowings |
- | |||||||||||||||||||||||
Lease liabilities |
- | |||||||||||||||||||||||
Other financial liabilities |
||||||||||||||||||||||||
Total financial liabilities (excluding investment/insurance contracts) |
||||||||||||||||||||||||
Investment contracts 1) |
||||||||||||||||||||||||
Investment contracts for account of policyholders 1) |
||||||||||||||||||||||||
Total investment contracts |
||||||||||||||||||||||||
1 |
Excluding investment contracts with discretionary participating features. |
Notes to the consolidated financial statements Note 5 |
Financial liabilities relating to insurance |
< 1 yr | 1 < 5 yrs | 5 < 10 yrs | > 10 yrs | Total |
|||||||||||||||||||
and investment contracts 1) |
On demand | amount | amount | amount | amount | amount |
||||||||||||||||||
2021 |
||||||||||||||||||||||||
Insurance contracts |
- | |||||||||||||||||||||||
Insurance contracts for account of policyholders |
- | |||||||||||||||||||||||
Investment contracts |
- | |||||||||||||||||||||||
Investment contracts for account of policyholders |
||||||||||||||||||||||||
2020 |
||||||||||||||||||||||||
Insurance contracts |
- | |||||||||||||||||||||||
Insurance contracts for account of policyholders |
- | |||||||||||||||||||||||
Investment contracts |
- | |||||||||||||||||||||||
Investment contracts for account of policyholders |
||||||||||||||||||||||||
1 |
The liability amount in the consolidated financial statements reflects the discounting for interest as well as adjustments for the timing of other factors as described above. As a result, the sum of the cash benefit payments shown for all years in the table exceeds the corresponding liability amounts included in notes 34 Insurance contracts and 35 Investments contracts. |
Maturity analysis relating to derivatives 1) |
< 1 yr | 1 < 5 yrs | 5 < 10 yrs | > 10 yrs | Total |
|||||||||||||||||||
(Contractual cash flows) |
On demand | amount | amount | amount | amount | amount |
||||||||||||||||||
2021 |
||||||||||||||||||||||||
Gross settled |
||||||||||||||||||||||||
Cash inflows |
- | |
||||||||||||||||||||||
Cash outflows |
- | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||
Net settled |
||||||||||||||||||||||||
Cash inflows |
- | |||||||||||||||||||||||
Cash outflows |
- | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||
2020 |
||||||||||||||||||||||||
Gross settled |
||||||||||||||||||||||||
Cash inflows |
- | |||||||||||||||||||||||
Cash outflows |
- | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||
Net settled |
||||||||||||||||||||||||
Cash inflows |
- | |||||||||||||||||||||||
Cash outflows |
- | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||
1 |
Derivatives includes all financial derivatives regardless whether they have a positive or a negative value. It does not include bifurcated embedded derivatives. These are presented together with the host contract. For interest rate derivatives only, cash flows related to the pay leg are taken into account for determining the gross undiscounted cash flows. |
¨ |
Americas: |
¨ |
The Netherlands: which covers businesses activities from Aegon the Netherlands; |
¨ |
United Kingdom: which covers businesses activities from platform business and traditional insurance in the United Kingdom; |
¨ |
International: |
¨ |
Asset Management: |
Notes to the consolidated financial statements Note 5 |
¨ |
Holding and other activities: one operating segment which includes financing, employee and other administrative expenses of holding companies. |
¨ |
The running cost of the US macro hedge related to the variable annuity portfolio is recorded within Operating result instead of in Fair value items. Management views this as a better reflection of Aegon’s operating performance and improves the relevance of Aegon’s operating result. |
¨ |
The periodic intangibles unlocking, caused by short term market movements, in the US Life and TLB business is recorded in Fair value items, instead of Operating result, to improve the insight in Aegon’s recurring operating result. |
¨ |
Results from run-off businesses, mainly related to US are part of Aegon’s operating result. The results of run-off businesses were previously recorded outside of Aegon’s operating result. Based on management actions executed in prior years the importance of run-off businesses has diminished and continuing to report this as a separate line item is considered no longer relevant. |
¨ |
Following the announcement to sell Aegon’s operations in CEE, results from these businesses, previously reported in operating result, are prospectively recorded within Other income / charges. |
Notes to the consolidated financial statements Note 5 |
¨ |
Items which cannot be directly allocated to a specific line of business; |
¨ |
The impact of actuarial and economic assumption and model updates used to support calculations of our liabilities for insurance and investment contracts sold to policyholders and related assets (refer to note 3 Critical accounting estimates and judgement in applying accounting policies); and |
¨ |
Items that are outside the normal course of business, including restructuring charges. |
Notes to the consolidated financial statements Note 5 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Income statement - Operating result |
Americas |
The Netherlands |
United Kingdom |
International |
Asset Management |
Holding and other activities |
Eliminations |
Segment total |
Joint ventures and associates eliminations |
Consolidated |
||||||||||||||||||||||||||||||
| 2021 |
||||||||||||||||||||||||||||||||||||||||
Operating result before tax |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||
| Fair value items |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| Realized gains / (losses) on investments |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||
| Impairment charges |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||
| Impairment reversals |
||||||||||||||||||||||||||||||||||||||||
| Non-operating items |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||
| Other income / (charges) |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||
| Result before tax |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||
| Income tax (expense) / benefit |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||
| Net result |
( |
) |
||||||||||||||||||||||||||||||||||||||
| Inter-segment operating result |
( |
) |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||
| Revenues |
||||||||||||||||||||||||||||||||||||||||
| 2021 |
||||||||||||||||||||||||||||||||||||||||
| Life insurance gross premiums |
( |
) | ||||||||||||||||||||||||||||||||||||||
| Accident and health insurance |
( |
) | ||||||||||||||||||||||||||||||||||||||
| General insurance |
( |
) | ||||||||||||||||||||||||||||||||||||||
| Total gross premiums |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||
| Investment income |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||
| Fee and commission income |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||
| Other revenues |
( |
) | ||||||||||||||||||||||||||||||||||||||
| Total revenues |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||
| Inter-segment revenues |
||||||||||||||||||||||||||||||||||||||||
Notes to the consolidated financial statements Note 5 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Income statement -Operating result |
Americas | The Netherlands |
United Kingdom |
International | Asset Management |
Holding and other activities |
Eliminations | Segment total |
Joint ventures and associates eliminations |
Consolidated |
||||||||||||||||||||||||||||||
| 2020 |
||||||||||||||||||||||||||||||||||||||||
| Operating result before tax |
( |
|||||||||||||||||||||||||||||||||||||||
| Fair value items |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | - | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||
| Realized gains / (losses) on investments |
- | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||||||||
| Impairment charges |
( |
) | ( |
) | - | ( |
) | ( |
) | ( |
) | - | ( |
) | ( |
) | ||||||||||||||||||||||||
| Impairment reversals |
- | - | - | - | - | |||||||||||||||||||||||||||||||||||
| Non-operating items |
( |
) |
( |
) |
( |
) |
( |
) |
- |
( |
) |
( |
) |
( |
) | |||||||||||||||||||||||||
| Other income / (charges) |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | - | ( |
) | ( |
) | |||||||||||||||||||||||||
| Result before tax |
( |
) |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||||||
| Income tax (expense) / benefit |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||
| Net result |
( |
) |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||||||||
| Inter-segment operating result |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| Revenues |
||||||||||||||||||||||||||||||||||||||||
| 2020 |
||||||||||||||||||||||||||||||||||||||||
| Life insurance gross premiums |
- | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||
| Accident and health insurance |
- | - | - | ( |
) | |||||||||||||||||||||||||||||||||||
| General insurance |
- | - | - | - | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| Total gross premiums |
- |
( |
) |
( |
) |
|||||||||||||||||||||||||||||||||||
| Investment income |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||
| Fee and commission income |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||||
| Other revenues |
- | - | - | ( |
) | |||||||||||||||||||||||||||||||||||
| Total revenues |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||
| Inter-segment revenues |
- | - | ||||||||||||||||||||||||||||||||||||||
Notes to the consolidated financial statements Note 5 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Income statement - Operating result |
Americas | The Netherlands |
United Kingdom |
International | Asset Management |
Holding and other activities |
Eliminations | Segment total |
Joint ventures and associates eliminations |
Consolidated |
||||||||||||||||||||||||||||||
| 2019 |
||||||||||||||||||||||||||||||||||||||||
Operating result before tax |
( |
) |
||||||||||||||||||||||||||||||||||||||
| Fair value items |
( |
) | ( |
) | ( |
) | - | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||||||||||||
| Realized gains / (losses) on investments |
- | - | ( |
) | ||||||||||||||||||||||||||||||||||||
| Impairment charges |
( |
) | ( |
) | - | ( |
) | - | ( |
) | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||
| Impairment reversals |
- | - | - | - | - | |||||||||||||||||||||||||||||||||||
| Non-operating items |
( |
) |
( |
) |
- |
( |
) |
- |
( |
) |
( |
) |
( |
) | ||||||||||||||||||||||||||
| Other income / (charges) |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||
| Result before tax |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||
| Income tax (expense) / benefit |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
| Net result |
( |
) |
( |
) |
- |
|||||||||||||||||||||||||||||||||||
| Inter-segment operating result |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||||||||
| Revenues |
||||||||||||||||||||||||||||||||||||||||
| 2019 |
||||||||||||||||||||||||||||||||||||||||
| Life insurance gross premiums |
- | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||
| Accident and health insurance |
- | - | - | ( |
) | |||||||||||||||||||||||||||||||||||
| General insurance |
- | - | - | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||
| Total gross premiums |
- |
( |
) |
( |
) |
|||||||||||||||||||||||||||||||||||
| Investment income |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||
| Fee and commission income |
- | ( |
) | ( |
) | |||||||||||||||||||||||||||||||||||
| Other revenues |
- | - | - | ( |
) | |||||||||||||||||||||||||||||||||||
| Total revenues |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||
| Inter-segment revenues |
- | - | ||||||||||||||||||||||||||||||||||||||
Notes to the consolidated financial statements Note 5 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Presentation Non-Operating result |
Note |
2021 |
2020 | 2019 | ||||||||||||
| Operating result |
||||||||||||||||
| Elimination of share in earnings of joint ventures and associates |
||||||||||||||||
| Premium income |
6 |
( |
) | ( |
) | |||||||||||
| Rental income |
7 |
( |
) | ( |
) | ( |
) | |||||||||
| Dividend income |
7 |
( |
) | |||||||||||||
| Fee and commission income |
8 |
( |
) | - | ||||||||||||
| Recovered claims and benefits |
9 |
( |
) | ( |
) | |||||||||||
| Change in valuation of reinsurance ceded |
9 |
( |
) | - | ||||||||||||
| Net fair value change of general account financial investments at fair value through profit or loss, other than derivatives |
10 |
( |
) | ( |
) | ( |
) | |||||||||
| Net fair value change on borrowings and other financial liabilities |
10 |
( |
) | |||||||||||||
| Realized gains and losses on financial investments |
10 |
|||||||||||||||
| Gains and (losses) on investments in real estate |
10 |
|||||||||||||||
| Net fair value change of derivatives |
10 |
( |
) | |||||||||||||
| Other income |
11 |
|||||||||||||||
| Benefits and claims paid life |
12 |
( |
) | |||||||||||||
| Change in valuation of liabilities for insurance contracts |
12 |
( |
) | ( |
) | |||||||||||
| Change in valuation of liabilities for investment contracts |
12 |
( |
) | ( |
) | ( |
) | |||||||||
| Policyholder claims and benefits - Other |
12 |
|||||||||||||||
| Commissions and expenses |
14 |
( |
) | ( |
) | ( |
) | |||||||||
| Impairment (charges) reversals |
15 |
( |
) | ( |
) | |||||||||||
| Interest charges and related fees |
16 |
( |
) | |||||||||||||
| Other charges |
17 |
( |
) | ( |
) | ( |
) | |||||||||
| Results of CEE businesses which were previously reported in operating results |
||||||||||||||||
| Result before tax |
( |
) |
||||||||||||||
¨ |
Net fair value change of general account financial investments at fair value through profit or loss, other than derivatives is reported as part of the respective line in note 10 and reflects the over- or underperformance of investments and guarantees held at fair value for which the expected long-term return is included in operating result. |
¨ |
Net fair value change of derivatives is reported as part of the respective line in note 10 and includes: 1) the over- or underperformance of derivatives of EUR |
¨ |
Net foreign currency gains and (losses) are reported as part of the respective line in note 10. |
¨ |
Benefits and claims paid life relate to the lump-sum buy-out program for certain variable annuities in the Americas and is reported as part of the respective line in note 12. |
¨ |
Change in valuation of liabilities for insurance contracts is reported as part of the respective line in note 12. |
¨ |
Change in valuation of liabilities for investment contracts is reported as part of the respective line in note 12. |
¨ |
Policyholder claims and benefits - Other are reported as part of the ‘Other’ line in note 12 and is related to policyholder tax. |
¨ |
Commissions and expenses include: 1) Restructuring charges of EUR |
¨ |
Impairment (charges) reversals include: 1) Impairment charges and reversals on financial assets, excluding receivables of EUR |
¨ |
There are no interest charges and related fees that are classified for segment reporting purposes as non-operating results. |
Notes to the consolidated financial statements Note 5 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other selected income statement items |
Americas | The Netherlands |
United Kingdom |
International | Asset Management |
Holding and other activities |
Total |
|||||||||||||||||||||
| 2021 |
||||||||||||||||||||||||||||
| Amortization of deferred expenses, VOBA and future servicing rights |
- | - | - | |||||||||||||||||||||||||
| Depreciation |
||||||||||||||||||||||||||||
| Impairment charges / (reversals) on financial assets, excluding receivables |
( |
) | ( |
) | - | - | - | ( |
) | ( |
) | |||||||||||||||||
| Impairment charges / (reversals) on non- financial assets and receivables |
- | - | ||||||||||||||||||||||||||
| 2020 |
||||||||||||||||||||||||||||
| Amortization of deferred expenses, VOBA and future servicing rights |
- | - | - | |||||||||||||||||||||||||
| Depreciation |
||||||||||||||||||||||||||||
| Impairment charges / (reversals) on financial assets, excluding receivables |
- | - | ||||||||||||||||||||||||||
| Impairment charges / (reversals) on non- financial assets and receivables |
||||||||||||||||||||||||||||
| 2019 |
||||||||||||||||||||||||||||
| Amortization of deferred expenses, VOBA and future servicing rights |
- | - | ||||||||||||||||||||||||||
| Depreciation |
||||||||||||||||||||||||||||
| Impairment charges / (reversals) on financial assets, excluding receivables |
( |
) | - | - | - | |||||||||||||||||||||||
| Impairment charges / (reversals) on non- financial assets and receivables |
- | - | ||||||||||||||||||||||||||
Notes to the consolidated financial statements Note 5 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of employees |
Americas | The Netherlands |
United Kingdom |
International | Asset Management |
Holding and other activities |
Total | |||||||||||||||||||||
| 2021 |
||||||||||||||||||||||||||||
| Number of employees - headcount |
||||||||||||||||||||||||||||
| Of which Aegon’s share of employees in joint ventures and associates |
- | - | ||||||||||||||||||||||||||
| 2020 |
||||||||||||||||||||||||||||
| Number of employees - headcount |
||||||||||||||||||||||||||||
| Of which Aegon’s share of employees in joint ventures and associates |
- | - | ||||||||||||||||||||||||||
| 2019 |
||||||||||||||||||||||||||||
| Number of employees - headcount |
||||||||||||||||||||||||||||
| Of which Aegon’s share of employees in joint ventures and associates |
- | - | ||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summarized assets and liabilities per segment |
Americas |
The Netherlands |
United Kingdom |
International |
Asset Management |
Holding and other activities |
Eliminations |
Total | ||||||||||||||||||||||||
| 2021 |
||||||||||||||||||||||||||||||||
| Assets |
||||||||||||||||||||||||||||||||
| Cash and Cash equivalents |
- | |||||||||||||||||||||||||||||||
| Investments |
- | |||||||||||||||||||||||||||||||
| Investments for account of policyholders |
- | - | ( |
) | ||||||||||||||||||||||||||||
| Investments in joint ventures |
- | - | ||||||||||||||||||||||||||||||
| Investments in associates |
- | ( |
) | |||||||||||||||||||||||||||||
| Deferred expenses |
- | - | - | |||||||||||||||||||||||||||||
| Other assets |
( |
) | ||||||||||||||||||||||||||||||
| Total assets |
( |
) |
||||||||||||||||||||||||||||||
| Liabilities |
||||||||||||||||||||||||||||||||
| Insurance contracts |
- | - | ( |
) | ||||||||||||||||||||||||||||
| Insurance contracts for account of policyholders |
- | - | - | |||||||||||||||||||||||||||||
| Investment contracts |
- | - | - | |||||||||||||||||||||||||||||
| Investment contracts for account of policyholders |
- | - | - | |||||||||||||||||||||||||||||
| Other liabilities |
( |
) | ||||||||||||||||||||||||||||||
| Total liabilities |
( |
) |
||||||||||||||||||||||||||||||
Notes to the consolidated financial statements Note 5 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Summarized assets and liabilities per segment |
Americas | The Netherlands |
United Kingdom |
International | Asset Management |
Holding and other activities |
Eliminations | Total | ||||||||||||||||||||||||
| 2020 |
||||||||||||||||||||||||||||||||
| Assets |
||||||||||||||||||||||||||||||||
| Cash and Cash equivalents |
- | |||||||||||||||||||||||||||||||
| Investments |
- | |||||||||||||||||||||||||||||||
| Investments for account of policyholders |
- | - | ( |
) | ||||||||||||||||||||||||||||
| Investments in joint ventures |
- | - | ||||||||||||||||||||||||||||||
| Investments in associates |
( |
) | ||||||||||||||||||||||||||||||
| Deferred expenses |
- | - | - | |||||||||||||||||||||||||||||
| Other assets |
( |
) | ||||||||||||||||||||||||||||||
| Total assets |
( |
) |
||||||||||||||||||||||||||||||
| Liabilities |
||||||||||||||||||||||||||||||||
| Insurance contracts |
- | - | ( |
) | ||||||||||||||||||||||||||||
| Insurance contracts for account of policyholders |
- | - | - | |||||||||||||||||||||||||||||
| Investment contracts |
- | - | - | |||||||||||||||||||||||||||||
| Investment contracts for account of policyholders |
- | - | - | |||||||||||||||||||||||||||||
| Other liabilities |
( |
) | ||||||||||||||||||||||||||||||
| Total liabilities |
( |
) |
||||||||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments |
Americas |
The Netherlands |
United Kingdom |
International |
Asset Management |
Holding and other activities |
Eliminations |
Total | ||||||||||||||||||||||||
| 2021 |
||||||||||||||||||||||||||||||||
| Shares |
||||||||||||||||||||||||||||||||
| Debt securities |
||||||||||||||||||||||||||||||||
| Loans |
||||||||||||||||||||||||||||||||
| Other financial assets |
||||||||||||||||||||||||||||||||
| Investments in real estate |
||||||||||||||||||||||||||||||||
| Investments general account |
||||||||||||||||||||||||||||||||
| Shares |
( |
) | ||||||||||||||||||||||||||||||
| Debt securities |
||||||||||||||||||||||||||||||||
| Unconsolidated investment funds |
||||||||||||||||||||||||||||||||
| Other financial assets |
||||||||||||||||||||||||||||||||
| Investments in real estate |
||||||||||||||||||||||||||||||||
| Investments for account of policyholders |
( |
) |
||||||||||||||||||||||||||||||
| Investments on balance sheet |
( |
) | ||||||||||||||||||||||||||||||
| Off-balance sheet investments third parties |
||||||||||||||||||||||||||||||||
Total revenue-generating investments |
( |
) |
||||||||||||||||||||||||||||||
| Investments |
||||||||||||||||||||||||||||||||
| Available-for-sale |
||||||||||||||||||||||||||||||||
| Loans |
||||||||||||||||||||||||||||||||
| Financial assets at fair value through profit or loss |
( |
) | ||||||||||||||||||||||||||||||
| Investments in real estate |
||||||||||||||||||||||||||||||||
Total investments on balance sheet |
( |
) |
||||||||||||||||||||||||||||||
| Investments in joint ventures |
||||||||||||||||||||||||||||||||
| Investments in associates |
( |
) | ||||||||||||||||||||||||||||||
| Other assets |
( |
) | ||||||||||||||||||||||||||||||
Consolidated total assets |
( |
) |
||||||||||||||||||||||||||||||
Notes to the consolidated financial statements Note 6 |
Investments |
Americas | The Netherlands |
United Kingdom |
International 1) |
Asset Management |
Holding and other activities |
Eliminations | Total | ||||||||||||||||||||||||
2020 |
||||||||||||||||||||||||||||||||
Shares |
||||||||||||||||||||||||||||||||
Debt securities |
||||||||||||||||||||||||||||||||
Loans |
||||||||||||||||||||||||||||||||
Other financial assets |
||||||||||||||||||||||||||||||||
Investments in real estate |
||||||||||||||||||||||||||||||||
Investments general account |
||||||||||||||||||||||||||||||||
Shares |
( |
) | ||||||||||||||||||||||||||||||
Debt securities |
||||||||||||||||||||||||||||||||
Unconsolidated investment funds |
||||||||||||||||||||||||||||||||
Other financial assets |
||||||||||||||||||||||||||||||||
Investments in real estate |
- | |||||||||||||||||||||||||||||||
Investments for account of policyholders |
( |
) |
||||||||||||||||||||||||||||||
Investments on balance sheet |
( |
) | ||||||||||||||||||||||||||||||
Off-balance sheet investments third parties |
( |
) | ||||||||||||||||||||||||||||||
Total revenue-generating investments |
( |
) |
||||||||||||||||||||||||||||||
Investments |
||||||||||||||||||||||||||||||||
Available-for-sale |
||||||||||||||||||||||||||||||||
Loans |
||||||||||||||||||||||||||||||||
Financial assets at fair value through profit or loss |
( |
) | ||||||||||||||||||||||||||||||
Investments in real estate |
||||||||||||||||||||||||||||||||
Total investments on balance sheet |
( |
) |
||||||||||||||||||||||||||||||
Investments in joint ventures |
( |
) | ( |
) | ||||||||||||||||||||||||||||
Investments in associates |
( |
) | ||||||||||||||||||||||||||||||
Other assets |
( |
) | ||||||||||||||||||||||||||||||
Consolidated total assets |
( |
) |
||||||||||||||||||||||||||||||
2021 |
2020 | 2019 | ||||||||||
Life insurance |
||||||||||||
Non-life insurance |
||||||||||||
Total premium income |
||||||||||||
Accident and health insurance |
||||||||||||
General insurance |
||||||||||||
Non-life insurance premium income |
||||||||||||
2021 |
2020 | 2019 | ||||||||||
Life insurance |
||||||||||||
Non-life insurance |
||||||||||||
Total premiums paid to reinsurers |
||||||||||||
Accident and health insurance |
||||||||||||
General insurance |
||||||||||||
Non-life insurance premiums paid to reinsurers |
||||||||||||
Notes to the consolidated financial statements Note 7 |
2021 |
2020 | 2019 | ||||||||||
Interest income |
||||||||||||
Dividend income |
||||||||||||
Rental income |
||||||||||||
Total investment income |
||||||||||||
Interest income accrued on impaired financial assets |
||||||||||||
Interest income on financial assets that are not carried at Fair value through profit or loss |
||||||||||||
Total investment income from: |
2021 |
2020 | 2019 | |||||||||
Shares |
||||||||||||
Debt securities and money market instruments |
||||||||||||
Loans |
||||||||||||
Real estate |
||||||||||||
Other |
||||||||||||
Total |
||||||||||||
Investment income is split into: |
2021 |
2020 | 2019 | |||||||||
Investment income related to general account |
||||||||||||
Investment income for account of policyholders |
||||||||||||
Total |
||||||||||||
Investment income from financial assets held for general account: |
||||||||||||
Available-for-sale |
||||||||||||
Loans |
||||||||||||
Financial assets designated at fair value through profit or loss |
||||||||||||
Real estate |
||||||||||||
Derivatives |
( |
) | ( |
) | ||||||||
Other |
( |
) | ( |
) | ||||||||
Total |
||||||||||||
2021 |
2020 | 2019 | ||||||||||
Fee income from asset management |
||||||||||||
Commission income |
||||||||||||
Other |
||||||||||||
Total fee and commission income |
||||||||||||
Included in fee and commission income: |
||||||||||||
Fees on trust and fiduciary activities |
||||||||||||
2021 |
2020 | 2019 | ||||||||||
Recovered claims and benefits |
||||||||||||
Change in technical provisions |
||||||||||||
Commissions |
||||||||||||
Amortization Charges |
||||||||||||
Total |
||||||||||||
Notes to the consolidated financial statements Note 10 |
Results from financial transactions comprise: |
2021 |
2020 | 2019 | |||||||||
Net fair value change of general account financial investments at fair value through profit or loss, other than derivatives |
||||||||||||
Realized gains and (losses) on financial investments |
||||||||||||
Gains and (losses) on investments in real estate |
||||||||||||
Net fair value change of derivatives |
( |
) | ||||||||||
Net fair value change on account of policyholder financial assets at fair value through profit or loss |
||||||||||||
Net fair value change on investments in real estate for account of policyholders |
( |
) | ( |
) | ||||||||
Net foreign currency gains and (losses) |
( |
) | ||||||||||
Net fair value change on borrowings and other financial liabilities |
( |
) | ||||||||||
Total |
||||||||||||
Net fair value change of general account financial investments at fair value through profit or loss, other than derivatives comprise: |
2021 |
2020 | 2019 | |||||||||
Shares |
( |
) | ||||||||||
Debt securities and money market investments |
( |
) | ||||||||||
Other |
||||||||||||
Total |
||||||||||||
Realized gains and losses on financial investments comprise: |
2021 |
2020 | 2019 | |||||||||
Shares |
||||||||||||
Debt securities and money market investments |
||||||||||||
Loans |
||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||
Total |
||||||||||||
Realized gains and losses on financial investments comprise: |
2021 |
2020 | 2019 | |||||||||
Available-for-sale investments |
||||||||||||
Loans |
||||||||||||
Total |
||||||||||||
Net fair value change of derivatives comprise: |
2021 |
2020 | 2019 | |||||||||
Net fair value change on economic hedges where no hedge accounting is applied |
( |
) | ||||||||||
Net fair value change on bifurcated embedded derivatives |
( |
) | ( |
) | ||||||||
Ineffective portion of hedge transactions to which hedge accounting is applied |
- | |||||||||||
Total |
( |
) |
||||||||||
The ineffective portion of hedge transactions to which hedge accounting is applied comprises: |
2021 |
2020 | 2019 | |||||||||
Fair value change on hedging instruments in a fair value hedge |
( |
) | ( |
) | ||||||||
Fair value change on hedged items in a fair value hedge |
( |
) | ||||||||||
Ineffectiveness fair value hedge |
||||||||||||
Ineffectiveness cash flow hedges |
- | - | ||||||||||
Total |
||||||||||||
Notes to the consolidated financial statements Note 11 |
Net fair value change on for account of policyholder financial assets |
||||||||||||
at fair value through profit or loss comprise: |
2021 |
2020 | 2019 | |||||||||
Shares |
||||||||||||
Debt securities and money market investments |
( |
) | ||||||||||
Unconsolidated investment funds |
||||||||||||
Derivatives |
( |
) | ||||||||||
Total |
||||||||||||
Net fair value change on borrowings and other financial liabilities |
2021 |
2020 | 2019 | |||||||||
Borrowings |
||||||||||||
Other financial liabilities |
( |
) | ||||||||||
Total |
( |
) |
||||||||||
2021 |
2020 | 2019 | ||||||||||
Other income |
||||||||||||
2021 |
2020 | 2019 | ||||||||||
Benefits and claims paid life |
||||||||||||
Benefits and claims paid non-life |
||||||||||||
Change in valuation of liabilities for insurance contracts |
||||||||||||
Change in valuation of liabilities for investment contracts |
||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||
Total |
||||||||||||
Notes to the consolidated financial statements Note 13 |
2021 |
2020 | 2019 | ||||||||||
Surplus interest bonuses |
||||||||||||
Profit appropriated to policyholders |
||||||||||||
Total |
||||||||||||
2021 |
2020 | 2019 | ||||||||||
Commissions |
||||||||||||
Employee expenses |
||||||||||||
Administration expenses |
||||||||||||
Deferred expenses |
( |
) | ( |
) | ( |
) | ||||||
Amortization of deferred expenses |
||||||||||||
Amortization of VOBA and future servicing rights |
||||||||||||
Total |
||||||||||||
Included in administration expenses: |
||||||||||||
Depreciation of equipment, software and real estate held for own use |
||||||||||||
Employee expenses |
2021 |
2020 | 2019 | |||||||||
Salaries |
||||||||||||
Post-employment benefit costs |
||||||||||||
Social security charges |
||||||||||||
Other personnel costs |
||||||||||||
Shares |
||||||||||||
Total |
||||||||||||
Included in employee expenses: |
||||||||||||
Defined contribution expenses |
||||||||||||
Notes to the consolidated financial statements Note 14 |
| 2017 | 2018 | 2019 | 2020 | 2021 |
Total | |||||||||||||||||||
Conditionally granted 1) |
||||||||||||||||||||||||
Allocated 2) |
||||||||||||||||||||||||
1 |
The at target number of shares which were conditionally granted for the plan year. |
2 |
The allocated number of shares based on the actual performance during the plan year. |
Notes to the consolidated financial statements Note 15 |
| 2017 | 2018 | 2019 | 2020 | 2021 | Total |
|||||||||||||||||||
Unvested at January 1, 2020 |
- |
- |
||||||||||||||||||||||
Conditionally granted as variable compensation 1) |
- | - | - | |||||||||||||||||||||
Allocated 2) |
( |
) | - | |||||||||||||||||||||
Forfeited |
( |
) | ( |
) | ( |
) | ( |
) | - | ( |
) | |||||||||||||
Vested |
( |
) | ( |
) | ( |
) | ( |
) | - | ( |
) | |||||||||||||
Unvested at December 31, 2020 |
- |
|||||||||||||||||||||||
Conditionally granted as variable compensation 1) |
- | - | - | - | ||||||||||||||||||||
Allocated 2) |
( |
) | ( |
) | ||||||||||||||||||||
Forfeited |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Vested |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Unvested at December 31, 2021 |
||||||||||||||||||||||||
Grant price (in EUR) 3) |
||||||||||||||||||||||||
Fair value of shares at grant date (in EUR) 4) |
||||||||||||||||||||||||
1 |
The at target number of shares which were conditionally granted as variable compensation for the plan year. |
2 |
Shares allocated in the same year are a combination of shares allocated as fixed compensation and sign-on shares which have been allocated during that year (e.g. the |
3 |
This is the volume weighted average price (VWAP) of Aegon on the Euronext Amsterdam stock exchange for the period December 15 to January 15. For instance for the 2021 plan year, this is the VWAP for the period December 15, 2020 to January 15, 2021. |
4 |
These fair values are adjusted for expected dividend (for which the participants are not eligible during the deferral period) and for the impact of relative total shareholder return as performance indicator for variable compensation (where applicable). |
Impairment charges / (reversals) comprise: |
2021 |
2020 | 2019 | |||||||||
Impairment charges on financial assets, excluding receivables |
||||||||||||
Impairment reversals on financial assets, excluding receivables |
( |
) | ( |
) | ( |
) | ||||||
Impairment charges and reversals on non-financial assets and receivables |
||||||||||||
Total |
||||||||||||
Impairment charges on financial assets, excluding receivables, from: |
2021 |
2020 | 2019 | |||||||||
Shares |
||||||||||||
Debt securities and money market instruments |
||||||||||||
Loans |
||||||||||||
Total |
||||||||||||
Impairment reversals on financial assets, excluding receivables, from: |
2021 |
2020 | 2019 | |||||||||
Shares |
( |
) | - | - | ||||||||
Debt securities and money market instruments |
( |
) | ( |
) | ( |
) | ||||||
Loans |
( |
) | ( |
) | ( |
) | ||||||
Other |
( |
) | ( |
) | ( |
) | ||||||
Total |
( |
) |
( |
) |
( |
) | ||||||
Notes to the consolidated financial statements Note 16 |
2021 |
2020 | 2019 | ||||||||||
Subordinated loans |
||||||||||||
Trust pass-through securities |
||||||||||||
Borrowings |
||||||||||||
Other |
||||||||||||
Total |
||||||||||||
Included in interest charges and related fees: |
||||||||||||
Interest charges accrued on financial liabilities not carried at fair value through profit or loss |
||||||||||||
2021 |
2020 | 2019 | ||||||||||
Other charges |
||||||||||||
Notes to the consolidated financial statements Note 18 |
Note |
2021 |
2020 | 2019 | |||||||||||||
Current tax |
||||||||||||||||
Current year |
( |
) | ||||||||||||||
Adjustments to prior years |
( |
) | ( |
) | ( |
) | ||||||||||
( |
) |
|||||||||||||||
Deferred tax |
40 |
|||||||||||||||
Origination / (reversal) of temporary differences |
( |
) | ||||||||||||||
Changes in tax rates / bases |
( |
) | ( |
) | ||||||||||||
Changes in deferred tax assets as a result of recognition /write off of previously not recognized / recognized tax losses,tax credits and deductible temporary differences |
( |
) | ||||||||||||||
Non-recognition of deferred tax assets |
||||||||||||||||
Adjustments to prior years |
( |
) | ( |
) | ||||||||||||
Income tax for the period (income) / charge |
( |
) |
||||||||||||||
Reconciliation between standard and effective income tax: |
2021 |
2020 | 2019 | |||||||||
Result before tax |
( |
) | ||||||||||
Income tax calculated using weighted average applicable statutory tax rates |
( |
) | ||||||||||
Difference due to the effects of: |
||||||||||||
Non-taxable income |
( |
) | ( |
) | ( |
) | ||||||
Non-tax deductible expenses |
||||||||||||
Changes in tax rate/base |
( |
) | ( |
) | ||||||||
Tax credits |
( |
) | ( |
) | ( |
) | ||||||
Other taxes |
( |
) | ||||||||||
Adjustments to prior years |
( |
) | ( |
) | ( |
) | ||||||
Change in uncertain tax positions |
( |
) | - | - | ||||||||
Changes in deferred tax assets as a result of recognition / write off of previously not recognized / recognized tax losses, tax credits and deductible temporary differences |
( |
) | ||||||||||
Non-recognition of deferred tax assets |
||||||||||||
Tax effect of (profit) / losses from joint ventures and associates |
( |
) | ( |
) | ( |
) | ||||||
Other |
( |
) | ( |
) | ( |
) | ||||||
( |
) |
( |
) |
( |
) | |||||||
Income tax for the period (result) / charge |
( |
) |
( |
) | ||||||||
Notes to the consolidated financial statements Note 19 |
2021 |
2020 | 2019 | ||||||||||
Items that will not be reclassified to profit and loss: |
||||||||||||
Changes in revaluation reserve real estate held for own use |
( |
) | ||||||||||
Remeasurements of defined benefit plans |
( |
) | ||||||||||
( |
) |
|||||||||||
Items that may be reclassified subsequently to profit and loss: |
||||||||||||
(Gains) / losses on revaluation of available-for-sale investments |
( |
) | ( |
) | ||||||||
(Gains) / losses transferred to the income statement on disposal and impairment of available-for-sale investments |
||||||||||||
Changes in cash flow hedging reserve |
||||||||||||
Movement in foreign currency translation and net foreign investment hedging reserve |
( |
) | ( |
) | ||||||||
( |
) |
( |
) | |||||||||
Total income tax related to components of other comprehensive income |
( |
) |
( |
) | ||||||||
2021 |
2020 | 2019 | ||||||||||||||
Income tax related to equity instruments and other |
||||||||||||||||
Income tax related to equity instruments |
31 |
|||||||||||||||
Other |
( |
) | ||||||||||||||
Total income tax recognized directly in retained earnings |
||||||||||||||||
2021 |
2020 | 2019 | ||||||||||
Net result attributable to owners of Aegon N.V. |
( |
) | ||||||||||
Coupons on perpetual securities |
( |
) | ( |
) | ( |
) | ||||||
Net result attributable to owners for basic earnings per share calculation |
( |
) |
||||||||||
Net result attributable to common shareholders |
( |
) | ||||||||||
Net result attributable to common shareholders B |
( |
) | ||||||||||
Weighted average number of common shares outstanding (in million) |
||||||||||||
Weighted average number of common shares B outstanding (in million) |
||||||||||||
Basic earnings per common share (EUR per share) |
( |
) | ||||||||||
Basic earnings per common share B (EUR per share) |
||||||||||||
Notes to the consolidated financial statements Note 2 0 |
Notes to the consolidated financial statements Note 21 |
2021 |
2020 | 2019 | ||||||||||
Cash at bank and in hand |
||||||||||||
Short-term deposits |
||||||||||||
Money market investments |
||||||||||||
Short-term collateral |
- | |||||||||||
At December 31 |
||||||||||||
Cash collateral received related to securities lending, repurchase agreements and margins on derivatives transactions |
||||||||||||
Income from security lending programs |
||||||||||||
Weighted effective interest rate on short-term deposits |
( |
( |
( |
|||||||||
Average maturity days on short-term deposits |
||||||||||||
Summary cash flow statement |
2021 |
2020 | 2019 | |||||||||
Net cash flows from operating activities |
( |
( |
|
|||||||||
Net cash flows from investing activities |
( |
( |
( |
|||||||||
Net cash flows from financing activities |
( |
( |
||||||||||
Net increase / decrease in cash and cash equivalents |
( |
( |
||||||||||
Net cash and cash equivalents are impacted by: |
||||||||||||
Positive (negative) effects of changes in exchange rates |
( |
|||||||||||
Notes to the consolidated financial statements Note 21 |
Notes to the consolidated financial statements Note 22 |
Cash flows |
Non-cash changes |
|||||||||||||||||||
Reconciliation of debt from financing activities |
At January 1, 2021 |
Addition |
Repay- ment |
Realized gains / losses in income statement |
Movements related to fair value hedges |
Amorti- zation |
Transfer to/from other headings |
Other |
Net exchange difference |
At December 31, 2021 | ||||||||||
Subordinated borrowings |
- | - | - | - | - | - | |
|||||||||||||
Trust pass-through securities |
- | - | - | ( |
- | - | - | |||||||||||||
Borrowings |
( |
- | ( |
- | - | |
||||||||||||||
Assets held to hedge Trust pass-through securities |
- | - | ( |
- | - | - | - | |||||||||||||
Assets held to hedge Borrowings |
- | ( |
( |
- | - | - | - | - | - | |||||||||||
| Cash flows | Non-cash changes |
|||||||||||||||||||
Reconciliation of debt from financing activities |
At January 1, 2020 |
Addition | Repay- ment |
Realized gains / losses in income statement |
Movements related to fair value hedges |
Amorti- zation |
Transfer to/from other headings |
Other | Net exchange difference |
At December 31, 2020 | ||||||||||
Subordinated borrowings |
- | - | - | - | - | - | ( |
|||||||||||||
Trust pass-through securities |
- | - | - | |
- | - | - | ( |
||||||||||||
Borrowings |
( |
( |
- | - | ( |
|||||||||||||||
Assets held to hedge Trust pass-through securities |
- | - | - | - | - | - | ( |
|||||||||||||
Assets held to hedge Borrowings |
- | - | ( |
- | - | - | - | - | ||||||||||||
Note |
2021 |
2020 | ||||||||||
Available-for-sale (AFS) |
||||||||||||
Loans |
||||||||||||
Financial assets at fair value through profit or loss (FVTPL) |
||||||||||||
Total financial assets, excluding derivatives |
22.1 |
|||||||||||
Investments in real estate |
22.2 |
|||||||||||
Total investments for general account |
||||||||||||
Notes to the consolidated financial statements Note 22 |
| AFS | FVTPL | Loans | Total |
Fair value | ||||||
2021 |
||||||||||
Shares |
- | |||||||||
Debt securities |
- | |||||||||
Money market and other short-term investments |
- | |||||||||
Mortgage loans |
- | - | ||||||||
Private loans |
- | - | ||||||||
Deposits with financial institutions |
- | - | ||||||||
Policy loans |
- | - | ||||||||
Other |
||||||||||
At December 31, 2021 |
||||||||||
2020 |
||||||||||
Shares |
- | |||||||||
Debt securities |
- | |||||||||
Money market and other short-term investments |
- | |||||||||
Mortgage loans |
- | - | ||||||||
Private loans |
- | - | ||||||||
Deposits with financial institutions |
- | - | ||||||||
Policy loans |
- | - | ||||||||
Other |
||||||||||
At December 31, 2020 |
||||||||||
2021 |
2020 | |||||||||
Current portion: |
||||||||||
Debt securities, money market and other short-term investments, mortgage and private loans |
|
|||||||||
2021 |
2020 | |||||||||
At January 1 |
( |
( | ||||||||
Addition charged to income statement |
( |
( | ||||||||
Reversal to income statement |
||||||||||
Amounts written off |
||||||||||
At December 31 |
( |
( | ||||||||
Notes to the consolidated financial statements Note 23 |
2021 |
2020 | |||||||
At January 1 |
||||||||
Additions |
||||||||
Subsequent expenditure capitalized |
||||||||
Disposals |
( |
( |
||||||
Transfer from real estate for own use and equipment |
||||||||
Fair value gains / (losses) |
||||||||
Net exchange differences |
( |
|||||||
At December 31 |
||||||||
Investments in real estate held by: |
||||||||
Americas |
||||||||
The Netherlands |
||||||||
Value of Aegon’s properties which were appraised in the current year |
||||||||
Appraisals performed by independent external appraisers |
||||||||
2021 |
2020 | 2019 | ||||||||||
Rental income reported as part of investment income |
||||||||||||
Direct operating expenses (Including repairs and maintenance expenses): |
||||||||||||
- From investment property that generated rental income |
||||||||||||
- From investment property that did not generate rental income |
||||||||||||
Note |
2021 |
2020 | ||||||||||
Shares |
||||||||||||
Debt securities |
||||||||||||
Money market and other short-term investments |
||||||||||||
Deposits with financial institutions |
||||||||||||
Unconsolidated investment funds |
||||||||||||
Other |
||||||||||||
Total investments for account of policyholders at fair value through profit or loss, excluding derivatives |
||||||||||||
Investments in real estate |
23.1 |
|||||||||||
Total investments for account of policyholders |
||||||||||||
Notes to the consolidated financial statements Note 24 |
2021 |
2020 | |||||||
At January 1 |
||||||||
Additions |
- | |||||||
Subsequent expenditure capitalized |
||||||||
Disposals |
( |
) | ( |
) | ||||
Fair value gains / (losses) |
( |
) | ||||||
Net exchange differences |
( |
) | ||||||
At December 31 |
||||||||
The investment properties are leased out under operating leases. |
||||||||||||
2021 |
2020 | 2019 | ||||||||||
Rental income reported as part of investment income |
||||||||||||
Direct operating expenses from investment in real estate for account of policyholders |
||||||||||||
| Derivative asset | Derivative liability | |||||||||||||||
2021 |
2020 | 2021 |
2020 | |||||||||||||
Derivatives for general account |
||||||||||||||||
Derivatives not designated in a hedge |
||||||||||||||||
Derivatives designated as fair value hedges |
||||||||||||||||
Derivatives designated as cash flow hedges |
||||||||||||||||
Derivatives desginated as Net foreign investment hedges |
||||||||||||||||
Derivatives for account of policyholders |
||||||||||||||||
Derivatives not designated in a hedge |
||||||||||||||||
Total derivatives 1) |
||||||||||||||||
Of which: |
||||||||||||||||
Current |
||||||||||||||||
1 |
Refer to note 44 Fair value for a summary of all financial assets and financial liabilities at fair value through profit or loss. |
Notes to the consolidated financial statements Note 24 |
Derivatives not designated in a hedge – general account |
Derivative asset | Derivative liability | ||||||||||||||
2021 |
2020 | 2021 |
2020 | |||||||||||||
Derivatives held as an economic hedge |
||||||||||||||||
Bifurcated embedded derivatives |
||||||||||||||||
Total |
||||||||||||||||
2021 |
2020 | |||||||||||||||
Credit derivative disclosure by quality |
Notional |
Fair value |
Notional | Fair value | ||||||||||||
AAA |
||||||||||||||||
AA |
||||||||||||||||
A |
||||||||||||||||
BBB |
||||||||||||||||
BB |
||||||||||||||||
B or lower |
||||||||||||||||
Total |
||||||||||||||||
Notes to the consolidated financial statements Note 24 |
2021 |
2020 | 2019 | ||||||||||
Gains (losses) related to the ineffectiveness portion of designated fair value hedges |
||||||||||||
Hedge ineffectiveness and reclassification of gains (losses) |
2021 |
|||||||||||
Hedge ineffectiveness on cash flow hedges |
||||||||||||
Gains (losses) reclassified from equity into the income statement |
( |
) | ||||||||||
Expected deferred gain (loss) to be reclassified from equity into net result during the next 12 months |
||||||||||||
The periods when the cash flows are expected to occur are as follows: |
||||||||||||||||||||
< 1 year |
1 – 5 years |
5 – 10 years |
> 10 years |
2021 Total |
||||||||||||||||
Cash inflows |
||||||||||||||||||||
Cash outflows |
||||||||||||||||||||
Net cash flows |
||||||||||||||||||||
| < 1 year | 1 – 5 years | 5 – 10 years | > 10 years | 2020 Total | ||||||||||||||||
Cash inflows |
||||||||||||||||||||
Cash outflows |
||||||||||||||||||||
Net cash flows |
||||||||||||||||||||
Notes to the consolidated financial statements Note 25 |
| Joint ventures | Associates | |||||||||||||||
2021 |
2020 | 2021 |
2020 | |||||||||||||
At January 1 |
||||||||||||||||
Additions |
||||||||||||||||
Disposals |
- | ( |
) | - | ( |
) | ||||||||||
Share in net result |
||||||||||||||||
Share in changes in equity (note 30.6) |
( |
) | ||||||||||||||
Impairment reversals / (charges) |
- | ( |
) | ( |
) | |||||||||||
Dividends |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Net exchange difference |
( |
) | ( |
) | ||||||||||||
Transfer to / (from) other headings |
( |
) | ( |
) | ||||||||||||
Other |
( |
) | - | |||||||||||||
At December 31 |
||||||||||||||||
Notes to the consolidated financial statements Note 25 |
| Santander Spain Life | AIFMC | Other Joint ventures | ||||||||||||||||||||||
2021 |
2020 | 2021 |
2020 | 2021 |
2020 | |||||||||||||||||||
Summarized statement of financial position |
||||||||||||||||||||||||
Cash and cash equivalents |
||||||||||||||||||||||||
Other current assets |
||||||||||||||||||||||||
Total current assets |
||||||||||||||||||||||||
Non-current assets |
||||||||||||||||||||||||
Total assets |
||||||||||||||||||||||||
Current financial liabilities excluding trade payables and other provisions |
||||||||||||||||||||||||
Other current liabilities |
||||||||||||||||||||||||
Total current liabilities |
||||||||||||||||||||||||
Non-current financial liabilities excluding trade payables and other provisions |
||||||||||||||||||||||||
Other non-current liabilities |
||||||||||||||||||||||||
Total non-current financial liabilities |
||||||||||||||||||||||||
Total liabilities |
||||||||||||||||||||||||
Net assets |
||||||||||||||||||||||||
Summarized statement of comprehensive income |
||||||||||||||||||||||||
Revenue |
||||||||||||||||||||||||
Results from financial transactions |
( |
) | ||||||||||||||||||||||
Depreciation and amortization |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Interest income |
||||||||||||||||||||||||
Interest expense |
( |
) | ||||||||||||||||||||||
Profit or loss |
||||||||||||||||||||||||
Income tax (expense) or result |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||
Post-tax profit or (loss) |
||||||||||||||||||||||||
Other comprehensive income |
( |
) | ||||||||||||||||||||||
Total comprehensive income |
||||||||||||||||||||||||
Dividends received |
||||||||||||||||||||||||
Notes to the consolidated financial statements Note 25 |
| Santander Spain Life | AIFMC | Other Joint ventures | ||||||||||||||||||||||
2021 |
2020 | 2021 |
2020 | 2021 |
2020 | |||||||||||||||||||
Net assets of joint venture as presented above |
||||||||||||||||||||||||
Net assets of joint venture excluding goodwill |
||||||||||||||||||||||||
Group share of net assets of joint venture, excluding goodwill |
||||||||||||||||||||||||
Goodwill on acquisition |
||||||||||||||||||||||||
Carrying amount |
||||||||||||||||||||||||
| Santander Spain Life | AIFMC | Other Joint ventures | ||||||||||||||||||||||
2021 |
2020 | 2021 |
2020 | 2021 |
2020 | |||||||||||||||||||
Post-tax profit or loss |
||||||||||||||||||||||||
Other comprehensive income |
( |
) | - | - | ( |
) | ||||||||||||||||||
Total comprehensive income |
||||||||||||||||||||||||
| Amvest Residential Core Fund | Other Associates | |||||||||||||||
2021 |
2020 | 2021 |
2020 | |||||||||||||
Summarized statement of financial position |
||||||||||||||||
Current assets |
||||||||||||||||
Non-current assets |
||||||||||||||||
Total assets |
||||||||||||||||
Current liabilities |
||||||||||||||||
Non-current liabilities |
||||||||||||||||
Total liabilities |
||||||||||||||||
Net assets |
||||||||||||||||
Summarized statement of comprehensive income |
||||||||||||||||
Revenue |
||||||||||||||||
Interest expense |
- | ( |
) | |||||||||||||
Profit or loss |
( |
) | ||||||||||||||
Income tax (expense) or result |
- | ( |
) | |||||||||||||
Post-tax profit or (loss) |
( |
) |
||||||||||||||
Other comprehensive income |
- | - | ( |
) | ||||||||||||
Total comprehensive income |
( |
) |
||||||||||||||
Dividends received |
||||||||||||||||
Notes to the consolidated financial statements Note 2 6 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amvest Residential Core Fund | Other Associates | |||||||||||||||
2021 |
2020 | 2021 |
2020 | |||||||||||||
| Post-tax profit or loss |
( |
) | ||||||||||||||
| Other comprehensive income |
( |
) | ||||||||||||||
| Total comprehensive income |
( |
) |
||||||||||||||
| Carrying amount |
||||||||||||||||
| |
|
|
|
|
|
|
|
|
| Assets arising from reinsurance contracts related to: |
2021 |
2020 | ||||||
| Life insurance general account |
||||||||
| Non-life insurance |
||||||||
| Investment contracts |
||||||||
| At December 31 |
||||||||
| Current |
||||||||
| Non-current |
||||||||
| |
|
|
|
|
Movements during the year in reinsurance assets relating to life insurance: |
Life insurance general account | |||
| At January 1, 2021 |
||||
| Gross premium and deposits – existing and new business |
||||
| Unwind of discount / interest credited |
||||
| Insurance liabilities released |
( |
) | ||
| Fund charges released |
( |
) | ||
| Changes to valuation of expected future benefits |
( |
) | ||
| Net exchange differences |
||||
| Transfer to/from insurance contracts |
||||
| Other movements |
||||
| At December 31, 2021 |
||||
| At January 1, 2020 |
||||
| Gross premium and deposits – existing and new business |
||||
| Unwind of discount / interest credited |
||||
| Insurance liabilities released |
( |
) | ||
| Fund charges released |
( |
) | ||
| Changes to valuation of expected future benefits |
||||
| Net exchange differences |
( |
) | ||
| Transfer to/from insurance contracts |
||||
| Other movements |
||||
| At December 31, 2020 |
||||
Notes to the consolidated financial statements Note 27 |
| |
|
|
|
|
|
|
|
|
Movements during the year in reinsurance assets relating to non-life insurance: |
2021 |
2020 | ||||||
| At January 1 |
||||||||
| Gross premium and deposits – existing and new business |
||||||||
| Unwind of discount / interest credited |
||||||||
| Insurance liabilities released |
( |
) | ( |
) | ||||
| Changes in unearned premiums |
( |
) | ( |
) | ||||
| Incurred related to current year |
||||||||
| Incurred related to prior years |
||||||||
| Release for claims settled current year |
( |
) | ( |
) | ||||
| Release for claims settled prior years |
( |
) | ( |
) | ||||
| Change in IBNR |
||||||||
| Net exchange differences |
( |
) | ||||||
| Other movements |
( |
) | ||||||
| At December 31 |
||||||||
| |
|
|
|
|
|
|
|
|
Assets arising from reinsurance contracts related to: |
2021 |
2020 | ||||||
| Normal course of business |
||||||||
| Exit of a business |
||||||||
| At December 31 |
||||||||
| |
|
|
|
|
|
|
|
|
| 27 Deferred expenses |
|
| ||||||
| |
|
|
|
|
|
|
|
|
2021 |
2020 | |||||||
| DPAC for insurance contracts and investment contracts with discretionary participation features |
||||||||
| Deferred cost of reinsurance |
||||||||
| Deferred transaction costs for investment management services |
||||||||
| At December 31 |
||||||||
| Current |
||||||||
| Non-current |
||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
2020 | |||||||||||||||||||||||
DPAC |
Deferred costs of reinsurance |
Deferred transaction costs |
DPAC | Deferred costs of reinsurance |
Deferred transaction costs |
|||||||||||||||||||
| At January 1 |
||||||||||||||||||||||||
| Costs deferred during the year |
( |
) | ||||||||||||||||||||||
| Amortization through income statement |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
| Shadow accounting adjustments |
( |
) | ( |
) | ||||||||||||||||||||
| Impairments |
||||||||||||||||||||||||
| Net exchange differences |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
| Disposal of Group Assets |
||||||||||||||||||||||||
| Other |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
| At December 31 |
||||||||||||||||||||||||
Notes to the consolidated financial statements Note 28 |
28 Other assets and receivables |
Note |
2021 |
2020 | ||||||||||
Real estate held for own use and equipment |
28.1 |
|||||||||||
Receivables |
28.2 |
|||||||||||
Accrued income |
28.3 |
|||||||||||
Right-of-use assets |
28.4 |
|||||||||||
At December 31 |
||||||||||||
28.1 Real estate held for own use and equipment |
||||||||||
Total real estate held for own use and equipment |
2021 |
2020 | ||||||||
General account real estate held for own use |
||||||||||
Equipment |
||||||||||
At December 31 |
||||||||||
General account real estate held for own use |
2021 |
2020 | ||||||||
Net book value |
||||||||||
At January 1 |
||||||||||
Additions |
- | |||||||||
Capitalized subsequent expenditure |
( |
) | ||||||||
Disposals |
- | ( |
) | |||||||
Transfer to investments in real estate |
( |
) | - | |||||||
Unrealized gains/(losses) through equity |
( |
) | ||||||||
Realized gains/(losses) through income statement |
- | ( |
) | |||||||
Depreciation through income statement |
( |
) | ( |
) | ||||||
Impairment losses |
( |
) | ( |
) | ||||||
Impairment losses reversed |
- | |||||||||
Net exchange differences |
( |
) | ||||||||
At December 31 |
||||||||||
Gross carrying value |
||||||||||
Accumulated depreciation and impairment losses |
( |
) | ( |
) | ||||||
Net book value |
||||||||||
General account real estate held for own use: |
||||||||||
Carrying amount under a historical cost model |
||||||||||
% of real estate appraised in the current year |
||||||||||
% of appraisals performed by independent external appraisers |
||||||||||
Notes to the consolidated financial statements Note 28 |
Equipment |
2021 |
2020 |
||||||
Net book value |
||||||||
At January 1 |
||||||||
Additions |
||||||||
Disposals |
( |
) | ( |
) | ||||
Depreciation through income statement |
( |
) | ( |
) | ||||
Impairment losses |
( |
) | - | |||||
Net exchange differences |
( |
) | ||||||
Other |
|
( |
) |
|
- |
| ||
At December 31 |
||||||||
Gross carrying value |
||||||||
Accumulated depreciation and impairment losses |
|
( |
) |
|
( |
) | ||
Net book value |
||||||||
2021 |
2020 |
|||||||
Loans to associates |
||||||||
Receivables from policyholders |
||||||||
Receivables from brokers and agents |
||||||||
Receivables from reinsurers |
||||||||
Cash outstanding from assets sold |
||||||||
Trade receivables |
||||||||
Cash collateral |
||||||||
Income tax receivable |
||||||||
Other |
||||||||
Provision for doubtful debts |
|
( |
) |
|
( |
) | ||
At December 31 |
||||||||
Current |
||||||||
Non-current |
|
|
|
| ||||
2021 |
2020 | |||||||
At January 1 |
( |
) | ( |
) | ||||
Additions charged to earnings |
( |
) | ( |
) | ||||
Unused amounts reversed through the income statement |
||||||||
Used during the year |
||||||||
Net exchange differences |
|
( |
) |
|
| |||
At December 31 |
( |
) |
( |
) | ||||
Notes to the consolidated financial statements Note 28 |
2021 |
2020 | |||||||
Accrued interest |
||||||||
Other |
||||||||
At December 31 |
||||||||
Current |
||||||||
Non-current |
||||||||
Real estate for own use |
Equipment |
Other |
Total |
|||||||||||||
Net book value |
||||||||||||||||
At January 1, 2021 |
||||||||||||||||
Additions |
||||||||||||||||
Disposals |
( |
) | ( |
) | ||||||||||||
Modification of lease contracts |
- | - | ||||||||||||||
Depreciation through income statement |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Net exchange differences |
( |
) | ||||||||||||||
At December 31, 2021 |
||||||||||||||||
Gross carrying value |
||||||||||||||||
Accumulated depreciation and impairment losses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Net book value 2021 |
||||||||||||||||
Net book value |
||||||||||||||||
At January 1, 2020 |
||||||||||||||||
Additions |
||||||||||||||||
Disposals |
( |
) | - | - | ( |
) | ||||||||||
Modification of lease contracts |
- | - | ||||||||||||||
Depreciation through income statement |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Net exchange differences |
( |
) | ( |
) | - | ( |
) | |||||||||
At December 31, 2020 |
||||||||||||||||
Gross carrying value |
||||||||||||||||
Accumulated depreciation and impairment losses |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Net book value 2020 |
||||||||||||||||
Notes to the consolidated financial statements Note 29 |
Goodwill |
VOBA |
Future servicing rights |
Software |
Other |
Total |
|||||||||||||||||||
Net book value |
||||||||||||||||||||||||
At January 1, 2021 |
||||||||||||||||||||||||
Additions |
- | - | - | |||||||||||||||||||||
Amortization through income statement |
- | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||
Impairment losses |
- | - | - | ( |
) | ( |
) | ( |
) | |||||||||||||||
Shadow accounting adjustments |
- | - | - | - | ||||||||||||||||||||
Capital expenditure |
- | - | - | - | ||||||||||||||||||||
Business combinations, disposals and other changes |
- | - | - | ( |
) | ( |
) | |||||||||||||||||
Net exchange differences |
|
|
|
|
|
|
|
( |
) |
|
( |
) |
|
| ||||||||||
At December 31, 2021 |
||||||||||||||||||||||||
Gross carrying value |
||||||||||||||||||||||||
Accumulated amortization, depreciation and impairment losses |
|
( |
) |
|
( |
) |
|
( |
) |
|
( |
) |
|
( |
) |
|
( |
) | ||||||
Net book value 2021 |
||||||||||||||||||||||||
Net book value |
||||||||||||||||||||||||
At January 1, 2020 |
||||||||||||||||||||||||
Additions |
- | - | - | |||||||||||||||||||||
Amortization through income statement |
- | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | |||||||||||||
Impairment losses |
- | - | - | ( |
) | ( |
) | ( |
) | |||||||||||||||
Shadow accounting adjustments |
- | - | - | - | ||||||||||||||||||||
Capital expenditure |
- | - | - | - | ||||||||||||||||||||
Business combinations, disposals and other changes |
- | - | ( |
) | ( |
) | ||||||||||||||||||
Net exchange differences |
|
( |
) |
|
( |
) |
|
( |
) |
|
- |
|
|
( |
) |
|
( |
) | ||||||
At December 31, 2020 |
||||||||||||||||||||||||
Gross carrying value |
||||||||||||||||||||||||
Accumulated amortization, depreciation and impairment losses |
|
( |
) |
|
( |
) |
|
( |
) |
|
( |
) |
|
( |
) |
|
( |
) | ||||||
Net book value 2020 |
||||||||||||||||||||||||
Notes to the consolidated financial statements Note 30 |
Goodwill |
2021 |
2020 |
||||||
Americas |
||||||||
The Netherlands |
||||||||
United Kingdom |
||||||||
International |
||||||||
Asset Management |
|
|
|
| ||||
At December 31 |
||||||||
Note |
2021 |
2020 |
2019 |
|||||||||||||
Share capital – par value |
30.1 |
|||||||||||||||
Share premium |
30.2 |
|
|
|
|
|
| |||||||||
Total share capital |
||||||||||||||||
Retained earnings |
||||||||||||||||
Treasury shares |
30.3 |
|
( |
) |
|
( |
) |
|
( |
) | ||||||
Total retained earnings |
||||||||||||||||
Revaluation reserves |
30.4 |
|||||||||||||||
Remeasurement of defined benefit plans |
30.5 |
( |
) | ( |
) | ( |
) | |||||||||
Other reserves |
30.6 |
|
|
|
( |
) |
|
| ||||||||
Total shareholders’ equity |
||||||||||||||||
Notes to the consolidated financial statements Note 30 |
2021 |
2020 | 2019 | ||||||||||
Share capital transactions relating to common shares |
Number of shares (thousands) |
Number of shares (thousands) |
Number of shares (thousands) |
|||||||||
Transactions in 2021: |
||||||||||||
Final dividend 2020 1) |
( |
) |
||||||||||
Share buyback program (final dividend 2020) |
||||||||||||
Interim dividend 2021 1) |
( |
) | ||||||||||
Share buyback program (interim dividend 2021) |
||||||||||||
Transactions in 2020: |
||||||||||||
Interim dividend 2020 1) |
( |
) |
||||||||||
Share buyback program (interim dividend 2020) |
||||||||||||
Transactions in 2019: |
||||||||||||
Final dividend 2018 1) |
( |
) | ||||||||||
Share buyback program (final dividend 2018) |
||||||||||||
Interim dividend 2019 1) |
( |
) | ||||||||||
Share buyback program (interim dividend 2019) |
||||||||||||
1 |
Dividend distribution paid from treasury shares (note 30.3) |
2021 |
2020 |
2019 |
||||||||||
Common shares |
||||||||||||
Common shares B |
|
|
|
|
|
| ||||||
At December 31 |
||||||||||||
Common shares |
2021 |
2020 |
2019 |
|||||||||
Authorized share capital |
||||||||||||
Number of authorized shares (in million) |
||||||||||||
Par value in cents per share |
|
|
|
|
|
|
|
|
| |||
Common shares B |
2021 |
2020 |
2019 |
|||||||||
Authorized share capital |
||||||||||||
Number of authorized shares (in million) |
||||||||||||
Par value in cents per share |
|
|
|
|
|
|
|
|
| |||
| Common shares | Common shares B | |||||||||||||||
Number of shares (thousands) |
Total amount |
Number of shares (thousands) |
Total amount |
|||||||||||||
At January 1, 2019 |
||||||||||||||||
Dividend |
|
|
|
|
|
- |
|
|
- |
| ||||||
At December 31, 2019 |
||||||||||||||||
Shares withdrawn |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Dividend |
|
|
|
|
|
- |
|
|
- |
| ||||||
At December 31, 2020 |
||||||||||||||||
Shares withdrawn |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Dividend |
|
|
|
|
|
|
|
| ||||||||
At December 31, 2021 |
||||||||||||||||
Notes to the consolidated financial statements Note 30 |
Weighted average number of common shares (thousands) |
Weighted average number of common shares B (thousands) |
|||||||
2019 |
||||||||
2020 |
||||||||
2021 |
||||||||
2021 |
2020 |
2019 |
||||||||||
At January 1 |
||||||||||||
Share dividend |
|
( |
) |
|
( |
) |
|
( |
) | |||
At December 31 |
||||||||||||
Share premium relating to: |
||||||||||||
- Common shares |
||||||||||||
- Common shares B |
|
|
|
|
|
| ||||||
Total share premium |
||||||||||||
Notes to the consolidated financial statements Note 30 |
2021 |
2020 |
2019 |
||||||||||||||||||||||
Number of shares (thousands) |
Amount |
Number of shares (thousands) |
Amount |
Number of shares (thousands) |
Amount |
|||||||||||||||||||
At January 1 |
||||||||||||||||||||||||
Transactions in 2021: |
||||||||||||||||||||||||
Sale: transactions, average price 3.90 |
( |
) | ( |
) | ||||||||||||||||||||
Shares withdrawn: 1 transaction average price 3.89 |
( |
) | ( |
) | ||||||||||||||||||||
Sale: 1 transaction, average price 3.89 |
( |
) | ( |
) | ||||||||||||||||||||
Purchase: 1 transaction average price 3.70 |
||||||||||||||||||||||||
Sale: 1 transaction, average price 3.02 |
( |
) | ( |
) | ||||||||||||||||||||
Purchase: 1 transaction average price 4.46 |
||||||||||||||||||||||||
Transactions in 2020: |
||||||||||||||||||||||||
Sale: transactions, average price 4.52 |
( |
) | ( |
) | ||||||||||||||||||||
Shares withdrawn: 1 transaction average price 4.52 |
( |
) | ( |
) | ||||||||||||||||||||
Sale: 1 transaction, average price 4.13 |
( |
) | ( |
) | ||||||||||||||||||||
Purchase: 1 transaction average price 2.46 |
||||||||||||||||||||||||
Transactions in 2019: |
||||||||||||||||||||||||
Sale: transactions, average price 5.10 |
( |
) | ( |
) | ||||||||||||||||||||
Sale: 1 transaction, average price 5.25 |
( |
) | ( |
) | ||||||||||||||||||||
Purchase: 1 transaction average price 4.52 |
||||||||||||||||||||||||
Sale: 1 transaction, average price 5.16 |
( |
) | ( |
) | ||||||||||||||||||||
Purchase: 1 transaction average price 3.89 |
|
|
|
| ||||||||||||||||||||
At December 31 |
||||||||||||||||||||||||
2021 |
2020 |
2019 |
||||||||||||||||||||||
Number of shares (thousands) |
Amount |
Number of shares (thousands) |
Amount |
Number of shares (thousands) |
Amount |
|||||||||||||||||||
At January 1 |
||||||||||||||||||||||||
Transactions in 2021: |
||||||||||||||||||||||||
Sale: 1 transaction, average price 0.10 |
( |
) | - | |||||||||||||||||||||
Shares withdrawn: 1 transaction average price 0.10 |
( |
) | - | |||||||||||||||||||||
Purchase: 1 transaction average price 0.10 |
||||||||||||||||||||||||
Transactions in 2020: |
||||||||||||||||||||||||
Sale: 1 transaction, average price 0.13 |
( |
) | - | |||||||||||||||||||||
Shares withdrawn: 1 transaction average price 0.13 |
( |
) | ( |
) | ||||||||||||||||||||
Purchase: 1 transaction average price 0.08 |
- | |||||||||||||||||||||||
Transactions in 2019: |
||||||||||||||||||||||||
Sale: 1 transaction, average price 0.12 |
( |
) | - | |||||||||||||||||||||
Purchase: 1 transaction average price 0.10 |
|
|
|
| ||||||||||||||||||||
At December 31 |
||||||||||||||||||||||||
Notes to the consolidated financial statements Note 30 |
2021 |
2020 | 2019 | ||||||||||||||||||||||
Number of shares (thousands) |
Total amount |
Number of shares (thousands) |
Total amount |
Number of shares (thousands) |
Total amount |
|||||||||||||||||||
| Common shares |
||||||||||||||||||||||||
| Held by Aegon N.V. |
||||||||||||||||||||||||
| Held by subsidiaries |
||||||||||||||||||||||||
| Common shares B |
||||||||||||||||||||||||
| Held by Aegon N.V. |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||
| At December 31 |
||||||||||||||||||||||||
| Weighted average number of treasury shares, including treasury shares held by subsidiaries (thousands) |
Weighted average number of treasury shares B (thousands) |
|||||||
| 2019 |
||||||||
| 2020 |
||||||||
| 2021 |
||||||||
Available-for-sale investments |
Real estate held for own use |
Cash flow hedging reserve |
Total |
|||||||||||||
| At January 1, 2021 |
||||||||||||||||
| Gross revaluation |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Shadow accounting adjustment |
||||||||||||||||
| Net (gains) / losses transferred to income statement |
( |
) | ( |
) | ( |
) | ||||||||||
| Foreign currency translation differences |
||||||||||||||||
| Tax effect |
||||||||||||||||
| Other |
|
( |
) |
|
|
|
|
|
( |
) | ||||||
| At December 31, 2021 |
||||||||||||||||
| At January 1, 2020 |
||||||||||||||||
| Gross revaluation |
( |
) | ||||||||||||||
| Shadow accounting adjustment |
( |
) | ( |
) | ||||||||||||
| Net (gains) / losses transferred to income statement |
( |
) | ( |
) | ||||||||||||
| Foreign currency translation differences |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
| Tax effect |
|
( |
) |
|
( |
) |
|
|
|
( |
) | |||||
| At December 31, 2020 |
||||||||||||||||
| At January 1, 2019 |
||||||||||||||||
| Gross revaluation |
( |
) | ||||||||||||||
| Shadow accounting adjustment |
( |
) | - | - | ( |
) | ||||||||||
| Net (gains) / losses transferred to income statement |
( |
) | - | ( |
) | ( |
) | |||||||||
| Net (gains) / losses transferred to retained earnings |
( |
) | ( |
) | ||||||||||||
| Foreign currency translation differences |
||||||||||||||||
| Tax effect |
|
( |
) |
|
|
|
|
|
( |
) | ||||||
| At December 31, 2019 |
||||||||||||||||
Notes to the consolidated financial statements Note 30 |
| 2021 |
2020 |
2019 |
||||||||||
| Shares |
||||||||||||
| Debt securities |
||||||||||||
| Other |
|
( |
) |
|
( |
) |
|
( |
) | |||
| Revaluation reserve for available-for-sale |
||||||||||||
| 2021 |
2020 |
2019 |
||||||||||
| At January 1 |
( |
) | ( |
) | ( |
) | ||||||
| Remeasurements of defined benefit plans |
( |
) | ( |
) | ||||||||
| Tax effect |
( |
) | ||||||||||
| Net exchange differences |
|
( |
) |
|
|
|
( |
) | ||||
| Total remeasurement of defined benefit plans |
( |
) |
( |
) |
( |
) | ||||||
| Foreign currency translation reserve |
Net foreign investment hedging reserve |
Equity movements of joint ventures and associates |
Total |
|||||||||||||
| At January 1, 2021 |
( |
) | ( |
) | ( |
) | ||||||||||
| Movement in foreign currency translation and net foreign investment hedging reserves |
( |
) | ||||||||||||||
| Disposal of a business |
( |
) | - | |||||||||||||
| Tax effect |
( |
) | - | |||||||||||||
| Equity movements of joint ventures |
- | - | ||||||||||||||
| Equity movements of associates |
|
- |
|
|
- |
|
|
( |
) |
|
( |
) | ||||
| At December 31, 2021 |
( |
) |
||||||||||||||
| At January 1, 2020 |
( |
) | ||||||||||||||
| Movement in foreign currency translation and net foreign investment hedging reserves |
( |
) | - | ( |
) | |||||||||||
| Disposal of a business |
( |
) | ( |
) | ( |
) | ||||||||||
| Tax effect |
( |
) | - | ( |
) | |||||||||||
| Equity movements of joint ventures |
- | - | ||||||||||||||
| Equity movements of associates |
|
- |
|
|
- |
|
|
|
|
| ||||||
| At December 31, 2020 |
( |
) |
( |
) |
( |
) | ||||||||||
| At January 1, 2019 |
( |
) | ||||||||||||||
| Movement in foreign currency translation and net foreign investment hedging reserves |
( |
) | - | |||||||||||||
| Disposal of a business |
( |
) | - | - | ( |
) | ||||||||||
| Tax effect |
( |
) | - | ( |
) | |||||||||||
| Equity movements of joint ventures |
- | - | ||||||||||||||
| Equity movements of associates |
|
- |
|
|
- |
|
|
|
|
| ||||||
| At December 31, 2019 |
( |
) |
||||||||||||||
Notes to the consolidated financial statements Note 31 |
| Perpetual contingent convertible securities |
Junior perpetual capital securities |
Perpetual cumulative subordinated bonds |
Long Term Incentive Plans 1) |
Total |
||||||||||||||||||||
| At January 1, 2021 |
||||||||||||||||||||||||
| Shares granted |
- | - | - | |||||||||||||||||||||
| Shares vested |
- | - | - | ( |
) | ( |
) | |||||||||||||||||
| Securities redeemed |
|
- |
|
|
( |
) |
|
- |
|
|
- |
|
|
( |
) | |||||||||
| At December 31, 2021 |
||||||||||||||||||||||||
| At January 1, 2020 |
||||||||||||||||||||||||
| Shares granted |
- | - | - | |||||||||||||||||||||
| Shares vested |
|
- |
|
|
- |
|
|
- |
|
|
( |
) |
|
( |
) | |||||||||
| At December 31, 2020 |
||||||||||||||||||||||||
| At January 1, 2019 |
- | |||||||||||||||||||||||
| Shares granted |
- | - | - | |||||||||||||||||||||
| Shares vested |
- | - | - | ( |
) | ( |
) | |||||||||||||||||
| Securities issued |
- | - | - | |||||||||||||||||||||
| Securities redeemed |
|
- |
|
|
( |
) |
|
- |
|
|
- |
|
|
( |
) | |||||||||
| At December 31, 2019 |
||||||||||||||||||||||||
| 1 Long Term Incentive Plans include the shares granted to personnel which are not yet vested. |
|
|||||||||||||||||||||||
Perpetual contingent convertible securities |
Coupon rate | Coupon date | Year of next call | 2021 |
2020 |
2019 |
||||||||||||||||||
| |
|
1) |
|
|
, April 15 |
|
|
|
|
|
|
|
|
| ||||||||||
| At December 31 |
500 |
500 |
500 |
|||||||||||||||||||||
1 |
The coupon is fixed at |
| Notes to the consolidated financial statements Note 32 |
| Junior perpetual capital securities |
Coupon rate |
Coupon date |
Year of next call |
2021 |
2020 |
2019 |
||||||||||||
| USD |
rate 1) |
- | ||||||||||||||||
| USD |
te 2) |
|||||||||||||||||
| EUR |
3) |
|
|
|
|
|
|
|
| |||||||||
| At December 31 |
1,352 |
1,564 |
1,564 |
|||||||||||||||
1 |
|
2 |
ten-year US dollar interest rate swap yield plus a spread of ten basis points, with a maximum of |
3 |
ten-year Dutch government bond yield plus a spread of ten basis points, with a maximum of |
| Perpetual cumulative subordinated bonds |
Coupon rate |
Coupon date |
Year of next call |
2021 |
2020 |
2019 |
||||||||||||||||||
| |
1), 4) |
|||||||||||||||||||||||
| |
2), 4) |
|||||||||||||||||||||||
| |
|
3), 4) |
|
|
ch 4 |
|
|
|
|
|
|
|
|
| ||||||||||
| At December 31 |
454 |
454 |
454 |
|||||||||||||||||||||
1 |
The coupon of the EUR |
2 |
The coupon of the EUR |
3 |
The coupon of the EUR |
4 |
ten-year Dutch government securities plus a spread of basis points. |
| Coupon rate |
Coupon date |
Issue / Maturity |
Year of next call |
2021 |
2020 |
|||||||||||||||||||
| Fixed to floating subordinated notes |
||||||||||||||||||||||||
| EUR |
2) |
|||||||||||||||||||||||
| USD |
3) |
|||||||||||||||||||||||
Fixed subordinated notes |
||||||||||||||||||||||||
| USD 1) |
|
|
|
Qh 15 |
|
|
|
|
|
|
|
|
| |||||||||||
| At December 31 |
2,194 |
2,085 |
||||||||||||||||||||||
| Fair value of subordinated borrowings |
|
|
|
| ||||||||||||||||||||
1 |
Issued by a subsidiary of, and guaranteed by Aegon N.V. |
2 |
The coupon is fixed at |
3 |
The coupon is fixed at |
Notes to the consolidated financial statements Note 33 |
| Coupon rate | Coupon date | Issue / Maturity |
Year of next call |
2021 |
2020 | |||||||||||||||||||
USD 225 million 1) |
1 |
n.a. | ||||||||||||||||||||||
USD 190 million 1) |
|
|
|
ber 15 |
|
|
|
|
n.a. |
|
|
|
|
| ||||||||||
At December 31 |
||||||||||||||||||||||||
Fair value of trust pass-through securities |
|
|
|
| ||||||||||||||||||||
1 |
Issued by a subsidiary of, and guaranteed by Aegon N.V. |
Notes to the consolidated financial statements Note 34 |
2021 |
2020 | |||||||||||||||
Estimated approximate effect |
On shareholders’ equity |
On net result |
On shareholders’ equity |
On net result | ||||||||||||
20% increase in lapse rates |
( |
) | ||||||||||||||
20% decrease in lapse rates |
( |
) | ( |
) | ( |
) | ||||||||||
5% increase in mortality rates |
( |
) | ( |
) | ||||||||||||
5% decrease in mortality rates |
( |
) | ( |
) | ||||||||||||
10% increase in morbidity rates |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
10% decrease in morbidity rates |
|
|
|
|
|
|
|
| ||||||||
2021 |
2020 | |||||||
Life insurance |
||||||||
Non-life insurance |
||||||||
- Unearned premiums and unexpired risks |
||||||||
- Outstanding claims |
||||||||
- Incurred but not reported claims |
||||||||
Incoming reinsurance |
|
|
|
| ||||
At December 31 |
||||||||
2021 |
2020 | |||||||
Non-life insurance: |
||||||||
- Accident and health insurance |
||||||||
- General insurance |
|
|
|
| ||||
Total non-life insurance |
||||||||
Notes to the consolidated financial statements Note 34 |
Movements during the year in life insurance: |
2021 |
2020 | ||||||
| At January 1 |
||||||||
| Portfolio transfers and acquisitions |
( |
) | ( |
) | ||||
| Gross premium and deposits – existing and new business |
||||||||
| Unwind of discount / interest credited |
||||||||
| Insurance liabilities released |
( |
) | ( |
) | ||||
| Changes in valuation of expected future benefits |
( |
) | ||||||
| Loss recognized as a result of liability adequacy testing |
( |
) | ||||||
| Shadow accounting adjustments |
( |
) | ||||||
| Net exchange differences |
( |
) | ||||||
| Transfer (to) / from reinsurance assets |
( |
) | ||||||
| Transfer (to) / from insurance contracts for account of policyholders |
||||||||
| Other |
||||||||
| At December 31 |
||||||||
Sensitivity analysis of net result and shareholders’ equity |
Estimated approximate effects on net result |
Estimated approximate effects on shareholders’ equity |
||||||
| 2021 |
||||||||
| Shift up 50 basis points - Bond credit spreads |
( |
) | ( |
) | ||||
| Shift down 50 basis points - Bond credit spreads |
||||||||
| Shift up 50 basis points - Mortgage spreads |
( |
) | ( |
) | ||||
| Shift down 50 basis points - Mortgage spreads |
||||||||
| Shift up 5 basis points - Liquidity premium |
||||||||
| Shift down 5 basis points - Liquidity premium |
( |
) | ( |
) | ||||
| 2020 |
||||||||
| Shift up 50 basis points - Bond credit spreads |
( |
) | ( |
) | ||||
| Shift down 50 basis points - Bond credit spreads |
||||||||
| Shift up 50 basis points - Mortgage spreads |
( |
) | ( |
) | ||||
| Shift down 50 basis points - Mortgage spreads |
||||||||
| Shift up 5 basis points - Liquidity premium |
||||||||
| Shift down 5 basis points - Liquidity premium |
|
( |
) |
|
( |
) | ||
Notes to the consolidated financial statements Note 34 |
| Movements during the year in non-life insurance: |
2021 |
2020 |
||||||
| At January 1 |
||||||||
| Disposals |
( |
) | - | |||||
| Portfolio transfers and acquisitions |
||||||||
| Gross premiums – existing and new business |
||||||||
| Unwind of discount / interest credited |
||||||||
| Insurance liabilities released |
( |
) | ( |
) | ||||
| Changes in valuation of expected future claims |
( |
) | ||||||
| Change in unearned premiums |
( |
) | ( |
) | ||||
| Change in unexpired risks |
- | |||||||
| Incurred related to current year |
||||||||
| Incurred related to prior years |
||||||||
| Release for claims settled current year |
( |
) | ( |
) | ||||
| Release for claims settled prior years |
( |
) | ( |
) | ||||
| Shadow accounting adjustments |
( |
) | ||||||
| Change in IBNR |
( |
) | ||||||
| Net exchange differences |
( |
) | ||||||
| Other |
|
( |
) |
|
( |
) | ||
| At December 31 |
||||||||
| Movements during the year in incoming reinsurance: |
2021 |
2020 |
||||||
| At January 1 |
||||||||
| Gross premium and deposits – existing and new business |
||||||||
| Unwind of discount / interest credited |
||||||||
| Insurance liabilities released |
( |
) | ( |
) | ||||
| Changes in valuation of expected future benefits |
( |
) | ||||||
| Shadow accounting adjustments |
( |
) | ||||||
| Loss recognized as a result of liability adequacy |
( |
) | ||||||
| Net exchange differences |
( |
) | ||||||
| Other |
|
( |
) |
|
| |||
| At December 31 |
||||||||
| Insurance contracts for account of policyholders |
2021 |
2020 |
||||||
| At January 1 |
||||||||
| Portfolio transfers and acquisitions |
( |
) | ( |
) | ||||
| Gross premium and deposits – existing and new business |
||||||||
| Unwind of discount / interest credited |
||||||||
| Insurance liabilities released |
( |
) | ( |
) | ||||
| Fund charges released |
( |
) | ( |
) | ||||
| Changes in valuation of expected future benefits |
( |
) | ( |
) | ||||
| Transfer (to) / from insurance contracts |
( |
) | ||||||
| Net exchange differences |
( |
) | ||||||
| Other |
|
|
|
- |
| |||
| At December 31 |
||||||||
Notes to the consolidated financial statements Note 35 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Without discretionary participation features |
With discretionary participation features |
Total |
||||||||||
| At January 1, 2021 |
||||||||||||
| Deposits |
||||||||||||
| Withdrawals |
( |
) | ( |
|||||||||
| Investment contracts liabilities released |
( |
) | ( |
|||||||||
| Interest credited |
||||||||||||
| Net exchange differences |
||||||||||||
| Transfer (to)/from other headings |
||||||||||||
| Other |
|
( |
) |
|
|
|
( |
| ||||
| At December 31, 2021 |
||||||||||||
| At January 1, 2020 |
|
|||||||||||
| Deposits |
- | |||||||||||
| Withdrawals |
( |
) | - | ( |
||||||||
| Investment contracts liabilities released |
- | ( |
) | ( |
||||||||
| Interest credited |
- | |||||||||||
| Net exchange differences |
( |
) | ( |
) | ( |
|||||||
| Transfer (to)/from other headings |
- | |||||||||||
| Other |
|
( |
) |
|
|
|
( |
| ||||
| At December 31, 2020 |
||||||||||||
| |
|
|
|
|
|
|
|
|
| Investment contracts consist of the following: |
2021 |
2020 |
||||||
| Institutional guaranteed products |
||||||||
| Fixed annuities |
||||||||
| Savings accounts |
||||||||
| Investment contracts with discretionary participation features |
||||||||
| Other |
|
|
|
| ||||
| At December 31 |
||||||||
Notes to the consolidated financial statements Note 36 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| Without discretionary participation features |
With discretionary participation features |
Total |
||||||||||
| At January 1, 2021 |
||||||||||||
| Gross premium and deposits – existing and new business |
||||||||||||
| Withdrawals |
( |
) | ( |
) | ||||||||
| Interest credited |
||||||||||||
| Investment contracts liabilities released |
( |
) | ( |
) | ||||||||
| Fund charges released |
( |
) | ( |
) | ||||||||
| Net exchange differences |
||||||||||||
| Transfer (to)/from other headings |
( |
) | ( |
) | ( |
) | ||||||
| Other |
|
|
|
|
|
| ||||||
| At December 31, 2021 |
||||||||||||
| At January 1, 2020 |
||||||||||||
| Gross premium and deposits – existing and new business |
||||||||||||
| Withdrawals |
( |
) | - | ( |
) | |||||||
| Interest credited |
||||||||||||
| Investment contracts liabilities released |
- | ( |
) | ( |
) | |||||||
| Fund charges released |
( |
) | - | ( |
) | |||||||
| Net exchange differences |
( |
) | ( |
) | ( |
) | ||||||
| Transfer (to)/from other headings |
( |
) | ( |
) | ( |
) | ||||||
| Other |
|
( |
) |
|
|
|
( |
) | ||||
| At December 31, 2020 |
||||||||||||
| a. | Financial guarantees: these guarantees are treated as bifurcated embedded derivatives, valued at fair value and presented as derivatives (refer to note 2.9 and note 44 Fair value); |
| b. | Total return annuities: these guarantees are not bifurcated from their host contracts because they are presented and valued at fair value together with the underlying insurance contracts (refer to note 2.19); |
| c. | Life contingent guarantees in the United States: these guarantees are not bifurcated from their host contracts, presented and valued in accordance with insurance accounting together with the underlying insurance contracts (refer to note 2.19); and |
| d. | Minimum investment return guarantees in the Netherlands: these guarantees are not bifurcated from their host contracts, valued at fair value and presented together with the underlying insurance contracts (refer to note 2.19 and note 44 Fair value). |
Notes to the consolidated financial statements Note 36 |
2021 |
2020 |
|||||||||||||||||||||||
United States 1) |
The Netherlands 2) |
Total 3) |
United States 1) |
The Netherlands 2) |
Total 3) |
|||||||||||||||||||
At January 1 |
||||||||||||||||||||||||
Incurred guarantee benefits 4) |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
Paid guarantee benefits |
( |
) | ( |
) | ( |
) | - | ( |
) | |||||||||||||||
Net exchange differences |
|
|
|
|
|
|
|
( |
) |
|
- |
|
|
( |
) | |||||||||
At December 31 |
||||||||||||||||||||||||
Account value 5) |
||||||||||||||||||||||||
Net amount at risk 6) |
|
|
|
|
|
|
|
|
|
|
|
| ||||||||||||
1 |
Guaranteed minimum accumulation and withdrawal benefits. |
2 |
Fund plan and unit-linked guarantees. |
3 |
Balances are included in the derivatives liabilities on the face of the statement of financial position; refer to note 24 Derivatives. |
4 |
Incurred guarantee benefits mainly comprise the effect of guarantees from new contracts, releases related to expired out-of-the-money |
5 |
Account value reflects the actual fund value for the policyholders. |
6 |
The net amount at risk represents the sum of the positive differences between the discounted maximum amount payable under the guarantees and the account value. |
Notes to the consolidated financial statements Note 36 |
2021 |
2020 |
|||||||||||||||||||||||
GMDB 1) |
GMIB 2) |
Total 4) |
GMDB 1) |
GMIB 2) |
Total 4) |
|||||||||||||||||||
At January 1 |
||||||||||||||||||||||||
Incurred guarantee benefits 5) |
( |
) | ( |
) | ||||||||||||||||||||
Paid guarantee benefits |
( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||
Net exchange differences |
|
|
|
|
|
|
|
( |
) |
|
( |
) |
|
( |
) | |||||||||
At December 31 |
||||||||||||||||||||||||
GMDB 1) |
GMIB 2) |
GMDB 1) ,3) |
GMIB 2) ,3) |
|||||||||||||||||||||
Account value 6) |
||||||||||||||||||||||||
Net amount at risk 7) |
||||||||||||||||||||||||
Average attained age of contract holders |
|
|
|
|
|
|
|
|
||||||||||||||||
1 |
Guaranteed minimum death benefit in the United States. |
2 |
Guaranteed minimum income benefit in the United States. |
3 |
Note that the variable annuity contracts with guarantees may offer more than one type of guarantee in each contract; therefore, the amounts listed are not mutually exclusive. |
4 |
Balances are included in the insurance liabilities on the face of the statement of financial position; refer to note 34 Insurance contracts. |
5 |
Incurred guarantee benefits mainly comprise the effect of guarantees from new contracts, releases related to expired out-of-the-money |
6 |
Account value reflects the actual fund value for the policyholders. |
7 |
The net amount at risk is defined as the present value of the minimum guaranteed annuity payments available to the contract holder determined in accordance with the terms of the contract in excess of the current account balance. |
Notes to the consolidated financial statements Note 36 |
2021 |
2020 |
|||||||
GMI 1), 2) |
GMI 1), 2) |
|||||||
At January 1 |
||||||||
Incurred guarantee benefits 3) |
|
( |
) |
|
| |||
At December 31 |
||||||||
Account value 4) |
||||||||
Net amount at risk 5) |
|
|
|
| ||||
1 |
Guaranteed minimum investment return in the Netherlands. |
2 |
Balances are included in the insurance liabilities on the face of the statement of financial position; refer to note 34 Insurance contracts. |
3 |
Incurred guarantee benefits mainly comprise the effect of guarantees from new contracts, releases related to expired out-of-the-money |
4 |
Account value reflects the liability value of the insurance contracts as a whole. |
5 |
The net amount at risk represents the sum of the differences between the guaranteed and actual amount that is credited to the policyholders. For Individual policies only positive differences are included, for Group pensions contracts carry forwards of negative differences are recognized. |
Notes to the consolidated financial statements Note 37 |
2021 |
2020 | |||||||
Capital funding |
||||||||
Operational funding |
|
|
|
| ||||
At December 31 |
||||||||
Current |
||||||||
Non-current |
||||||||
Fair value of borrowings |
|
|
|
| ||||
(sorted at maturity) |
Coupon rate | Coupon date | Issue / Maturity |
2021 |
2020 | |||||||||||||||
EUR 500 million Senior Unsecured Notes |
23 |
|||||||||||||||||||
GBP 250 million Medium-Term Notes |
||||||||||||||||||||
GBP 400 million Senior Unsecured Notes |
||||||||||||||||||||
Other |
|
|
|
| ||||||||||||||||
At December 31 |
||||||||||||||||||||
Notes to the consolidated financial statements Note 38 |
| Coupon rate | Coupon date | Issue / Maturity |
2021 |
2020 | ||||||||||||||||
Revolving Loan Facility Warehouse Mortgage Loans 1) |
||||||||||||||||||||
Revolving Loan Facility Warehouse Mortgage Loans 1) |
||||||||||||||||||||
EUR 875 million “SAECURE 16” RMBS Note 1) , 2) |
||||||||||||||||||||
EUR 512 million “SAECURE 18” RMBS Note 1) , 3) |
||||||||||||||||||||
EUR 657 million “SAECURE 20” RMBS Note 1) , 4) |
||||||||||||||||||||
EUR 500 million Conditional Pass-Through Covered Bond 1) , 5) |
||||||||||||||||||||
EUR 500 million Conditional Pass-Through Covered Bond 1) , 6) |
||||||||||||||||||||
EUR 500 million Conditional Pass-Through Covered Bond 1) , 7) |
||||||||||||||||||||
EUR 500 million Conditional Pass-Through Covered Bond 1) , 8) |
||||||||||||||||||||
EUR 500 million Conditional Pass-Through Covered Bond 1) , 9) |
||||||||||||||||||||
FHLB Secured borrowings 1) |
||||||||||||||||||||
Aegon Bank Senior Non-Preferred debt1) |
||||||||||||||||||||
Other |
|
|
|
| ||||||||||||||||
At December 31 |
||||||||||||||||||||
1 |
Issued by a subsidiary of Aegon N.V. |
2 |
The first optional redemption date is October 30, 2023; the final legal maturity date is October 30, 2091. Notes are fully collateralized by mortgage loans which are part of Aegon’s general account investments. |
3 |
The first optional redemption date is July 28, 2025; the final legal maturity date is April 28, 2092. Notes are fully collateralized by mortgage loans which are part of Aegon’s general account investments. |
4 |
The first optional redemption date is October 28, 2027; the final legal maturity date is April 28, 2093. Notes are fully collateralized by mortgage loans which are part of Aegon’s general account investments. |
5 |
The maturity date is May 25, 2023; the extended due for payment date is May 25, 2055. |
6 |
The maturity date is November 21, 2024; the extended due for payment date is November 21, 2056. |
7 |
The maturity date is November 16, 2025; the extended due for payment date is November 16, 2057. |
8 |
The maturity date is June 27, 2027; the extended due for payment date is June 27, 2059. |
9 |
The maturity date is June 9, 2036; the extended due for payment date is June 9, 2037. |
Undrawn committed borrowing facilities: |
2021 |
2020 | ||||||
Floating-rate |
||||||||
- Expiring within one year |
||||||||
- Expiring beyond one year |
|
|
|
| ||||
At December 31 |
||||||||
2021 |
2020 | |||||||
At January 1 |
||||||||
Additional provisions |
||||||||
Disposals |
( |
) | ( |
) | ||||
Unused amounts reversed through the income statement |
( |
) | ||||||
Used during the year |
( |
) | ( |
) | ||||
Net exchange differences |
|
|
( |
) | ||||
At December 31 |
||||||||
Current |
||||||||
Non-current |
|
|
|
| ||||
Notes to the consolidated financial statements Note 39 |
2021 |
2020 | |||||||
Retirement benefit plans |
||||||||
Other post-employment benefit plans |
|
| ||||||
Total defined benefit plans |
||||||||
Retirement benefit plans in surplus |
|
| ||||||
Total defined benefit assets |
||||||||
Retirement benefit plans in deficit |
||||||||
Other post-employment benefit plans in deficit |
|
| ||||||
Total defined benefit liabilities |
||||||||
2021 |
2020 | |||||||||||||||||||||||||||||||
Movements during the year in defined benefit plans |
Retirement benefit plans |
Other post- employment benefit plans |
Total |
Retirement benefit plans |
Other post- employment benefit plans |
Total |
||||||||||||||||||||||||||
At January 1 |
||||||||||||||||||||||||||||||||
Defined benefit expenses |
( |
) |
||||||||||||||||||||||||||||||
Remeasurements of defined benefit plans |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||
Contributions paid |
( |
) |
( |
) |
( |
) | - | ( |
) | |||||||||||||||||||||||
Benefits paid |
( |
) |
( |
) |
( |
) |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Net exchange differences |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
Other |
( |
) |
( |
) |
|
|
|
- |
|
|
| |||||||||||||||||||||
At December 31 |
||||||||||||||||||||||||||||||||
2021 |
2020 | |||||||||||||||||||||||||||||||
Retirement benefit plans |
Other post- employment benefit plans |
Total |
Retirement benefit plans |
Other post- employment benefit plans |
Total |
|||||||||||||||||||||||||||
Present value of wholly or partly funded obligations |
- | |||||||||||||||||||||||||||||||
Fair value of plan assets |
( |
) | ( |
) | ( |
) | - | ( |
) | |||||||||||||||||||||||
( |
) |
( |
) |
- |
||||||||||||||||||||||||||||
Present value of wholly unfunded obligations 1) |
||||||||||||||||||||||||||||||||
At December 31 |
||||||||||||||||||||||||||||||||
1 |
As all pension obligations are insured at subsidiary Aegon Levensverzekering almost all assets held by Aegon Nederland backing retirement benefits of EUR |
2021 |
2020 | |||||||||||||||||||||||||||||||
Defined benefit expenses |
Retirement benefit plans |
Other post- employment benefit plans |
Total |
Retirement benefit plans |
Other post- employment benefit plans |
Total |
||||||||||||||||||||||||||
Current year service cost |
||||||||||||||||||||||||||||||||
Net interest on the net defined benefit liability (asset) |
||||||||||||||||||||||||||||||||
Past service cost |
|
( |
) |
|
- |
|
|
( |
) |
|
|
|
|
|
| |||||||||||||||||
Total defined benefit expenses |
( |
) |
||||||||||||||||||||||||||||||
Notes to the consolidated financial statements Note 39 |
| 2019 | ||||||||||||
| Retirement benefit plans |
Other post- employment benefit plans |
Total |
||||||||||
Current year service cost |
||||||||||||
Net interest on the net defined benefit liability (asset) |
||||||||||||
Past service cost |
|
( |
) |
|
- |
|
|
( |
) | |||
Total defined benefit expenses |
||||||||||||
Movements during the year of the present value of the defined benefit obligations |
2021 |
2020 | ||||||
At January 1 |
||||||||
Current year service cost |
||||||||
Interest expense |
||||||||
Remeasurements of the defined benefit obligations: |
||||||||
- Actuarial gains and losses arising from changes in demographic assumptions |
( |
) | ( |
) | ||||
- Actuarial gains and losses arising from changes in financial assumptions |
( |
) | ||||||
Past service cost |
( |
) | ||||||
Benefits paid |
( |
) | ( |
) | ||||
Amounts paid in respect of settlements |
( |
) | - | |||||
Net exchange differences |
( |
) | ||||||
Other |
|
( |
) |
|
| |||
At December 31 |
||||||||
Movements during the year in plan assets for retirement benefit plans |
2021 |
2020 | ||||||
At January 1 |
||||||||
Interest income (based on discount rate) |
||||||||
Remeasurements of the net defined liability (asset) |
||||||||
Contributions by employer |
||||||||
Benefits paid |
( |
) | ( |
) | ||||
Amounts paid in respect of settlements |
( |
) | - | |||||
Net exchange differences |
|
|
|
( |
) | |||
At December 31 |
||||||||
2021 |
2020 | |||||||||||||||||||||||||||||||
Breakdown of plan assets for retirement benefit plans |
Quoted |
Unquoted |
Total |
in % of total plan assets |
Quoted |
Unquoted |
Total |
in % of total plan assets |
||||||||||||||||||||||||
Equity instruments |
||||||||||||||||||||||||||||||||
Debt instrument |
||||||||||||||||||||||||||||||||
Real estate |
||||||||||||||||||||||||||||||||
Derivatives |
( |
) | ( |
) | ( |
|||||||||||||||||||||||||||
Investment funds |
||||||||||||||||||||||||||||||||
Other |
||||||||||||||||||||||||||||||||
At December 31 |
||||||||||||||||||||||||||||||||
Notes to the consolidated financial statements Note 39 |
Notes to the consolidated financial statements Note 39 |
Actuarial assumptions used to determine defined benefit obligations at year-end |
2021 |
2020 |
||||||
Demographic actuarial assumptions |
||||||||
Mortality |
1) |
1) |
||||||
Financial actuarial assumptions |
||||||||
Discount rate 2) |
||||||||
Salary increase rate |
||||||||
Health care trend rate |
|
|
|
| ||||
1 |
2021 assumption -PRI-2012 MP-2021. Comparative figures are as included in the Annual Report 2020. |
Estimated approximate effects on the defined benefit obligation |
||||||||
2021 |
2020 | |||||||
Demographic actuarial assumptions |
||||||||
10% increase in mortality rates |
( |
) | ( |
) | ||||
10% decrease in mortality rates |
||||||||
Financial actuarial assumptions |
||||||||
100 basis points increase in discount rate |
( |
) | ( |
) | ||||
100 basis points decrease in discount rate |
||||||||
100 basis points increase in salary increase rate |
||||||||
100 basis points decrease in salary increase rate |
( |
) | ||||||
100 basis points increase in health care trend rate |
||||||||
100 basis points decrease in health care trend rate |
|
( |
) |
|
( |
) | ||
Target allocation of plan assets for retirement benefit plans for the next annual period is: |
||||
Equity instruments |
||||
Debt instruments |
||||
Other |
|
| ||
Notes to the consolidated financial statements Note 39 |
Actuarial assumptions used to determine defined benefit obligations at year-end |
2021 |
2020 |
||||||
Demographic actuarial assumptions |
||||||||
Mortality |
1) |
1) |
||||||
Financial actuarial assumptions |
||||||||
Discount rate |
||||||||
Salary increase rate 2) |
||||||||
Indexation 3) |
|
|
|
| ||||
1 |
Based on prospective mortality table of the Dutch Actuarial Society with minor methodology adjustments. |
2 |
Based on Dutch Consumer Price Index. |
3 |
Based on Dutch Consumer Price Index. |
Estimated approximate effects on the defined benefit obligation |
||||||||
2021 |
2020 | |||||||
Demographic actuarial assumptions |
||||||||
10% increase in mortality rates |
( |
) | ( |
) | ||||
10% decrease in mortality rates |
||||||||
Financial actuarial assumptions |
||||||||
100 basis points increase in discount rate |
( |
) | ( |
) | ||||
100 basis points decrease in discount rate |
||||||||
100 basis points increase in salary increase rate |
- | |||||||
25 basis points increase in indexation |
||||||||
25 basis points decrease in indexation |
|
( |
) |
|
( |
) | ||
1 |
Aegon Nederland deducts employee contributions from the total pension expenses. |
Notes to the consolidated financial statements Note 39 |
Actuarial assumptions used to determine defined benefit obligations at year-end |
2021 |
2020 | ||||||
Demographic actuarial assumptions |
||||||||
Mortality |
1) |
2) |
||||||
Financial actuarial assumptions |
||||||||
Discount rate |
||||||||
Price inflation |
|
|
|
| ||||
1 |
Club Vita tables based on analysis of Scheme membership CMI 2019 %/% p.a. (males/females) |
2 |
Club Vita tables based on analysis of Scheme membership CMI 2019 %/% p.a. (males/females) |
Notes to the consolidated financial statements Note 40 |
Estimated approximate effects on the defined benefit obligation |
||||||||
2021 |
2020 | |||||||
Demographic actuarial assumptions |
||||||||
10% increase in mortality rates |
( |
) | ( |
) | ||||
10% decrease in mortality rates |
||||||||
Financial actuarial assumptions |
||||||||
100 basis points increase in discount rate |
( |
) | ( |
) | ||||
100 basis points decrease in discount rate |
||||||||
100 basis points increase in price inflation |
||||||||
100 basis points decrease in price inflation |
|
( |
) |
|
( |
) | ||
Target allocation of plan assets for retirement benefit plans for the next annual period is: |
||||
Equity instruments |
||||
Debt instruments |
|
| ||
2021 |
2020 |
|||||||
Deferred tax assets |
||||||||
Deferred tax liabilities |
|
|
|
| ||||
Total net deferred tax liability / (asset) |
||||||||
Deferred tax assets comprise temporary differences on: |
2021 |
2020 |
||||||
Financial assets |
( |
) | ||||||
Insurance and investment contracts |
( |
) | ( |
) | ||||
Deferred expenses, VOBA and other intangible assets |
( |
) | ( |
) | ||||
Defined benefit plans |
- | |||||||
Tax losses and credits carried forward |
||||||||
Other |
|
|
|
( |
) | |||
At December 31 |
||||||||
Notes to the consolidated financial statements Note 40 |
| Deferred tax liabilities comprise temporary differences on: |
2021 |
2020 |
||||||
| Real estate |
||||||||
| Financial assets |
||||||||
| Insurance and investment contracts |
( |
) | ( |
) | ||||
| Deferred expenses, VOBA and other intangible assets |
||||||||
| Defined benefit plans |
( |
) | ( |
) | ||||
| Tax losses and credits carried forward |
( |
) | ( |
) | ||||
| Other |
|
( |
) |
|
( |
) | ||
| At December 31 |
||||||||
| Real estate | Financial assets |
Insurance and investment contracts |
Deferred expenses, VOBA and other intangible assets |
Defined benefit plans |
Tax losses and credits carried forward |
Other | Total |
|||||||||||||||||||||||||
| At January 1, 2021 |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||
| Charged to income statement |
( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||||
| Charged to OCI |
( |
) | ( |
) | - | - | ( |
) | ( |
) | ||||||||||||||||||||||
| Net exchange differences |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||
| Transfer (to)/from current income tax |
- | - | - | - | - | - | ||||||||||||||||||||||||||
| Transfer (to) /from other headings |
|
- |
|
|
( |
) |
|
- |
|
|
- |
|
|
- |
|
|
( |
) |
|
|
|
- |
| |||||||||
| At December 31, 2021 |
( |
) |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||
| At January 1, 2020 |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||
| Acquisitions / Additions |
- | - | - | - | - | - | ||||||||||||||||||||||||||
| Charged to income statement |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||
| Charged to OCI |
- | - | ( |
) | - | |||||||||||||||||||||||||||
| Net exchange differences |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||||||
| Transfer (to)/from current income tax |
- | - | - | - | - | ( |
) | - | ( |
) | ||||||||||||||||||||||
| Transfer (to)/from other headings |
|
- |
|
|
- |
|
|
( |
) |
|
- |
|
|
- |
|
|
- |
|
|
|
|
- |
| |||||||||
| At December 31, 2020 |
( |
) |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||
Gross amounts 1) |
Not recognized deferred tax assets |
|||||||||||||||
2021 |
2020 | 2021 |
2020 | |||||||||||||
| < 5 years |
||||||||||||||||
| ≥ 5 – 10 years |
||||||||||||||||
| ≥ 10 – 15 years |
||||||||||||||||
| ≥ 15 – 20 years |
- | |||||||||||||||
| Indefinitely |
|
|
|
|
|
|
|
| ||||||||
| At December 31 |
||||||||||||||||
1 |
The gross value of state tax loss carry forward is not summarized in the disclosure, due to the fact that the United States files in different state jurisdictions with various applicable tax rates and apportionment rules |
Notes to the consolidated financial statements Note 41 |
2021 |
2020 | |||||||
| Payables due to policyholders |
||||||||
| Payables due to brokers and agents |
||||||||
| Payables out of reinsurance |
||||||||
| Social security and taxes payable |
||||||||
| Income tax payable |
||||||||
| Investment creditors |
||||||||
| Cash collateral on derivative transactions |
||||||||
| Cash collateral on securities lended |
||||||||
| Cash collateral - other |
||||||||
| Repurchase agreements |
||||||||
| Short term deposits |
||||||||
| Commercial paper |
||||||||
| Lease liabilities |
||||||||
| Other creditors |
||||||||
| At December 31 |
||||||||
| Current |
||||||||
| Non-current |
||||||||
2021 |
2020 | |||||||
| Accrued interest |
||||||||
| Accrued expenses |
|
|
|
| ||||
| At December 31 |
||||||||
| |
Notes to the consolidated financial statements Note 43 |
| December 31, 2021 1) |
December 31, 2020 |
|||||||
| US RBC ratio |
||||||||
| NL Life Solvency II ratio |
||||||||
| Scottish Equitable Plc (UK) Solvency II ratio |
|
|
|
| ||||
1 |
The Solvency II ratios are estimates and are not final until filed with the respective supervisory authority. |
Notes to the consolidated financial statements Note 43 |
| December 31, 2021 1) |
December 31, 2020 |
|||||||
| Group Own Funds |
||||||||
| Group SCR |
||||||||
| Group Solvency II ratio |
|
|
|
| ||||
1 |
The Solvency II ratios are estimates and are not final until filed with the respective supervisory authority. |
Notes to the consolidated financial statements Note 43 |
2021 |
2020 |
|||||||||||||||
Available Own Funds |
Available Own Funds |
Percentage total |
Available Own Funds |
Percentage total |
||||||||||||
Tier 1 (Unrestricted Tier 1 + Restricted Tier 1) |
||||||||||||||||
Unrestricted Tier 1 |
||||||||||||||||
Restricted Tier 1 |
||||||||||||||||
Junior Perpetual Capital Securities |
||||||||||||||||
Perpetual Cumulative Securities |
||||||||||||||||
Perpetual Contingent Convertible Securities |
||||||||||||||||
Tier 2 |
||||||||||||||||
Subordinated notes issued by AFC |
||||||||||||||||
Subordinated liabilities Aegon NV |
||||||||||||||||
Grandfathered subordinated notes |
||||||||||||||||
Tier 3 |
|
|
|
|
|
|
|
| ||||||||
Total Available Own Funds |
||||||||||||||||
Notes to the consolidated financial statements Note 43 |
2021 |
2020 |
|||||||
IFRS Shareholders’ Equity |
||||||||
IFRS adjustments for Other Equity instruments and non controlling interests |
||||||||
IFRS Group Equity |
||||||||
Solvency II revaluations & reclassifications |
( |
) | ( |
) | ||||
Transferability restrictions 1) |
|
( |
) |
|
( |
) | ||
Excess of Assets over Liabilities |
||||||||
Availability adjustments |
||||||||
Fungibility adjustments |
|
( |
) |
|
( |
) | ||
Available Own Funds |
||||||||
1 |
This includes the transferability restriction related to the RBC CAL conversion methodology. |
◆ |
Items that are not recognized under Solvency II. The most relevant examples of this category for Aegon include Goodwill, deferred policy acquisition costs (DPAC) and other intangible assets (EUR |
◆ |
Items that have a different valuation treatment between IFRS and Solvency II. Solvency II is a market consistent framework hence all assets and liabilities are to be presented at fair value while IFRS also includes other valuation treatments in addition to fair value. The most relevant examples of this category for Aegon Group include loans and mortgages, reinsurance recoverables, and technical provisions. The revaluation difference stemming from this category amounted to EUR |
◆ |
The Net Asset Value of subsidiaries that are included under the D&A method (on provisional equivalence or Standard Formula basis) in the Group Solvency II results. The revaluation difference stemming from this category amounted to EUR |
◆ |
Reclassification of subordinated liabilities of EUR |
◆ |
Shareholders’ equity excluding revaluation reserves based on IFRS as adopted by the EU; |
◆ |
Non-controlling interests and Long Term Incentive Plans not yet vested; and |
◆ |
Total financial leverage. |
Notes to the consolidated financial statements Note 43 |
Note |
2021 |
2020 | ||||||||||
Total shareholders’ equity - based on IFRS as adopted by the EU |
30 |
|||||||||||
Non-controlling interests and Long Term Incentive Plans not yet vested |
31, SOFP 2) |
|||||||||||
Revaluation reserves |
30 |
( |
) | ( |
) | |||||||
Adjusted shareholders’ equity |
||||||||||||
Perpetual contingent convertible securities |
31 |
|||||||||||
Junior perpetual capital securities |
31 |
|||||||||||
Perpetual cumulative subordinated bonds |
31 |
|||||||||||
Fixed floating subordinated notes |
32 |
|||||||||||
Fixed subordinated notes |
32 |
|||||||||||
Trust pass-through securities |
33 |
|||||||||||
Currency revaluation other equity instruments 1) |
( |
) | ||||||||||
Hybrid leverage |
||||||||||||
Senior debt 3) |
37 |
|||||||||||
Senior leverage |
||||||||||||
Total gross financial leverage |
||||||||||||
Total capitalization |
||||||||||||
Gross financial leverage ratio |
||||||||||||
Fixed Charge Coverage |
||||||||||||
1 |
Other equity instruments that are denominated in foreign currencies are, for purpose of calculating hybrid leverage, revalued to the period-end exchange rate. |
2 |
Non-controlling interests are disclosed in the statement of financial position. |
3 |
Senior debt for the gross financial leverage calculation also contains swaps for an amount of EUR ( |
Distributable items |
2021 |
2020 | ||||||
Equity attributable to shareholders based on IFRS as adopted by the EU |
||||||||
Non-distributable items: |
||||||||
Share capital |
( |
) | ( |
) | ||||
Legal reserves 1) |
( |
) | ( |
) | ||||
At December 31 |
||||||||
1 |
The legal reserves in respect of the foreign currency translation reserve (FCTR), group companies and the positive revaluations in the revaluation reserves, cannot be freely distributed. |
Distributable reserves |
2021 |
2020 | ||||||
Reserves available for financial surpervision purposes |
|
|||||||
Solvency requirement under the Financial Supervision Act |
||||||||
Total distributable reserves on the basis of solvency requirements |
||||||||
Notes to the consolidated financial statements Note 44 |
Notes to the consolidated financial statements Note 44 |
Level I |
Level II |
Level III |
Total 2021 | |||||||||||||
Assets carried at fair value |
||||||||||||||||
Available-for-sale |
||||||||||||||||
Shares |
||||||||||||||||
Debt securities |
||||||||||||||||
Money market and other short-term instruments |
- | |||||||||||||||
Other investments at fair value |
- | |||||||||||||||
Fair value through profit or loss |
||||||||||||||||
Shares |
||||||||||||||||
Debt securities |
||||||||||||||||
Money market and other short-term instruments |
- | |||||||||||||||
Other investments at fair value |
||||||||||||||||
Investments for account of policyholders 1) |
||||||||||||||||
Derivatives |
||||||||||||||||
Investments in real estate |
- | - | ||||||||||||||
Investments in real estate for policyholders |
- | - | ||||||||||||||
Revalued amounts |
||||||||||||||||
Real estate held for own use |
- | - | ||||||||||||||
- |
- |
|||||||||||||||
Total assets at fair value |
||||||||||||||||
Liabilities carried at fair value |
||||||||||||||||
Investment contracts for account of policyholders 2) |
- | ( |
) | |||||||||||||
| - | - | - | - | |||||||||||||
Derivatives |
||||||||||||||||
Total liabilities at fair value |
||||||||||||||||
1 |
The investments for account of policyholders include investments carried at fair value through profit or loss. |
2 |
The investment contracts for account of policyholders represents only those investment contracts carried at fair value. |
Notes to the consolidated financial statements Note 44 |
| Level I | Level II | Level III | Total 2020 | |||||||||||||
Assets carried at fair value |
||||||||||||||||
Available-for-sale |
||||||||||||||||
Shares |
||||||||||||||||
Debt securities |
||||||||||||||||
Money market and other short-term instruments |
- | |||||||||||||||
Other investments at fair value |
- | |||||||||||||||
Fair value through profit or loss |
||||||||||||||||
Shares |
||||||||||||||||
Debt securities |
||||||||||||||||
Money market and other short-term instruments |
- | |||||||||||||||
Other investments at fair value |
||||||||||||||||
Investments for account of policyholders 1) |
||||||||||||||||
Derivatives |
||||||||||||||||
Investments in real estate |
- | - | ||||||||||||||
Investments in real estate for policyholders |
- | - | ||||||||||||||
Revalued amounts |
||||||||||||||||
Real estate held for own use |
- | - | ||||||||||||||
- |
- |
|||||||||||||||
Total assets at fair value |
||||||||||||||||
Liabilities carried at fair value |
||||||||||||||||
Investment contracts for account of policyholders 2) |
- | ( |
) | |||||||||||||
Derivatives |
||||||||||||||||
Total liabilities at fair value |
||||||||||||||||
1 |
The investments for account of policyholders include investments carried at fair value through profit or loss. |
2 |
The investment contracts for account of policyholders represents only those investment contracts carried at fair value. |
3 |
Total borrowings on the statement of financial position contain borrowings carried at amortized cost that are not included in the above schedule. |
Total 2021 |
Total 2020 | |||||||||||||||
Transfers Level I to Level II |
Transfers Level II to Level I |
Transfers Level I to Level II |
Transfers Level II to Level I |
|||||||||||||
Assets carried at fair value |
||||||||||||||||
Available-for-sale |
||||||||||||||||
Debt securities |
- | |||||||||||||||
- |
||||||||||||||||
Total assets at fair value |
- |
|||||||||||||||
Total Liabilities carried at fair value |
- |
- |
- |
- |
||||||||||||
Notes to the consolidated financial statements Note 44 |
| Assets carried at fair value |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Available-for-sale |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares |
- | - | ( |
) | ( |
) | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||
| Debt securities |
- | - | ( |
) | ( |
) | ( |
) | - | ( |
) | - | - | |||||||||||||||||||||||||||||||||||||||||||||||
| Money markets and other short-term instruments |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||
| Other investments at fair value |
- | - | ( |
) | ( |
) | ( |
) | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||
- |
- |
( |
) |
( |
) |
( |
) |
- |
( |
) |
- |
- |
||||||||||||||||||||||||||||||||||||||||||||||||
Fair value through profit or loss |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares |
- | - | - | ( |
) | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt securities |
- | - | ( |
) | - | ( |
) | ( |
) | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||||
| Other investments at fair value |
- | - | - | ( |
) | - | - | - | - | - | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||||||
| Investments for account of policyholders |
- | - | ( |
) | ( |
) | ( |
) | - | - | - | ( |
) | - | ||||||||||||||||||||||||||||||||||||||||||||||
| Derivatives |
- | - | ( |
) | - | - | ( |
) | - | - | - | - | - | - | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Investments in real estate |
- | - | - | ( |
) | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments in real estate for policyholders |
- | - | - | ( |
) | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||||||||
- |
- |
( |
) |
( |
) |
- |
- |
( |
) |
- |
||||||||||||||||||||||||||||||||||||||||||||||||||
| Revalued amounts |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real estate held for own use |
- | - | ( |
) | ( |
) | - | ( |
) | ( |
) | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||||
- |
- |
( |
) |
( |
) |
- |
( |
) |
( |
) |
- |
- |
- |
|||||||||||||||||||||||||||||||||||||||||||||||
Total assets at fair value |
- |
- |
( |
) |
( |
) |
- |
( |
) |
- |
||||||||||||||||||||||||||||||||||||||||||||||||||
Liabilities carried at fair value |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investment contracts for account of policyholders |
( |
) | - | - | ( |
) | - | ( |
) | - | - | - | - | - | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Derivatives |
- | - | ( |
) | - | - | ( |
) | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||
- |
- |
( |
) |
- |
( |
) |
- |
- |
- |
- |
- |
|||||||||||||||||||||||||||||||||||||||||||||||||
1 |
Includes impairments and movements related to fair value hedges. Gains and losses are recorded in the line item Results from financial transactions of the income statement. |
2 |
Total gains and losses are recorded in line items: Gains / (losses) on revaluation of available-for-sale available-for-sale |
3 |
Total gains / (losses) for the period during which the financial instrument was in Level III. |
Notes to the consolidated financial statements Note 44 |
| Assets carried at fair value |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Available-for-sale |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares |
- | - | ( |
) | ( |
) | ( |
) | ( |
) | - | - | ( |
) | - | - | ||||||||||||||||||||||||||||||||||||||||||||
| Debt securities |
- | - | ( |
) | ( |
) | ( |
) | ( |
) | - | ( |
) | - | - | |||||||||||||||||||||||||||||||||||||||||||||
| Money markets and other short-term instruments |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||
| Other investments at fair value |
- | - | ( |
) | ( |
) | ( |
) | ( |
) | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||
- |
- |
( |
) |
( |
) |
( |
) |
( |
) |
- |
( |
) |
- |
- |
||||||||||||||||||||||||||||||||||||||||||||||
Fair value through profit or loss |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Shares |
- | - | ( |
) | - | ( |
) | - | ( |
) | - | - | - | - | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Debt securities |
- | - | - | - | ( |
) | - | - | - | - | - | - | - | |||||||||||||||||||||||||||||||||||||||||||||||
| Other investments at fair value |
- | - | - | ( |
) | - | ( |
) | - | ( |
) | - | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||||
| Investments for account of policyholders |
- | - | - | ( |
) | ( |
) | - | ( |
) | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||||
| Derivatives |
- | - | ( |
) | - | - | - | - | - | - | - | - | - | ( |
) | |||||||||||||||||||||||||||||||||||||||||||||
| Investments in real estate |
- | - | - | ( |
) | - | ( |
) | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||||||
| Investments in real estate for policyholders |
- | - | ( |
) | - | ( |
) | - | ( |
) | - | - | - | - | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
- |
- |
( |
) |
- |
( |
) |
- |
( |
) |
- |
( |
) |
- |
|||||||||||||||||||||||||||||||||||||||||||||||
| Revalued amounts |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real estate held for own use |
- | - | ( |
) | ( |
) | - | ( |
) | - | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||||
- |
- |
( |
) |
( |
) |
- |
( |
) |
- |
- |
- |
- |
- |
|||||||||||||||||||||||||||||||||||||||||||||||
Total assets at fair value |
- |
- |
( |
) |
( |
) |
( |
) |
( |
) |
- |
( |
) |
- |
||||||||||||||||||||||||||||||||||||||||||||||
Liabilities carried at fair value |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investment contracts for account of policyholders |
- | - | - | ( |
) | ( |
) | - | ( |
) | - | - | - | - | ( |
) | ||||||||||||||||||||||||||||||||||||||||||||
| Derivatives |
- | - | ( |
) | - | ( |
) | - | ( |
) | - | - | - | - | ||||||||||||||||||||||||||||||||||||||||||||||
- |
- |
( |
) |
( |
) |
( |
) |
- |
( |
) |
- |
- |
- |
- |
||||||||||||||||||||||||||||||||||||||||||||||
1 |
Includes impairments and movements related to fair value hedges. Gains and losses are recorded in the line item Results from financial transactions of the income statement. |
2 |
Total gains and losses are recorded in line items: Gains / (losses) on revaluation of available-for-sale available-for-sale |
3 |
Total gains / (losses) for the period during which the financial instrument was in Level III. |
Notes to the consolidated financial statements Note 44 |
| Valuation technique 1) |
Significant unobservable input 2) |
December 31, 2021 |
Range (weighted average) |
December 31, 2020 |
Range (weighted average) | |||||||||||||||
Assets carried at fair value |
||||||||||||||||||||
Available-for-sale |
||||||||||||||||||||
Shares |
||||||||||||||||||||
| n.a. | n.a. | |||||||||||||||||||
| n.a. | n.a. | |||||||||||||||||||
Debt securities |
||||||||||||||||||||
| n.a. | n.a. | |||||||||||||||||||
| - | n.a. | |||||||||||||||||||
| n.a. | ||||||||||||||||||||
| n.a. | n.a. | |||||||||||||||||||
Other investments at fair value |
||||||||||||||||||||
Tax credit investments |
|
|
||||||||||||||||||
Investment funds |
n.a. | n.a. | ||||||||||||||||||
Other |
n.a. | n.a. | ||||||||||||||||||
At December 31 |
||||||||||||||||||||
Fair value through profit or loss |
||||||||||||||||||||
Shares |
n.a. | n.a. | ||||||||||||||||||
Debt securities |
n.a. | n.a. | ||||||||||||||||||
Debt securities |
- | n.a. | n.a. | |||||||||||||||||
Other investments at fair value |
||||||||||||||||||||
Investment funds |
n.a. | n.a. | ||||||||||||||||||
Other |
n.a. | n.a. | ||||||||||||||||||
Derivatives |
||||||||||||||||||||
Longevity swap |
- | n.a. | n.a. | |||||||||||||||||
- |
||||||||||||||||||||
Total assets at fair value 3) |
||||||||||||||||||||
Liabilities carried at fair value |
||||||||||||||||||||
Derivatives |
||||||||||||||||||||
Embedded derivatives in insurance contracts |
% | |||||||||||||||||||
Total liabilities at fair value |
||||||||||||||||||||
1 |
Other in the table above (column Valuation technique) includes investments for which the fair value is uncorroborated and no broker quote is received. |
2 |
Not applicable (n.a.) has been included when the unobservable inputs are not developed by the Group and are not reasonably available. Refer to the section Fair value measurement in this note for a detailed description of Aegon’s methods of determining fair value and the valuation techniques. |
3 |
Investments for account of policyholders are excluded from the table above and from the disclosure regarding reasonably possible alternative assumptions. Policyholder assets, and their returns, belong to policyholders and do not impact Aegon’s net result or equity. The effect on total assets is offset by the effect on total liabilities. Derivatives exclude derivatives for account of policyholders amounting to |
Notes to the consolidated financial statements Note 44 |
December 31, 2021 |
Effect of reasonably possible alternative assumptions (+/-) |
December 31, 2020 |
Effect of reasonably possible alternative assumptions (+/-) | |||||||||||||||||
Increase |
Decrease |
Increase | Decrease | |||||||||||||||||
Financial liabilities carried at fair value |
||||||||||||||||||||
Embedded derivatives in insurance contracts |
( |
) | ( | |||||||||||||||||
2021 |
Estimated fair value hierarchy |
Total estimated |
||||||||||||||||||
Carrying amount December 31, 2021 |
Level I |
Level II |
Level III |
fair value December 31, 2021 |
||||||||||||||||
Assets |
||||||||||||||||||||
Mortgage loans - held at amortized cost |
- | |||||||||||||||||||
Private loans - held at amortized cost |
- | |||||||||||||||||||
Other loans - held at amortized cost |
||||||||||||||||||||
Liabilities |
||||||||||||||||||||
Subordinated borrowings - held at amortized cost |
- | |||||||||||||||||||
Trust pass-through securities - held at amortized cost |
- | - | ||||||||||||||||||
Borrowings – held at amortized cost |
||||||||||||||||||||
Investment contracts - held at amortized cost |
- | - | |
|||||||||||||||||
2020 |
Estimated fair value hierarchy | Total estimated | ||||||||||||||||||
| Carrying amount December 31, 2020 |
Level I | Level II | Level III | fair value December 31, 2020 |
||||||||||||||||
Assets |
||||||||||||||||||||
Mortgage loans - held at amortized cost |
- | |||||||||||||||||||
Private loans - held at amortized cost |
- | |||||||||||||||||||
Other loans - held at amortized cost |
||||||||||||||||||||
Liabilities |
||||||||||||||||||||
Subordinated borrowings - held at amortized cost |
- | |||||||||||||||||||
Trust pass-through securities - held at amortized cost |
- | |||||||||||||||||||
Borrowings – held at amortized cost |
||||||||||||||||||||
Investment contracts - held at amortized cost |
- | - | ||||||||||||||||||
Notes to the consolidated financial statements Note 44 |
Notes to the consolidated financial statements Note 44 |
Notes to the consolidated financial statements Note 44 |
Notes to the consolidated financial statements Note 44 |
Notes to the consolidated financial statements Note 44 |
2021 |
2020 | |||||||||||||||
Trading |
Designated |
Trading | Designated | |||||||||||||
Investments for general account |
||||||||||||||||
Investments for account of policyholders |
- | - | ||||||||||||||
Derivatives with positive values not designated as hedges |
- | - | ||||||||||||||
Total financial assets at fair value through profit or loss |
||||||||||||||||
Investment contracts for account of policyholders |
- | - | ||||||||||||||
Derivatives with negative values not designated as hedges |
- | - | ||||||||||||||
Total financial liabilities at fair value through profit or loss |
||||||||||||||||
Notes to the consolidated financial statements Note 45 |
2021 |
2020 1) | |||||||
Trading |
Designated |
Trading | Designated | |||||
Net gains and (losses) |
( |
|||||||
1 |
Comparative amounts have been updated. |
2021 |
2020 | |||||||
Purchase |
Sale |
Purchase | Sale | |||||
Real estate |
||||||||
Mortgage loans |
||||||||
Private loans |
- | |||||||
Other |
- | |||||||
Notes to the consolidated financial statements Note 45 |
| < 1 year amounts |
1 < 2 years amounts |
2 < 3 years amounts |
3 < 4 years amounts |
4 < 5 years amounts |
> 5 years amounts | |||||||
| 2021 |
||||||||||||
| Operating lease rights |
||||||||||||
2020 |
||||||||||||
| Operating lease rights |
||||||||||||
2021 |
2020 | |||||||
| Guarantees |
|
|
||||||
| Standby letters of credit |
||||||||
| Share of contingent liabilities incurred in relation to interests in joint ventures |
||||||||
| Other guarantees |
||||||||
| Other commitments and contingent liabilities |
||||||||
Notes to the consolidated financial statements Note 45 |
◆ |
Due and punctual payment of payables under letter of credit agreements applied for by Aegon N.V. as co-applicant with its captive insurance companies that are subsidiaries of Transamerica Corporation and Commonwealth General Corporation. At December 31, 2021, the letter of credit arrangements utilized by captives to provide collateral to affiliates amounted to EUR |
◆ |
Due and punctual payment of payables by the consolidated group companies Transamerica Corporation, Aegon Funding Company LLC and Commonwealth General Corporation with respect to fixed subordinated notes, bonds, capital trust pass-through securities and notes issued under commercial paper programs amounting to EUR |
◆ |
Due and punctual payment of any amounts owed to third parties by the consolidated group company Aegon Derivatives N.V. in connection with derivative transactions. Aegon Derivatives N.V. enters into derivative transactions with counterparties with which ISDA master netting agreements, including collateral support annex agreements, have been agreed. Net (credit) exposure on derivative transactions with these counterparties was therefore limited as of December 31, 2021. |
Notes to the consolidated financial statements Note 45 |
Notes to the consolidated financial statements Note 46 |
◆ |
Transferred financial assets that are not derecognized in their entirety: |
◆ |
Securities lending; whereby Aegon legally (but not economically) transfers assets and receives cash and non-cash collateral. The transferred assets are not derecognized. The obligation to repay the cash collateral is recognized as a liability. The non-cash collateral is not recognized in the statement of financial position; and |
◆ |
Repurchase activities; whereby Aegon receives cash for the transferred assets. The financial assets are legally (but not economically) transferred, but are not derecognized. The obligation to repay the cash received is recognized as a liability. |
◆ |
Transferred financial assets that are derecognized in their entirety and Aegon does not have a continuing involvement (normal sale); |
◆ |
Transferred financial assets that are derecognized in their entirety, but where Aegon has a continuing involvement; |
◆ • |
Collateral accepted in the case of securities lending, reverse repurchase agreement and derivative transactions; and |
◆ |
Collateral pledged in the case of (contingent) liabilities, repurchase agreements, securities borrowing and derivative transactions. |
2021 | ||||||||
Available-for-sale financial assets |
Financial assets at fair value through profit or loss | |||||||
Shares |
Debt securities |
Debt securities |
Investments for account of policyholders | |||||
| Carrying amount of transferred assets |
||||||||
| Carrying amount of associated liabilities |
||||||||
Notes to the consolidated financial statements Note 46 |
2020 | ||||||||
Available-for-sale financial assets |
Financial assets at fair value through profit or loss | |||||||
| Shares | Debt securities | Debt securities | Investments for account of policyholders | |||||
Carrying amount of transferred assets |
||||||||
Carrying amount of associated liabilities |
- | |||||||
Securities lending |
2021 |
2020 | ||||||
Carrying amount of transferred financial assets |
|
|
||||||
Fair value of cash collateral received |
||||||||
Fair value of non-cash collateral received |
||||||||
Net exposure |
( |
) |
( |
) | ||||
Non-cash collateral that can be sold or repledged in the absence of default |
||||||||
Non-cash collateral that has been sold or transferred |
||||||||
Reverse repurchase agreements |
2021 |
2020 | ||||||
Cash paid for reverse repurchase agreements |
|
|
||||||
Fair value of non-cash collateral received |
||||||||
Net exposure |
( |
) |
( |
) | ||||
Non-cash collateral that can be sold or repledged in the absence of default |
||||||||
Non-cash collateral that has been sold or transferred |
||||||||
Notes to the consolidated financial statements Note 47 |
Assets pledged for general account and contingent liabilities |
2021 |
2020 | ||
General account (contingent) liabilities |
|
| ||
Collateral pledged |
||||
Net exposure |
( |
( | ||
Non-cash collateral that can be sold or repledged by the counterparty |
||||
Assets pledged for repurchase agreements |
2021 |
2020 | ||||
Cash received on repurchase agreements |
|
| ||||
Collateral pledged (transferred financial assets) |
||||||
Net exposure |
( | |||||
Financial assets subject to offsetting, enforceable master netting arrangements and similar agreements |
Gross amounts of recognized financial assets |
Gross amounts of recognized financial liabilities set off in the statement of financial position |
Net amounts of financial assets presented in the statement of financial position |
Related amounts not set off in the statements of financial position |
Net amount |
|||||||||
| Financial instruments |
Cash collateral received (excluding surplus collateral) | |||||||||||||
2021 |
||||||||||||||
Derivatives |
||||||||||||||
At December 31 |
||||||||||||||
2020 |
||||||||||||||
Derivatives |
||||||||||||||
At December 31 |
||||||||||||||
Notes to the consolidated financial statements Note 48 |
Financial liabilities subject to offsetting, enforceable master netting arrangements and similar agreements |
Gross amounts of recognized financial liabilities |
Gross amounts of recognized financial assets set off in the statement of financial position |
Net amounts of financial liabilities presented in the statement of financial position |
Related amounts not set off in the statements of financial position |
Net amount |
|||||||||
| Financial instruments |
Cash collateral pledged (excluding surplus collateral) | |||||||||||||
| 2021 |
||||||||||||||
| Derivatives |
||||||||||||||
| At December 31 |
||||||||||||||
| 2020 |
||||||||||||||
| Derivatives |
||||||||||||||
| At December 31 |
||||||||||||||
Notes to the consolidated financial statements Note 49 |
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
◆ |
|
Notes to the consolidated financial statements Note 50 |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
◆ |
Notes to the consolidated financial statements Note 50 |
2021 |
2020 2) |
2019 | ||||||||||
Supervisory Board 1) |
||||||||||||
Executive Board |
||||||||||||
Key Management |
|
|
|
|||||||||
In fixed compensation |
||||||||||||
In cash based variable compensation |
||||||||||||
In share based variable compensation |
||||||||||||
In pension contributions |
||||||||||||
In other benefits |
||||||||||||
1 |
Based on a Decree of the Dutch State Secretary of Finance which came into force as from May 7, 2021, the Supervisory Board fees were not subject to Dutch VAT anymore, retroactively as from June 13, 2019. Therefore, Aegon has not paid Dutch VAT anymore on the fees of the Supervisory Board Members as from Q2 2021. Additionally, Aegon reclaimed VAT for the period Q3 2019 - Q1 2021, except for its Supervisory Board members based in the Netherlands for practical reasons. The 2019 and 2020 amounts were restated in this table for this VAT reclaim. |
2 |
Retroactively, fixed compensation in 2020 included sign-on expenses and other benefits in 2020 included mandatory local social security expenses for Key Management members that were not included in this table last year. |
Notes to the consolidated financial statements Note 50 |
| Shares held in Aegon at December 31 |
2021 |
2020 | ||||||
| Ben J. Noteboom |
||||||||
| Dona D. Young |
||||||||
| Total |
||||||||
Notes to the consolidated financial statements Note 50 |
Financial statements of Aegon N.V. |
| Financial statements of Aegon N.V. | ||||
267 |
||||
268 |
||||
| Notes to the financial statements of Aegon N.V. | ||||
269 |
1 |
|||
269 |
2 |
|||
269 |
3 |
|||
269 |
4 |
|||
270 |
5 |
|||
270 |
6 |
|||
270 |
7 |
|||
270 |
8 |
|||
271 |
9 |
|||
271 |
10 |
|||
271 |
11 |
|||
271 |
12 |
|||
271 |
13 |
|||
273 |
14 |
|||
276 |
15 |
|||
277 |
16 |
|||
277 |
17 |
|||
277 |
18 |
|||
278 |
19 |
|||
278 |
20 |
|||
278 |
21 |
|||
278 |
22 |
|||
279 |
23 |
|||
| Other information | ||||
280 |
||||
281 |
||||
| Other financial information | ||||
284 |
||||
285 |
||||
287 |
||||
289 |
||||
290 |
||||
291 |
||||
Financial statements of Aegon N.V. |
| Amounts in EUR million |
Note |
2021 |
2020 | |||||||||
| Result |
||||||||||||
| Investment Income |
3 |
|||||||||||
| Total revenues |
||||||||||||
| Results from financial transactions |
4 |
|||||||||||
| Total result |
||||||||||||
| Charges |
||||||||||||
| Commissions and expenses |
5 |
|||||||||||
| Interest charges and related fees |
6 |
|||||||||||
| Total charges |
||||||||||||
| Result before tax |
( |
) |
( |
) | ||||||||
| Income Tax |
7 |
|||||||||||
| Result after tax |
( |
) |
( |
) | ||||||||
| Net result group companies |
8 |
|||||||||||
| Net result |
( |
) | ||||||||||
Financial statements of Aegon N.V. |
Before profit appropriation, amounts in EUR million |
Note |
2021 |
2020 | |||||||||
| Non-current assets |
||||||||||||
| Financial fixed assets |
||||||||||||
| Shares in group companies |
8 |
|||||||||||
| Loans to group companies |
9 |
|||||||||||
| Other non-current assets |
10 |
|||||||||||
| Current assets |
||||||||||||
| Receivables |
||||||||||||
| Receivables from group companies |
11 |
|||||||||||
| Other receivables |
11 |
|||||||||||
| Other current assets |
12 |
|||||||||||
| Accrued interest and rent |
||||||||||||
| Cash and cash equivalents |
||||||||||||
| Cash and cash equivalents |
||||||||||||
| Total assets |
||||||||||||
| Shareholders’ equity |
||||||||||||
| Share capital |
13 |
|||||||||||
| Paid-in surplus |
14 |
|||||||||||
| Revaluation account |
14 |
|||||||||||
| Legal reserves – foreign currency translation reserve |
14 |
( |
) | |||||||||
| Legal reserves in respect of group companies |
14 |
|||||||||||
| Retained earnings, including treasury shares |
14 |
|||||||||||
| Remeasurement of defined benefit plans of group companies |
14 |
( |
) | ( |
) | |||||||
| Net result |
14 |
( |
) | |||||||||
| Other equity instruments |
15 |
|||||||||||
| Total equity |
||||||||||||
| Non-current liabilities |
||||||||||||
| Subordinated borrowings |
16 |
|||||||||||
| Long-term borrowings |
17 |
|||||||||||
| Current liabilities |
18 |
|||||||||||
| Loans from group companies |
||||||||||||
| Payables to group companies |
||||||||||||
| Other current liabilities |
||||||||||||
| Accruals and deferred income |
||||||||||||
| Total liabilities |
||||||||||||
| Total equity and liabilities |
||||||||||||
Notes to the financial statements of Aegon N.V. Note 1 |
2021 |
2020 | |||||||||
| Interest income from intercompany loans |
||||||||||
| Interest income from derivatives |
( |
) | ||||||||
| Total |
||||||||||
2021 |
2020 | |||||||||
| Net fair value change of derivatives |
( |
) | ||||||||
| Net foreign currency gains and (losses) |
( |
) | ||||||||
| Total |
||||||||||
Notes to the financial statements of Aegon N.V. Note 5 |
2021 |
2020 |
|||||||||
Employee expenses |
||||||||||
Administration expenses |
||||||||||
Cost sharing to group companies |
( |
) | ( |
) | ||||||
Total |
||||||||||
2021 |
2020 |
|||||||||
Subordinated borrowings |
||||||||||
Borrowings |
||||||||||
Other |
||||||||||
Total |
||||||||||
2021 |
2020 |
|||||||||
Current Tax |
||||||||||
Current Tax |
||||||||||
Income tax for the period (result) / charge |
||||||||||
Reconciliation between standard and effective tax |
||||||||||
Result before tax |
( |
) | ( |
) | ||||||
Tax on result on Dutch corporate result tax rate |
||||||||||
Differences due to the effect of: |
||||||||||
Tax rate changes |
- | |||||||||
Change in uncertain tax positions |
- | |||||||||
Non deductible expenses |
( |
) | ( |
) | ||||||
Total |
||||||||||
2021 |
2020 |
|||||||||
At January 1 |
||||||||||
Capital contributions and acquisitions |
||||||||||
Dividend received |
( |
) | ( |
) | ||||||
Net result for the financial year |
0 | - | ||||||||
Revaluations |
||||||||||
At December 31 |
||||||||||
Notes to the financial statements of Aegon N.V. Note 9 |
2021 |
2020 | |||||||
At January 1 |
||||||||
Additions / (repayments) |
||||||||
Other changes |
( |
) | ||||||
At December 31 |
||||||||
Current |
||||||||
Non-current |
||||||||
Issued and outstanding capital |
2021 |
2020 | ||||||
Common shares |
||||||||
Common shares B |
||||||||
Total share capital |
||||||||
Common shares |
2021 |
2020 | ||||||
Authorized share capital |
||||||||
Number of authorized shares (in million) |
||||||||
Par value in cents per share |
||||||||
Common shares B |
2021 |
2020 | ||||||
Authorized share capital |
||||||||
Number of authorized shares (in million) |
||||||||
Par value in cents per share |
||||||||
Notes to the financial statements of Aegon N.V. Note 13 |
| Common shares | Common shares B | |||||||||||||||
| Number of shares (thousands) |
Total amount |
Number of shares (thousands) |
Total amount |
|||||||||||||
At January 1, 2020 |
||||||||||||||||
Shares withdrawn |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Dividend |
||||||||||||||||
At December 31, 2020 |
||||||||||||||||
Shares withdrawn |
( |
) | ( |
) | ( |
) | ( |
) | ||||||||
Dividend |
||||||||||||||||
At December 31, 2021 |
||||||||||||||||
Weighted average number of common shares (thousands) |
Weighted average number of common shares B (thousands) |
|||||
2020 |
||||||
2021 |
||||||
Notes to the financial statements of Aegon N.V. Note 14 |
Share capital |
Paid- in surplus |
Revaluation account |
Legal reserves FCTR |
Legal reserves group compa- nies |
Retained earnings |
Remeasure- ment of defined benefit plans of group companies |
Treasury shares |
Net result |
Total |
|||||||||||||||||||||||||||||||
At January 1, 2021 |
( |
) |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||
Net result 2020 retained |
- | - | - | - | - | ( |
) | - | - | - | ||||||||||||||||||||||||||||||
Net result 2021 |
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||
Total net result |
- |
- |
- |
- |
- |
( |
) |
- |
- |
|||||||||||||||||||||||||||||||
Foreign currency translation differences and movement in foreign investment hedging reserves |
- | - | - | - | ( |
) | - | - | ||||||||||||||||||||||||||||||||
Changes in revaluation in subsidiaries |
- | - | ( |
) | - | - | - | - | - | - | ( |
) | ||||||||||||||||||||||||||||
Changes in revaluation reserve real estate held for own use |
- | - | ( |
) | - | - | ( |
) | ||||||||||||||||||||||||||||||||
Remeasurement of defined benefit plans of group companies |
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||
Changes and transfer to legal reserve |
- | - | - | - | ( |
) | - | - | - | |||||||||||||||||||||||||||||||
Other |
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||
Other comprehensive income / (loss) |
- |
- |
( |
) |
( |
) |
- |
- |
||||||||||||||||||||||||||||||||
Shares issued |
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||
Shares withdrawn |
( |
) | - | - | - | - | - | - | - | - | ( |
) | ||||||||||||||||||||||||||||
Dividends paid on common shares |
- | ( |
) | - | - | - | ( |
) | - | - | - | ( |
) | |||||||||||||||||||||||||||
Issuance and purchase of treasury shares |
- | - | - | - | - | - | ( |
) | - | ( |
) | |||||||||||||||||||||||||||||
Coupons on perpetual securities |
- | - | - | - | - | ( |
) | - | - | - | ( |
) | ||||||||||||||||||||||||||||
At December 31, 2021 |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||||||
Notes to the financial statements of Aegon N.V. Note 14 |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share capital |
|
Paid- in surplus |
|
|
Revalua- tion account |
|
|
Legal reserves FCTR |
|
|
Legal reserves group companies |
|
Retained earnings |
|
|
Remeasurement of defined benefit plans of group companies |
|
Treasury shares |
|
Net result |
|
Total | ||||||||||||||||||
| At January 1, 2020 |
( |
) | ( |
) | ||||||||||||||||||||||||||||||||||||
| Net result 2019 retained |
- | - | - | - | - | - | - | ( |
) | - | ||||||||||||||||||||||||||||||
| Net result 2020 |
- | - | - | - | - | - | - | - | ( |
) | ( |
) | ||||||||||||||||||||||||||||
| Total net result |
- |
- |
- |
- |
- |
- |
- |
( |
) |
( |
) | |||||||||||||||||||||||||||||
| Foreign currency translation differences and movement in foreign investment hedging reserves |
- | - | ( |
) | - | - | - | - | ( |
) | ||||||||||||||||||||||||||||||
| Changes in revaluation in subsidiaries |
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||
| Changes in revaluation reserve real estate held for own use |
- | - | - | - | ||||||||||||||||||||||||||||||||||||
| Remeasurement of defined benefit plans of group companies |
- | - | - | - | - | - | ( |
) | - | - | ( |
) | ||||||||||||||||||||||||||||
| Changes and transfer to legal reserve |
- | - | ( |
) | - | - | - | - | ||||||||||||||||||||||||||||||||
| Other |
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||
| Other comprehensive income / (loss) |
- |
- |
( |
) |
( |
) |
- |
- |
||||||||||||||||||||||||||||||||
| Shares withdrawn |
( |
) | - | - | - | - | ( |
) | - | - | - | |||||||||||||||||||||||||||||
| Dividends paid on common shares |
- | ( |
) | - | - | - | ( |
) | - | - | - | ( |
) | |||||||||||||||||||||||||||
| Dividend withholding tax reduction |
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||
| Issuance and purchase of treasury shares |
- | - | - | - | - | ( |
) | - | - | |||||||||||||||||||||||||||||||
| Coupons on perpetual securities |
- | - | - | - | - | ( |
) | - | - | - | ( |
) | ||||||||||||||||||||||||||||
| Incentive plans |
- | - | - | - | - | - | - | - | ||||||||||||||||||||||||||||||||
| At December 31, 2020 |
( |
) |
( |
) |
( |
) |
( |
) |
||||||||||||||||||||||||||||||||
Notes to the financial statements of Aegon N.V. Note 14 |
2021 |
2020 | |||||||||||||||
Number of shares (thousands) |
Amount |
Number of shares (thousands) |
|
Amount | ||||||||||||
| At January 1 |
||||||||||||||||
| Transactions in 2021: |
||||||||||||||||
| Sale: transactions, average price 3.90 |
( |
) | ( |
) | ||||||||||||
| Shares witdrawn: 1 transaction, average price EUR 3.89 |
( |
) | ( |
) | ||||||||||||
| Sale: 1 transaction, average price 3.89 |
( |
) | ( |
) | ||||||||||||
| Purchase: 1 transaction average price 3.70 |
||||||||||||||||
| Sale: 1 transaction, average price 3.02 |
( |
) | ( |
) | ||||||||||||
| Purchase: 1 transaction average price 4.46 |
||||||||||||||||
| Transactions in 2020: |
||||||||||||||||
| Sale: transactions, average price EUR 4.52 |
( |
) | ( |
) | ||||||||||||
| Shares witdrawn: 1 transaction, average price EUR 4.52 |
( |
) | ( |
) | ||||||||||||
| Sale: 1 transaction, average price EUR 4.13 |
( |
) | ( |
) | ||||||||||||
| Purchase: 1 transaction, average price EUR 2.46 |
||||||||||||||||
| At December 31 |
||||||||||||||||
2021 |
2020 | |||||||||||||||
Number of shares (thousands) |
Amount |
Number of shares (thousands) |
|
Amount | ||||||||||||
| At January 1 |
||||||||||||||||
| Transactions in 2021: |
||||||||||||||||
| Sale: 1 transaction, average price EUR 0.10 |
( |
) | - | |||||||||||||
| Shares withdrawn: 1 transaction, average price EUR 0.10 |
( |
) | - | |||||||||||||
| Purchase: 1 transaction, average price EUR 0.10 |
||||||||||||||||
| Transactions in 2020: |
||||||||||||||||
| Sale: 1 transaction, average price EUR 0.13 |
( |
) | - | |||||||||||||
| Shares withdrawn: 1 transaction, average price EUR 0.13 |
( |
) | ( |
) | ||||||||||||
| Purchase: 1 transaction, average price EUR 0.08 |
- | |||||||||||||||
| At December 31 |
||||||||||||||||
2021 |
2020 | |||||||||||||||
Number of shares (thousands) |
Total amount |
Number of shares (thousands) |
|
Total amount | ||||||||||||
| Common shares |
||||||||||||||||
| Held by Aegon N.V. |
||||||||||||||||
| Held by subsidiaries |
||||||||||||||||
| Common shares B |
||||||||||||||||
| Held by Aegon N.V. |
||||||||||||||||
| At December 31 |
||||||||||||||||
Notes to the financial statements of Aegon N.V. Note 15 |
| Perpetual contingent convertible securities |
Junior perpetual capital securities |
Perpetual cumulative subordinated bonds |
Long Term Incentive Plans 1) |
Total |
||||||||||||||||
| At January 1, 2021 |
||||||||||||||||||||
| Shares granted |
- | - | - | |||||||||||||||||
| Shares vested |
- | - | - | ( |
) | ( |
) | |||||||||||||
| Securities redeemed |
- | ( |
) | - | - | ( |
) | |||||||||||||
| At December 31, 2021 |
||||||||||||||||||||
| At January 1, 2020 |
||||||||||||||||||||
| Shares granted |
- | - | - | |||||||||||||||||
| Shares vested |
- | - | - | ( |
) | ( |
) | |||||||||||||
| At December 31, 2020 |
||||||||||||||||||||
1 |
Long Term Incentive Plans include the shares granted to personnel which are not yet vested. |
Perpetual contingent convertible securities |
Coupon rate | Coupon date | Year of next call | 2021 |
2020 | |||||||||||||||
| |
1) |
ally, April 15 |
||||||||||||||||||
| At December 31 |
||||||||||||||||||||
1 |
The coupon is fixed at |
Junior perpetual capital securities |
Coupon rate | Coupon date | Year of next call | 2021 |
2020 | |||||||||||||||
| USD 250 million |
1) |
|||||||||||||||||||
| USD 500 million |
2) |
|||||||||||||||||||
| EUR 950 million |
3) |
|||||||||||||||||||
| At December 31 |
||||||||||||||||||||
1 |
|
2 |
ten-year US dollar interest rate swap yield plus a spread of basis points, with a maximum of |
3 |
ten-year Dutch government bond yield plus a spread of basis points, with a maximum of |
Notes to the financial statements of Aegon N.V. Note 16 |
Perpetual cumulative subordinated bonds |
Coupon rate | Coupon date | Year of next call | 2021 |
2020 | |||||||||||||
| |
1), 4) |
|||||||||||||||||
| |
2), 4) |
|||||||||||||||||
| |
3), 4) |
|||||||||||||||||
| At December 31 |
||||||||||||||||||
1 |
The coupon of the EUR |
2 |
The coupon of the EUR |
3 |
The coupon of the EUR |
4 |
, the coupons will be reset at the then prevailing effective yield of ten-year Dutch government securities plus a spread of basis points. |
Fixed to floating subordinated notes |
Coupon rate | Coupon date | Issue /Maturity | Year of next call | 2021 |
2020 | ||||||||||||||||||
| EUR |
1) |
, April 25 | ||||||||||||||||||||||
| USD |
2) |
lly, April 11 |
||||||||||||||||||||||
| At December 31 |
||||||||||||||||||||||||
| Fair value of subordinated borrowings |
||||||||||||||||||||||||
1 |
The coupon is fixed at |
2 |
The coupon is fixed at |
2021 |
2020 | |||||||
| Remaining terms less than 1 year |
||||||||
| Remaining terms 1 - 5 years |
||||||||
| Remaining terms 5 - 10 years |
||||||||
| Remaining terms over 10 years |
||||||||
| At December 31 |
||||||||
| Fair value of long-term borrowings |
||||||||
Notes to the financial statements of Aegon N.V. Note 19 |
¨ |
Due and punctual payment of payables due under letter of credit agreements applied for by Aegon N.V. as co-applicant with its captive insurance companies that are subsidiaries of Transamerica Corporation and Commonwealth General Corporation. At December 31, 2021, the letter of credit arrangements utilized by captives to provide collateral to affiliates amounted to EUR |
¨ |
Due and punctual payment of payables by the consolidated group companies Transamerica Corporation, Aegon Funding Company LLC and Commonwealth General Corporation with respect to fixed subordinated notes, bonds, capital trust pass-through securities and notes issued under commercial paper programs amounted to EUR |
¨ |
Due and punctual payment of any amounts owed to third parties by the consolidated group company Aegon Derivatives N.V. in connection with derivative transactions. Aegon Derivatives N.V. enters into derivative transactions with counterparties with which ISDA master netting agreements including collateral support annex agreements have been agreed; net (credit) exposure on derivative transactions with these counterparties was therefore limited as of December 31, 2021. |
| Total remuneration of the group | Of which PricewaterhouseCoopers Accountants N.V. (NL) | |||||||
2021 |
2020 | 2021 |
2020 | |||||
Audit fees |
||||||||
Audit-related service fees |
||||||||
Total |
||||||||
Notes to the financial statements of Aegon N.V. Note 23 |
2021 |
2020 | |||||||
Final dividend on common shares |
||||||||
Earnings to be retained |
- | |||||||
To be deducted from retained earnings |
- | ( |
) | |||||
Net result attributable to owners of Aegon N.V. |
( |
) | ||||||
Supervisory Board |
Executive Board |
|||||
| William L. Connelly | Lard Friese | |||||
| Mark A. Ellman | Matthew J. Rider | |||||
| Jack McGarry | ||||||
| Ben J. Noteboom | ||||||
| Caroline Ramsay | ||||||
| Thomas Wellauer | ||||||
| Corien M. Wortmann-Kool | ||||||
Dona D. Young |
||||||
Other information Profit appropriation |
| 1. | The General Meeting of Shareholders will adopt the Annual Accounts; |
| 2. | If the adopted profit and loss account shows a profit, the Supervisory Board may decide, upon the proposal of the Executive Board, to set aside part of the profit to augment and/or form reserves; |
| 3. | The profits remaining after application of 2 above shall be put at the disposal of the General Meeting of Shareholders. The Executive Board, subject to the approval of the Supervisory Board, shall make a proposal for that purpose. A proposal to pay a dividend shall be dealt with as a separate agenda item at the General Meeting of Shareholders; |
| 4. | The Executive Board may, subject to the approval of the Supervisory Board, make one or more interim distributions to the holders of common shares and common shares B; |
| 5. | Distributions are made in accordance with the principle set forth in article 4 of the Articles of Association of Aegon N.V. that the financial rights of a common share B are one fortieth (1/40th) of the financial rights of a common share; |
| 6. | The Executive Board may, subject to the approval of the Supervisory Board, decide that a distribution on common shares and common shares B shall not take place as a cash payment but as a payment in common shares. Alternatively, it may decide that holders of common shares and common shares B shall have the option to receive a distribution as a cash payment and/or as a payment in common shares, out of the profit and/or at the expense of reserves, provided that the Executive Board is designated by the General Meeting to issue shares. Subject to the approval of the Supervisory Board, the Executive Board shall also determine the conditions applicable to the aforementioned choices; and |
| 7. | The Company’s policy on reserves and dividends shall be determined and can be amended by the Supervisory Board, upon the proposal of the Executive Board. The adoption and each amendment of the policy on reserves and dividends thereafter, shall be discussed and accounted for at the General Meeting of Shareholders under a separate agenda item. |
Other information Major shareholders |
Other information Major shareholders |
Other information Major shareholders |
Other financial information Schedule I |
| Schedule I – Summary of Investments other than Investments in Related Parties as at December 31, 2021 |
| Schedule II – Condensed Financial Information of Registrant (Parent Company Only) |
| Schedule II – Statement of Financial Position as of December 31, 2021 and 2020 |
| Schedule II – Income Statement (Loss) for the years ended December 31, 2021, 2020 and 2019 |
| Schedule II – Condensed Cash Flow Statement for the years ended December 31, 2021, 2020 and 2018 |
| Schedule II – Dividends from and Capital Contributions to Business Units for the years ended December 31, 2021, 2020 and 2019 |
| Schedule III – Supplementary Insurance Information for the years ended December 31, 2021, 2020 and 2019 |
| Schedule IV – Reinsurance for the years ended December 31, 2021, 2020 and 2019 |
| Schedule V – Valuation and Qualifying Accounts for the years ended December 31, 2021, 2020 and 2019 |
Amounts in EUR million |
Cost 1) |
Fair value |
Book value |
|||||||||
| Shares: |
||||||||||||
| Available-for-sale |
||||||||||||
| Fair value through profit or loss |
||||||||||||
| Bonds: |
||||||||||||
| Available-for-sale held-to-maturity: |
||||||||||||
| US government |
||||||||||||
| Dutch government |
||||||||||||
| Other government |
||||||||||||
| Mortgage backed |
||||||||||||
| Asset backed |
||||||||||||
| Corporate |
||||||||||||
| Money market investments |
||||||||||||
| Other |
||||||||||||
| Subtotal |
||||||||||||
| Bonds: |
||||||||||||
| Fair value through profit or loss |
||||||||||||
| Other investments at fair value through profit or loss |
||||||||||||
| Mortgages |
||||||||||||
| Private loans |
||||||||||||
| Deposits with financial institutions |
||||||||||||
| Policy loans |
||||||||||||
| Other |
||||||||||||
| Subtotal |
||||||||||||
| Real estate: |
||||||||||||
| Investments in real estate |
||||||||||||
| Total |
||||||||||||
1 |
Cost is defined as original cost for available-for-sale available-for-sale held-to-maturity |
Other financial information Schedule II |
| Before profit appropriation, amounts in EUR million |
2021 |
2020 | ||||||
| Non-current assets |
||||||||
| Financial fixed assets |
||||||||
| Shares in group companies |
||||||||
| Loans to group companies |
||||||||
| Other non-current assets |
||||||||
| Current assets |
||||||||
| Receivables |
||||||||
| Receivables from group companies |
||||||||
| Other receivables |
||||||||
| Other current assets |
||||||||
| Accrued interest and rent |
||||||||
| Cash and cash equivalents |
||||||||
| Cash and cash equivalents |
||||||||
| Total assets |
||||||||
| Shareholders’ equity |
||||||||
| Share capital |
||||||||
| Paid-in surplus |
||||||||
| Revaluation account |
||||||||
| Legal reserves – foreign currency translation reserve |
( |
) | ||||||
| Legal reserves in respect of group companies |
||||||||
| Retained earnings, including treasury shares |
||||||||
| Remeasurement of defined benefit plans of group companies |
( |
) | ( |
) | ||||
| Net result |
( |
) | ||||||
| Other equity instruments |
||||||||
| Total equity |
||||||||
| Non-current liabilities |
||||||||
| Subordinated borrowings |
||||||||
| Long-term borrowings |
||||||||
| Current liabilities |
||||||||
| Loans from group companies |
||||||||
| Payables to group companies |
||||||||
| Other current liabilities |
||||||||
| Accruals and deferred income |
||||||||
| Total liabilities |
||||||||
| Total equity and liabilities |
||||||||
Other financial information Schedule II |
Amounts in EUR million |
2021 |
2020 | 2019 | |||||||||
Net result group companies |
- | |||||||||||
Other income / (loss) |
( |
) | ( |
) | ( |
) | ||||||
Net result |
( |
) |
||||||||||
Amounts in EUR million |
2021 |
2020 | 2019 | |||||||||
Result before tax |
( |
) |
||||||||||
Adjustments |
( |
) | ( |
) | ( |
) | ||||||
Net cash flows from operating activities |
( |
) |
( |
) | ||||||||
Dividends and capital repayments of subsidiaries, associates and joint ventures |
||||||||||||
Other |
( |
) | ( |
) | ( |
) | ||||||
Net cash flows from investing activities |
||||||||||||
Issuance of perpetuals |
- | - | ||||||||||
Issuance of treasury shares |
- | - | ||||||||||
Purchase of treasury shares |
( |
) | ( |
) | ( |
) | ||||||
Issuance and repurchase of borrowings |
( |
) | ||||||||||
Repayment of perpetuals |
( |
) | - | ( |
) | |||||||
Dividends paid |
( |
) | ( |
) | ( |
) | ||||||
Coupons on perpetual securities |
( |
) | ( |
) | ( |
) | ||||||
Net cash flows from financing activities |
( |
) |
( |
) |
( |
) | ||||||
Net increase / (decrease) in cash and cash equivalents |
( |
) |
( |
) | ||||||||
2021 |
2020 | |||||||||||||||
Amounts in EUR million |
Subordinated borrowings |
Long-term Borrowings |
Subordinated borrowings |
Long-term Borrowings |
||||||||||||
Remaining terms less than 1 year |
||||||||||||||||
Remaining terms 1 - 2 years |
||||||||||||||||
Remaining terms 2 - 3 years |
||||||||||||||||
Remaining terms 3 - 4 years |
||||||||||||||||
Remaining terms 4 - 5 years |
||||||||||||||||
Remaining terms longer than 5 years |
||||||||||||||||
At December 31 |
||||||||||||||||
Other financial information Schedule III |
Column A |
Column B | Column C | Column D | Column E | Column F | |||||||||||||||
Segment |
Deferred policy acquisition costs |
Future policy benefits |
Unearned premiums |
Other policy claims and benefits |
Premium revenue |
|||||||||||||||
Amounts in EUR million | ||||||||||||||||||||
2021 |
||||||||||||||||||||
Americas |
||||||||||||||||||||
The Netherlands |
||||||||||||||||||||
United Kingdom |
- | - | ||||||||||||||||||
International |
||||||||||||||||||||
Holding and other activities |
- | - | - | - | - | |||||||||||||||
Eliminations |
- | ( |
) | - | - | - | ||||||||||||||
Total |
||||||||||||||||||||
2020 |
||||||||||||||||||||
Americas |
||||||||||||||||||||
The Netherlands |
||||||||||||||||||||
United Kingdom |
||||||||||||||||||||
International |
||||||||||||||||||||
Holding and other activities |
- | - | - | - | ||||||||||||||||
Eliminations |
- | ( |
) | - | - | - | ||||||||||||||
Total |
||||||||||||||||||||
2019 |
||||||||||||||||||||
Americas |
||||||||||||||||||||
The Netherlands |
||||||||||||||||||||
United Kingdom |
||||||||||||||||||||
International |
||||||||||||||||||||
Holding and other activities |
- | - | ||||||||||||||||||
Eliminations |
- | ( |
) | - | - | - | ||||||||||||||
Total |
||||||||||||||||||||
Other financial information Schedule III |
| Column G | Column H | Column I | Column J | Column K | ||||||||||||||||
Amounts in EUR million |
Net investment income |
Benefits, claims and losses |
Amortization of deferred policy acquisition costs |
Other operating expenses |
Premiums written |
|||||||||||||||
2021 |
||||||||||||||||||||
Americas |
||||||||||||||||||||
The Netherlands |
— | |||||||||||||||||||
United Kingdom |
||||||||||||||||||||
International |
||||||||||||||||||||
Asset Management |
- | - | - | - | ||||||||||||||||
Holding and other activities |
( |
) | - | - | - | |||||||||||||||
Eliminations |
( |
) | - | - | ( |
) | - | |||||||||||||
Total |
||||||||||||||||||||
2020 |
||||||||||||||||||||
Americas |
||||||||||||||||||||
The Netherlands |
- | |||||||||||||||||||
United Kingdom |
||||||||||||||||||||
International |
||||||||||||||||||||
Asset Management |
- | - | - | - | ||||||||||||||||
Holding and other activities |
- | |||||||||||||||||||
Eliminations |
( |
) | ( |
) | - | ( |
) | - | ||||||||||||
Total |
||||||||||||||||||||
2019 |
||||||||||||||||||||
Americas |
||||||||||||||||||||
The Netherlands |
||||||||||||||||||||
United Kingdom |
||||||||||||||||||||
International |
||||||||||||||||||||
Asset Management |
- | - | - | - | ||||||||||||||||
Holding and other activities |
- | - | ||||||||||||||||||
Eliminations |
( |
) | ( |
) | - | ( |
) | - | ||||||||||||
Total |
||||||||||||||||||||
Other financial information Schedule IV |
Amounts in EUR million |
Gross amount | Ceded to other companies |
Assumed from other companies |
Net amount | % of amount assumed to net |
|||||||||||||||
For the year ended December 31, 2021 |
||||||||||||||||||||
Life insurance in force |
||||||||||||||||||||
Premiums |
||||||||||||||||||||
Life insurance |
- | |||||||||||||||||||
Non-life insurance |
- | |||||||||||||||||||
Total premiums |
- |
|||||||||||||||||||
For the year ended December 31, 2020 |
||||||||||||||||||||
Life insurance in force |
||||||||||||||||||||
Premiums |
||||||||||||||||||||
Life insurance |
||||||||||||||||||||
Non-life insurance |
||||||||||||||||||||
Total premiums |
||||||||||||||||||||
For the year ended December 31, 2019 |
||||||||||||||||||||
Life insurance in force |
||||||||||||||||||||
Premiums |
||||||||||||||||||||
Life insurance |
||||||||||||||||||||
Non-life insurance |
||||||||||||||||||||
Total premiums |
||||||||||||||||||||
Other financial information Schedule V |
Amounts in EUR million |
2021 |
2020 | 2019 | |||||||||
Balance at January 1 |
||||||||||||
Addition charged to earnings |
||||||||||||
Amounts written off and other changes |
( |
) | ( |
) | ( |
) | ||||||
Currency translation |
( |
) | ||||||||||
Balance at December 31 |
||||||||||||
The provisions can be analyzed as follows: |
||||||||||||
Mortgages |
||||||||||||
Other loans |
||||||||||||
Receivables |
||||||||||||
Total |
||||||||||||
¨ |
• Auditor Name: |
¨ |
• Auditor FirmId: PCAOB ID |
¨ |
Auditor Location: |
Auditor’s report on the Annual Report on Form 20-F |
Auditor’s report on the Annual Report on Form 20-F |
Auditor’s report on the Annual Report on Form 20-F |
Additional information Schedule V |
Additional information | ||
| 295 |
||
| 301 |
||
| 307 |
||
| 311 |
||
| 317 |
||
| 319 |
||
| 342 |
||
| 343 |
||
| 344 |
||
| 345 |
||
| 346 |
||
| 347 |
||
| 349 |
||
| 350 |
||
| 350 |
||
| 351 |
||
| 355 |
||
| 356 |
||
Additional information Overview of Americas |
1 |
SUSEP, http://www2.susep.gov.br/menuestatistica/SES/principal.aspx. Webpage visited October 8, 2021. |
2 |
SICOOB, https://www.bancoob.com.br/sobre-o-sicoob. |
Additional information Overview of Americas |
¨ |
53,200 independent life insurance agents associated with WFGIA in the United States and its affiliated insurance agency operating in Canada; |
¨ |
2,600 insurance agents associated with TAN, comprised of both employees and independent producers; and |
¨ |
3,000 WFGIA and TAN agents associated with TFA as registered representatives, of whom approximately 1,300 are registered as investment advisor representatives. |
Additional information Overview of Americas |
Additional information Overview of Americas |
1 |
Based on a compilation of qualitative and quantitative responses received from PLANSPONSOR magazine’s 2021 Recordkeeping Survey. PLANSPONSOR, June 21, 2021, https://www.plansponsor.com/research/2021-recordkeeping-survey. Ranking as of December 2020. |
Additional information Overview of Americas |
Additional information Overview of Americas |
Additional information Overview of the Netherlands |
¨ |
• Life; |
¨ |
• Mortgages; |
¨ |
• Banking; and |
¨ |
• Workplace Solutions. |
¨ |
• Aegon Bank N.V.; |
¨ |
• Aegon Cappital B.V.; |
¨ |
• Aegon Hypotheken B.V.; |
¨ |
• Aegon Levensverzekering N.V.; |
¨ |
• Aegon Schadeverzekering N.V.; |
¨ |
• Aegon Spaarkas N.V.; |
¨ |
• Nedasco B.V.; |
¨ |
• Robidus Groep B.V.; |
¨ |
• TKP Pensioen B.V. |
Additional information Overview of the Netherlands |
¨ |
• Separate account group contracts with individually determined asset investment strategies, profit sharing and guarantees; |
¨ |
• Contracts with profit sharing based on a pre-determined interest rate; |
¨ |
• Traditional variable unit-linked products; |
¨ |
• DB subscriptions, a standardized product that offers a 1-year guarantee; and |
¨ |
• Contracts without profit sharing. |
Additional information Overview of the Netherlands |
Additional information Overview of the Netherlands |
1 |
Company source data at the end of 2019 |
2 |
Dutch Association of Insurers – annual reports insurers 2020 |
3 |
Dutch Association of Insurers – Production data Non-Life 2021 |
4 |
Land register (Kadaster) |
5 |
Market data DNB in combination with data Knab |
6 |
PPI Association 2020 |
Additional information Overview of the Netherlands |
¨ |
• Aegon Levensverzekering; |
¨ |
• Aegon Schadeverzekering; |
¨ |
• Aegon Spaarkas. |
Additional information Overview of the Netherlands |
Additional information Overview of United Kingdom |
¨ |
Scottish Equitable plc; |
¨ |
Cofunds Ltd.; |
¨ |
Aegon Investment Solutions Ltd.; and |
¨ |
Aegon Investments Ltd. |
Additional information Overview of United Kingdom |
Additional information Overview of United Kingdom |
¨ |
An institutional trading platform which powers 27 of the UK’s leading platforms, wealth management firms and investment houses (e.g., Brooks MacDonald, Charles Stanley); and |
¨ |
An investment-only proposition for Workplace pension schemes, which provides access to insured funds for approximately 154 clients. |
Additional information Overview of United Kingdom |
Additional information Overview of International |
¨ |
Aegon España S.A.U. de Seguros y Reaseguros (Aegon España Insurance and Reinsurance); |
¨ |
Santander Generales Seguros y Reaseguros S.A. (Santander General Insurance and Reinsurance) (51%); |
¨ |
Santander Vida Seguros y Reaseguros S.A. (Santander Life Insurance and Reinsurance) (51%); |
¨ |
Liberbank Vida y Pensiones, Seguros y Reaseguros, S.A. (Liberbank Life and Pensions, Insurance and Reinsurance) (50%); |
¨ |
Aegon Santander Portugal Não Vida-Companhia de Seguros S.A. (Aegon Santander Portugal Non-Life Insurance Co.) (51%); and |
¨ |
Aegon Santander Portugal Vida-Companhia de Seguros de Vida S.A. (Aegon Santander Portugal Life Insurance Co.) (51%). |
¨ |
Aegon Magyarország Általános Biztosító Zártkörűen Működő Részvénytársaság (Aegon Hungary Composite Insurance Co.). |
¨ |
Aegon Pension Fund Management Company |
¨ |
Aegon Intermediary and Marketing Company |
¨ |
Help 24 Assistance Company |
¨ |
Aegon Asset Fund Management Company |
¨ |
Transamerica Life (Bermuda) Ltd. |
¨ |
Aegon THTF Life Insurance Co., Ltd. (50%) in China. |
¨ |
Aegon Towarzystwo Ubezpieczeń na Życie Spótka Akcyjna (Aegon Poland Life); |
¨ |
Aegon Powszechne Towarzystwo Emerytalne Spótka Akcyjna (Aegon Poland Pension Fund Management Co.); |
¨ |
Aegon Emeklilik ve Hayat A.Ş. (Aegon Turkey); |
¨ |
Aegon Pensii Societate de Administrare a Fondurilor de Pensii Private S.A (Aegon Romania Pension Administrator Co.); |
¨ |
Aegon Life Insurance Company Ltd. (49%) in India; and |
¨ |
Aegon Insights Ltd. |
Additional information Overview of International |
Additional information Overview of International |
Additional information Overview of International |
Additional information Overview of International |
¨ |
General Directorate of Insurance and Pension Funds (DGSFP) (Spain); |
¨ |
The Insurance and Pension Funds Supervisory Authority (ASF) (Portugal); |
¨ |
The Central Bank of Hungary (MNB) (Hungary); |
¨ |
The Financial Supervision Authority (KNF) (Poland); |
¨ |
Authority for Financial Supervision (ASF) (Romania); and |
¨ |
Insurance and Private Pension Regulatory and Supervisory Board’s (IRSB) (Turkey). |
Additional information Overview of International |
Additional information Overview of Asset Management |
¨ |
In China, Aegon AM owns 49% of Aegon Industrial Fund Management Company (AIFMC), a Shanghai-based asset manager that offers mutual funds, segregated accounts, and advisory services; |
¨ |
In France, Aegon AM owns 25% of La Banque Postale Asset Management (LBPAM). LBPAM offers a comprehensive range of investment strategies to French institutional clients, and to retail investors through La Banque Postale group’s retail banking network and affiliated insurance company CNP; |
Additional information Overview of Asset Management |
Additional information Risk factors Aegon N.V. |
¨ |
Interest rate volatility, and sustained low or negative interest rate levels |
¨ |
Rapidly rising interest rates |
¨ |
Disruptions in the global financial markets and general economic conditions |
¨ |
Illiquidity of certain investment assets |
¨ |
Declines in value and defaults in Aegon’s debt securities, private placements, mortgage loan portfolios and other instruments or the failure of certain counterparties |
¨ |
Decline in equity markets |
¨ |
Downturn in the real estate market |
¨ |
Default of a major market participant |
¨ |
Failure by reinsurers to which Aegon has ceded risk |
¨ |
Downgrade in Aegon’s credit ratings |
¨ |
Fluctuations in currency exchange rates |
¨ |
Unsuccessful management of derivatives |
¨ |
Subjective valuation of Aegon’s investments, allowances and impairments |
¨ |
Higher inflation |
¨ |
Differences between actual claims experience/underwriting and reserve assumptions |
¨ |
Changes in assumptions, estimations, and discrepant valuations of DPAC and value of business acquired |
¨ |
Products with guarantees |
¨ |
Restrictions on underwriting criteria and the use of data |
¨ |
Unexpected return on offered financial and insurance products |
¨ |
Reinsurance may not be available, affordable, or adequate |
¨ |
Catastrophic events |
Additional information Risk factors Aegon N.V. |
¨ |
Competitive factors |
¨ |
Difficulty in managing the Company’s acquisitions and divestments |
¨ |
Difficulties in distributing and marketing products through its current and future distribution channels. |
¨ |
Inability to adapt to and apply new technologies |
¨ |
Failure of data management and governance |
¨ |
Epidemics or pandemics |
¨ |
Unsuccessful in managing exposure to climate risk and adequately adapting investment portfolios |
¨ |
Unidentified or unanticipated risk events |
¨ |
Failure of Aegon’s information technology or communications systems |
¨ |
Computer system failure or security breach |
¨ |
Breach of data privacy or security obligations |
¨ |
Inaccuracies in econometric, financial, or actuarial models, or differing interpretations of underlying methodologies |
¨ |
Inaccurate, incomplete or unsuccessful quantitative models, algorithms or calculations |
¨ |
Issues with third party providers, including events such as bankruptcy, disruption of services, or standards of service level agreements not being upheld |
¨ |
Inability to attract and retain personnel |
¨ |
Requirement to increase technical provisions and/or hold higher amounts of regulatory capital as a result of changes in the regulatory environment or changes in rating agency analysis |
¨ |
Political or other instability in a country or geographic region |
¨ |
Changes in accounting standards |
¨ |
Inability of Aegon’s subsidiaries to pay dividends to Aegon N.V. |
¨ |
Risks of application of intervention measures |
¨ |
Unfavorable outcomes of legal and arbitration proceedings and regulatory investigations and actions |
¨ |
Changes in government regulations in the jurisdictions in which Aegon operates |
¨ |
Evolving ESG standards and requirements |
¨ |
Tax risks |
¨ |
Judgments of US courts may not be enforceable against Aegon in Dutch courts |
¨ |
Inability to manage risks associated with the reform and replacement of benchmark rates |
¨ |
Inability to protect intellectual property |
¨ |
Volatility of Aegon’s share price |
¨ |
Offering of additional common shares in the future |
¨ |
Significant influence of Vereniging Aegon over Aegon’s corporate actions |
¨ |
Currency fluctuations |
¨ |
Influence of Perpetual Contingent Convertible over the market price for Aegon’s common shares |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
¨ |
The European Commission has recently published a formal legislative proposal for amendments to the Solvency II Directive following an extensive technical advice by EIOPA to the European Commission. Proposals to amend the Solvency II Delegated Regulation, amend existing or introduce additional technical standards and/or EIOPA guidelines may follow in a later stage. The impact on Aegon’s financial position and results depends on the final form of the requirements, standards and guidelines; |
¨ |
Following the end of the Brexit transition period on 31 December 2020, UK insurers are no longer directly subject to regulation under the EU’s Solvency II. The UK government launched a review into the European Union’s Solvency II framework in October 2020 which has resulted in divergence between the UK and EU regulatory regimes in 2021. Increasing divergence cannot be ruled out going forward which could further impact the UK capital ratio; |
¨ |
In the US, the NAIC periodically updates various prudential requirements. The NAIC is currently updating the risk-based capital (‘RBC’) charges for mortality risk and is embarking on a project to reconsider the RBC treatment of structured investments. These initiatives or other regulatory changes to capital factors may lead to higher risk-based capital requirements. In addition, the NAIC has constructed a US group capital calculation (‘GCC’) using an RBC aggregation approach that would be used by regulators as a monitoring tool. The results of the GCC could impact the translation of RBC in the Group capital ratio for the United States; and |
¨ |
Aegon utilizes affiliated captive insurance companies to manage risks of various insurance policies issued before the adoption of principle-based reserves, including universal life with secondary guarantees and level term life insurance. These structures have been utilized to finance regulatory reserves. To the extent that state insurance regulations restrict or require insurers to restate the valuation of the assets used to finance these structures, this could increase costs or reduce available capital. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
Additional information Risk factors Aegon N.V. |
¨ |
The EUR 2 billion syndicated revolving credit facility and the USD 2 billion LOC facility have been updated in order to prepare for the cessation of the relevant benchmark rates; |
¨ |
Financial risks, arising from any changes in the valuation of financial instruments linked to benchmark rates, such as derivatives and floating rate notes, issued by, or invested in by Aegon; |
¨ |
Pricing risks, as changes to benchmark indices could impact pricing mechanisms on some funding instruments or investments; |
¨ |
Operational risks, due to the potential requirement to adapt informational technology systems, trade reporting infrastructure and operational processes; and |
¨ |
Conduct risks, relating to communication regarding potential impact on Aegon’s customers, and engagement during the transition period. |
Additional information Risk factors Aegon N.V. |
¨ |
Investor perception of Aegon as a company; |
¨ |
Actual or anticipated fluctuations in Aegon’s results of operations; |
¨ |
Announcements of intended acquisitions, disposals (and related approvals or refusals from governmental or regulatory authorities) or financings, or speculation about such acquisitions, disposals (and related approvals or refusals from governmental or regulatory authorities) or financings; |
¨ |
Changes in Aegon’s dividend policy, which may result from changes in Aegon’s cash flow and capital position; |
¨ |
Offering of additional shares by Aegon or sales of blocks of Aegon’s shares by significant shareholders, including Vereniging Aegon; |
¨ |
A downgrade or rumored downgrade of Aegon’s credit or financial strength ratings, including placement on credit watch; |
¨ |
Potential litigation or regulatory actions involving Aegon or the insurance industry in general; |
¨ |
Changes in financial estimates and recommendations by securities research analysts; |
¨ |
Fluctuations in capital markets, including foreign exchange rates, interest rates and equity markets; |
¨ |
The performance of other companies in the insurance sector; |
¨ |
Regulatory developments in the United States, the Netherlands, the United Kingdom, and other countries in which Aegon operates; |
¨ |
International political and economic conditions, including the effects of terrorist attacks, military operations and other developments stemming from such events, and the uncertainty related to these developments; |
¨ |
News or analyst reports related to markets or industries in which Aegon operates; and |
¨ |
General insurance market conditions. |
Additional information Risk factors Aegon N.V. |
Additional information Compliance with regulations |
Additional information Property, plant and equipment |
Additional information Compliance with regulations |
2021 |
2020 | 2019 | ||||||||||
| Americas |
7,675 | 7,960 | 8,570 | |||||||||
| The Netherlands |
3,855 | 3,930 | 3,998 | |||||||||
| United Kingdom |
2,476 | 2,307 | 2,261 | |||||||||
| International |
6,590 | 6,598 | 7,393 | |||||||||
| Asset Management |
1,675 | 1,527 | 1,535 | |||||||||
22,271 |
22,322 |
23,757 |
||||||||||
| Of which Aegon’s share of employees in joint ventures and associates |
4,228 | 4,193 | 5,162 | |||||||||
Additional information Dividend policy |
Additional information The offer and listing |
Additional information Memorandum and Articles of Association |
¨ |
The objects of Aegon are to incorporate, acquire and alienate shares and interests in, to finance and grant security for commitments of, to enter into general business relationships with, and to manage and grant services to legal entities and other entities, in particular those involved in the insurance business, and to do all that is connected therewith or which may be conducive thereto, all to be interpreted in the broadest sense; and |
¨ |
In achieving the aforesaid objects due regard shall be taken, within the scope of sound business operations, to provide fair safeguards for the interests of all the parties directly or indirectly involved in Aegon. |
¨ |
All shares are in registered form; |
¨ |
All shares have dividend rights except for those shares (if any) held by Aegon as treasury stock. Dividends which have not been claimed within five years lapse to Aegon; |
¨ |
Each currently outstanding share is entitled to one vote except for shares held by Aegon as treasury stock. There are no upward restrictions; |
¨ |
However, under normal circumstances, i.e. except in the event of a Special Cause, based on the Voting Rights Agreement, Vereniging Aegon will not be able to exercise more votes than is proportionate to the financial rights represented by its shares. This means that in the absence of a Special Cause, Vereniging Aegon may cast one vote for every common share it holds and one vote only for every 40 common shares B it holds. As Special Cause qualifies the acquisition of a 15% interest in Aegon N.V., a tender offer for Aegon N.V. shares or a proposed business combination by any person or group of persons, whether individually or as a group, other than in a transaction approved by the Executive Board and the Supervisory Board. If, in its sole discretion, Vereniging Aegon determines that a Special Cause has occurred, Vereniging Aegon will notify the General Meeting of Shareholders and retain its right to exercise the full voting power of one vote per common share B for a limited period of six months; |
¨ |
All shares have the right to participate in Aegon’s net profits. Net profit is the amount of profits after contributions, if any, to a reserve account; |
¨ |
In the event of liquidation, all shares have the right to participate in any remaining balance after settlement of all debts; |
¨ |
The General Meeting of Shareholders may, at the proposal of the Executive Board, as approved by the Supervisory Board, resolve to reduce the outstanding capital either by (i) repurchasing shares and subsequently canceling them, or (ii) by reducing their nominal share value; |
¨ |
There are no sinking fund provisions; |
¨ |
All issued shares are fully paid-up; so, there is no liability for further capital calls; and |
¨ |
There are no provisions discriminating against any existing or prospective holder of shares as a result of such shareholder owning a substantial number of shares. |
¨ |
The common shares are listed; the common shares B are not listed; |
¨ |
The financial rights attaching to a common share B are one-fortieth (1/40th) of the financial rights attaching to a common share; and |
¨ |
A repayment on common shares B needs approval of the holders of common shares B. |
¨ |
A transfer of common shares B requires approval of the Supervisory Board of Aegon N.V.. |
Additional information Memorandum and Articles of Association |
Additional information Differences between Dutch and US company laws |
Additional information Material contracts |
Additional information United States tax consequences to holders of shares |
¨ |
Financial institutions; |
¨ |
Insurance companies; |
¨ |
Dealers or traders in securities or currencies; |
¨ |
Tax-exempt entities; |
¨ |
Regulated investment companies; |
¨ |
Persons that at any time hold the common shares as part of a ’hedging’ or ‘conversion’ transaction or as a position in a ’straddle’ or as part of a ’synthetic security’ or other integrated transaction for US Federal income tax purposes; |
¨ |
US expatriates and former citizens or former residents of the United States; |
¨ |
Persons subject to special tax accounting rules as a result of any item of gross income with respect to the stock being taken into account in an applicable financial statement; |
¨ |
Holders that own (or are deemed to own for US Federal income tax purposes) 10% or more of the voting shares of Aegon; |
¨ |
Partnerships, or arrangements treated as partnerships for US tax purposes, or pass-through entities or persons who hold common shares through partnerships or other pass-through entities; and |
¨ |
Holders that have a ’functional currency’ other than the US dollar. |
¨ |
A citizen or individual resident of the United States; |
¨ |
A corporation created or organized in or under the laws of the United States or any state of the United States (including the District of Columbia); |
¨ |
An estate, the income of which is subject to US Federal income taxation regardless of its source; |
¨ |
A trust, if a court within the United States is able to exercise primary supervision over its administration and one or more US persons have the authority to control all of the substantial decisions of such trust. |
¨ |
Direct or indirect distributions of profit, regardless of their name or form. |
¨ |
Liquidation proceeds, proceeds on redemption of Aegon common shares and, as a rule, the consideration for the repurchase of its own common shares by Aegon in excess of the average paid-in capital recognized for Dutch dividend withholding tax purposes, unless a particular statutory exemption applies. |
Additional information United States tax consequences to holders of shares |
¨ |
The nominal value of new common shares issued to a holder of Aegon common shares or an increase of the nominal value of Aegon common shares, except insofar as the (increase in the) nominal value of Aegon common shares is funded out of its paid-in capital as recognized for Dutch dividend withholding tax purposes. |
¨ |
Partial repayments of paid-in capital recognized for Dutch dividend withholding tax purposes, if and to the extent there are qualifying profits (zuivere winst), unless Aegon’s General Meeting of Shareholders has resolved in advance to make such repayment and provided that the nominal value of Aegon common shares concerned has been reduced by an equal amount by way of an amendment of the Articles of Association. The term ‘qualifying profits’ includes anticipated profits that have yet to be realized. |
¨ |
That the proceeds have in whole or in part accumulated, directly or indirectly, to a person or legal entity that would: (i) as opposed to the recipient paying the consideration, not be entitled to an exemption from dividend withholding tax; or (ii) in comparison to the recipient paying the consideration, to a lesser extent be entitled to a reduction or refund of dividend withholding tax; and |
¨ |
That such person or legal entity has, directly or indirectly, retained or acquired an interest in Aegon common shares or in profit sharing certificates or loans, comparable to the interest it had in similar instruments prior to the series of transactions being initiated. |
Additional information United States tax consequences to holders of shares |
Additional information United States tax consequences to holders of shares |
Additional information Principal accountant fees and services |
in EUR million |
2021 |
2020 | ||||||
| Audit |
31 | 34 | ||||||
| Audit-related |
3 | 5 | ||||||
| Tax |
- | - | ||||||
| Other |
- | - | ||||||
35 |
40 |
|||||||
¨ |
May be pre-approved by the Audit Committee without consideration of specific case-by-case services (general pre-approval); or |
¨ |
Require the specific pre-approval of the Audit Committee (specific pre-approval). Appendices to the Pre-approval Policy (that are adopted each year) set out the audit, audit-related, tax and other services that have received general pre-approval of the Audit Committee. All other audit, audit-related, tax and other services must receive specific pre-approval from the Audit Committee. |
Additional information Purchases of equity securities by the issuer and affiliated purchasers |
Period |
Total number of shares purchased 1) |
Average price paid per share in EUR |
Total number of shares purchased as part of publicly announced plans or programs |
Maximum number of shares that may yet be purchased under the plans or programs at end of month |
||||||||||||
| January 1 - 31, 2021 |
- | - | - | - | ||||||||||||
| February 1 - 28, 2021 |
- | - | - | - | ||||||||||||
| March 1 - 31, 2021 |
- | - | - | - | ||||||||||||
| April 1 - 30, 2021 |
- | - | - | - | ||||||||||||
| May 1 - 31, 2021 |
- | - | - | - | ||||||||||||
| June 1 - 30, 2021 |
- | - | - | - | ||||||||||||
| July 1 - 31, 2021 2) |
20,989,001 | 3.52 | 20,989,001 | 35,933,035 | ||||||||||||
| August 1 - 31, 2021 |
14,944,034 | 3.96 | 14,944,034 | - | ||||||||||||
| September 1 - 30, 2021 3) |
- | - | - | 21,531,927 | ||||||||||||
| October 1 - 31, 2021 |
21,531,927 | 4.46 | 21,531,927 | - | ||||||||||||
| November 1 - 30, 2021 |
- | - | - | - | ||||||||||||
| December 1 - 31, 2021 |
- | - | - | - | ||||||||||||
| Total |
57,464,962 |
57,464,962 |
||||||||||||||
1 |
The shares have been purchased as part of a share purchase program, to neutralize the dilution effect of issued stock dividends and agent-related incentive programs. Excluding Aegon shares purchased by index funds controlled by Aegon. Such purchases are made to the extent necessary to maintain a basket of securities within the relevant fund reflecting the underlying index. Please refere to note 20 ‘Dividend per common share’ and to the section ‘Major shareholders’ in the ‘Other information’. |
2 |
Share purchase program to neutralize impact of 2020 final stock dividend and share based-variable compensation plans announced on July 7, 2021. Between July 8, 2021 and August 20, 2021 common shares for an amount of EUR 133 million were repurchased. A total of 35,933,035 common shares were repurchased, at an average price of EUR 3.7013 per share. |
3 |
Share purchase program to neutralize impact of 2021 interim stock dividend announced on September 17, 2021. Between October 1, 2021 and October 26, 2021 common shares for an amount of EUR 96 million were repurchased. A total of 21,531,927 common shares were repurchased at an average price of EUR 4.46 per share. |
Basis of preparation |
Basis of preparation |
| Indicator topics by stakeholder |
Operating segment | |||||||||||
| Customers |
||||||||||||
| Number of customers |
● |
● |
● |
● |
● |
– | ||||||
| Customer satisfaction |
● |
● |
● |
¡ |
– |
– | ||||||
| Complaints |
● |
● |
● |
● |
– |
– | ||||||
| Fines and settlements |
● |
● |
● |
● |
● |
● | ||||||
| Claims, benefits and plan withdrawals |
● |
● |
● |
● |
● |
– | ||||||
| Employees |
||||||||||||
| Workforce |
● |
● |
● |
● |
● |
● | ||||||
| Inclusion and diversity |
● |
● |
● |
● |
● |
● | ||||||
| Recruitment and retention |
● |
● |
● |
● |
● |
● | ||||||
| Health and safety |
● |
● |
● |
● |
● |
● | ||||||
| Training and development |
● |
● |
● |
● |
● |
● | ||||||
| Employee engagement |
● |
● |
● |
● |
● |
● | ||||||
| Remuneration |
● |
● |
● |
● |
● |
● | ||||||
| Business partners |
||||||||||||
| Brokers and intermediaries |
● |
● |
● |
● |
● |
– | ||||||
| Reinsurers |
● |
● |
● |
● |
● |
– | ||||||
| Goods and services |
● |
● |
● |
¡ |
● |
● | ||||||
| Investors |
||||||||||||
| Corporate governance |
● |
● |
● |
● |
● |
● | ||||||
| Financial returns |
¡ |
¡ |
¡ |
¡ |
¡ |
● | ||||||
| Society |
||||||||||||
| Responsible investment |
● |
● |
● |
● |
● |
● | ||||||
| Investment footprint |
● |
● |
● |
● |
● |
– | ||||||
| Tax transparency |
● |
● |
● |
● |
● |
● | ||||||
| Community investment |
● |
● |
● |
● |
● |
● | ||||||
| Compliance |
● |
● |
● |
● |
● |
● | ||||||
| Operational footprint |
● |
● |
● |
● |
● |
● | ||||||
● |
reported |
¡ |
not reported |
– |
not applicable |
Integration and monitoring |
Key performance indicators |
Stakeholder group supported |
Description and purpose | ||
| Customer Satisfaction 1) |
Customers |
To ensure customer satisfaction in each of our core markets (measured in NPS) is in line with or above the average of those of our peers. | ||
Employee Engagement 2) |
Employees | To ensure a 70% employee engagement score for 2022, measured through our Global Employee Survey. | ||
Gender Diversity 3) |
Employees | To ensure 36% female representation amongst our senior management for 2022. | ||
Net-Zero Emissions4) |
Society | To ensure at least 25% reduction in weighted average carbon intensity of our corporate fixed income and listed equity investments by 2025. | ||
| 1 | Customer satisfaction is measured in benchmarked Net Promoter Score (SM) (NPS® ), and is based on the question: ‘How likely are you to recommend Aegon/Transamerica to a friend or colleague?” It is a single, easy-to-understand 0-10 scale, where those answering 9 or 10 are deemed ‘promoters’, those answering 7 or 8 are ‘passive’, and 6 to 0 are ‘detractors’. NPS is calculated by subtracting the percentage of detractors from the percentage of promoters. On an annual basis, we measure the NPS of our core markets (the Netherlands, the United Kingdom, and the United States) and compare findings against peers in each local market. To achieve this, each core market worked with local research experts who specialize in NPS benchmarking: |
¨ |
NL: In partnership with Ipsos, the aggregated gap to market average score has been calculated as a weighted average of the gaps to market average of the various lines of business in active markets in the Netherlands. Weights are based on the number of contracts in each business line. |
¨ |
UK: In partnership with Respondi, the required market sample size was obtained from a group of panel participants. The Aegon score was taken from Aegon UK’s own NPS survey using the same questionnaire. The gap to market score is calculated as the difference between the Aegon NPS and the average NPS of all active brands in the market as established by the external research partner. |
¨ |
US: In partnership with Qualtrics, the required sample size was collected through an external consumer panel for both the Life and Retirement businesses. The aggregated gap to market average is calculated by weighting the gaps to market average for Life and Retirement. Weights are based on the number of contracts for each product. |
¨ |
In the Netherlands, the competitive set used per line of business for the survey consisted of 25 brands (life), 37 brands (pension schemes), 22 brands (savings), 30 brands (P&C), 27 brands (mortgages) |
¨ |
In the UK, the competitive set used for the survey consisted of 10 brands (pension providing peers) |
¨ |
In the United States the competitive set per line of business used for the survey consisted of 25 brands (life) and 19 brands (retirement) |
| 2 | Employee engagement is measured on a five-point scale (strongly disagree to strongly agree), and it is the average score of four statements: |
¨ |
“The company motivates me to go beyond expectations” |
¨ |
“I am proud to work for this company” |
¨ |
“I see myself still working at this company in two years’ time” |
¨ |
“I would recommend this company as a great place to work” |
| 3 | In this context, senior management includes our Management Board and extends up to two levels below the Management Board (depending on the number of employees in each business or country unit). |
| 4 | Aegon will set targets on its General Account investments in line with membership requirements of the Net-Zero Asset Owner Alliance, following five-year increments of increasing ambition toward achieving net-zero greenhouse gas emissions by 2050. For details on the methodology used, please see our TCFD disclosure (Methodology) on page 378. |
| |
Integration and monitoring |
Topics |
Policy / Statement |
Indicators (used to monitor compliance and/or outcomes) |
Outcome / Performance 2021 | |||
| Business conduct and ethics |
Code of Conduct |
|||||
| Externally published document prescribing a mandatory set of conditions for how Aegon employees should conduct business, comply with all applicable laws and regulations, and exercise sound judgment in reaching ethical business decisions in the long-term interests of our stakeholders. Training on the Code of Conduct is mandatory for all employees). Aegon also has the Speak Up program, allowing employees and third parties to report suspected illegal or unethical behavior in confidence. |
● • Total number of incidents of fraud involving employees, intermediaries, and third parties • ● Significant fines (in excess of EUR 100,000) to address cases of mis-selling.● Proportion of employees completing mandatory training on the Code of Conduct. |
● Incidents of possible fraud involving employees, intermediaries and third parties: 889 (2020: 4,014).● No significant fines were imposed (2020: EUR 8.2 million).● 98% of employees completed mandatory Code of Conduct training (2020: 97%).1) | ||||
| Anti-Bribery & Corruption |
||||||
| In addition to the Code of Conduct, Aegon has internal, globally applicable policies addressing the prevention of financial crime (fraud, money laundering, economic sanctions), including our dedicated Anti-Bribery and Corruption policy. | ● Policy attestation for Anti-Bribery and Corruption policy |
● 87% compliance with Aegon Anti-Bribery and Corruption Policy (2020: 86%).2) | ||||
| Conflict of Interest |
||||||
| In addition to the Code of Conduct, Aegon has internal, globally applicable policies addressing the prevention of financial crime (fraud, money laundering, economic sanctions), including our dedicated Conflict of Interest policy. | ● Policy attestation for Conflict of Interest policy |
● 98% compliance with Conflict of Interest Policy (2020: 86%).2) | ||||
| Community investment |
Charitable Donations Standards |
|||||
| Externally published set of standards covering Aegon’s objectives with regard to community investment, including key themes (‘financial security and education’ and ‘well-being and longevity’), selection criteria, governance and approval. The Standards also detail Aegon’s contribution to humanitarian aid. | ● Cash donations to charities and other good causes.● Allocation of more than 50% of annual cash donations to the key themes.● Employee volunteering time for to charities and other good causes.● Total value of community investment |
● Cash donations totaled EUR 9.4 million (2020: EUR 9.5 million).● Proportion of cash donations to priority areas amounted to 81% (2020: 92%).● Volunteering totaled 6,806 hours with a value of EUR 0.3 million (2020: 4,399 hours with a value of EUR 0.2 million). • ● Total value of community investment amounted to EUR 9.7 million and 0.6% of our net result (2020: EUR 9.7 million and 17.6% of our net result). | ||||
| 1 | A rate of (mandatory) completion less than 100% reflects new hires and legitimate circumstances where employees have not yet been through the annual cycle. |
| 2 | Prior to 2021, compliance with Aegon anti-bribery and corruption policies was expressed as combined metric of the separate Aegon Conflict of Interest and Aegon Gift & Entertainment policies. The latter has since been incorporated into a new unified Aegon Anti-bribery and Corruption policy. As such, there is not a complete like-for-like like-for-like |
Integration and monitoring |
Topics |
Policy / Statement |
Indicators (used to monitor compliance and/or outcomes) |
Outcome /Performance 2021 | |||
Data protection |
Global Information Security Policy |
|||||
| Internal policy overseen by the Global Chief Information Security Officer, setting out the company’s approach to cyberthreats and data protection. The policy applies to all Aegon businesses worldwide (including all units, entities or joint ventures where Aegon has operational control) and is supported by mandatory training in data and cyber security. | ● Maintenance of an internal IT Control Framework, and action items to address gaps in performance are documented and monitored. • ● The internal IT Control Framework is regularly mapped and updated to embed new and updated market standards.● Periodic attestation to the internal IT Control Framework, with certain exceptions as applicable by country unit, for among other reasons adequate implementation timelines. |
● Institutions such as Aegon will continue to remain subject to information security attacks. To Aegon’s knowledge, the cyber-security attacks and events it experienced in 2021 were not material in nature. | ||||
Inclusion and Diversity |
Statement on Inclusion & Diversity Externally published statement setting out Aegon’s approach to inclusion and diversity to creating an environment where our employees can bring their authentic selves to work. The statement incorporates our commitment to enabling this through our actions and inclusive policies. The statement applies to all Aegon businesses worldwide. Aegon UK also publishes its annual Gender Pay Gap Report |
● Balanced representation of women in senior management. • ● Balanced representation of women across Aegon’s workforce.● Employee perception of key themes from the Statement are also tracked in the Global Employee Survey. |
● Against a target of 34% for 2021, women accounted for 34% of Aegon’s senior management (2020: 32%) • ● Women accounted for 50% of Aegon’s workforce (2020: 50%) • ● New benchmark set in 2021, based on updated question sets in the Survey. On ‘Openness & Inclusion’ 74% of participants scored favorably, and on ‘Diversity & Equity’ 72% of particpants scored favorably. | |||
Environment |
Environmental Policy Externally published policy outlining how Aegon seeks to minimize the negative impacts of its direct business operations on the environment whilst maximizing opportunities for performance improvement. 1) |
● Commits Aegon to using renewable or sustainable sources of energy where possible. |
● Fuel (gas) consumption: 27,288 MWh (2019: 30,002 MWh)● Electricity consumption: 49,863 MWh (2019: 83,249 MWh)● Proportion of renewable electricity consumption: 99% (2019: 98%)● Renewable electricity generated on-site 24 MWh (2019: 28 MWh)● Renewable energy as a proportion of total energy consumption: 64% (2019: 72%) | |||
| ● Commits Aegon to assessing the impact of air travel. |
● Total distance traveled: 16,3 million km (2019: 103.4 million km)● Travel class as proportion of total distance: Economy 87%, Premium 13%● Route type as proportion of total distance: <500km 3%, >500km 97% | |||||
| ● Commits Aegon, to annually reporting environmental impacts and activities and monitoring progress against targets. |
● Total (gross / location-based) GHG emissions 24,024 metric tons (2019: 52,536 metric tons).● Reduction in total (gross / location-based) GHG emissions on 2019 target baseline: 54% | |||||
| 1 | In line with the net-zero commitment announced in November 2021, Aegon has set a supporting GHG reduction target to reduce the carbon footprint of its operational activities by 25% by 2025. While some of these reductions can be traced to our initiatives to stimulate hybrid working – there has also been a temporary benefit from fewer employees in the office due to the COVID-19 pandemic, which we expect to reverse over time. |
| |
Integration and monitoring |
Topics |
Policy / Statement |
Indicators (used to monitor compliance and/or outcomes) |
Outcome /Performance 2021 | |||
Human rights |
Statement on Human Rights ● Externally published statement designed to frame Aegon’s ongoing stewardship of human rights, including both the direct impacts of our daily operations as well as the indirect impacts of our business activities. Based on the UN Declaration of Human Rights, core standards of the International Labor Organization (ILO), and the principles of the UN Global Compact. The statement commits Aegon to upholding international human rights standards at all businesses where the company has sufficient management control and, where possible, to ensure partners uphold the same standards.● Consideration for human rights is built into Aegon’s Responsible Investment Policy, Vendor Code of Conduct and Statement on Inclusion & Diversity. Other company policies also cover aspects of human rights, including:- Code of Conduct - Speak Up - Anti-bribery and corruption - Conflict of Interest - Employment Screening - Anti-money laundering - Sanctions - Anti-fraud - Distribution Risk management - Third Party Risk management • ● Aegon UK also issues a modern slavery statement (in line with the UK government’s 2015 Modern Slavery Act) |
● Results of Aegon’s biennial global Human Rights Risk Assessment (conducted internally and based on external sources1) . The assessment scores Aegon’s countries against a combination of 10 publicly available indicators:- Civil and political rights - Corruption - Human development - Health coverage - Business environment - Illicit economy - Gender development - Working conditions - Rule of law - Internet inclusion |
● Our most recent assessment (2020) identified four ‘Aegon’ countries where the operating environment presents a meaningful human rights risk:- China - India - Indonesia - Turkey ● These risks relate essentially to outside political factors. In the United States, the Netherlands and the United Kingdom, Aegon faces little or no significant human rights risk. In Central and Eastern Europe, the environment is potentially more difficult, particularly with regard to corruption. In the Americas, risk is concentrated in Brazil. Again, this relates mainly to corruption.● • For those countries with the highest risk, Aegon has recommended preventative or remedial measures for local management2) focusing on indicators where Aegon has the greatest potential to minimize the human rights faced by the company. The aim of these measures is to ensure Aegon’s overall human rights risk remains low. | |||
Investment |
Responsible Investment Policy |
|||||
| Externally published policy acting as the basis for how our assets should be managed consistently with our responsible business objectives and relevant laws and governance standards. It is applicable to all of our proprietary assets globally, regardless of country of operation or whether they are managed by Aegon business units or externally. Local business units within Aegon may implement additional mechanisms to further identify, manage and mitigate ESG risks, within the context of local norms and stakeholder expectations. The policy covers all major asset classes and sets out minimum social and environmental standards for Aegon’s investments that incorporates exclusions in areas including controversial weapons, tobacco, Arctic or oil sands production and transportation and thermal coal. |
● Total investments in responsible investment solutions (RIS) |
● Our responsible investment solutions totaled EUR 177.7 billion at the end of 2021• | ||||
| ● Companies engaged with as part of Aegon’s approach to responsible investment |
● In 2021, 38% of our engagements addressed corporate governance matters, including corruption, remuneration, and board structure. Social issues addressed included health and well-being (opioids, drug price increases and meat sourcing), and human rights (UN Global Compact principles 1 & 2). Climate change (GHG emission reduction) and pollution were topics most commonly discussed in engagements concerning the environment. Of our engagements related to social themes, 27% of those were related to human rights issues. | |||||
| The policy also incorporates a commitment to net-zero emissions, to ensure the reduction in the weighted average carbon intensity of the company’s investment portfolio is aligned with its net-zero ambitions. |
● Weighted average carbon intensity of the company’s investment portfolio |
● In 2021, the weighted average carbon intensity of our corporate fixed income and listed equity investments remained flat at 490 metric tons CO2 e/EURm revenue), no changenet-zero commitment. | ||||
| 1 | The methodology for Aegon’s Human Rights Risk Assessment is derived from the UN Declaration of Human Rights. The assessment uses publicly available data from 10 non-governmental organizations specializing in human rights and which have a reputation for conducting fair and appropriate assessments. These organizations include Freedom House, Transparency International, UN Development Program, the World Bank and the World Health Organization. |
| 2 | These remedial measures include effective access to Speak Up, raising employees’ awareness of human rights risk, ensuring basic healthcare and financial services for employees, suggesting alternative employee representation where there is no independent trade union, ensuring neutrality at times of regime change and enforcing a zero tolerance approach to corruption and discrimination in the workplace. |
Integration and monitoring |
Topics |
Policy / Statement |
Indicators (used to monitor compliance and/or outcomes) |
Outcome / Performance 2021 | |||
| Procurement |
Vendor Code of Conduct The externally published Vendor Code of Conduct contains the standards for the business relationship between Aegon and its vendors in order to enable Aegon manage the most material business conduct, social and environmental risks (also referred to as sustainability risks) associated with its procurement of goods and services. The code sets the standards for the business relationship between Aegon and its vendors to enable Aegon to manage the most material environ-ment, social and governance (ESG) risks associated with our procurement of goods and services under the following categories: - Corporate governance - Human rights - Labor rights and good health and well-being - Climate change and biodiversity Aegon requires its vendors to comply with the Code and assesses the ESG-related performance of those vendors against its standards. |
● Top 250 suppliers by spend (in-scope suppliers) scored for ESG performance through the EcoVadis rating platform. |
● Spend with ‘in-scope’ suppliers comprised 86% of overall procurement spend in 2021 (2020:85%) • ● By the end of 2021, 59% of Aegon’s ‘in-scope’ spend had been assessed for ESG performance through the implementation of the EcoVadis rating platform (2020:56%) | |||
| Occupational health and safety |
Global Health & Safety Statement Externally published statement committing Aegon to provide and maintain high health and safety standards across all its business units worldwide, outlining our objectives and expectations. |
● Aim to limit absentee rate to an absolute minimum. |
● Employee absenteeism: 1.7% (2020: 1.7%) | |||
| Product development |
Pricing and Product Development Policy Internal policy setting out market conduct principles, aimed at ensuring fair treatment of customers and reasonable distribution of returns between customers, intermediaries and shareholders. |
● Policy attestation for terms of Pricing and Product Development Policy |
● 97% compliance with Pricing and Product Development Policy (2020: 93%) | |||
Remuneration |
Global Remuneration Framework Internal framework, detailing the company’s approach to pay. The Framework is based on the principle of pay for performance, setting down the principles of governance covering both fixed and variable pay. On variable pay, remuneration for Aegon executives and other senior management is based on both financial and non-financial performance metrics (including employee engagement and customer loyalty scores). |
● Policy attestation for terms of the Global Remuneration Framework |
● 95% compliance with requirements of the Global Remuneration Framework (2020: 95%)1) | |||
Tax |
Global Tax Policy and Principles of Conduct Externally published policy outlining Aegon’s approach to responsible taxpaying, which seeks to align the long-term interests of all our stakeholders, including customers, employees, business partners, investors, and wider society. Aegon seeks to pay ‘fair taxes’, which means paying the right amount of tax in the right places. |
● Applying global tax reporting standards that support public disclosure of the company’s tax policies and tax contributions on a country-by-country |
● Annual Aegon Global Tax Report2) • ● Total taxes borne by Aegon:EUR381 million (2020:EUR 319 million) • ● Taxes collected on behalf of others:EUR2.41 billion (2020:EUR 2.51 billion) | |||
| 1 | The assessment of compliance against the Global Remuneration Framework was limited to our largest business units only (Aegon NL, Aegon UK and Transamerica). |
| 2 | Developed in accordance with the GRI 207: Tax standard of GRI Sustainability Reporting Standards, and which provides Aegon’s tax contributions on a country-by-country |
Regulation |
Regulation |
Regulation |
| EU Non-Financial Reporting Directive(NFRD) requirement 1) |
Reference (IAR 2021) |
Equivalent requirement under Dutch law 2) | ||
| Brief description of company’s business model |
Our strategy and value creation (pages 16-34) Value creation (pages 24-25) |
Decree non-financial information (article 3.1.a) | ||
| Description of the policies relating to environmental |
Sustainability (page 20-23) Table under ‘Policies and Procedures’ (pages 353-356) |
|||
| The outcome of these policies |
Sustainability (pages 20-23) Sharing value with our stakeholders (pages 26-32) Table under ‘Policies and Procedures’ (pages 353-356) Tables under ‘Value Created’: Business partners/Goods and services, (page 386) Society/ Investment footprint, and Operational footprint (pages 388-392) |
Decree non-financial information(article 3.1.b) | ||
| Description of the policies relating to social and employee |
Sustainability (pages 20-23) Table under ‘Policies and Procedures’ (pages 353-356) |
|||
| The outcome of these policies |
Sustainability (pages 20-23) Sharing value with our stakeholders (pages 26-32) Table under ‘Policies and Procedures’ (pages 353-356) Tables under ‘Value Created’: Employees/Inclusion and diversity, Recruitment and retention, Health and safety, Training and development and Engagement (pages 383-385) Business partners/Goods and services (page 386) Society/Responsible investment, Tax transparency, Community investment (pages 388-392) |
Decree non-financial information(article 3.1.b) | ||
| Description of policies relating to respect for human rights |
Sustainability (pages 20-23) Table under ‘Policies and Procedures’ (pages 353-356) |
|||
| The outcome of these policies |
Table under ‘Policies and Procedures’ (pages 20-23) Sharing value with our stakeholders (pages 26-32) Tables under ‘Value Created’: Employees/Inclusion and diversity, Health and safety, and Engagement (pages 383-385) Business partners/Goods and services (page 386) Society/Responsible investment (pages 388-392) |
Decree non-financial information(article 3.1.b) | ||
| Description of policies relating to anti-corruption and bribery |
Code of Conduct (page 88) Table under ‘Policies and Procedures’ (pages 353-356) |
Decree non-financial information(article 3.1.b) | ||
| The outcome of these policies |
Sharing value with our stakeholders (pages 26-32) Table under ‘Policies and Procedures’ (pages 353-356) Tables under ‘Value Created’: Business partners/Goods and services (page 386) Society/Responsible investment, and Compliance (pages 388-392) |
Decree non-financial information(article 3.1.b) | ||
| Description of the principal risks with regard to environmental, social and employee matters, respect for human rights, and the fight against corruption and bribery; and, how these risks are managed |
Our business environment (pages 8-13) Our purpose (pages 14-15) Our strategy and value creation (pages 16-34) Business environment scan (page 10) Risk management (pages 73-77) Risk factors Aegon N.V. (pages 326-348) Task Force on Climate-related Disclosures (pages 372-378) |
Decree non-financial information(article 3.1.c) | ||
| Non-financial key performance indicators relating to environmental, social and employee matters, respect for human rights, and the fight against corruption and bribery |
Performance in 2021 (pages 33-34) Sharing value with our stakeholders (pages 26-32) Table under ‘Policies and Procedures’ (pages 353-356) Tables under ‘Value Created’: Employees/Inclusion and diversity, Recruitment and retention, Health and safety, Training and development, and Engagement (pages 383-385) Business partners/Goods and services (page 386) Society/Responsible investment, Investment footprint, Tax transparency, Community investment, Compliance, and Operational footprint (pages 388-392) |
Decree non-financial information(article 3.1.d) | ||
| Diversity of the Management Board and Supervisory Board |
Diversity section of Aegon’s Corporate Governance Statement Tables under ‘Value Created’: Employees/Inclusion and diversity (pages 383-385) Investors/Corporate Governance (page 387) |
Decree content of the management report (article 3a) |
| 1 | As included in the EU Accounting Directive |
| 2 | The EU Non-Financial Reporting Directive was transposed into Dutch law through two decrees relating respectively to non-financial information and diversity policy (Besluit bekendmaking niet-financiële informatie/Besluit Bekendmaking diversiteitsbeleid Besluit tot vaststelling nadere voorschriften omtrent de inhoud van het jaarverslag |
Regulation |
¨ |
Substantially contributing to one of the six EU environmental objectives: |
¨ |
Doing no harm to any of the other objectives, and |
¨ |
Meeting minimum safeguards, including OECD Guidelines for Multinational Enterprises and the UN Guiding Principles on Business and Human Rights |
Regulation |
Regulation |
EU Taxonomy underwriting |
Eligibility based on actual information (mandatory disclosure) |
|||||||
| Absolute premium (EUR million) |
% of non-life premium |
|||||||
| Eligible non-life activities |
270 | 13% | ||||||
| - Of which reinsured |
13 | |||||||
| Taxonomy-non-eligible |
1,774 | 87% | ||||||
| Total premium non-life |
2,044 |
|||||||
EU Taxonomy investment (on-balance) |
Eligibility based on actual information (mandatory disclosure) |
Eligibility including estimates (mandatory and voluntary disclosure) | ||||||
Absolute value (EUR million) |
Percentage of investments covered |
Absolute value (EUR million) |
Percentage of investments covered | |||||
| Eligible investments (numerator) |
44,015 | 11% 1) |
59,471 | 15% | ||||
| - Of which General Account investments |
43,267 | 55,898 | ||||||
| - Of which Investments for account |
563 | 3,388 | ||||||
| of policyholders |
||||||||
| - Of which real estate for own use |
185 | 185 | ||||||
| Non-eligible investments (numerator) |
320,555 | 83% | 305,099 | 79% | ||||
| Excluded from numerator only: |
8,827 | 2% | 8,827 | 2% | ||||
| exposures to derivatives |
||||||||
| Excluded from numerator only: |
11,304 | 3% | 11,304 | 3% | ||||
| exposures to undertakings that are not obliged to publish non-financial information pursuant to Article 19a or 29a of Directive 2013/34/EU and data is not available |
||||||||
| Total investments covered (denominator) |
384,701 |
384,701 |
||||||
| Excluded from numerator and denominator: exposures to central governments, central banks and supranational issuers | 33,727 | 33,727 | ||||||
| Total investments in scope |
418,428 |
418,428 |
||||||
| Which includes: |
||||||||
| - Investments General Account |
158,463 | 158,463 | ||||||
| - Investments for account |
250,953 | 250,953 | ||||||
| of policyholders |
||||||||
| - Derivatives |
8,827 | 8,827 | ||||||
| - Real estate for own use |
185 | 185 | ||||||
| |
Regulation |
| Breakdown of eligible investments |
Eligibility per investment class covered |
Eligibility determined based on actual information (part of mandatory disclosure) |
Eligibility determined based on estimates (part of voluntary disclosure) | |||||||||||||
| Eligible (absolute value) (EUR million) |
Total value of investment class covered (EUR million) |
Percentage of investment class covered |
||||||||||||||
| General Account investments in scope: |
||||||||||||||||
| - Shares |
71 | 644 | 11% | No | Yes | |||||||||||
| - Debt securities |
10,595 | 62,956 | 17% | No | Yes | |||||||||||
| - Mortgage loans |
40,624 | 40,624 | 100% | Yes | No | |||||||||||
| - Private loans |
1,910 | 4,886 | 39% | No | Yes | |||||||||||
| - Policy loans |
- | 1,893 | 0% | No | Yes | |||||||||||
| - Real estate |
2,643 | 2,643 | 100% | Yes | No | |||||||||||
| - Other 1) |
55 | 5,681 | 1% | No | Yes | |||||||||||
| Total eligible General Account investments (numerator) |
55,898 |
119,326 |
47% |
|||||||||||||
| Investments for account of policyholders in scope: |
||||||||||||||||
| - Shares |
2,155 | 15,604 | 14% | No | Yes | |||||||||||
| - Debt securities |
581 | 6,098 | 10% | No | Yes | |||||||||||
| - Unconsolidated |
89 | 208,976 | 0% | No | Yes | |||||||||||
| investment funds |
||||||||||||||||
| - Real estate |
563 | 563 | 100% | Yes | No | |||||||||||
| - Other 1) |
- | 6,344 | 0% | No | Yes | |||||||||||
| Total eligible investments for account of policyholders (numerator) |
3,388 |
237,586 |
1% |
|||||||||||||
| Total eligible Real estate assets for own use (numerator) |
185 |
185 |
100% |
Yes |
No | |||||||||||
| 1 | Mainly includes deposits with financial institutions and money market funds which do not qualify for eligibility. |
Frameworks and initiatives |
| Disclosure |
Topic |
Page reference 2) (or details of omissions if applicable) | ||
Guiding principles |
Strategic focus and future orientation | Our business environment (pages 8-13) | ||
| Our purpose (pages 14-15) | ||||
| Our strategy and value creation (pages 16-34) | ||||
| Sustainability (pages 20-23) | ||||
| Connectivity of information |
The topics mentioned in Our busines environment (pages 8-13) and Business Environment Scan (page 12) are linked to risks and opportunities, which are considered for Our strategy and value creation (page 18) | |||
| Stakeholder relationships |
Sharing value with our stakeholders (pages 26-32) | |||
| Materiality |
Basis of preparation (pages 350-351) | |||
| Conciseness |
Pages 1-34 are structured around our material topics, risks, opportunities and strategy, as well as the performance and value associated with these. We have also applied the materiality principle to define the content of this IAR (pages 350-351) | |||
| Reliability and completeness |
Basis of preparation (pages 350-351) | |||
| Consistency and comparability |
This Integrated Annual Report (IAR) is prepared in accordance with the International Financial Reporting Standards (IFRS), as adopted by the European Union, as well as the Integrated Reporting Framework (<IR> Framework) of the International Integrated Reporting Council (IIRC). Aegon has used the <IR> Framework since 2014. We are making the shift to integrating more material frameworks; like that of the Task Force on Climate-related Financial Disclosures (pages 372-378). | |||
Content elements |
Organizational overview and external environment |
About Aegon (pages 2-3) | ||
| Our business environment (pages 8-13) | ||||
| Business Environment Scan (page 10) | ||||
| Governance |
Corporate governance (pages 38-41) | |||
| Business model |
Value creation (pages 24-25) | |||
| Risk and opportunities |
Our business environment (pages 8-13) | |||
| Business Environment Scan (page 10) | ||||
| Strategy and resource allocation |
Our strategy and value creation (pages 16-34) | |||
| Sharing value with our stakeholders (pages 26-32) | ||||
| Performance |
Performance in 2021 (pages 33-34) | |||
| Value created (pages 24-25) | ||||
| Outlook |
Our business environment (page 8-13) | |||
| Performance in 2021 (pages 33-34) | ||||
| Basis of preparation and presentation |
Basis of preparation (pages 350-351) | |||
| 1 | In June 2021, the IIRC merged with the Sustainability Accounting Standards Board (SASB) to form the Value Reporting Foundation (VRF). |
| 2 | All page numbers in this table refer to Aegon’s Integrated Annual Report 2021, unless otherwise stated. Where there are several examples, we have included principal references only. |
Frameworks and initiatives |
| UNGC Principles |
Policy and implementation | |
| Human Rights |
| |
| 1. Businesses should support and respect the protection of internationally proclaimed human rights; and |
Aegon’s Statement on Human Rights commits the company to upholding international human rights standards at all businesses where Aegon has sufficient management control and, where possible, to ensure partners live up to the same standards. Consideration for human rights is also built into Aegon’s Code of Conduct, Aegon’s Responsible Investment Policy, Vendor Code of Conduct, and Aegon’s Statement on Inclusion and Diversity. We have committed to several global initiatives to support the development of human rights, including the UN Declaration of Human Rights, the core labor and human rights standards of the International Labor Organization (ILO) and UNEP-FI’s Principles for Sustainable Insurance (PSI). | |
| 2. make sure that they are not complicit in human rights abuses. |
Aegon’s Statement on Human Rights commits the company to upholding international human rights standards. Consideration for human rights is also built into Aegon’s Code of Conduct, Aegon’s Responsible Investment Policy, Vendor Code of Conduct and Aegon’s Statement on Inclusion and Diversity. We carry out a biennial Human Rights Risk Assessment, through which we aim to identify, prevent, and mitigate adverse human rights impacts that may be linked to our operations, products, and services. | |
| Labor |
||
| 3. Businesses should uphold the freedom of association and the effective recognition of the right to collective bargaining; |
Aegon adheres to local laws regarding the freedom of association and the right to collective bargaining. For example, freedom of association and effective recognition of the right to collective bargaining are covered under the Aegon N.V. Responsible Investment Policy and the Aegon N.V. Vendor Code of Conduct. | |
| 4. the elimination of all forms of forced and compulsory labour; |
Aegon’s Statement on Human Rights commits the company to upholding international human rights. Consideration for human rights, and more specifically those related to forced and compulsory labor, is also built into Aegon’s Responsible Investment Policy and Vendor Code of Conduct. In line with our Responsible Investment Policy and Framework, we engage with our portfolio companies on issues related to human rights, including those related to forced and compulsory labor. In line with our Vendor Code of Conduct, we score our suppliers for sustainability performance through the EcoVadis rating platform, which covers forced and compulsory labor. |
Frameworks and initiatives |
| UNGC Principles |
Policy and implementation | |
| 5. the effective abolition of child labour; and |
Aegon’s Statement on Human Rights commits us to upholding international human rights. Consideration for human rights, and more specifically those related to effective abolition of child labor, is also built into Aegon’s Responsible Investment Policy and Vendor Code of Conduct. In line with our Responsible Investment Policy and Framework, we engage with our portfolio companies on issues related to human rights, including those related to forced and compulsory labor. In line with our Vendor Code of Conduct, we score our suppliers for sustainability performance through the EcoVadis rating platform, which covers effective abolition of child labor. | |
| 6. the elimination of discrimination in respect of employment and occupation. |
Aegon’s Statement on Human Rights commits us to upholding international human rights standards. Consideration for human rights, and more specifically those related to elimination of discrimination in respect of employment and occupation, is also built into Aegon’s Code of Conduct, Aegon’s Responsible Investment Policy, Vendor Code of Conduct, and Aegon’s Statement on Inclusion and Diversity. Aegon considers certain human rights fundamental and universal for its workforce. All Aegon employees are educated on the company’s Code of Conduct and acknowledge that they will abide by these standards. In line with our Responsible Investment Policy and Framework, we engage with our portfolio companies on issues related to human rights, including those related to discrimination. Our Vendor Code of Conduct sets clear expectations for our vendors, which are subject to due diligence and monitoring procedures as per the Third Party Risk Management Policy. | |
| Environment |
||
| 7. Businesses should support a precautionary approach to environmental challenges; |
As an insurance company, Aegon can support the transition to a climate-resilient economy and a net-zero world using both sides of our balance sheet. We finance the upside through our investment activities, while helping to mitigate the downside by managing our operational carbon footprint and risk management processes, and the savings and protection solutions we provide. The influence, both positive and negative, that we can have as an investor is particularly significant, and Aegon has committed to transitioning our General Account investment portfolio to net-zero GHG emissions by 2050.As an office-based company serving the financial sector, Aegon does not operate energy and resource-intensive processes as part of its business operations, for example those typical of manufacturing industries, and is not aware of any incidents relating to these activities impacting the natural environment. Energy consumption at our office buildings makes up by far the largest portion of our energy use, followed by our data centers. Our business operations have been carbon-neutral since 2019, which has been achieved by substituting our energy consumption with renewable sources and offsetting our remaining carbon emissions. In line with the net-zero commitment announced in November 2021, Aegon has set a supporting operational greenhouse gas emission reduction target to reduce the carbon footprint of its operational activities by 25% by 2025 from a 2019 baseline. Energy consumption at our office buildings makes up by far the largest portion of our energy use, followed by our data centers. and while our own operational footprint as a business is relatively small, it is important that we set a good example. |
Frameworks and initiatives |
| UNGC Principles |
Policy and implementation | |
| 8. undertake initiatives to promote greater environmental responsibility; and |
In line with our Responsible Investment Policy, through our investments, we encourage the development and diffusion of technologies that offer solutions to environmental issues, including those which reduce GHG emissions. With our net-zero commitment, we will engage with carbon-intensive investee companies to drive real-world reductions in emissions. | |
| 9. encourage the development and diffusion of environmentally friendly technologies. |
In line with our Responsible Investment Policy, through our (impact) investments, we encourage the development and diffusion of technologies that offer solutions to environmental issues, including those which reduce GHG emissions. | |
| Anti-corruption |
||
| 10. Businesses should work against corruption in all its forms, including extortion and bribery. |
Aegon’s Code of Conduct sets out rules and guidelines that shape and govern the actions of all our employees. It also commits us to complying with all legal and regulatory requirements and to prevent insider dealing, corruption, and bribery. In addition, in line with our Responsible Investment Policy and Framework, we engage with our portfolio companies on issues related to governance, including anti-corruption. In line with our Vendor Code of Conduct, we score our suppliers for sustainability performance through the EcoVadis rating platform, which covers anti-corruption. Aegon also has several relevant internal policies: Conflict of Interest Policy, Anti-Bribery and Corruption Policy, Financial Crime and Corruption Risk Policy, Insider Dealing Policy. |
Frameworks and initiatives |
| Sustainable Development Goal |
Aegon’s contribution to relevant SDG targets in 2021 (examples) | |||||
| |
1. No poverty End poverty in all its forms everywhere |
1.4 |
By 2030, ensure that all men and women, in particular the poor and the vulnerable, have equal rights to economic resources, as well as access to basic services, ownership and control over land and other forms of property, inheritance, natural resources, appropriate new technology and financial services, including microfinance. ● Aegon UK has partnered with the Initiative for Financial Wellbeing and Edinburgh University to launch the Financial Wellbeing Index, which helps advisors and employee benefits consultants provide personalized, needs-based advice to end-customers. (Strengthening engagement and trust, page 27)● As was the case in 2020, we prioritized helping our most vulnerable communities navigate the COVID-19 pandemic and its economic consequences, with a specific focus on people who needed help handling their finances. (Investing in our communities, page 32) | |||
| 1.5 |
By 2030, build the resilience of the poor and those in vulnerable situations and reduce their exposure and vulnerability to climate-related extreme events and other economic, social and environmental shocks and disasters. ● Together with the Aegon Transamerica Foundation in the United States, Aegon donated EUR 300,000 to support COVID-19 relief efforts in India. (Society, Supporting COVID-19 relief efforts in India, page 31) | |||||
| |
2. Zero hunger To end hunger, achieve food security and improved nutrition and promote sustainable agriculture |
2.1 |
By 2030, end hunger and ensure access by all people, in particular the poor and people in vulnerable situations, including infants, to safe, nutritious and sufficient food all year round. ● Aegon UK supports five schools in Edinburgh with breakfast clubs, which provide children meals in the morning before school starts. (Aegon Integrated Annual Report 2020, A foundation for change | |||
| |
3. Good health and well-being Ensure healthy lives and promote well-being for all at all ages |
3.4 |
By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.● Aegon has developed a Future Ways of Working plan, covering most of Aegon’s global business units to help our people achieve a healthy and productive balance between office-based and remote working. The approach is based on globally agreed principles – hybrid working, office utilization and location, and employee benefits – that are translated locally. (Employees, page 27, Introducing our hybrid working model, page 28) | |||
| 3.a |
Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate. ● Aegon N.V. has excluded tobacco from its investments to help address health concerns over smoking. (Policies and procedures, Aegon N.V. Responsible Investment Policy, page 355) | |||||
| |
4. Quality education Ensure inclusive and quality education for all and promote lifelong learning |
4.6 |
By 2030, ensure that all youth and a substantial proportion of adults, both men and women, achieve literacy and numeracy. ● In 2021 Aegon contributed EUR 1.6 million towards financial education and literacy projects in the communities of our customers and employees. (Value created - Society - Corporate citizenship, page 355) | |||
| |
5. Gender equality Achieve gender equality and empower all women and girls |
5.1 |
End all forms of discrimination against all women and girls everywhere. ● Aegon N.V. has explicitly incorporated the theme of ‘Gender development’ into its biennial Human Rights Risk Assessment process. Consideration for gender equality is incorporated into numerous Aegon policies including the Code of Conduct and Aegon N.V. Responsible Investment Policy as a fundamental element of human rights. (Policies and procedures, Aegon N.V. Statement on Human Rights, Aegon N.V. Responsible Investment Policy, page 355) | |||
Frameworks and initiatives |
| Sustainable Development Goal |
Aegon’s contribution to relevant SDG targets in 2021 (examples) | |||||
| 5. Gender equality (continued) |
5.5 |
Ensure women’s full and effective participation and equal opportunities for leadership at all levels of decision-making in political, economic and public life. | ||||
| ● In June 2021, Aegon N.V. CEO Lard Friese pledged to the G20 EMPOWER (Alliance for Empowerment and Progression of Women’s Economic Representation) Initiative. (Inclusion and diversity, page 21) | ||||||
| ● Following Aegon surpassing its target for female representation in senior management in 2020 (32% representation against a 30% target), a higher target of 34% was set for 2021. Aegon reached this target by the end of the year, with 34% female representation. A renewed target of 36% has been set for 2022. Sustainability, Inclusion and diversity, page 22) | ||||||
| 5.c |
Adopt and strengthen sound policies and enforceable legislation for the promotion of gender equality and the empowerment of all women and girls at all levels. • ● Aegon UK publishes its annual gender pay gap report | |||||
| |
6. Clean water and sanitation Ensure availability and sustainable management of water and sanitation for all |
6.6 |
By 2020, protect and restore water-related ecosystems, including mountains, forests, wetlands, rivers, aquifers and lakes. • ● The Aegon N.V. Responsible Investment Policy incorporates the company position on biodiversity, which specifically covers management for availability of water resources and their pollution. Furthermore, the Aegon N.V. Vendor Code of Conduct sets the standards for the business relationship between Aegon and its vendors in order to enable Aegon manage the most material ESG risks associated with our procurement of goods and services, specifically including biodiversity. (Policies and procedures, pages 355 and 356) | |||
| |
7. Affordable and clean energy Ensure access to affordable, reliable, sustainable and modern energy for all |
7.3 |
By 2030, ensure universal access to affordable, reliable and modern energy services. • ● Aegon the Netherlands has introduced a new ‘green’ mortgage to help people finance energy-efficient home improvements. (2021 milestones, page 4, Enhancing our propositions, page 26) | |||
| |
8. Decent work and economic growth Promote sustained, inclusive and sustainable economic growth, full and productive employment and decent work for all |
8.3 |
Promote development-oriented policies that support productive activities, decent job creation, entrepreneurship, creativity and innovation, and encourage the formalization and growth of micro-, small- and medium-sized enterprises, including through access to financial services.● Knab, Aegon the Netherlands’ digital banking platform provides entrepreneurs with an extensive online library for topics related to finance and entrepreneurship through their Knab Bieb. (Strengthening engagement and trust, page 27) | |||
| 8.5 |
By 2030, achieve full and productive employment and decent work for all women and men, including for young people and persons with disabilities, and equal pay for work of equal value. ● Aegon UK publishes its annual gender pay gap report ● In the Netherlands, Aegon runs ‘Silver Starters’, a learning program for entrepreneurs aged 50 and over.(Society - Adapting to the modern retirement landscape, page 32) | |||||
| 8.7 |
Take immediate and effective measures to eradicate forced labour, end modern slavery and human trafficking and secure the prohibition and elimination of the worst forms of child labour, including recruitment and use of child soldiers, and by 2025 end child labour in all its forms. | |||||
| ● Aegon N.V. has explicitly incorporated the themes of forced and child labor into its Statement on Human Rights and biennial Human Rights Risk Assessment process. Consideration for these specific themes (and wider human rights concerns) are also incorporated into numerous Aegon policies including the Code of Conduct, Aegon N.V. Responsible Investment Policy and the Vendor Code of Conduct. (Policies and procedures, Aegon N.V. Statement on Human Rights, Aegon N.V. Responsible Investment Policy, Aegon N.V. Vendor Code of Conduct pages 353-356) | ||||||
Frameworks and initiatives |
| Sustainable Development Goal |
Aegon’s contribution to relevant SDG targets in 2021 (examples) | |||||
| |
8. Decent work and economic growth (continued) |
8.8 |
Protect labour rights and promote safe and secure working environments for all workers, including migrant workers, in particular women migrants, and those in precarious employment. ● Each year Aegon UK issues a modern slavery statement (in line with the UK government’s 2015 Modern Slavery Act). (Policies and procedures, Aegon N.V. Statement on Human Rights, page 355)● Aegon employees in the Netherlands are covered by a collective bargaining / labor agreement, which in 2021 equated to 17.3% of employees across Aegon N.V. (Value created - Employees - Representation, page 385) | |||
| 8.10 |
Strengthen the capacity of domestic financial institutions to encourage and expand access to banking, insurance and financial services for all. ● Aegon UK acquired Pension Geeks in April 2021, a business specializing in connecting people with their finances through innovative engagement techniques, communication, and events. Pension Geeks will continue to help employers to encourage their people to engage with workplace benefits programs through the customer-centric approach of the wider Aegon family. (Improving customer service, page 27) | |||||
| |
9. Industry, innovation and infrastructure Build resilient infrastructure, promote inclusive and sustainable industrialization and foster innovation |
9.4 |
By 2030, upgrade infrastructure and retrofit industries to make them sustainable, with increased resource-use efficiency and greater adoption of clean and environmentally sound technologies and industrial processes, with all countries taking action in accordance with their respective capabilities.● Aegon Asset Management engaged a leading multinational steelmaker, who has introduced its first ‘green steel’ solutions for customers, which include steel produced via carbon-neutral processes as well as through the use of ‘green’ hydrogen generated from renewables (Aegon Integrated Annual Report 2020, Active ownership in action | |||
| |
10. Reduced inequalities Reduce inequality within and among countries |
10.2 |
By 2030, empower and promote the social, economic and political inclusion of all, irrespective of age, sex, disability, race, ethnicity, origin, religion or economic or other status. ● Aegon Asset Management (AAM) in the UK partnered with Black Professionals Scotland (BPS) in early 2021 to further expand recruitment and engagement to untapped talent. Members of BPS are provided with skills and information to support their chosen careers. BPS supports organizations in realizing their inclusion and diversity ambitions, and AAM UK now advertises all vacancies with BPS. Furthermore, AAM and BPS members jointly participated in events to celebrate Black History Month in the United Kingdom. (People at the heart of our transformation journey, page 28) • ● In 2021, Transamerica earned a score of 100% from the Human Rights Campaign Foundation on its annual Corporate Equality Index (CEI). (2021 milestones, page 4) | |||
| 10.3 |
Ensure equal opportunity and reduce inequalities of outcome, including by eliminating discriminatory laws, policies and practices and promoting appropriate legislation, policies and action in this regard. ● Aegon UK publishes its annual gender pay gap report | |||||
| 10.4 |
Adopt policies, especially fiscal, wage and social protection policies, and progressively achieve greater equality. ● In 2021 Aegon UK become a Living Wage Foundation accredited employer. (2021 milestones, page 5) | |||||
| |
11. Sustainable cities and communities Make cities and human settlements inclusive, safe, resilient and sustainable |
11.1 |
By 2030, ensure access for all to adequate, safe and affordable housing and basic services and upgrade slums. ● Aegon the Netherlands has invested in long-term residential property leases in the affordable housing segment. (Investments in real estates, page 201)● In the United States we have investments that provide affordable housing to individuals and families that meet median household income requirements. (Income tax, page 194) | |||
| |
12. Responsible consumption and production Ensure sustainable consumption and production patterns |
12.2 |
By 2030, achieve the sustainable management and efficient use of natural resources. ● We aim to capitalize on the Future Ways of Working plan to further reduce the footprint of our direct business operations. (Employees, page 27, Introducing our hybrid working model, page 28)● Year to year, the proportion of renewable electricity as part of our wider electricity mix is consistently greater than 95%. (Value created - Society: Operational footprint, page 392) | |||
Frameworks and initiatives |
| Sustainable Development Goal |
|
Aegon’s contribution to relevant SDG targets in 2021 (examples) | ||||||
| |
13. Climate action climate change and its impacts |
13.2 | Integrate climate change measures into national policies, strategies and planning. • · Aegon N.V. announced during the November 2021 ‘COP26’ UN Climate Change conference that it had joined the Net-Zero Asset Owner Alliance (NZAOA), a UN-convened group of institutional investors committed to decarbonization. (Sustainability - Aegon commits to a net-zero portfolio, page 20) | |||||
| · In joining the NZAOA, Aegon N.V. announced its company-wide commitment to transitioning its General Account investment portfolio to net-zero GHG emissions by 2050, supported by an interim 25% reduction target by 2025. (Sustainability - Aegon commits to a net-zero portfolio, page 20, Value created - Society: Investment footprint, page 389)· Aegon AM has joined the Net-Zero Asset Managers initiative, a group of international asset managers committed to supporting investing aligned with net-zero emissions by 2050. (2021 milestones, page 5)· The latest Aegon N.V. Responsible Investment Policy excludes from its investment universe companies that;- derive 25% or more of their revenue from the exploration, mining or refining of thermal coal (declining to 10% in 2027 and 5% in 2029); - produce more than 20 million tons of thermal coal annually and are actively expanding exploration, mining or refining operations; - derive 50% or more of their revenue from thermal coal-fired electricity generation; - own coal-fired electricity generation capacity greater than 10 gigawatts and are actively expanding coal-fired electricity production capacity; - derive 5% or more of their total oil equivalent production from oil sands; - are building or operating pipelines that significantly facilitate export of oil extracted from oil sands; and - derive 5% or more of their revenue from oil and gas exploration and production in the Arctic. (Policies and procedures, page 355) | ||||||||
| · Aegon N.V set a new target in 2021 to reduce the carbon footprint of its operational activities by 25% by 2025 from a 2019 baseline. (Value created - Society: Operational footprint, page 392)· Aegon’s direct business operations have been carbon-neutral since 2019 (on a market-based measurement) through substitution of the company’s energy consumption with renewable sources and offsetting its remaining carbon emissions. We have selected carbon offset projects with our customers and in alignment with the socio-economic benefits they bring to our purpose of Helping people live their best lives | ||||||||
| |
14. Life below water Conserve and sustainably use the oceans, seas and marine resources for sustainable development |
14.4 | By 2020, effectively regulate harvesting and end overfishing, illegal, unreported and unregulated fishing and destructive fishing practices and implement science-based management plans, in order to restore fish stocks in the shortest time feasible, at least to levels that can produce maximum sustainable yield as determined by their biological characteristics. • · The Aegon N.V. Responsible Investment Policy incorporates the company position on biodiversity, which specifically covers ocean use and over exploitation (i.e. overfishing). Furthermore, the Aegon N.V. Vendor Code of Conduct sets the standards for the business relationship between Aegon and its vendors in order to enable Aegon to manage the most material ESG risks associated with our procurement of goods and services, specifically including biodiversity. (Policies and procedures, pages 355 and 356) | |||||
| |
15. Life on land Protect, restore and promote sustainable use of terrestrial eco-systems, sustainably manage forests, combat desertification, and halt and reverse land degradation and halt biodiversity loss |
15.5 | Take urgent and significant action to reduce the degradation of natural habitats, halt the loss of biodiversity and, by 2020, protect and prevent the extinction of threatened species. • · The Aegon N.V. Responsible Investment Policy incorporates the company position on biodiversity. Furthermore, the Aegon N.V. Vendor Code of Conduct sets the standards for the business relationship between Aegon and its vendors in order to enable Aegon to manage the most material ESG risks associated with our procurement of goods and services, specifically including biodiversity. (Policies and procedures, pages 355 and 356) | |||||
Frameworks and initiatives |
| Sustainable Development Goal |
Aegon’s contribution to relevant SDG targets in 2021 (examples) | |||||
| |
16. Peace, justice and strong institutions Promote peaceful and inclusive societies for sustainable development, provide access to justice for all and build effective, accountable and inclusive institutions at all levels |
16.1 |
Significantly reduce all forms of violence and related death rates everywhere. • ● Under the Aegon N.V. Responsible Investment Policy, we exclude investment in controversial weapons. (Policies and procedures - Aegon N.V. Responsible Investment Policy, page 355) | |||
| 16.5 | Substantially reduce corruption and bribery in all their forms. • ● Aegon’s Code of Conduct embodies the company’s values and helps ensure that all employees act ethically and responsibly. The Code prescribes a mandatory set of standards for how Aegon employees should conduct business, comply with all applicable laws and regulations, and exercise sound judgment in reaching ethical business decisions in the long-term interests of Aegon’s stakeholders. (Code of Conduct, page 88) | |||||
| |
17. Partnerships for the goals Strengthen the means of implementation and revitalize the Global Partnership for Sustainable Development |
17.16 | Enhance the Global Partnership for Sustainable Development, complemented by multi-stakeholder partnerships that mobilize and share knowledge, expertise, technology and financial resources, to support the achievement of the Sustainable Development Goals in all countries, in particular developing countries. • ● Aegon N.V. is a signatory of the United Nations Global Compact. (Global initiatives - United Nations Global Compact, page 364) ● Aegon AM is a signatory to the Principles for Responsible Investment (PRI). (Task Force on Climate-related Financial Disclosures - Active Ownership, page 375) ● Aegon N.V. is a signatory to the UN Principles for Sustainable Insurance (PSI). (Sector specific initiatives, pages 379-380) | |||
| 17.17 | Encourage and promote effective public, public-private and civil society partnerships, building on the experience and resourcing strategies of partnerships. ● Aegon is dedicated to developing understanding around trends, issues, and opportunities related to saving and planning for retirement, and to the achievement of financial security in later life. This includes participating in relevant international projects, such as an Organisation for Economic Co-operation and Development (OECD) working group on the future of work, and the Living, Learning, and Earning Longer initiative led by the World Economic Forum (WEF), to examine the benefits of an age-inclusive workforce. (Adapting to the modern retirement landscape, page 32)● Aegon maintains a visible presence in the communities that benefit from its services, through initiatives such as the ‘Silver Starters’ learning program for entrepreneurs aged 50 and over. (Adapting to the modern retirement landscape, page 32) | |||||
Frameworks and initiatives |
| Case study: Transamerica Climate Risk Working Group |
Frameworks and initiatives |
| Case study: Net-Zero Asset Owner Alliance In November 2021, Aegon N.V. joined the Net-Zero Asset Owner Alliance, an UN-convened group of institutional investors committed to transitioning their portfolios to net-zero GHG emissions by 2050. Through the analysis conducted by its business units, Aegon N.V. defined a specific, actionable target for 2025 and will continue to set targets in five-year intervals in line with the Alliance’s principles. |
| Case study: Net Zero Asset Managers Initiative In November 2021, Aegon Asset Management joined the Net Zero Asset Managers Initiative, a group of international asset managers committed to supporting investing aligned with net-zero GHG emissions by 2050. This commitment requires Aegon Asset Management to work in partnership with asset owner clients on decarbonization goals consistent with an ambition to reach net-zero emissions by 2050 across all assets under management, and set interim targets at five-year intervals for the share of assets managed in-line with net-zero principles. |
Frameworks and initiatives |
| Case study: Global General Account scenario analysis Aegon worked with Ortec Finance to perform an extensive and systematic climate risk assessment for the General and Separate Account assets of all business units within Aegon. The analysis investigated three plausible climate pathways (orderly, disorderly and failed transitions) to explore potential future climate policies, interventions, and consequences of the world failing to mitigate climate change. These pathways are in line with the industry standard IPCC and Network of Central Banks and Supervisors for Greening the Financial System (NGFS) emission and climate scenarios. The employed climate model translates transition (i.e. policy & technological changes) and physical risks (i.e. gradual impact & extreme weather events) associated with climate change to produce a climate change adjusted economic and financial outlook. The model outcomes enable Aegon to identify portfolio weak spots - in terms of asset type, geography and sector - to aid decision making in responding to climate risk. Modelling results indicate resilience of the Aegon General Account portfolio allocation to key systemic climate risk drivers across all modelled climate scenarios. High allocation of fixed income assets is the key driver that limits the cumulative climate-related impact on returns over a 40-year horizon. Continuing to monitor developments in climate science, policy, technology and consumer sentiment will remain critical for understanding and adapting to the future.The results provide an initial directional signal; however, climate-related risks are dynamic in nature. Transition risks are expected to dominate in the near to medium term (certainly to 2030) if society is to achieve the objectives of the Paris Agreement while physical risks will materialize at any time as global temperatures continue to rise. As a result, continuing to monitor developments in climate science, policy, technology and consumer sentiment is critical for understanding and adapting to the future. |
Short-term climate-induced GDP losses for EU & US (in %) |
|||||
| Long-term climate-induced GDP losses for EU & US (in %) |
||||||
| Climate impact on nominal investment return (relative to baseline, in % cumulative) |
||||||
| Overview of Climate Scenarios Considered |
Frameworks and initiatives |
| Case study: Operational climate risk assessment Aegon performs a regular operational assessment of its exposure to climate risk. The assessment uses research and position papers from renowned institutions as input and is executed in cooperation with subject matter experts from Aegon’s risk, asset management and sustainability functions. In 2021, Aegon updated and enriched its assessment by incorporating findings from local climate risk assessments executed by Aegon’s country units and developments captured in the United Nations’ Intergovernmental Panel on Climate Change (IPCC) Sixth Assessment Report. The risk assessment identifies the relevant risks for the company and assesses severity per risk in terms of likelihood and impact and its manageability in terms of the speed of materialization and the possibilities for mitigation. The assessment concludes with recommendations and considerations to be taken forward and is included as part of our Own Risk Solvency Assessment (ORSA). |
Frameworks and initiatives |
2019 |
2021 |
Change | ||||||
| Weighted average carbon intensity |
tCO 2 e/EURm revenue |
490 | 490 | 0% |
Frameworks and initiatives |
Corporate FI |
Coverage |
|||||||||
| Absolute footprint |
tCO 2 e |
4,886,000 | 72 | % | ||||||
| Relative intensity |
tCO 2 e/EURm invested |
110 | 72 | % | ||||||
| Weighted average carbon intensity |
tCO 2 e/EURm GDP |
490 | 97 | % | ||||||
| Climate change resiliency |
ND-GAIN rating | 9.9 | 73 | % | ||||||
Frameworks and initiatives |
Sovereign FI |
Coverage |
|||||||||
| Absolute footprint |
tCO 2 e |
15,088,000 | 100 | % | ||||||
| Relative intensity |
tCO 2 e/EURm invested |
620 | 100 | % | ||||||
| Weighted average carbon intensity |
tCO 2 e/EURm GDP |
310 | 100 | % | ||||||
| Climate change resiliency |
ND-GAIN rating | 67 | 100 | % | ||||||
Frameworks and initiatives |
| Principles |
Actions taken (2021) | |
| 1. We will embed in our decision-making environmental, social and governance (ESG) issues relevant to the insurance business. |
As of December 2021, Aegon replaced its Responsible Business and Investment Committee (RBIC) with a Global Sustainability Board (GSB) that interfaces with Local Sustainability Boards in the business units. This step was taken to further integrate ESG topics across our organization. The GSB consists of relevant Management Board members, Local Sustainability Board Chairs and senior management. They discuss ESG matters related to the business and investing on a quarterly basis, and provide advice to Aegon’s Executive Board. Additionally, as per our Executive Board’s Remuneration Policy, at least 50% of a member’s variable compensation must be determined by non-financial performance indicators, where at least one must be ESG-related. Moreover, a significant risk or compliance incident related to ESG may result in a malus adjustment or claw-back of a member’s variable compensation. In November 2021, Aegon signed up to the UN Global Compact and the Net-Zero Asset Owner Alliance. In support of this, Aegon’s Responsible Investment Policy was updated in January 2022. All of our public ESG policies and frameworks are available at www.aegon.com. ESG risks are covered by Aegon’s risk universe. Risk management regularly interacts and cooperates on ESG risks, including climate risk. This is covered in more detail in the Sustainability section and the TCFD section of this report. Of note for 2021, were the climate scenarios run on our accounts to refine our understanding of our exposure to climate risk. We are working on expanding our offering of products and services that factor in ESG criteria. In 2021, we enhanced our customer propositions in the Netherlands by introducing a new ‘green’ mortgage to help people pay for sustainable home improvements. Aegon Asset Management (AAM) and Aegon UK partnered with the Global Ethical Finance Initiative (GEFI) to introduce the new Aegon Global Sustainable Sovereign Bond Fund. Aegon UK also acquired Pension Geeks, a business specializing in connecting people with their finances through innovative engagement techniques, communication, and events. From a general investment perspective, ESG integration and active ownership are principles we follow across all decisions and portfolios. AAM is a signatory to the Principles for Responsible Investment. For more information, please see: Business Environment Scan – page 10; Sustainability – pages 20-23; Sharing value with our stakeholders – pages 26-32; Policies and Procedures – pages 353-356; Enterprise Risk Management (ERM) framework – pages 73-77; Task Force on Climate-related Financial Disclosures – pages 372-378. | |
Frameworks and initiatives |
Principles |
Actions taken (2021) | |
| 2. We will work together with our clients and business partners to raise awareness of ESG issues, manage risk and develop solutions. |
For clients, guided by our overarching Responsible Investment Policy, Aegon Asset Management (Aegon AM) has established a Responsible Investment Framework that reflects these key elements including similar policies put forward by Aegon AM’s clients. Our Responsible Investment Framework is structured as follows: 1. ESG integration – Material ESG factors are fundamental to our investment decision- making across all Aegon AM portfolios. By integrating ESG considerations into traditional financial analysis, the Aegon AM research team arrives at an independent view of an issuer’s fundamentals. 2. Active ownership – We actively engage with investee companies across a wide range of industries to improve their ESG profile and address sustainability issues, often in cooperation with other investors to maximize our influence. We also exercise any shareholder voting rights we have to support our engagement efforts and enhance long-term value creation for all stakeholders. 3. Solutions – Aegon AM provides a range of responsible investment solutions to pursue ESG objectives alongside financial returns. These solutions are categorized into four types: exclusion-based strategies, best-in-class strategies, sustainability-themed strategies, and impact investments. For our business partners, in specific our suppliers, we are steadily integrating best- practice ESG criteria and requirements into our supplier selection, development, and ordering processes. 2021 was our second year working with sustainability rating company EcoVadis to evaluate the ESG risks of our top 250 vendors by spend (representing 85.5% of Aegon’s total procurement spend). We now have valid EcoVadis scorecards for 81 of our top vendor accounts, covering 59% of the spend of these relationships. For more information, please see: Sustainability; Sharing value with our stakeholders – pages 29-30. | |
| 3. We will work together with governments, regulators and other key stakeholders to promote widespread action across society on ESG issues. |
Aegon has a dedicated Global Government & Public Affairs department, whose aim is to support regulators and lawmakers. We advocate worldwide for people to have access to insurance and financial services, for people to be aware of opportunities for flexible employment in old age and for governments to plan and provide for their citizens in an age of increasing longevity. Aegon also encourages financial literacy around the world and engages with individuals and policymakers in service of helping people to achieve wealth and health wherever we can. Aegon is active in many international projects that aim to fulfill this goal; for example, an Organization for Economic Cooperation and Development (OECD) working group on the future of work, and the Living, Learning, and Earning Longer initiative led by the World Economic Forum (WEF). Within Aegon, our Silver Starters program (developed jointly with the Leyden Academy on Vitality and Ageing) provides online coaching to entrepreneurs aged 50 and over to promote lifelong learning and healthy attitudes to aging. For more information, please see: Sharing value with our stakeholders – pages 31-32. | |
| 4. We will demonstrate accountability and transparency in regularly disclosing publicly our progress in implementing the Principles. |
Each year, we publish progress against the PSI principles. Our progress report is included as part of our IAR, and is available at www.aegon.com. | |
Frameworks and initiatives |
| International Responsible Business Conduct (IRBC) Agreement in the insurance sector In 2018, Aegon stated its intent to support the spirit and objectives of the Dutch International Responsible Business Conduct Agreement in the insurance sector (also known as ‘the covenant’). By doing so, Aegon will attempt to act, where possible, in accordance with the objectives and undertakings agreed in the covenant and will be receptive to commitment, cooperation, and knowledge-sharing during the implementation of the covenant. The covenant is a collaborative initiative of the Dutch government, non-governmental organizations, and Dutch insurers. The objective of the covenant is to prevent, mitigate, and/or remediate adverse impacts on stakeholders and the environment that are caused or contributed to by Aegon’s investee companies The covenant asks insurance companies to apply investment policies and practices in accordance with the processes and principles of the OECD Guidelines for Multinational Enterprises and the UN Guiding Principles on Business and Human Rights. Aegon N.V.’s Responsible Investment Policy draws heavily on the aforementioned Principles and Guidelines. To stipulate the relevance hereof, Aegon became a signatory to the UN Global Compact (UNGC) in November 2021. The Policy is instrumental to Aegon’s investment practices as executed by Aegon Asset Management (Aegon AM), the company’s global asset manager responsible for managing most of Aegon’s investments. At the beginning of 2021, Aegon AM conducted a global investment screening to identify investee companies that allegedly breach the Principles and Guidelines, as well as the wider UNGC Principles (or are at risk of doing so). In addition, our screening exercise looked specifically at companies’ supply chain oversight, biodiversity controversies, access-to-medicine programs, and labor rights controversies. Applying these findings, we set the prioritization for our engagement activity, which in 2021 saw Aegon AM initiate or continue engagements with over 60 companies. In most cases, Aegon AM continues the process of engagement until we believe that the portfolio company is aligned with our policies, although exclusion ultimately remains an option. More information on the active ownership approach and practices on behalf of Aegon and other clients, see the Responsible Investment and Active Ownership reports published by Aegon AM. |
With biodiversity being the IRBC’s annual theme for 2021, Aegon AM actively participated in a series of dedicated collaborative engagements and in drafting a thematic framework. The framework brings together relevant information, international legislation and regulations, tips, and other support that insurers can use in relation to biodiversity. The engagements were geared toward reducing deforestation risks and providing relevant input and learnings. Together with signatories of the covenant including NGOs, Aegon AM supported engagement efforts with three major listed food companies processing, amongst others, meat and dairy products. With soy often being used as feed for cattle and with tropical forests in parts of Brazil being cleared for both soy production and use as pasture for grazing cattle, the selected companies were considered to be at risk of contributing to deforestation via their supply chain. Engagement focused on supply chain oversight regarding deforestation, sustainable use of soy, alternative sourcing, and the use of viable alternative protein sources. This included locally-sourced animal feed, nature-inclusive farming, and considerations on a different protein product selection, such as plant-based products. As in previous years, good health and wellbeing (SDG 3) continues to be one of our focal topics. The continued ill-effects of the COVID-19 outbreak confirmed our decision to address access to adequate health services and improve access to medicine. To avoid situations in which health emergencies push people into bankruptcy or poverty, we believe it is crucial to strive for universal health coverage and sustainable financing for health. It is also the case that, in the second year of the COVID-19 pandemic, a significant part of the global population still lacks sufficient and equitable access to vaccines. Based on the IRBC’s 2020 annual theme, Aegon AM continued to emphasize access-to-medicine programs in its collaborative engagement and voting efforts, where considered to be effective. Mitigating climate change (SDG 13) remains another focus area for Aegon. Please refer to the TCFD section for discussion of our actions and progress through 2021. | |
Value created |
Capital |
Indicator |
2021 |
2020 |
Change 2020 to 2021 |
2019 | |||||||||
| Customer: Number |
||||||||||||||
Total customers |
31.7 million | 30.4 million | 4.4% |
29.9 million | ||||||||||
| Americas |
17.5 million |
16.2 million |
8.3% |
16.1 million |
||||||||||
| Customer |
The Netherlands |
2.7 million | 2.5 million | 7.1% |
2.6 million | |||||||||
| United Kingdom |
3.9 million | 3.8 million | 1.1% |
3.7 million | ||||||||||
| International |
7.7 million |
7.9 million |
(3.1% |
) |
7.5 million |
|||||||||
| New customers | 3.8 million |
4.6 million |
(17.5%) |
4.3 million |
||||||||||
| Customer: Satisfaction |
||||||||||||||
| Benchmarked Net Promoter Score (NPS) 1) |
||||||||||||||
| Market Position |
||||||||||||||
| United States |
= Market Average | NM | NA |
NM | ||||||||||
| Customer |
The Netherlands |
≤ Market Average |
NM | NA |
NM | |||||||||
| United Kingdom |
> Market Average | NM | NA |
NM | ||||||||||
| Complaints |
||||||||||||||
| Total customer complaints 2) |
86,075 |
80,510 |
6.9% |
91,348 |
||||||||||
| Customer: Value |
||||||||||||||
| Manufactured |
Claims, benefits and plan withdrawals |
|||||||||||||
| Total claims, benefits and retirement plan withdrawals |
EUR 61.9 billion | EUR 57.4 billion | 7.9% |
EUR 59.4 billion | ||||||||||
| 1 | Customer satisfaction is measured in benchmarked Net Promoter Score (SM) (NPS® ), and is based on the question: ‘How likely are you to recommend Aegon/Transamerica to a friend or colleague?” It is a single, easy-to-understand 0-10 scale, where those answering 9 or 10 are deemed ‘promoters’, those answering 7 or 8 are ‘passive’, and 6 to 0 are ‘detractors’. NPS is calculated by subtracting the percentage of detractors from the percentage of promoters. On an annual basis, we measure the NPS of our core markets (the Netherlands, the United Kingdom, and the United States) and compare findings against peers in each local market. Our target is to ensure that customer satisfaction in each of our core markets, measured in benchmarked Net Promoter Score(SM) (NPS® ), remains at or above the average of our peers. In the UK, the competitive set used for the survey consisted of 10 brands (pension providing peers). In the Netherlands, the competitive set used per line of business for the survey consisted of 25 brands (life), 37 brands (pension schemes), 22 brands (savings), 30 brands (P&C), 27 brands (mortgages). In the United States the competitive set per line of business used for the survey consisted of 25 brands (life) and 19 brands (retirement). |
| 2 | Includes all written and verbal complaints. |
| |
Value created |
Capital |
Indicator |
2021 |
2020 |
Change 2020 to 2021 |
2019 | |||||||||
| Employees: Workforce |
||||||||||||||
Location |
||||||||||||||
Workforce 1) |
22,271 | 22,322 | (0.2% |
) |
23,757 | |||||||||
| Human and Intellectual |
United States |
7,675 | 7,960 | (3.6% |
) |
8,570 | ||||||||
| The Netherlands |
3,855 | 3,930 | (1.9% |
) |
3,998 | |||||||||
| United Kingdom |
2,476 | 2,307 | 7.3% |
2,261 | ||||||||||
| International |
6,590 | 6,598 | (0.1% |
) |
7,393 | |||||||||
| Asset Management |
1,675 | 1,527 | 9.7% |
1,535 | ||||||||||
Direct employees |
17,936 | 17,989 | (0.3% |
) |
18,905 | |||||||||
| Employees: Inclusion and diversity |
||||||||||||||
| Gender |
||||||||||||||
Proportion of women employees |
50% | 50% | 1pp |
49% | ||||||||||
Proportion of women in senior management |
34% (at target) | 32% (at target) | 2pp |
29% | ||||||||||
| Human |
Proportion of women in senior management (target) 2) |
34% | 32% | 2pp |
NA | |||||||||
Proportion of women in Supervisory Board |
38% | 38% | 0pp |
29% | ||||||||||
Proportion of women in Executive Board |
0% | 0% | 0pp |
0% | ||||||||||
Proportion of women in Management Board 3) |
20% | 17% | 3pp |
18% | ||||||||||
| 1 | Direct employees and tied agents |
| 2 | In this context, senior management includes our Management Board and extends up to two levels below the Management Board (depending on the number of employees in each business or country unit). The 2021 target and performance data do not include employees in our Central and Eastern Europe businesses that are in the process of being divested. |
| 3 | Includes the members of the Management Board and the Executive Board. |
| |
Value created |
Capital |
Indicator |
2021 |
2020 |
Change 2020 to 2021 |
2019 |
|||||||||||
| Employees: Recruitment and retention |
||||||||||||||||
Recruitment |
||||||||||||||||
Number of new hires |
2,540 | 2,217 | 15% |
2,974 | ||||||||||||
Leavers |
||||||||||||||||
Number of leavers |
1,727 | 2,831 | (39% |
) |
3,935 | |||||||||||
Proportion voluntary leavers |
78% | 69% | 8pp |
59% | ||||||||||||
| Resignation |
69% | NM | NM |
NM | ||||||||||||
| Retirement |
6% | NM | NM |
NM | ||||||||||||
| Other voluntary 1) |
3% | NM | NM |
NM | ||||||||||||
| Human and Intellectual |
Proportion involuntary leavers |
22% | 31% | (8pp |
) |
41% | ||||||||||
| Redundancy |
13% | 20% | (7pp |
) |
36% | |||||||||||
| Termination |
7% | NM | NM |
NM | ||||||||||||
| Transfer |
0% | NM | NM |
NM | ||||||||||||
| Other involuntary |
1% | NM | NM |
NM | ||||||||||||
Turnover |
||||||||||||||||
Turnover rate |
12% | 15% | (3pp |
) |
22% | |||||||||||
| Voluntary |
10% | 10% | 0pp |
13% | ||||||||||||
| Involuntary 2) |
3% | 5% | (2pp |
) |
9% | |||||||||||
| 1 | Includes leavers due to natural causes or personal reasons. |
| 2 | Involuntary turnover does not include strategic transfers where employees continue paid employment outside Aegon. |
| |
Value created |
Capital |
Indicator |
2021 |
2020 |
Change 2020 to 2021 |
2019 | |||||
| Employees: Health and safety |
||||||||||
Absence 1) |
||||||||||
| Human |
Number of days lost to employee absence |
96,479 | 93,464 | 3.2% |
107,313 | |||||
| Employee absence rate |
1.7% | 1.7% | 0pp |
1.8% | ||||||
| Employees: Training and development |
||||||||||
| Investment in training and career development |
EUR 9.5 million | EUR 10.8 million | (12.1%) |
EUR 16.9 million | ||||||
| Intellectual |
Average investment in training and career development per employee (EUR) |
428 | 486 | (11.9%) |
711 | |||||
| Employees: Engagement |
||||||||||
Global Employee Survey 2) |
||||||||||
| Engagement |
68 | 72 | (4pp) |
67 | ||||||
| Leadership |
57 | 63 | (6pp) |
55 | ||||||
| Inclusion |
74 | 79 | (5pp) |
76 | ||||||
| Social and Relationship |
Diversity |
72 | 73 | (1pp) |
69 | |||||
| Participation rate |
77% | 82% | (5pp) |
86% | ||||||
| Proportion of employees covered by collective bargaining / labor agreements 3) |
17.3% | 17.6% | (0.3pp) |
16.8% | ||||||
| Employees: Remuneration |
||||||||||
Total employment costs |
EUR 1.9 billion | EUR 2.0 billion | (4.9%) |
EUR 2.1 billion | ||||||
| Human |
Salary costs |
EUR 1.3 billion | EUR 1.3 billion | (0.5%) |
EUR 1.3 billion | |||||
Ratio of median to CEO salary 4) |
28:1 | 32:1 | NM |
33:1 | ||||||
| Policy compliance (Global Remuneration Framework) |
95% | 95% | 0.0pp |
94% | ||||||
| 1 | Employee absence refers to time off from work as a result of illness or injury. It excludes permitted leave of absence such as holiday, study/training, maternity or paternity leave and compassionate leave. |
| 2 | Global Employee Survey is provided through Culture Amp. In 2021, three engagement surveys were conducted throughout the year (Q1, Q2 and Q3). The results and participation rate disclosed are regarding the most recent survey, which was conducted in the third quarter of 2021. |
| 3 | All of Aegon’s employees in the Netherlands, other than senior management, are covered by the collective labor agreement of Aegon NL. Aegon, the unions and the Dutch Central Works Council are working closely together in a co-creation steering group which prepares new agreements and tracks the implementation thereof. The current collective labor agreement has a duration of two years, from July 1, 2020 up to and including June 30, 2022. Aegon has experienced no significant strike, work stoppage or labor dispute in recent years. |
| 4 | Figures cover all employment costs relating to both staff and CEO. Please refer to the Remuneration Report 2021 (pages 55-72) for more details. |
| |
Value created |
Capital |
Indicator |
2021 |
2020 |
Change 2020 to 2021 |
2019 | |||||||||||||
| Business partners: Brokers and intermediaries |
||||||||||||||||||
| Financial |
Commissions paid to brokers and other intermediaries |
EUR 2.6 billion | EUR 2.3 billion | 12.2% |
EUR 2.4 billion | |||||||||||||
| Business partners: Reinsurers |
||||||||||||||||||
| Financial |
Premiums paid to reinsurers |
EUR 3.5 billion | EUR 2.7 billion | 30.1% |
EUR 2.4 billion | |||||||||||||
| Business partners: Goods and services |
||||||||||||||||||
Total spend on goods and services |
EUR 1.7 billion | EUR 1.6 billion | 4.8% |
EUR 1.6 billion | ||||||||||||||
| Spend on goods and services with top 250 (‘in-scope’) suppliers1) |
EUR 1.4 billion | EUR 1.3 billion | 5.1% |
NM | ||||||||||||||
| Proportion total spend on goods and services with top 250 (‘in-scope’) suppliers |
85.5% | 85.3% | 0.3pp |
NM | ||||||||||||||
| Social and Relationship |
Number of ‘in-scope’ suppliers assessed for ESG performance2) |
81 | 67 | 20.9% |
NM | |||||||||||||
| Spend on goods and services with suppliers assessed for ESG performance 2) |
EUR 0.8 billion | EUR 0.8 billion | 10.4% |
NM | ||||||||||||||
| Proportion spend on goods and services with top 250 (‘in-scope’) suppliers assessed for ESG performance |
59.2% | 56.4% | 2.8pp |
NM | ||||||||||||||
| 1 | Our top 250 suppliers consistently represent at least 80% of our total supplier spend. |
| 2 | Scored for environment, social and governance (ESG) performance through the EcoVadis rating platform. |
| |
Value created |
Capital |
Indicator |
2021 |
2020 |
Change 2020 to 2021 |
2019 | |||||||||
| Investors: Corporate Governance 1) |
||||||||||||||
| Human and Intellectual |
Supervisory Board |
|||||||||||||
| Membership | 8 | 8 | NA |
6 | ||||||||||
| Average tenure (years) | 4 | NM | NA |
NM | ||||||||||
| Average age | 63 | NM | NA |
NM | ||||||||||
Executive Board |
||||||||||||||
| Membership | 2 | 2 | NA |
2 | ||||||||||
| Average tenure (years) | 3 | NM | NA |
NM | ||||||||||
| Average age | 58 | NM | NA |
NM | ||||||||||
Management Board |
||||||||||||||
| Membership | 8 | 10 | NA |
9 | ||||||||||
| Average tenure (years) | 4 | NM | NA |
NM | ||||||||||
| Average age | 52 | NM | NA |
NM | ||||||||||
| Investors: FInancial Returns |
||||||||||||||
| Financial |
Returns to investors paid in the year |
EUR 509 million | EUR 370 million | 37% |
EUR 899 million | |||||||||
| Dividend payments 2) |
EUR 289 million | EUR 123 million | 135% |
EUR 611 million | ||||||||||
| Interest (payments to bondholders) 3) |
EUR 220 million | EUR 248 million | (11% |
) |
EUR 288 million | |||||||||
| Dividend over the fiscal year per common share 4) |
EUR 0.17 | EUR 0.12 | 42% |
EUR 0.31 | ||||||||||
| Share price (change) | 35.8% | (20.0%) | NM |
0.3% | ||||||||||
| Total shareholder return (TSR) | 40.6% | (18.4%) | NM |
8.0% | ||||||||||
| 1 | Aegon has a two-tier system of corporate governance, with an independent Supervisory Board and a separate Executive Board. The Executive Board (consisting of the CEO and CFO) is supported by a Management Board. |
| 2 | Does not include impact of share buy-backs. Calculation reflects IFRS accounting of inventory effects of share repurchases relating to dividends paid in stock. |
| 3 | This was referred to as ‘Coupon payments’ in our previous IAR. |
| 4 | Aegon’s final dividend for 2021 is subject to approval by the company’s Annual General Meeting of Shareholders, due to take place in May 2022. |
| |
Value created |
Capital |
Indicator |
2021 |
2020 |
Change 2020 to 2021 |
2019 | |||||||
Society: Responsible investment |
||||||||||||
Responsible investment solutions (RIS) |
||||||||||||
Assets under management in RIS 1) |
EUR 177.7 billion | EUR 167.0 billion | 6.4% |
NM | ||||||||
| Manufactured |
Exclusions 2) |
EUR 160.5 billion | EUR 157.6 billion | 1.9% |
NM | |||||||
| Best-in-class 3) |
EUR 10.2 billion | EUR 3.3 billion | 207.9% |
NM | ||||||||
| Sustainability-themed 4) |
EUR 2.9 billion | EUR 2.4 billion | 23.5% |
NM | ||||||||
| Impact investments 5) |
EUR 4.1 billion | EUR 3.7 billion | 8.2% |
NM | ||||||||
Engagement and voting 6) |
||||||||||||
| Number of engagements with investee companies 7) |
596 | 575 | 3.7% |
564 | ||||||||
| Proportion engagements addressing environment themes |
31% | 25% | 6pp |
NM | ||||||||
| Intellectual |
Proportion engagements addressing social themes |
19% | 21% | (2pp |
) |
NM | ||||||
| Proportion engagements addressing governance themes |
38% | 53% | (15pp |
) |
NM | |||||||
| Proportion engagements addressing general disclosure themes |
11% | 8% | 3pp |
NM | ||||||||
| Number of shareholder meetings of invested companies where votes cast |
2,963 | 2,511 | 18.0% |
2,321 | ||||||||
| 1 | Assets under management/advisement by Aegon Asset Management, comprises both proprietary and non-proprietary assets of third party clients. Joint ventures are excluded. Responsible investment products and services may vary regionally. We have evaluated our approach to measuring assets under management (AuM) that follow exclusionary strategies, and have decided to narrow the definition thereof to make it more relevant. Although the Aegon N.V. Responsible Investment Policy and its mandated exclusions apply to all General Account assets of Aegon N.V. entities, we added a relevancy standard to our process to determine whether certain General Account asset classes should be counted in AuM subject to exclusions, given the applicability of the Aegon N.V. exclusion list to that asset class. The removal of asset classes such as commercial mortgage loans and US structured securities drove the decrease. Based on this evaluation, we re-stated 2020 figures. |
| 2 | Utilize negative screening to avoid certain sectors, companies or practices based on specific criteria. Covers proprietary investments of Aegon Asset Management and funds of third party clients which are also aligned to those same criteria. |
| 3 | Seek to outperform by emphasizing positive screening of issuers with better or improving ESG profiles relative to sector peers. |
| 4 | Focus on issuers whose activities or practices are aligned with sustainability themes in an effort to generate competitive returns over the long term. |
| 5 | Pursue financial returns alongside measurable positive social and/or environmental impact. |
| 6 | With regards to engagement, through our investment exposure, and where appropriate, we look to build a constructive dialogue with the companies and bodies either bilaterally or as part of an investor consortium, as we promote responsible business practices. With regards to voting, for Aegon AM’s relevant investment strategies that incorporate equities, we seek to execute votes in alignment with our engagement objectives and clients’ best interests, often in favor of shareholder resolutions. |
| 7 | Source Aegon AM as of December 31, 2021. Percentages may not sum to 100 due to rounding. Themes are divided according to the main issue. At times, there is more than one theme for an engagement. A small number of engagements were outsourced and therefore not included in this dataset. |
| |
Value created |
Capital Indicator |
2021 |
2020 |
Change 2020 to 2021 |
2019 |
||||||||||||||
| Society: Investment footprint |
||||||||||||||||||
Corporate Fixed Income + Listed Equity (CFI) 1) |
||||||||||||||||||
| Proportion CFI holding assessed for carbon emissions |
72% | 77% | (5pp) |
NM | ||||||||||||||
| CFI absolute footprint (metric tons CO 2 e) |
4,886,000 | 4,878,000 | 0.2% |
NM | ||||||||||||||
| CFI relative intensity (metric tons CO 2 e/EURm invested) |
110 | 110 | 0.0% |
NM | ||||||||||||||
| Weighted average carbon intensity (metric tons CO 2 e/EURm revenue) |
490 | 470 | 0.0% 2) |
490 | ||||||||||||||
| Weighted average carbon intensity (coverage) |
97% | 97% | (0pp) |
95% | ||||||||||||||
| Carbon Risk Rating (Sustainalytics) |
9.9 | 9.4 | 0.5 |
NM | ||||||||||||||
| Carbon Risk Rating (Sustainalytics) (coverage) |
73% | 63% | 10pp |
NM | ||||||||||||||
| Natural |
||||||||||||||||||
Sovereign Fixed Income (SFI) 3) |
||||||||||||||||||
| Proportion SFI holding assessed for carbon emissions |
100% | 98% | 2pp |
NM | ||||||||||||||
| Absolute footprint (metric tons CO 2 e) |
15,088,000 | 13,863,000 | 8.8% |
NM | ||||||||||||||
| Relative intensity (metric tons CO 2 e/EURm invested) |
620 | 500 | 24.0% |
NM | ||||||||||||||
| Weighted average carbon intensity (metric tons CO 2 e/EURm GDP) |
310 | 330 | (6.1%) |
NM | ||||||||||||||
| Weighted average carbon intensity (coverage) |
100% | 98% | 2pp |
NM | ||||||||||||||
| Climate change resiliency (ND-GAIN rating) |
67 | 67 | 0 |
NM | ||||||||||||||
| Climate change resiliency (coverage) |
100% | 98% | 2pp |
NM | ||||||||||||||
| 1 | Global General Account assets only. Aegon calculation. Values as of December 31, 2021. Climate metrics calculated per Methodology section. Relative intensity, weighted average carbon intensity and carbon risk values have been adjusted to account for variance in coverage. Climate change data availability may change over time and characteristics will vary. Certain information © 2022 Sustainalytics, MSCI ESG Research L.L.C. Reproduced with permission. Not for further distribution. |
| 2 | The change expressed here concerns 2019 to 2021. |
| 3 | Global General Account assets only. Aegon calculation. Values as of December 31,2021. Climate metrics calculated per Methodology section. Relative intensity, weighted average carbon intensity and carbon vulnerability values have been adjusted to account for variance in coverage. Climate change data availability may change over time and characteristics will vary. |
| |
Value created |
Capital |
Indicator |
2021 |
2020 |
Change 2020 to 2021 |
2019 |
|||||||||||||
| Society: Tax transparency |
||||||||||||||||||
Tax transparency |
||||||||||||||||||
Total taxes borne by Aegon |
EUR 381 million | EUR 319 million | NA |
EUR 615 million | ||||||||||||||
Corporate income tax 1) |
(EUR 18 million | ) | EUR 10 million | NA |
EUR 42 million | |||||||||||||
| Social and |
Americas |
EUR 55 million | (EUR 43 million | ) | NA |
(EUR 12 million | ) | |||||||||||
| Relationship |
The Netherlands |
(EUR 75 million | ) | EUR 33 million | NA |
EUR 32 million | ||||||||||||
| United Kingdom |
(EUR 2 million | ) | EUR 14 million | NA |
(EUR 9 million | ) | ||||||||||||
| Others |
(EUR 3 million | ) | EUR 6 million | NA |
EUR 31 million | |||||||||||||
Taxes collected on behalf of others |
EUR 2.41 billion | EUR 2.51 billion | NA |
EUR 2.45 billion | ||||||||||||||
| Society: Community investment |
||||||||||||||||||
Community investment |
||||||||||||||||||
Cash donations 2) |
EUR 9.4 million | EUR 9.5 million | (1.3% |
) |
EUR 8.2 million | |||||||||||||
Financial security and education |
EUR 2.0 million | EUR 3.0 million | (35.7% |
) |
NM | |||||||||||||
| Financial Education and Literacy |
EUR 1.6 million | EUR 2.7 million | (40.9% |
) |
NM | |||||||||||||
| Employability Later in Life |
EUR 0.3 million | EUR 0.3 million | 8.9% |
NM | ||||||||||||||
Well-Being and Longevity |
EUR 5.6 million | EUR 5.7 million | (1.1% |
) |
NM | |||||||||||||
| Physical Fitness |
EUR 0.2 million | EUR 0.2 million | (16.0% |
) |
NM | |||||||||||||
| Mental Vitality |
EUR 0.5 million | EUR 0.9 million | (38.7% |
) |
NM | |||||||||||||
| Prevention of Diseases |
EUR 1.3 million | EUR 1.7 million | (23.2% |
) |
NM | |||||||||||||
| Livable Communities |
EUR 3.6 million | EUR 2.9 million | 25.2% |
NM | ||||||||||||||
| Social and |
Other |
EUR 1.8 million | EUR 0.8 million | 131.5% |
NM | |||||||||||||
| Relationship |
Proportion of cash donations to key themes |
81% | 92% | (11pp |
) |
NM | ||||||||||||
| Financial security and education |
21% | 32% | (11pp |
) |
NM | |||||||||||||
| Well-Being and Longevity |
60% | 60% | 0pp |
NM | ||||||||||||||
| Number of organizations receiving donations |
469 | 481 | NA |
541 | ||||||||||||||
Volunteering |
||||||||||||||||||
| Volunteering hours |
6,806 | 4,399 | 54.7% |
19,448 | ||||||||||||||
| Volunteering value 3) |
EUR 0.3 million | EUR 0.2 million | 46.5% |
EUR 0.9 million | ||||||||||||||
Total investment |
||||||||||||||||||
| Total value community investment |
EUR 9.7 million | EUR 9.7 million | (0.3% |
) |
EUR 9.0 million | |||||||||||||
| Total value community investment as proportion of net result |
0.6% | 17.6% | (17pp |
) |
0.6% | |||||||||||||
| 1 | Please note, there is often no direct correlation between tax reported on earnings for any given year and amounts paid or received in tax. Part of the explanation for this is that certain tax-deductible items are not recognized in the Company’s profit & loss statement but directly in equity. Additionally payments and refunds for prior years can impact the amounts paid or received in the current year. Furthermore, the 2021 US tax liability will be satisfied entirely by losses carryforwards and tax credits, including low income housing tax credits. |
| 2 | Cash donations refer to charitable donations to charities and other non-profit organizations, done in accordance with the Aegon N.V. Charitable Donations Standards. |
| 3 | Volunteering value is calculated using an average hourly employee expenses rate based total employment costs. |
| |
Value created |
Capital |
Indicator |
2021 |
2020 |
Change 2020 to 2021 |
2019 |
|||||||||||||
| Society: Compliance |
|
|||||||||||||||||
Policy compliance 1) |
||||||||||||||||||
| Proportion employees completing training on Code of Conduct |
98% | 97% | 2pp |
95% | ||||||||||||||
| Anti-bribery and corruption |
87% | 89% | (2pp |
) |
89% | |||||||||||||
| Conflict of interest |
98% | 92% | 6pp |
85% | ||||||||||||||
| Pricing and product development |
97% | 93% | 4pp |
94% | ||||||||||||||
Systematic Integrity Risk Assessment (SIRA) 2) |
||||||||||||||||||
Social and Relationship |
Actions completed |
77% | 76% | 1pp |
69% | |||||||||||||
| Actions completed and progressing within deadline |
81% | 80% | 1pp |
77% | ||||||||||||||
Incidents |
||||||||||||||||||
| Incidents/attempts of fraud |
889 | 4,014 | (77.9% |
) |
4,541 | |||||||||||||
| Proportion through employees |
0.1% | NM | NM |
NM | ||||||||||||||
| Proportion through intermediaries |
21.4% | NM | NM |
NM | ||||||||||||||
| Proportion through third parties |
78.5% | NM | NM |
NM | ||||||||||||||
Fines and settlements 3) |
||||||||||||||||||
| Significant fines to address cases of mis-selling |
EUR 0.0 million | EUR 8.2 million | NM |
EUR 0.3 million | ||||||||||||||
| 1 | Policy compliance reflects business units’ compliance with specific requirements of those policies. Where there is not full compliance, this does not indicate a breach of the policy, but areas where units have requested time to further strengthen internal governance. Prior to 2021, compliance with Aegon anti-bribery and corruption policies was expressed as combined metric of the separate Aegon Conflict of Interest and Aegon Gift & Entertainment policies. The latter has since been incorporated into a new unified Aegon Anti-bribery and Corruption policy. As such, there is not a complete like-for-like like-for-like |
| 2 | Aegon undertakes an annual systematic integrity risk assessment (SIRA), as part of which all regions provide insight into their local anti-fraud programs and indicate that controls with regard to internal, external, and intermediary fraud are properly designed and operating effectively. Aegon takes actions to address any gaps in performance. |
| 3 | Includes any fines in excess of EUR 100,000. |
| |
Value created |
Capital |
Indicator |
2021 |
2020 |
Change 2019 to 2021 3) |
2019 | |||||||||
| Society: Operational footprint |
||||||||||||||
Greenhouse gas (GHG) emissions (metric tons CO 2 e)1) |
||||||||||||||
| Scope 1 (gas) |
5,557 | NM | (9.5% |
) |
6,138 | |||||||||
| Scope 2 (electricity gross/location) |
16,366 | NM | (54.1% |
) |
35,659 | |||||||||
| Scope 2 (electricity net/market) |
203 | NM | (60.7% |
) |
516 | |||||||||
| Scope 3 (air travel) |
2,101 | NM | (80.4% |
) |
10,739 | |||||||||
Total GHG emissions (gross/location) |
24,024 | NM | (54.3% |
) |
52,536 | |||||||||
| Total GHG emissions / EUR million revenue (gross/location) |
1.0 | NM | (48.8% |
) |
1.9 | |||||||||
| Total GHG emissions / employee (gross/location) |
1.3 | NM | (52.4% |
) |
2.8 | |||||||||
Total GHG emissions (net/market) |
7,861 | NM | (54.8% |
) |
17,392 | |||||||||
| Total GHG emissions / EUR million revenue (net/market) |
0.3 | NM | (49.4% |
) |
0.6 | |||||||||
| Total GHG emissions / employee (net/market) |
0.4 | NM | (53.0% |
) |
0.9 | |||||||||
Operational reduction target 2) |
||||||||||||||
| Absolute reduction against baseline |
(28,512) | NM | (54.3% |
) |
NA | |||||||||
Energy (MWh) |
||||||||||||||
Fuel (gas) |
27,288 | NM | (9.0% |
) |
30,002 | |||||||||
| Natural |
Electricity (renewable) |
49,283 | NM | (39.4% |
) |
81,282 | ||||||||
| Green tariff / Renewable Energy |
||||||||||||||
| Certificate (REC) |
49,259 | NM | (39.4% |
) |
81,254 | |||||||||
| Self-generated |
24 | NM | (11.5% |
) |
28 | |||||||||
Electricity (non-renewable) |
580 | NM | (70.5% |
) |
1,968 | |||||||||
Electricity (total) |
49,863 | NM | (40.1% |
) |
83,249 | |||||||||
Energy (total of fuel and electricity) |
77,151 | NM | (31.9% |
) |
113,252 | |||||||||
| Renewable electricity (% of total electricity) |
99% | NM | 1pp |
98% | ||||||||||
| Renewable energy (% of total energy) |
64% | NM | (8pp |
) |
72% | |||||||||
Air travel (million km) |
||||||||||||||
Total distance |
16.3 | NM | (84.2% |
) |
103.4 | |||||||||
| Travel class as proportion of total distance |
||||||||||||||
| Economy |
87% | NM | NA |
NM | ||||||||||
| Premium |
13% | NM | NA |
NM | ||||||||||
Route type as proportion of total distance |
||||||||||||||
| <500km |
3% | NM | NA |
NM | ||||||||||
| >500km |
97% | NM | NA |
NM | ||||||||||
| 1 | Operational GHG emissions are based on the energy consumption and air travel activity of our four largest business units (Transamerica, Aegon the Netherlands, Aegon UK and Aegon Asset Management), which in 2021 comprised 81% of our global (direct employee) headcount. GHG emissions are calculated according to the ‘market’ and ‘location’ based methodologies of the GHG Protocol, on a country-level basis and using locally applicable emission conversion factors. For the market-based measurement we source conversion factors for electricity consumption from individual suppliers, 99% of which is zero carbon through our purchase of renewable electricity in the form of ‘green tariff’ supply contracts and renewable energy certificates (RECs). For the location-based approach, we source conversion factors for electricity consumption from the Environmental Protection Agency (eGRID) for the US, from the European Environment Agency for the Netherlands and from the Department for Environment, Food & Rural Affairs (Defra) for the UK. Under both approaches, we source conversion factors for gas consumption from Defra (100% mineral for the US, and 5% biofuel blend for the Netherlands and the UK). Conversion factors for air travel are sourced solely from Defra due to applicability for all countries. As part of the calculation of GHG emissions, the underlying activity data is extrapolated to cover for unmeasured headcount. |
| 2 | Aegon has set a target to reduce the carbon footprint of its operational activities by 25% by 2025 against a 2019 baseline (using the location-based measurement). In 2021, the carbon footprint of Aegon’s operational activities reduced by 54.3% compared with 2019. While some of these reductions can be traced to our initiatives to stimulate hybrid working for instance reductions in leased space across the US in 2021 there has also been a temporary benefit from fewer employees in the office due to the COVID-19 pandemic, which we expect to reverse over time. Through implementing our hybrid working policy and other initiatives, we will work towards achieving our target. Aegon will also look towards expanding the scope of measurement of our GHG emissions and explore setting further targets against these in the future. |
| 3 | Supporting data and calculation methodology for measurement of GHG emissions has been re-evaluated for the 2019 baseline year, and applied to the 2021 reporting year. Operational GHG emissions for 2020 have not been recalculated, and to avoid inconsistency have been omitted from reporting. The change expressed here concerns 2019 to 2021. |
External recognition |
¨ |
Eurozone 120 |
¨ |
Benelux 20 |
| 1 | ©2022 MSCI INC. ALL RIGHTS RESERVED www.msci.com/research-and-insights/esg-ratings-corporate-search-tool |
| 2 | © 2022 Sustainalytics. All rights reserved. This information has been developed by Sustainalytics (www.sustainalytics.com). Such information and data are proprietary of Sustainalytics and/or its third party suppliers (Third Party Data) and are provided for informational purposes only. They do not constitute an endorsement of any product or project, nor an investment advice and are not warranted to be complete, timely, accurate or suitable for a particular purpose. |
| Their use is subject to conditions available at www.sustainalytics.com/legal-disclaimers |
| 3 | © 2022 ISS Corporate Solutions. All Rights Reserved. www.issgovernance.com/esg/ratings/corporate-rating/ |
| 4 | © FTSE Russell 2022 www.ftserussell.com/products/indices/ftse4good |
| 5 | © 2022 MOODY’S CORPORATION, MOODY’S INVESTORS SERVICE, INC., MOODY’S ANALYTICS, INC., FOUR TWENTY SEVEN, INC. (“FOUR TWENTY SEVEN”), VIGEO SAS (“V.E”) AND/OR THEIR LICENSORS AND AFFILIATES (COLLECTIVELY, “MOODY’S”). ALL RIGHTS RESERVED. www.moodys.com/esg-solutions |
| 6 | © 2022 CDP Europe AISBL www.cdp.net/en |
Disclaimer |
¨ |
Unexpected delays, difficulties, and expenses in executing against our environmental, climate, diversity and inclusion or other “ESG” targets, goals and |
| commitments outlined in this document, and changes in laws or regulations affecting us, such as changes in data privacy, environmental, safety and health laws; |
¨ |
Changes in general economic and/or governmental conditions, particularly in the United States, the Netherlands and the United Kingdom; |
¨ |
Civil unrest, (geo-) political tensions, military action or other instability in a country or geographic region; |
¨ |
Changes in the performance of financial markets, including emerging markets, such as with regard to: |
¨ |
The frequency and severity of defaults by issuers in Aegon’s fixed income investment portfolios; |
¨ |
The effects of corporate bankruptcies and/or accounting restatements on the financial markets and the resulting decline in the value of equity and debt securities Aegon holds; |
¨ |
The effects of declining creditworthiness of certain public sector securities and the resulting decline in the value of government exposure that Aegon holds; and |
¨ |
The impact from volatility in credit, equity, and interest rates; |
¨ |
Changes in the performance of Aegon’s investment portfolio and decline in ratings of Aegon’s counterparties; |
¨ |
Lowering of one or more of Aegon’s debt ratings issued by recognized rating organizations and the adverse impact such action may have on Aegon’s ability to raise capital and on its liquidity and financial condition; |
¨ |
Lowering of one or more of insurer financial strength ratings of Aegon’s insurance subsidiaries and the adverse impact such action may have on the written premium, policy retention, profitability and liquidity of its insurance subsidiaries; |
¨ |
The effect of the European Union’s Solvency II requirements and other regulations in other jurisdictions affecting the capital Aegon is required to maintain; |
¨ |
Changes affecting interest rate levels and continuing low or rapidly changing interest rate levels; |
¨ |
Changes affecting currency exchange rates, in particular the EUR/USD and EUR/GBP exchange rates; |
¨ |
Changes in the availability of, and costs associated with, liquidity sources such as bank and capital markets funding, as well as conditions in the credit markets in general such as changes in borrower and counterparty creditworthiness; |
¨ |
Increasing levels of competition in the United States, the Netherlands, the United Kingdom and emerging markets; |
¨ |
Catastrophic events, either manmade or by nature, including by way of example acts of God, acts of terrorism, acts of war and pandemics, could result in material losses and significantly interrupt Aegon’s business; |
¨ |
The frequency and severity of insured loss events; |
¨ |
Changes affecting longevity, mortality, morbidity, persistence and other factors that may impact the profitability of Aegon’s insurance products; |
Disclaimer |
¨ |
Aegon’s projected results are highly sensitive to complex mathematical models of financial markets, mortality, longevity, and other dynamic systems subject to shocks and unpredictable volatility. Should assumptions to these models later prove incorrect, or should errors in those models escape the controls in place to detect them, future performance will vary from projected results; |
¨ |
Reinsurers to whom Aegon has ceded significant underwriting risks may fail to meet their obligations; |
¨ |
Changes in customer behavior and public opinion in general related to, among other things, the type of products Aegon sells, including legal, regulatory or commercial necessity to meet changing customer expectations; |
¨ |
Customer responsiveness to both new products and distribution channels; |
¨ |
As Aegon’s operations support complex transactions and are highly dependent on the proper functioning of information technology, operational risks such as system disruptions or failures, security or data privacy breaches, cyberattacks, human error, failure to safeguard personally identifiable information, changes in operational practices or inadequate controls including with respect to third parties with which we do business may disrupt Aegon’s business, damage its reputation and adversely affect its results of operations, financial condition and cash flows; |
¨ |
The impact of acquisitions and divestitures, restructurings, product withdrawals and other unusual items, including Aegon’s ability to integrate acquisitions and to obtain the anticipated results and synergies from acquisitions; |
¨ |
Aegon’s failure to achieve anticipated levels of earnings or operational efficiencies, as well as other management initiatives related to cost savings, Cash Capital at Holding, gross financial leverage and free cash flow; |
¨ |
Changes in the policies of central banks and/or governments; |
¨ |
Litigation or regulatory action that could require Aegon to pay significant damages or change the way Aegon does business; |
¨ |
Competitive, legal, regulatory, or tax changes that affect profitability, the distribution cost of or demand for Aegon’s products; |
¨ |
Consequences of an actual or potential break-up of the European monetary union in whole or in part, or the exit of the United Kingdom from the European Union and potential consequences if other European Union countries leave the European Union; |
¨ |
Changes in laws and regulations, particularly those affecting Aegon’s operations’ ability to hire and retain key personnel, taxation of Aegon companies, the products Aegon sells, and the attractiveness of certain products to its consumers; |
¨ |
Regulatory changes relating to the pensions, investment, and insurance industries in the jurisdictions in which Aegon operates; |
¨ |
Standard setting initiatives of supranational standard setting bodies such as the Financial Stability Board and the International Association of Insurance Supervisors or changes to such standards that may have an impact on regional (such as EU), national or US federal or state level financial regulation or the application thereof to Aegon, including the designation of Aegon by the Financial Stability Board as a Global Systemically Important Insurer (G-SII); and |
¨ |
Changes in accounting regulations and policies or a change by Aegon in applying such regulations and policies, voluntarily or otherwise, which may affect Aegon’s reported results, shareholders’ equity or regulatory capital adequacy levels. |
Contact |
| Colophon |
||
Consultancy and design |
DartGroup, Amsterdam (NL) | |
Editing and production |
Aegon Corporate Communications (NL) | |
Typesetting |
DartGroup, Amsterdam (NL) | |
Documents on display |
u |
Incorporated documents are considered part of this Annual Report on Form 20-F; and |
u |
Aegon can disclose important information to you by referring you to those documents. |
Index to Exhibits |
Index to Exhibits | ||
1 |
Articles of Association. (1) | |
2.1 |
Any instruments defining the rights of long-term debt holders. None of our instruments relating to long-term debt has total amount of securities authorized thereunder that exceed 10% of our consolidated total assets. Pursuant to the requirement of this item, we agree to furnish to the SEC upon request a copy of any instrument defining the rights of holders of long-term debt of us or of our subsidiaries for which consolidated or unconsolidated financial statements are required to be filed. | |
2.2 |
Description of securities. (2) | |
4.1 |
1983 Amended Merger Agreement. (3) | |
4.2 |
Voting Rights Agreement. (4) | |
4.3* |
Transamerica 401(k) Retirement Savings Plan. (5) | |
8 |
List of Subsidiaries of Aegon N.V. - Incorporation by reference to Note 49 of this Annual Report. | |
12.1** |
Certification of the Chief Executive Officer pursuant to Rule 13A-14 or 15D-14 of the Securities Exchange Act of 1934. | |
12.2** |
Certification of the Chief Financial Officer pursuant to Rule 13A-14 or 15D-14 of the Securities Exchange Act of 1934. | |
13** |
Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350. | |
15** |
Consent of independent registered public accounting firm. | |
101.INS |
XBRL Instance Document | |
101.SCH |
XBRL Taxonomy Schema Linkbase Document | |
101.CAL |
XBRL Taxonomy Calculation Linkbase Document | |
101.DEF |
XBRL Taxonomy Definition Linkbase Document | |
101.LAB |
XBRL Taxonomy Labels Linkbase Document | |
101.PRE |
XBRL Taxonomy Presentation Linkbase Document | |
104. |
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) | |
| (1) Incorporated by reference to Form 6K (0001104659-13-046533) | ||
| (2) Incorporated by reference to Exhibit 2 to Form 8-A12B filed with the SEC on April 11, 2018. | ||
| (3) Incorporated by reference to Exhibit 4.1 to Form 20-F 2013 filed with the SEC on March 21, 2014. | ||
| (4) Incorporated by reference to Exhibit 4.2 to Form 20-F 2013 filed with the SEC on March 21, 2014. | ||
| (5) Incorporated by reference to Exhibit 99.1 to Registration Statement on Form S-8 (No. 333-238186) filed with the SEC on May 12, 2020. | ||
| * | Indicates management contract or compensatory plan. |
| ** | Furnished herewith. |
Signatures |
| Aegon N.V. | ||
| /s/ Matthew J. Rider | ||
| |
||
| Matthew J. Rider Chief Financial Officer |
||
| Date: March 21, 2022 |
||